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Introduction: Despite management advances worldwide, tuberculosis still remains a 
serious uncontrolled disease. The absence of either a ‘gold’ standard diagnostic test, 
or a conventional rapid ‘reference’ laboratory test for asymptomatic Mycobacterium 
tuberculosis (MTB) carriers complicates disease control. Through mandatory 
screening of high-risk groups, early diagnosis of latent tuberculosis infection (LTBI) 
cases allows recognition and better control of the tuberculosis pandemic. 
Materials and Methods: The current tuberculosis screening guidelines as 
recommended by the World Health Organization, chest X-ray and tuberculin skin 
test were assessed and revealed rises in TB morbidity and fatality trends in the 
Kuwait population (low incidence country). In order to evaluate options for LTBI 
diagnosis, the current work implemented a 4-month prospective, observational, 
repeated-measure and randomly implemented survey on 180 new immigrants to 
Kuwait using a structured risk factor questionnaire whilst, simultaneously evaluating 
the performance of the two standard diagnostics (chest X-ray and tuberculin skin 
test) with the new biomarker interferon gamma release assays (T-SPOT .TB test and 
QuantiFERON Gold In-Tube test (QNF-GIT)); which detect the release of interferon 
gamma (INF-γ) released from sensitization to specific MTB antigens.  
Results: Associations between various epidemiological risk factors - such as socio-
demographic status, smoking and environmental exposure-contact - were associated 
in the laboratory diagnosed LTBI participants. Positive identification of LTBI 
prevalence detected by two radiologists was 10.1% having ‘moderate’ inter-reader 
agreement (Kappa = 0.505), compared to no positives being detected by three 
pulmonologists. TST results were negative (less than 10-mm ‘cut-off’) even in the 
86.1% Bacillus Calmette-Guérin vaccinated expatriates. Estimated LTBI using QNF-
GIT was 28.3% compared to 41.1% positive T-SPOT .TB test. Both interferon 
gamma assays revealed concordant ‘abnormal’ results in 26.1% with ‘good’ 
agreement (kappa = 0.627).  
Conclusion: Detection of latent tuberculosis infection can be facilitated by 
introducing evidence-based diagnostic classification depending on history taking of 
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1.1.1 Disease definition 
Tuberculosis (TB) is a contagious bacterial infectious disease that is considered to be 
one of the deadliest infectious diseases worldwide. Infection with tuberculosis is fatal 
and TB had a major impact on global health, grasping international attention with an 
increase in number of cases worldwide, critically including both developed and 
developing countries. It is estimated that one third of the world’s population are 
infected with the causal agent of TB, Mycobacterium tuberculosis (MTB), an aerobic 
pathogenic bacillus which establishes infection in the lungs. Two billion people are 
believed to be carrying non-eradicated intra-granulomatous TB bacilli as latent 
tuberculosis infection (LTBI) and one in 10 of them will become sick with active TB 
during their lifetime. 
The Mycobacterium tuberculosis complex consists of seven organisms: M. 
tuberculosis, M. bovis, M. africanum, M. microti, M. canetti, M. caprae and M. 
pinipedi. The majority of TB in humans is caused by M. tuberculosis with a small 
proportion of TB disease caused by M. bovis and M. africanum (LoBue et al., 2010). 
TB remains one of the biggest global human killers accounting for 9.4 million new 
cases of active TB (3.6 million of which are in women) and 3 million TB-related 
deaths with an incidence of 140 cases per 100,000 inhabitants.  TB today is a disease 
of poverty, with more than 90% (up to 8 million) of total TB cases occurring in 
developing countries and more than half of all deaths (2 million) occurring in Asia.  
People living with human mmune deficiency virus (HIV) (approximately 1.4 million) 
are at a greater risk of contracting TB and TB is the leading cause of death in HIV-
positive people.  HIV individuals infected with TB are 20 to 40 times more likely to 
develop active TB (WHO, 2010c).  
The observed decline in the global TB pandemic during the last century is considered 
to be largely due to improved living standards and the use of antibiotics in the 20
th
 
Century. But while TB has gradually disappeared from the health agenda of countries 
in the developed world, TB has increased in the developing south and has become 




of 50/100,000 during 2010, with more than 95% of deaths in developing countries).  
In 1993, TB was declared by the World Health Organization (WHO) a global public 
health emergency and WHO established TB in the General Program of Work for 
2002-2005 as a major communicable, notifiable (but now curable) disease that posses 
a serious threat to health and economic development (WHO, 2010c; WHO, 2010g).  
Among the world population of 5,288 billion people in 1990, the global case 
detection rate for TB was estimated at 55% with the incidence of new cases at 6, 800 
million (incidence rate 128/100,000 population in 2010). In 2009 the global case 
detection rate was 63% with the incidence of new cases at 9,300 million (incidence 
rate 137/100,000 population) translating to about 4,700 deaths a day among 6,825 
billion people (WHO, 2010d). The detected incidence in China was 4.5 million 
active TB cases with 80% were living in rural areas (WHO, 2008a). India (the 1
st
 
highest TB nation) and China (2
nd
 highest TB nation) together account for 35% of the 
annual new cases globally and 43% of global TB prevalence (WHO, 2009a). 
Most of the global burden of new cases come from South East Asia, with up to 70% 
being detected in India (1,824,400 new cases) and Indonesia (540,000 new cases).  
The African continent contributes up to 18% of the worldwide new cases, mostly 
concentrated in Nigeria (373,682) and Ethiopia (267,147), followed by Latin 
America and the Caribbean (Brazil 110,000 new cases and Mexico 34,000 new 






Figure 1.1: World map showing reported cases of tuberculosis per 100,000 citizens in 2006. Red 
= >300, orange = 200-300; yellow = 100-200; green 50-100; blue = <50 and grey = N/A) (USAID, 
2008) (Date of access (DOA): 27/06/2008)  
1.1.2 The history of TB and present day importance 
Tuberculosis is considered one of scientific, medical, social, and political failures 
since TB remains one of the leading causes of mortality and morbidity (WHO, 
2010d).  Tuberculosis disease has been known as ’Consumption disease’ (because 
TB consumes people from the major disease symptoms of bloody cough, fever, 
pallor and long relentless wasting or cachexia) after ’phthisis’ (Greek for 
consumption) or ‘Wasting disease’ since without treatment, patients would waste 
away or Pott’s disease (gibbus of the spine and joints) or ’Koch’s Disease’ (after 
Robert Koch who discovered the tuberculosis bacillus) (Gupta et al., 2009). 
Early evidence of TB has been found in pre-historic skeletal human remains (7000 
BC) and skeletal bone spots and tubercular decay have been observed in Egyptian 
mummies dating from 3000-2400 BC (Zink et al., 2003). Severe TB disease was 
mentioned around 2000 BC in both India and the Americas, and there are references 
to the human 'White Plaque and White Death' around 460 BC where Hippocrates 




Until the mid-1800s, tuberculosis was still considered a hereditary disorder and 
symptomatic people who were considered contagious and difficult to treat, were 
usually sent to sanatoriums to breathe fresh air and required routine follow-ups to 
assess their general health and nutrient progress. On March 24, 1882 a German 
scientist named Robert Koch discovered the tuberculosis bacterium bacillus that 
causes TB (Figure 1.2). Until 1940s and 1950s, there was no antibiotic treatment for 
TB but, after anti-tuberculosis (anti-TB) drugs were discovered, many infected 
people were treated and death rates dropped dramatically. 
 
Figure 1.2: Robert Koch (1843–1910), Nobel Laureate 
1905 discovered Mycobacterium tuberculosis in 1882 
(http://www.erj.ersjournals.com/cgi/reprint/29/3/423.pdf)    
The discovery that TB was a bacterial infection led to a plethora of research activity, 
the development of the Bacille Calmette-Geurin (BCG) vaccine and development of 




theory’. A major breakthrough came in 1944, when Selman Waksman and Albert 
Schatz, discovered streptomycin an antibiotic that killed the TB bacteria and over the 
following three decades two further treatments were licensed for treatment of TB 
isoniazid (INH) in 1952 and rifampicin (R) in the early 1970’s.  
During the 20
th
 century, globally tuberculosis has killed approximately 100 million 
people. However following the discovery that TB was a bacterial disease, public 
health measures were implemented to combat its spread and during the 2
nd
 half of 
20
th
 century in developed countries the total number of TB cases was observed to 
have declined due to raised socio-economic levels and greater public health 
awareness.  
However, in the mid-1980’s, the number of global TB cases started rising.  The 
increase in TB cases in developed nations was associated with the immigration of 
workers from highly endemic TB countries (foreign-born immigrants) and in 
globally with the emergence of TB/HIV syndemic co-infection arising from the 
HIV/AIDS pandemic, TB drug resistance, and the use of immune-suppressive agents 
(WHO, 2009a).  
1.1.3 Epidemiology of tuberculosis 
The magnitude of the global TB burden is expressed as the number of incident cases 
per 100,000 population. Asia (South-East Asia and Western Pacific regions) account 
for 55% of global cases, the African subcontinent for 31%, and the Americas, 
European and Eastern Mediterranean regions accounting for the remainder. The 
WHO 2008 report shows the South-East Asia region carrying one third (36%), five 
million, of the total annual incidence (USAID, 2008). 
Tuberculosis incidence from surveillance and survey data collated by WHO 
estimates 9.27 million new cases of TB in 2007 (139 per 100,000 population), 
compared with 9.24 million new cases (140 per 100,000 population) in 2006. Of 
these 9.27 million new cases, an estimated 44% or 4.1 million (61 per 100,000 





The latest estimates of the global burden of TB disease in 2009 were 9.4 million 
incident cases, 14 million prevalent cases, 1.3 million deaths among normal HIV-
negative people and 0.38 million deaths among HIV-positive people. Most cases 
were in the South-East Asia (35%), African (30%) and the Western Pacific (20%) 
regions. An estimated 11–13% incident cases were HIV-positive with cases from the 
African Region accounting for around 80% of cases (WHO, 2010d).  
An individual’s geographical history is important when considering diagnoses 
particularly in the context of rising immigration and foreign travel.  In 2004, a high 
percentage of Asians (95%) and Hispanics (75%) born outside the US were reported 
to have TB, nine times higher than among people born in the United States. In 2006, 
the Centers for Disease Control and Prevention (CDC) reported 13,799 cases of 
active TB and estimated 10-15 million people to have latent TB in the US (NIAID, 
2006).  
In 2006, WHO reported the prevalence of active TB infection at 14 million with a 
prevalence of 219/100,000 persons (WHO, 2009a; Yew et al., 2007). Tuberculosis in 
22 countries accounted for more than 95% of new cases and mortality rates with 
disease burdens in South and East Asia (India, China, Indonesia, Bangladesh, 
Philippines, Pakistan, Thailand, Russian Federation) followed by Africa (Nigeria, 
Ethiopia, Uganda, South Africa) and the Western Pacific regions (Brazil, Mexico, 
Peru).  
The incidence of TB has been estimated by the WHO to be 139/100,000 per healthy 
people based on the number of new cases of TB reported in 2006 (WHO, 2009a).  
South Africa has one of the highest worldwide incidences with more than 200 new 
cases/100,000 country population and 35 deaths daily (Mathema et al., 2006).  
Almost 9 million new cases were estimated worldwide in 2004, but this figure is 
believed to be subject to gross underreporting due to missing cases and increasing 
difficulties in TB control (Dye, 2006; WHO, 2009a). Tuberculosis incidence rates 
can vary even between neighboring countries due to different community risk factors 
and differences in health care systems. Even countries with endemic TB face 
difficulties’ in case registration and WHO notification gaps e.g. miss-diagnosed cases 
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Figure 1.3: Missed cases in common eight tuberculosis-endemic countries 
(http://app.who.int/tb/surveillanceworkshop) (DOA: 27/06/2008) 
In India TB remains one of the leading infectious causes of mortality, in 2006 
estimated to have caused more than 325,000 deaths. There were nearly 2 million new 
TB cases in 2006 (representing more than 21 % of all TB cases worldwide) with an 
estimated incidence rate of 168 new cases per 100,000 in population. 
China has the second largest number of TB patients in the world, 80% of which are 
living in rural areas with restricted access to health services (Long et al., 2008).  
China is also one of the countries with high levels of drug resistant TB and accounts 
for approximately 24% of the global burden of multi-drug resistant Mycobacterium 
tuberculosis (MDR-TB) (He et al., 2010). A recent national anti-tuberculosis drug 
resistance survey estimated approximately 120,000 new multi-drug resistant TB 
cases emerging annually in China, including 9,000 extensively drug-resistant 
Mycobacterium tuberculosis (XDR-TB) cases.   
In comparison in the Americas there are only 41 reported cases per 100,000 in 
population compared to 356 per 100,000 populations in Africa.  
Case detection rates fell globally in 2006 but began rising in China and India (due to 
WHO support) compared to continued low detection rates in the African Region 
(Dye, 2009). Funding for TB control reached U.S.$3.3 billion across 90 countries in 




gaps (despite, U.S.$385 million being provided for registration and notification 
system purpose in 2008) (WHO, 2009a).    
TB incidence and prevalence has dropped in nations with advanced socio-economic 
status compared to persistence in areas with disparities between socio-political-
economic growth and community instability (demographic shifts). Increasing 
globalization brings sustained risks of introduction of active TB and potential re-
activation of LTBI in nations who have achieved domestic TB control (Figure 1.4). 
Regional progress towards 70% case detection:






































Figure 1.4: Worldwide progress toward TB case detection (Dye, 2009) (DOA: 26/01/2012) 
Nigeria has the highest number (449,558 in 2006) of detected TB cases in sub-
Saharan Africa (largely due to its enormous population) and has been placed among 
the top 5 of WHO’s 22 high-TB burden countries (Iliyasu et al., 2009). In Europe, 
USA and Canada, rates of TB detected by screening range from 0.80 - 4.9% and for 
latent tuberculosis infection (LTBI) from 7.6 - 47%.   
Tuberculosis epidemiology and the efficacy of control activities are known 
complicated by the emergence of drug-resistant bacilli and by the synergism of TB 




especially in the developing world. In Geneva all cases of TB identified are in 
individuals born outside Switzerland (Langenskiold et al., 2008). 
1.1.4 Global burden and TB impact 
Since 1993 WHO has considered TB as an uncontrolled, fatal contagious, epidemic 
and global health emergency. Tuberculosis is a highly infectious but curable disease 
with 5-10% latency in infected immune-competent individuals (LTBI or reservoirs of 
dormant M. tuberculosis bacilli that re-activate during a persons life time). Even 
though prevalence has decreased in the developed nations e.g. West Europe, North 
America, Japan, still, it remains a major disease burden in tropical and developing 
countries (Dye et al., 1999). Tuberculosis is responsible for 25% of adult deaths in 
the developing world, more than caused by malaria, diarrhea or autoimmune 
deficiency syndrome (AIDS). The estimated peak of the global incidence rate was 
143 cases in 2004 but this has fallen slowly to 139 cases per 100,000 populations in 
2007 in the five WHO regions (WHO, 2009a).  
1.1.5 Infectious agent 
The bacteria from the Mycobacterium tuberculosis complex that are found primarily 
in humans and are known to cause TB include M. tuberculosis, M. bovis, M. 
africanum, M. microti and M. canetti. The Mycobacterium species belong to the 
order actinomycetales, family mycobacteriaceae and genus Mycobacterium. There 
are more than 70 species of mycobacterium of which two are considered major 
human pathogens; Mycobacterium tuberculosis (Tuberculosis or Koch’s disease, 
Koch, 1882) and Mycobacterium leprae (leprosy or Hansen’s disease, Hansen, 
1874).  
The remaining Mycobacterium’s are considered environmental and are known 
collectively as Mycobacterium Other Than Tuberculosis (MOTT) organisms. 
MOTTs are responsible for various opportunistic infections that can occur without 
person-to-person transmission and are generally resistant to drugs. Mycobacterium 




and/or organ tissue culturing and is frequently seen in immune-compromised 
individuals and requires life-long antibiotic therapy (Abe et al., 1999).  
Mycobacteria are aerobic, slender, non-motile, non-encapsulated, non-spore forming 
and rod-shaped bacilli (2-4 micrometers (µ) in length and 0.2-0.5 µ in width). These 
intra-cellular pathogens infect alveolar macrophages (i.e. are macrophage 
inhabitants) and are found within membrane-bound particles or ‘phagosomes’.  
Mycobacterias are resilient bacilli capable of adapting to different environmental 
conditions, they are resistant to phagocytosis and remain dormant for decades within 
phagocytic or non-phagocytic tissue cells with the ability to re-activate.  Their lipid 
rich (lipoid) cell wall makes it impermeable and resistant to bacterial standard stains 
e.g. Gram stain. Acid-fast stains depend on the ability of mycobacteria to retain dye 
when treated with mineral acid or an acid-alcohol solutions such as the Ziehl-Neelsen 
(ZN stain) for acid fast bacilli (AFB) that is used for M. tuberculosis (Glickman et 
al., 2001; Hernandez-Pando et al., 2000) (see Figure 1.5). 
 
Figure 1.5: Mycobacterium tuberculosis (red bacilli) visualization using the Ziehl-
Neelsen stain for acid fast micro-organisms in a sputum sample (Magnified with 
light microscope x1000) (Image of a work of the Centers for Disease Control and 
Prevention, http://en.wikipedia.org/wiki/File:Mycobacterium_tuberculosis_Ziehl-
Neelsen_stain_02.jpg) (DOA: 26/01/2012) 
The thickness of the bacterial cell wall induces mycobacterium intra-granulomatous 
necrosis, interrupting specific immunity forcing the bacilli to remain in a stationary 




generation time of 15 and 20 hours. MTB forms obligate aerobic complexes in well-
aerated body tissues (Figure 1.6). 
 
Figure 1.6: Mycobacterium tuberculosis culture showing colourless rough colonial 
morphology (Adopted from CDC’s Public Health Image Library (PHIL) ID number 4428, 
http://phil.cdc.gov/phil/details.asp/pid=4428) (DOA: 26/01/2012) 
Externally expelled MTB can survive in soil for 18-24 hours, from sputum for 20-30 
hours and in droplet nuclei for 8-10 days. Bacilli are sensitive to heat and are killed 
at high temperatures and in ultra-violet light e.g. direct sunlight (Hussein, 2007). 
A single released airborne droplet nucleus from an infected individual may contain 
between 1-3 MTB organisms. Organisms can remain suspended in the air for several 
hours, sufficient to infect alveolar macrophages and establish respiratory pulmonary 
tuberculosis (PTB) infection and TB disease in humans (Tang et al., 2006). The main 
determinants for TB transmission include the number of inhaled bacilli, duration of 
exposure to the contaminated infection source and organism virulence. 
Infectiousness is quantitatively estimated as the amount/number of bacilli. This route 
of transmission is more critical in the developing country environments due to 
poverty-related direct close contact and longer periods of exposure to an infectious 
TB case (Lienhardt et al., 2002b).   
An active TB case or an infectious un-diagnosed and un-treated case for example an 




persons over the course of a year, and contagiousness is increased in adults compared 
with a child’s’ weak cough (Escombe et al., 2007; Maddineni et al., 2008). 
1.1.6 Modes of transmission 
Tuberculosis is mainly transmitted from human to human by inhalation of the 
contagious, infectious droplets containing TB organisms that are expelled through 
coughing by an infected person into the air via the respiratory tract pathways, except 
in the case of M. bovis which is contacted from cattle, commonly by ingestion of 
contaminated raw milk. An infected person with active TB disease e.g. pulmonary or 
laryngeal TB can transmit bacilli through coughing, sneezing, spitting, shouting, 
laughing, talking and expectorating the infectious airborne droplets.  Other modes of 
mycobacterial transmission such as occupational inhalation of droplets during 
laboratory-personnel mucus manipulations or might be from oral infection of bovine 
tuberculosis. There is no evidence for TB transmission from shaking hands or from 
drinking fluids or sharing towels (Mathema et al., 2006). 
The inhaled bacilli lodge in the lung terminal air spaces and replicate within host 
macrophages. Bacillary clearance from affected tissues or sputum is a sign of an 
effective host response (resistance) and cure in response to antibiotic treatment, but 
any recent transmissions may complicate resolution after MTB infection. 
The period of tubercle communicability is unlimited for as long as infectious bacilli 
are being discharged. ‘Time delay’ (the period from onset of symptoms to reporting 
the case to a health care facility) is a significant factor that serves to aggravate the 
severity of TB epidemics and undermines TB control programs (Gele et al., 2009).  
In Tanzania, for example, endemic for TB, the mean time delay was 266 days from 
the first visit to a traditional healer compared with 94 days for individuals who 
consulted a health facility (Wandwalo et al., 2000).   
Bovine tuberculosis presents a significant zoonotic risk to humans through 
uncommon inhalation of infectious aerosols and/or by ingestion of raw milk (un-
pasteurized or non-boiled) and dairy products from infected cattle reservoirs (LoBue 




1)- infectiousness of the source patients, 2)- susceptibility of contacts, duration of 
exposure and 3)- the exposure environment (CDC, 2005b). 
1.1.7 Tuberculosis pathology & pathogenesis  
Understanding the pathogenesis of TB may provide a means for its control.  The 
stages in progression of TB termed are defined in terms of the ‘three E’s’; 1)- 
Elimination (immune detection and destruction of phagocytic cells harbouring 
tubercle bacilli), 2)- Equilibration (latent infection with MTB), and 3)- Escape 
(development of primary or post-primary tuberculosis with/without lymph node or 
distant sites involvement) (Grange et al., 2011). Following entry of contagious 
tubercle organisms into inside the body of the host, the bacilli have three potential 
fates; i) they may be killed by the immune system, ii) they may multiply and cause 
primary TB or iii) they can become dormant and remain asymptomatic as a latent 
tuberculosis infection (LTBI) (Figure 1.7).  
 




Dormant MTB can proliferate after a latency period in relation to endogenous re-
activation or exogenous re-infection phenomenon. The immunological response of 
MTB to maintain LTBI is a complex phenomenon, the host is in constant battle with 
the microbe at the granuloma level to control infection and prevent activation 
(Tufariello et al., 2003). Re-activation of TB disease may occur following either (B) 
or (C) as described by Richeldi (2006) and supported by Grange et al. (2011) (Figure 
1.7).  
Tuberculosis disease has three main disease phases:  
A- Minor infection with no symptoms. The patient is in good health with mild or 
no symptoms (in most cases). The bacterium, MTB, has invaded the body, changes 
its chemical signature, and lives in a dormant state. A small scar on the lung may be 
observed on a chest X-ray (CXR). This is considered as latent tuberculosis infection 
(LTBI). It is estimated that one-third of the world population have LTBI representing 
a large reservoir for TB disease.  In the absence of active TB disease, infected people 
cannot spread the infection to other people. 
B- Infection may progress to active, symptomatic TB. This occurs in less than 5% 
of cases. Tuberculosis bacilli can multiply and spread within the body, the high 
bacillary concentration may be enough to generate spontaneous mutations and induce 
drug resistance. Common examples are those at risk of being affected are immuno-
compromized people or malnourished people and those living in poverty or poor 
health environments. The immune response is directed at the growing bacilli 
(Cardona, 2007). Depending on risk factors, an ‘infectious index case’ occurs when 
an active TB case becomes acute, infectious and expels high numbers of TB bacilli 
(Uys et al., 2007).  
C- Re-activated (secondary) infection due to dormant bacilli can cause active TB 
symptomatic disease months or years after the initial infection. The ‘'walled off’’ 
bacteria within the formed granulomatous scar, multiply, and re-circulate within the 
host. Post-dormancy re-activations occur commonly in the lungs (main route of 
entry) and less within other organs (Glickman et al., 2001). Re-activation is probably 




groups e.g. HIV/AIDS, extreme ages, malnourished or taking immune-suppressive 
drugs (Blanco et al., 2002). Tuberculosis virulence is directly affected by the rate of 
re-activation from latency among hosts (Basu et al., 2009). 
The pathology of TB may be observed from the defences of the host immune system 
reacting against TB bacilli. Bacillary clearance from affected tissues or sputum is a 
sign of response to antibiotic treatment (and cure). The human immune system cells, 
such as lung alveolar or epithelioid macrophages, Langhans giant cells, with 
lymphocytes or plasma cells, can resist TB infection. This inflammatory immune 
response is a delayed hypersensitivity reaction-type 4 (DTH-IV) and is used as the 
basis of the tuberculin skin test (TST) (see section 1.4; Laboratory diagnosis of 
tuberculosis; 1.4.1 TST).  
Defender cells are able to: 1. Surround TB bacilli forming a granulomatous scar 
lesion around it, 2. Isolate it from the rest of body tissues and 3. Halt the bacterial 
multiplication and localize the infection.  
Virulence factors for MTB include: 1. A thick hydrophobic cell wall (filled with 
mycolic acids); 2. Ability to induce intra-granulomatous necrosis and 3. Slow 
metabolism (x 100 times slower than Escherichia coli).  
In 90% of immune-competent individuals, the host cellular immune response is 
elicited through cytokines and chemokines that contain or limit infection to the 
primary invasion site by forming granulomatous lesions named ‘’Ghon complex or 





Figure 1.8: Histopathology section showing multiple Mycobacterium tuberculosis 
bacillary ’Ghon complex’ granulomas (pale pink) containing multinucleated Langhans 
giant cells (http://library.med.utah.edu/WebPath/TUTORIAL/MTB/MTB011.html) (DOA: 
26/01/2012) 
The presence of epithelioid cells denoting granulomatous chronic lesions with or 
without caseation (caseous necrotic tissue) is the best diagnostic criteria for a MTB 
infection. In 10% of cases un-contained infection and bacillary replication result in 
TB lesions including tissue necrosis and cavitations. Infected tissue maintains stable 
latent bacilli (LB) populations, and prolongs production of foamy macrophages (FM) 
which facilitate LB escape to re-grows within near alveolar spaces inducing new 
granulomas once freed up from old granulomas. Cavitations’ are well recognized to 
correlate with high colony forming unit (CFU) levels and estimated bacillary loads in 








 in caseous necrosis 
lesion areas. TB pathogenesis is associated with bacillary loads which increases both 
infectiousness and disease severity (Palaci et al., 2007). 
After four weeks post-infection, neutrophils accumulate and then surrounded by 
lymphocytes forming an external ring followed by external accumulation of FM to 
clean the alveolar spaces. These macrophages ingest mycobacterial bacilli and are 
filled internally with respiratory cells, surfactant, bacilli and lipoid vacuoles, they 
then leave the alveolar spaces via the main respiratory airway tracts and are removed 
by the stomach swallowing reflex or by expectoration (coughing). Re-infection may 




move toward the alveolar spaces, continuously producing low levels of interferon 
gamma (INF-γ) and targeting only TB growing bacilli. 
During active immunity, macrophages that are already infected and the newly arrived 
macrophages become foamy and filled with acid fast bacilli which are easier to 
detect than in the chronic phase (Cardona, 2007). Vitamin D deficiency plays a role 
in the dysfunction of macrophages and is a risk factor for tuberculosis (Gupta et al., 
2009). 
1.1.8 Incubation period 
The incubation period (IP) is defined as the time period from bacillary entry and 
infection until appearance of TB disease symptoms and signs. Incubation periods are 
variable and range from few weeks to several years or even for life if the infection is 
not treated but most commonly between four and twelve weeks from primary 
lesion(s) exposure. It is commonly accepted that the IP is within the first five years of 
TB infection and the risk of infection declines as this time interval increases 
(Lienhardt et al., 2002b) i.e. acquired infection at early age (e.g. in children) is 
associated with longer incubation periods than adulthood acquired infection 
(Lillebaek et al., 2002). During this incubation period, bacillary organisms can reach 
and infect other body systems and organs such as the lymph nodes, kidney and 
meninges and cause extra-pulmonary tuberculosis (EPTB). 
Epidemiological control programs aim to detect infected TB cases before the 
‘threshold time’ (maximum time period from starting infectiousness until TB 
diagnosis and treatment) and reduce progression to active TB disease (NICE, 2006). 
The elimination phase is achieved when the incidence of all forms of active 
tuberculosis fall below 1 per 100,000 population per year in the high incidence 
population group (Rieder et al., 1994).  
Recent infection is defined as a significant skin test reaction after documentation of a 
negative tuberculin skin test within the preceding two years. This is used 




1.1.9 Tuberculosis immunology  
Pathogenesis strategies for tuberculosis bacilli include: 
1. Resistance (or modification) of the host immune response; 2. Arrest of phagosome 
maturation and inhibition of phago-lysosome fusion (considered a hostile 
compartment for TB bacilli); 3. Persistence (inactive dormant form but retaining re-
activation potential) after which the bacilli can 4. Replicate within host macrophages. 
Dormant live bacilli divide slowly, liberating secreted proteins to maintain their 
cytoplasm proteins, evading the immune system recognition and controlling the host 
environment. Mycobacterium tuberculosis is potent inducer of apoptosis in host 
macrophages through pore formation in the phagosomal membranes to allow the 
exchange of molecular cytoplasm nutrients to MTB and promote antigen 
translocation to major histocompatability complex (MHC) class II pathway. A strong 
and specific protective immunity against these cytoplasmic proteins (liberated from 
dying or dead bacilli) can prevent the transition from dormancy to active disease 
(Wiker, 2001).  
Bacterial containment of the protective immune response is focused on the 
granulomatous-resisting different participating T cells as follows; 
1. CD4 T cells (CD4+) or T-helper type (Th1) recognizes antigen peptides encoded 
by the major histocompatibility complex (MHC) class II 
2. CD8 T cells (CD8+) or cytotoxic T cells recognize cytoplasmic antigens (e.g. 
tumor cell or viral cell) or peptides bound to MHC class I cells 
3. CD1 restricted T cells recognize MTB cell wall-abundant glycolipids. 
Both CD8+ and CD1 secrete perforin and granulysin that directly kill the 
mycobacterium within the infected macrophages (Kaufmann, 2002). 
CD4+ T-cells also play a principal immune response against invading 
mycobacterium by producing lymphotoxin alpha (LT-α). Inflammatory cytokines 
like interferon gamma (INF-γ), tumor necrosis factor-alpha (TNF-α), interleukin-2 




then together with dendritic cells and T-cell populations will cause the formation of 
organized productive TB-containing granuloma’s. Missing such cellular balance lead 
to non-containing caseous lesions with/without MTB re-activations and TB 
disseminations.  
Granuloma in response to chronic infection requires CD4+ to regulate the protective 
function, restrict pathogen dissemination from the inflammation site and protect the 
surrounding healthy tissues from immune-pathology associated with chronically 
activated macrophages. With CD4+ T cells quantitative depletions, MTB re-activate 
at the injury site and with the presence of INF-γ from CD8+ T cells e.g. T cells less 
than 200 cells/ml is risk factor for TB/HIV flare-up (Hogan et al., 2007). The median 
CD4+ count is significantly higher in patients with M. tuberculosis than those with 
mycobacteria other than tuberculosis (MOTT) (Tamhane et al., 2009). 
Proportions of INF-γ, IL-2 and TNF-α secreting CD4+ T cells that are re-stimulated 
with MTB usually higher in TB infected children as compared with LTBI or other 
study groups and this increase is indicative of active TB infection. T cell-derived 
cytokines like INF-γ are indicators of efficient immune memory and protection. The 
effecter mechanisms that kill MTB are taken up by macrophages activated from T 
cell lymphocytes. Bacilli inhibit phagosome maturation, lysosome fusion and INF-γ 
mediated activation and so, blocks the classical active macrophage killing. Th1 INF-
γ producing lymphocytes are found to be in balance with type 2 helper (Th2) 
stimulated by parasitic infections, atopy or asthma.  
1.1.10 Tuberculosis and interferon-gamma 
Interferon gamma’s (INF-γ) are natural proteins or soluble cytokines released from 
the immune system T cells Th1 as a host defensive mechanism against foreign 
organisms. INF-γ has anti-bacterial, anti-viral and anti-tumor properties. INF-γ 
belongs to the class of cytokine glycoprotein’s that act directly by inhibiting viral 
replication, stimulating natural killer cells (NK) and as a central mediator for 
macrophages activation either alone or in synergy with TNF-α. Host cell resistance 




to lymphocytes (T and B cells) acting as potent mediator of activation to macrophage 
bactericidal activity against MTB (Herrmann et al., 2009).  
INF-γ has also has a crucial protective role against various pathogens through 
stimulation of normal cells to increase the expression of MHC complex type I and 
immunoglobulin receptors of antigens presentation for macrophage, activating 
lysosome activity within macrophages, and recruiting bactericidal T lymphocyte. 
This is carried out in synergy with TNF-α and both activate infected macrophages by 
initiating effecter mechanism of cell-mediated immunity (CMI).  
MTB infection inhibits the INF-γ signalling pathway to evade the human immune 
response and defects in INF-γ genes or receptors predispose individual to 
mycobacterial infections. After antigen exposure, INF-γ or INF-γ-producing cells are 
used as a marker for effecter cell activity, and lymphocytic cell absence or antigens 
of remote infection are not related to the boosting effects of INF-γ (Choi et al., 
2008).  
MTB re-infection begins during the chronic phase once FM leaves the 
granulomatous tissue toward alveolar spaces. MTB–infected alveolar epithelial cells 
release sustainably cytokine INF-γ at high concentrations post-infection at 48 hours 
(33 +/- 3 pg/ml) and 72 hours (111 +/- 4 pg/ml) compared to non-infected cells (2.6 
+/- 1.6 pg/ml) as measured by enzyme linked immunosorbant assay (ELISA). This 
INF-γ plays a role in the regulation of the intra-cellular innate immune response and 
internalizes only live TB pathogen rather than cell surface-attached dead bacilli 
(Sharma et al., 2007). INF-γ responses are more common in latent TB subjects as 
compared to those without TB infection (Lahey et al., 2009). 
Advances in genomics and immunology for MTB detection has lead to the 
development of several promising alternative tests to the TST. In-vitro interferon 
gamma release assays (IGRAs) tests measure the released INF-γ specifically 
produced by MTB-stimulated T (Th1) cells (section 1.4; Laboratory diagnosis of 
tuberculosis; 1.4.2 IGRAs).   
An evaluation of 130 children in France using IGRAs QuantiFERON test has shown 




of active TB, particularly in the significant difference between LTBI (INF-γ median 
value 0.85 IU/ml) and the higher median value in active MTB (INF-γ median value 
3.28 IU/ml). Peripheral blood INF-γ levels have also been observed to differ between 
treated and untreated patients, which are also related to the individual’s immunity 
against TB and also can be useful to monitor INF-γ levels before/after anti-TB 
treatment (Tiwari et al., 2007).  
A decline in INF-γ values during treatment allows the clinician to monitor effect of 
curative or preventive chemotherapy (Herrmann et al., 2009). Therapeutic INF-γ 
binds and then activates the cell-surface INF-γ receptor, stimulating antibody-
dependent cytotoxicity and enhances NK cell attachment to tumor cells, and thereby 
inducing apoptosis in malignant cells. 
1.1.11 Latent tuberculosis infection (LTBI) 
The WHO recommends effective TB control, but diagnosis and control are 
dependent on early detection and identification of LTBI individuals at high risk of re-
activation and progression to active TB disease (Hussein, 2007). Identification of a 
primary source or suspicion of LTBI or active TB disease is a crucial step in 
targeting investigation(s) but communities worldwide face difficulties in TB control 
due to the absence of any gold standard diagnostic tests. 
Areas highly endemic for TB disease suffer from negative consequences of the 
disease, for example economic costs related directly or indirectly to TB. WHO 
estimated the total direct cost of TB control to be U.S.$2.0 billion by WHO in 2006 
while TB screening costs were estimated at U.S.$72.1 million (Nolte, 2006). WHO 
recommends governments worldwide to continuously co-operate towards TB and 
LTBI elimination. 
1.1.12 Difference between LTBI and active TB disease 
Latent tuberculosis infection occurs when the number and activity of tuberculosis 
bacterial germs becomes enough to cause symptoms in normal healthy looking 




as a chronic cough for more than 3 weeks, fever with hemoptysis or weight loss, 
and/or fatigue and night sweats (see Table 1.1). 
Table 1.1 The major differences between latent tuberculosis infection and active 
tuberculosis disease (CDC, 2011e) 
 
The mechanism of evolution of LTBI granulomatous lesions can be summarized as 
follows; 1)- LTBI diagnosis is complicated by the fact that slow growing resilient 
bacilli are able to resist stressful conditions and survive in necrotic tissues with 
ability to grow within the granuloma’s periphery; 2)- Growing TB bacilli are resisted 
by the host immunological response mainly through active immunity (CD4+) and 3)- 
Post-accumulation of necrotic tissues and dead MTB, foamy macrophages harbor 
latent TB bacilli but exert local immune-suppression by reducing antigen 
presentation of actively growing TB bacilli.  
LBTI 
 
Active TB disease 
 
Asymptomatic 
Symptomatic : bad cough > 3weeks, chest pain, 
hemoptysis, weakness, weight loss >10% normal body 
weight, fever/chills relieved by night sweating 
 




Cannot spread TB bacilli to others 
 
Spread TB bacteria to others 
Usually variable TST and blood  
test result (not indicative result) 
 
Usually has positive TST and blood test results indicative 
of TB infection 
 
 
Normal chest X-ray (common), 
sputum and culture 
 
Higher chances than LTBI to have positive CXR, sputum 
and culture 
Need prophylactic treatment for 6-
9 months (prevent progression to 
active TB disease) 




1.1.13 Disease susceptibility and resistance 
Susceptibility to TB is multifactorial and host genetic factors are believed to play a 
major role in disease development and progression. Host susceptibility and resistance 
are directly associated with human leukocyte antigens (HLA) and non-HLA genes 
serve as genetic markers of TB pre-disposure and have been established in different 
ethnic groups e.g. for Asian PTB, ethinic Indians present HLA-DR2 and HLA–DQ1 
(Selvaraj, 2004) and HLA-DRB1*14 as susceptibility alleles for MTB disease 
(Duarte et al., 2011).   
Human genetic variation is an important determinant for MTB infection outcome. 
Bellamy and colleagues conducted a study of the two-stage genome-wide linkage, 
searching for regions in the human genome containing tuberculosis-susceptibility 
genes, they disproved monogenicity and identified two regions on chromosome 15q 
and Xq for TB susceptibility. X chromosome susceptibility may contribute to male 
predominance observed in some populations (Bellamy et al., 2000).  
Anaerobic and acidic conditions within closed lesions reduce bacterial metabolism 
but the existence of ‘persisters’ or resuscitation-promoting factors (rpfs) genes, 
isolated from tissues MTB DNA actively promote emergence from dormancy and 
low susceptibility to drug treatment (Davies et al., 2008). 
Tuberculosis may present as a resurgent disease in immune-suppressed individuals 
such as those with diabetes mellitus, cancer patients and renal dialysis or organ 
transplant patients. MTB infection is among the most important of HIV-related 
opportunistic infections due to compression of the host’s immune defenses, leading 
to failure to control latent MTB infection with subsequent development of active 
‘symptomatic’ tuberculosis (Raviglione et al., 1992). 
Culture-positive isolates can be matched with outbreak strains using genotyping. 
Genome-wide studies identify macrophage response genes and different clinical 
outcomes due to variations of innate immune response genes that regulate 
susceptibility and resistance to TB (Balamurugan et al., 2004; Thuong et al., 2008). 




(CR1) polymorphism has been associated with susceptibility in healthy population 
but was not observed among HIV positive (+ve) cases due to overriding genetic 
influences. Heterozygosity was also associated with protection against TB in both 
HIV+ve and HIV–ve cases suggestive of influences on the innate immune response 
even in immune-compromised individuals (Fitness et al., 2004). Genotyping studies 
of HIV infection support the concept of LTBI progression to active TB status from 
remote re-activation rather than recent TB infection (Driver et al., 2006). TB/HIV 
co-infected patients soon become asymptomatic and non-infectious usually within 
10-14 days post–anti-TB treatments, having a low transmission rate (due to weak-
type of cough) even if still having a TB positive sputum smear (Campbell et al., 
2006).  
Kibiki and colleagues showed that one third of Tanzanian’s (TB endemic African 
country) were TB/HIV co-infected and nearly 11% of tested strains using 
spoligotyping were resistant to anti-TB drugs (Kibiki et al., 2007). 
1.1.14 Morbidity and mortality 
Worldwide, TB is the highest leading cause of morbidity and mortality from a 
curable contagious infectious disease (CDC, 2008a). Untreated, it can be deadly. 
More people died during the last decade from TB than perhaps any other decade in 
history. In 1999 WHO reported a global TB prevalence of 32% (1.86 billion people), 
with the total new and existing cases between 7.96 and 16.2 million, and 1.67 million 
deaths, representing a global case fatality rate of 23%. The WHO published reports 
of 2005 on the last World TB Day held on 24
th
 March 2008 estimated that all TB 







Table 1.2: Estimated tuberculosis incidence, prevalence and mortality, 2005 (WHO, 2008a)  
a Incidence  = defined as new disease cases arising in given period; prevalence =defined as the number 
of cases which exist in the population at a given point in time  
b Smear-positive cases are those confirmed by smear microscopy, and are the most infectious cases 
(http://www.who.int/mediacentre/factsheets/fs104/en/index.html) (DOA: 26/01/2012) 
TB infection or morbidity progresses rapidly particularly in early adulthood (within 
the first few years of infection). Nearly 14-17 million older children and adults die 
each year in developing countries. Mortality is related to the disease severity or 
systemic disseminations of disease, such as meningeal or miliary tuberculosis.  
Children born to HIV positive parents, whether infected or not, are at high risk for 
death. A study of ‘healthy adults’ in Mumbai, India, to detect LTBI showed that 80% 
of residents were already infected with TB and were harboring MTB-exposed T-cells 
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1.1.15 Risk factors 
Screening of TB and LTBI can be facilitated for identification through combination 
of the aggravating-associated risk factors. The risk of acquiring infection depends on 
the infectiousness of the index case, the duration and degree of exposure to 
surrounding environments, and organism virulence (CDC, 2005b; Maddineni et al., 
2008). Risk factors for TB can be directly or indirectly related to social, behavioral, 
biological, physiological, environmental/occupational, and multi-factorial combined 
variables. 
1.1.15.1 Social factors 
Tuberculosis disease is directly related to community socio-economic conditions.  
The WHO report published in 2008 considers TB as one of the top 10 leading causes 
of death in 2004 in relation to an individual’s income; the seventh cause in low-
income groups, the ninth cause in middle-income groups (but not in high-income 
populations) (WHO, 2004). Tuberculosis threatens the poorest and low-income 
community groups and decreases developments of economic-public health systems 
such as emergence of TB drug-resistant strains.  
The prevalence of health care workers (HCWs) having LTBI in these two population 
groups ranges between 33-79% compared with 5-55% in high-income regions (Topic 
et al., 2009). Parent education and employment are other significant risk factors for 
TB infection and detected more in BCG positively vaccinated compared with non-
vaccinated people (Soysal et al., 2005).   
To halt the disease’s advance and globalization, the WHO considers the first 
requirement to be accurate and rapid diagnosis of all suspected TB individuals, 
followed by control measures and treatment administration. For example, any subject 
aged between 12-14 years and living in a country with a TB incidence rate of more 
than (≥) 20 new cases per 100,000 people (as identified by WHO) is considered as a 
suspected TB case and tested using the tuberculin skin test. Improved living 
conditions both in country of origin and newly occupied regions (especially in the 




The prevalence increases with close contacts to a TB index case. Age is known 
infection social marker for children and is directly affected by both community 
internal exposures e.g. close contact to same household and parent TB index case 
with/ without external exposures due to mobility outside households e.g. inside the 
school or playground (Langenskiold et al., 2008). 
Increased age is also at risk for TB infection, with a 100-fold higher than non-
exposed healthy people (Pai et al., 2005). Older age reveals significant results of 
positive interferon gamma release assays (IGRAs) testing due to waning of anti-
tuberculosis immunity (Horsburgh et al., 2010).   
Tuberculosis is considered an infectious killer of women of reproductive age 
worldwide due to less protective sex steroid hormones (Weiss, 2008). 
Anaemia with significantly low hemoglobin levels is prevalent among adults with 
pulmonary tuberculosis, and is associated with severe infection (Gupta et al., 2009). 
1.1.15.2 Behavioral factors 
Smoking is the major behavioural and occupational risk factor, which is increasing 
throughout the world. Passive smoking is significantly associated with increased risk 
for clinical TB, and children exposed to passive smoking exhibit more positive TST 
results than non-exposed subjects (Kolappan and Gopi, 2002; Lin et al., 2007). 
Individuals living in the same household together with smoking parents are 
significantly at higher risk (odds ratio (OR) 4.6) of developing TB disease than non-
smoking infected households (OR 1.2). Coughing in heavy smokers can delay a TB 
diagnosis due to an increase in the infectious stage and longer exposure intensity 
facilitating bacillary transmission (den Boon et al., 2007). Both smoking crack with 
cocaine addiction and history of alcohol abuse increase LTBI environmental risk 
exposure (Grimes et al., 2007; Lin et al., 2007). 
Tobacco neutralization of TNF-α in pulmonary macrophages is also associated with 
excess iron in broncho-alveolar macrophages in the smoker’s lung. Low immunity 
can also be related to other factors such as decrease muco-ciliary activity and 




permeability, change in epithelial mucus amount and consistency, increase number of 
non-functional phagocytosis versus pathogenic organisms, and decrements of T-
helper cells, NK cells, T-cytotoxic cells fighting capacity and innate immunity (den 
Boon et al., 2007; d’Arc Lyra Batista et al., 2008).    
Stopping smoking and close monitoring of adherence for six-month anti-TB therapy 
reduces the risks of LTBI re-activation. Relapse phenomenon with the bulk (up to 
65%) occurring within the first year of follow-up after completing anti-TB 
therapeutic course was related to living in areas with non functional family health 
programs e.g. inadequate drug supply, wrong prescriptions/dosages, or adverse 
effects, related with independent causation to smoking (OR 2.53) (d'Arc Lyra Batista 
et al., 2008). 
1.1.15.3 Biological factors 
Host-related genetic factors vary between cases and community controls, which 
continuously been validated through family-based association studies to improve 
understanding of biology and MTB transmission. Valid associations can explain 
various risk factors like; 1- source of infectivity, 2- intensity of TB infection, and 3- 
infection susceptibility (Lienhardt et al., 2005). 
Longer duration of exposure and daily exposures in TB high-prevalence regions 
present an additive risk (Soysal et al., 2005).  
Diagnostic positive test concordance is greater in monozygotic twins than dizygotic 
twins, and is associated with human leukocyte antigen (HLA) and immunological 
differences between infected and healthy controls in the same households for their 
pattern of clinical disease (Lienhardt et al., 2002a). Diabetes mellitus (DM) directly 
impairs the innate and adaptive immune responses needed to resist MTB 
proliferation after reduction in Th1 cells, IFN-gamma levels, and reduced neutrophil 
chemotaxis, oxidative killing and leukocyte bactericidal activity (Jeon et al., 2008). 




Impaired cellular immunity is associated with; 1- young age less than 5 years old, 2- 
pathological factors (e.g. HIV and related-opportunistic infections, diabetes mellitus, 
chronic renal failure on hemo-dialysis), and 3- iatrogenic immune-suppression (e.g. 
organ transplant, TNF-α  agents, systemic steroids).  
Although changes in the immune system during aging lead to increased susceptibility 
to mycobacterial infections and re-activation of latent foci, TB remains associated 
with younger age groups in developing countries (independently of HIV status). This 
may be explained by the higher proportion of young people, a higher annual risk of 
infection and shorter life expectancies in developing countries (Solari et al., 2008). 
TNF-α cytokines control TB infection by maintaining an immunological balance 
between infected host and tubercle bacilli to avoid MTB re-activation, therefore anti-
TNF-α therapeutic agents (e.g. anti-rheumatoid treatment) or steroids (e.g. 
prednisolone), and lack of compliance to anti-TB treatment would arrest TNF-α  
activities and ameliorate the immune response (Cardona, 2007; Kobashi et al., 2008). 
Other indirectly associated risk factors, related to other conditions, include silicosis 
(Risk ratio [RR] = 30), immuno-suppressive therapy (RR = 12), hemo-dialysis (RR = 
10-15), jejunoileal bypass (RR = 27-39), and carcinoma of head and neck (RR = 16) 
(Pai et al., 2005). 
1.1.15.5 Environmental/occupational factors 
There is always considerable heterogeneity in the risk of LTBI between different 
occupations. Occupational exposure to TB infected case noticed in nosocomial 
infections is acquired within the community which usually includes health care 
workers (HCWs) and their relatives (Freeman et al., 2010). He and colleagues 
concluded that LTBI prevalence in medical staff (56%) was significantly higher than 
that in administrative/logistic staff (42%) within the same TB centre (He et al., 
2010), in addition to varying degrees of patient contact such as with a nurse, doctor, 





Overcrowding and using small transport vehicles with longer exposure-time of public 
employees are a variety known risk factor combinations that are difficult to control 
(Horna-Campos et al., 2011). Health service providers and HCWs can be related 
with inadequate data availability can increase transmission risks e.g. nurse in TB 
hospital ward, doctors admitting TB infectious cases are associated with delayed 
diagnosis of acute or chronic TB patients (Schablon et al., 2009; Schablon et al., 
2010b). 
In industrialized countries, populations at high risk are those comprising: 1)- 
individuals exposed to or infected from MTB close contacts, foreign-born 
immigrants and recent arrivals within five years from TB high prevalence region, 
elderly, special racial and ethnic minority population, residents of long-term care 
facilities e.g. HCWs in nursing homes, drug abusers, medically under-served, 
homeless, occupational exposure in comparison to, 2)- individuals developing TB 
disease once recently re-infected within two years, HIV-co-infected, immuno-
suppressive conditions or medications, age extremes, history of inadequate anti-TB 
treatment with appearance of drug-resistance strains; multi-drug resistance (MDR-
TB) and extreme-drug resistance (XDR-TB) (Maddineni et al., 2008). 
The variability of job category reflects variation in exposure frequency and intensity. 
A study revealed 104 out of total 160 healthy looking nurses with OR of 1.55 having 
positive TST and IGRAs test (Pai et al., 2005). Close contact and proximity of jail 
inmates raise HIV and TB possibilities due to overcrowding, shared respiratory 
ventilation buildings (> 12 hours) and poor living conditions facilitate MTB 
transmission to others from undetected active TB cases. Environmental conditions 
and proximity to a contagious index case (> 8 hours) complicates TB control 
programs e.g. hospital wards, aircraft (Al-Jahdali et al., 2003; Demkow et al., 2008).  
Proximity exposure (OR 3.5) and/or past history of TB infection (OR 4.3) are highly 
associated risk factors with positive TB diagnostic tests. Regular investigation is 
needed to identify even the contacts of treated-TB index case where less than 30-
40% is only completing LTBI prophylactic therapy (Bur et al., 2003).  




TB exposure is affected by combined internal and external occupational-
environmental risk factors. Combined socio-economic factors are complicating TB 
elimination and affecting assessments of the implemented control programme 
outcomes and are commonly noticed in the developing countries (Lienhardt et al., 
2002b). Low social class, overcrowding, illiteracy, poverty (low income and property 
ownership), under/malnutrition are all related to immune-suppression (CD4+ counts 
< 200 cells/mm
3
) with anergic DTH-IV immune responses against TB concomitant 
infections and LTBI re-activations (Pai et al., 2005).  
The relative frequency of exogenous re-infection against endogenous re-activation is 
still ambiguous and undetermined. For example endogenous re-activations are 
commonly related to impairment of the immune system such as poverty and alcohol 
and drug abuse are known risks leading to other related TB risk factors e.g. smoking 
or medical re-activation risk factors - such as DM, HIV/AIDS and other related 
debilitating medical conditions, poor eating habits and inadequate nutrition with 
vitamin deficiency (LoBue et al., 2010).  
Environmental effects such as nutritional status or living on traditional farms or 
parasitic (helminth) infections are known risk factors that affect the immune system 
in early (neonatal) life with consequences for later disease outcomes or for responses 
to BCG vaccination in infancy (Djuardi et al., 2010). Vitamin D deficiency due to 
poor nutrition and low socio-economic status also increases the probability of LTBI 
and TB (Talat et al., 2010).  
Large case control study including 820 cases done in 3 different countries sharing 
similar socio-economic environmental conditions and geographic borders in West 
Africa; Gambia, in Conakry and Bissau, revealed that TB control difficulties can be 
due to various risk factors. Multifactorial combination of host–related and 
environmental-related risk factors such as male gender (due to migration for job and 
crowding with others), HIV infection (due to LTBI re-activation), smoking habits 
(related to dose–effect relationship and smoking duration), history of asthma (due to 
MTB eliciting Th1 immune mechanism and production of IL-12, INF-γ, TNF-α but 
inhibiting Th2 activity), family history of TB, marital status (widow and divorced 




degree social proximity) between household occupants and low socio-economic 
status (poverty and absence of ownership) (Lienhardt et al., 2005). 
Risk factor combinations increase the difficulty of distinguishing TB from other 
respiratory disorders. Shared risk factors are targeted by TB control programmes in 
reducing TB globalization and health system overburden. A comparative study of 
404 treated PTB in group 1 during the period between (1986-1995) against other 
PTB treated 414 patients in group 2 during the period between (1996-2005) revealed 
a significant increase in atypical chest findings in group 2 related to non-respiratory 
conditions and with lower lung field predominance e.g. cancer, collagen vascular 
disease or use of immune-suppressive medication, compared with positive 
microbiological findings e.g. sputum smear and culture positive results in group 1  
(Kobashi et al., 2008). 
Previous history of TB infection is a common risk factor and integrated as pulmonary 
tuberculosis with higher suspicion than CXR performances (Wu et al., 2009). 
Common additional risks are prevalence of TB infection within exposed populations, 
presence of an infectious source, air density carrying TB droplet nuclei, duration of 
exposure to infected polluted air and quality of indoor/outdoor air ventilation 
(filtration).  
In 2004, a retrospective study done on 2,508 TB cases between 1996-7 in Catalonia, 
Spain, found a TB incidence of 41 per 100,000 person-years with detection of 
combined behavioural changes; 19.4% (487/2,506) were co-infected with HIV, and 
35.6% (893/2,508) presented with positive sputum smear, 16% (401/2,508) were 
alcohol abusers and 13% were intravenous drug abusers (IVIG) (327/2,508) (Godoy 
et al., 2004).  
1.1.16 Impact of migration on LTBI & TB  
Human migration is a well-documented increasing phenomenon and immigrants are 
in particular need of close monitoring and screening programmes to tackle TB 
transmission and to improve public health. Migration is a major risk factor with an 




contact-exposure phenomenon and importation of LTBI and active TB disease from 
high- toward low-prevalence regions (McCarthy, 1984). An individual’s 
geographical history is important in any assessment (immigration and foreign travel, 
destinations, travel-exposure durations), as well as consideration of the age and 
general health of travelers including the risks of work type (Freeman et al., 2010).  
Since the 1980’s, human migration has reached an un-precedented scale, with more 
than 150 million people estimated to be long-term residents in a country other than 
that of their country of birth. In addition, the numbers of short-term travellers exceed 
those seeking permanent resident status by 50 times (7,500 million). Immigration 
demographics show that Asians, Blacks, and Hispanics bear the greatest burden of 
TB and screening of immigrants can protect community public health in nations of 
low TB incidence. In 2003, the total number of reported TB cases in Australia was 
1,013 cases with 80% being foreign born. In the UK there were 6,400 reported cases, 
with 64% cases being in foreign-born residents. Western Europe faces irregular 
migration of TB cases - phenomena that has increased during the past two decades 
and is investigated using routine medical examination and migrant screening 
(MacPherson and Gushulak, 2006). The incidence of TB in the country of birth is 
crucial to predict variation in demographic changes, and this can be used to focus and 
target TB elimination and prevention efforts toward the high-risk TB groups 
(Watkins et al., 2002). 
The increase in TB incidence and prevalence due to immigration was observed in 4-
year universal genotyping of TB patient isolates from the Almeria region of Spain, 
which had high immigration from TB endemic areas in North and Sub-Saharan 
Africa and has showed a rise in number of TB cases from 19% in 1997 to 48.9% in 
2006 (Miguel et al., 2008).   
Tuberculosis notification rate been rising quickly in Eastern Europe countries (5% 
per year, 1997-2002), and in African countries due to high HIV prevalence (East and 
West African countries; 7% per year), but a slowing of rate was detected since the 
mid 1990s (Figure 1.9). The case notification rate is stable or in mild decline in the 





Figure 1.9: Annual changes in TB notification rates 1992–2002 (average percent change on 
previous year) in notification rates (all forms, DOTS and non-DOTS) between consecutive years 
for two groups of countries; Africa – high HIV (red) and eastern European countries (grey) 
(http://www.who.int/tb/publications/global_report/2004/06_results1/en/index1.html) (DA 26/7/2008) 
The total reported TB cases in England between 1999 and 2003 were 31,290 and 
37% (n = 11,404) were from Indian, Pakistani and Bangladeshi ethnic origins, 29% 
were from white ethnic groups and 19% (n = 5,665) were from black African ethnic 
groups. Nearly 66 % (n = 17,987) of all TB cases were from non-UK born residents. 
In London, the TB incidence rate and tuberculosis cases increased from 32.3 to 41.3 
per 100,000 healthy populations compared with only mild increases outside London 
(from 7.7 to 8.4 per 100,000). After adjustment of all other variables, most cases of 
TB were shown to belong to non-UK born population groups that had arrived in UK 
within five years prior to their diagnosis. These cases were also associated with 
increased number of INH-resistant strains and MDR-TB resistance (Crofts et al., 
2008). Treating drug-resistant TB is expensive costing between £50,000 and £70,000 
per patient and has serious financial implications for National Health Boards.  
In Germany, the influx of BCG-vaccinated immigrants since 1998 from TB high-
incidence countries represents a potential pool for new TB infection and highlights 




children, and lowering the raised frequency of non-Mycobacterium tuberculosis 
(NTM) infection by differentiation from other mycobacterial types by using INF-γ 
levels and IGRAs test (Pai and Menzies, 2007). A screening study in Northern 
Germany on 270 HCWs concluded that LTBI prevalence with IGRA positive results 
reached 3.5% in 115 participants under 30 years of age and 22% in the 41 
participants that were over 50 years. A higher prevalence was associated with job-
exposure risk e.g. physicians and nurses than among other professional workers e.g. 
radiologists (Schablon et al., 2009).  
Risk factors associated with delays in diagnoses pose a significant barrier to TB 
diagnosis and control e.g. low public awareness and inadequate health service 
funding (Kariminia et al., 2009; Long et al., 2008). Worldwide, it is essential to have 
adequate knowledge as regards drug susceptibility for M. tuberculosis, especially in 
the low TB prevalence regions, due to the risks of high travel of hosts and 
uncontrolled immigration (Saif Alfaresi and Hag-Ali, 2010). 
In Victoria, the second most populous state of Australia, 80% of TB new cases 
develop in foreign-born individuals (109/100,000) accounting for 18 times more TB 
incidence than rates of the total population (6/100,000), and were common during the 
first five years post-migration resettlement and from South-East Asia regions related 
to migration displacements (MacIntyre et al., 1999). There was however a 
contradictory result from a comparison between Canada and Australia of TB patients 
diagnosed after sputum smear stratification that did not show an association between 
TB incidence in immigrants and country of birth (due to in-appropriate, in-accurate 
available data about historical exposure in their origin or destination region (Watkins 
et al., 2002). 
A study done between 1994-2005 in Norway to assess immigration impact on the 
3,131 notified TB cases over the 12-year period showed that 705 of the strains 
isolated from TB high-incidence expatriates (the majority from Somalia, Pakistan, 
the former Yugoslavia, Ethiopia, Vietnam, Thailand, India) were associated with a 
steady increased number of notified TB cases from 4.7 to 7.2 per 100,000 population 
due to importation and spreading of M. tuberculosis bacilli. The majority of MDR-




Importation of immigrant pathogenic strains can influence local population strains 
over extended time periods (Dahle et al., 2007). In 2008, total immigrants present in 
Geneva, Switzerland represented 45% population with 84% of TB cases being 
foreign-born, which can be related to increased immigration of close contacts 
harbouring or acquired LTBI and history of BCG vaccination e.g. approved TST 
more than 5-mm ‘cut-off’  size (rather than > 10-mm) was significantly associated 
with previous BCG (Brodie et al., 2008).  
Between 5 and 10% of total infected immune-competent individuals turn out to be 
asymptomatic LTBI cases, where then 50% can progress to active TB within the first 
one and two years post-exposure.  
An Australian historical cohort study done on 24,610 refugees reaching Sydney 
between 1984-1998 reveals that most TB cases already came from South Asian 
countries and 29% of LTBI re-activation within the 1
st
 year and 65% within five 
years post-arrival (Marks et al., 2001).  
1.1.17 Impact of smoking on LTBI & TB  
TB and tobacco usually are regarded as two colliding epidemics of public health 
importance (Pai and Menzies, 2007). Tobacco smoking increased substantially in the 
past two decades with a pandemic of 1.3 billion smoker’s worldwide. The risk of 
prevalence, incidence, recurrences and mortality of clinical TB infection with male 
predominance is more among current than ex-smokers and non-smokers, and in turn, 
more with the duration of smoking than the number of cigarettes smoked daily 
(Gajalakshmi et al., 2003; Jee et al., 2009). Susceptibility and exposures to smoking 
of school students in South Asian families and low-income countries was observed 
by Guindon et al. (2008). Smoking is responsible for more than one-third of TB 
deaths (38%) in the Taiwanese population (Wen et al., 2010). 
Both tuberculosis (LTBI/TB) and tobacco dependence, which is common in low- and 
middle-income countries are regarded as two colliding epidemics of public health 
importance. Smoking is associated with treatment non-adherence and tuberculosis 




2009). A casual association also showed positive dose-response relationship with 
daily number of cigarettes smoked of estimated OR 2.5 (95% confidence interval 
(C.I.): 1.42 to 4.37) (Kolappan et al., 2002). Tobacco delays the recovery of 
pulmonary tuberculosis and induces pulmonary tissue sequels despite correctly 
applied anti-tuberculosis treatment due to treatment failures, defaults, and relapses.  
Smoking is perhaps one of the risk factors that should be most amenable to change.  
The number of active tuberculosis cases increases with numbers of smokers due to 
increases in miss-management practices, treatment failure and relapses, MTB 
transmission and control difficulties (d'Arc Lyra Batista et al., 2008; Kolappan et al., 
2002; Ng et al., 2008; Pradeepkumar et al., 2008; Santha et al., 2002). 
Smoking influences the clinical progress of TB lesions and delays LTBI/TB 
diagnosis. Exposure to smoking produces alterations in both natural and acquired cell 
immunity, affecting macrophages and leukocytes. It induces apoptosis in both 
activated and non-activated macrophages, leading to bacillary multiplication. On a 
biological basis, smoking increases TB risk through a decreased immune response, 
mechanical disruption of ciliary function, defects in macrophage immune responses, 
and/or tissue CD4+ lymphopenia. Similar to HIV/AIDS pathology, smoking alters 
the mucociliary apparatus such as cell dysfunction and destruction and lysozyme 
activity, resulting in great numbers of germs and toxic substances reaching the 
alveolar tissues.  
Cigarette exposure has been shown to increase MTB bacillary burden in mice 
infected with M. tuberculosis, and increased weight loss and mortality in mice 
infected with influenza virus. This study provides the first direct evidence that 
cigarette smoke exposure increases bacillary burden through direct inhibition of the 
pulmonary T-cell response versus MTB in a mouse animal model increasing 
susceptibility to MTB pathogen (Arcavi et al., 2004; Feng Y. et al., 2010). 
1.1.18 Impact of BCG vaccine on LTBI & TB  
The Bacille Calmette-Guérin vaccine (or Bacillus Calmette-Guérin, BCG) was 




cultured in humans. The BCG vaccine is injected intra-dermally as a single injection 
into the upper arm (deltoid muscle) and injection is preceded by tuberculin skin test, 
performed by a skilled nurse and not having a false positive result. BCG stimulates 
the immune system to produce antibodies against MTB and tuberculosis infection. 
The indicated age range and vaccination frequency varies between different 
countries. For example: WHO’s new BCG policy (applied in Kuwait) recommends 
vaccination of all children born in TB-endemic regions at  three months of age. India 
introduced BCG mass immunization in 1948 recommending 2 and/or 3 
immunizations during life. In the UK, BCG vaccination, which was a compulsory 
since 1954, was withdrawn as a routine immunization in 2005 because it was 
considered as not cost-effective. BCG vaccination can have obvious public health 
advantages. It can lessen the burden of TB-related disorders such as LTBI prevalence 
and active TB incidence in children (Soysal et al., 2005; Trunz et al., 2006).   
The latest WHO policy for BCG immunization rules out vaccination in HIV positive 
children but recommends vaccination for travelers to TB endemic areas. The initial 
absence or low predominance of emerging antigens for sensitizing immunity, added 
to the gradual degeneration and necrosis of antigen-specific T cells in infected lungs, 
would physically prevent cellular penetration and promote bacillary resistance 
(Henao-Tamayo et al., 2009). BCG lacks a group of genes (Rv3971 to rv3879) 
including the genes for antigenic proteins ‘Region of Difference’ (RD-1) made by 
MTB early during culture growth but with unclear precise action (discussed further 
in section 1.4.2 IGRAs). Data show that non-mutant bacilli expressing RD-1 causes 
dramatic necrosis in mice lungs unable to make INF-γ. Under in vivo conditions, the 
RD-1 encoded proteins cause direct or indirect progressive necrosis secondary to 
interactions between host cells and bacterial proteins, but not due to bacterial 
overloads (Junqueira-Kipnis et al., 2006). 
The tuberculosis skin test (TST) cannot distinguish between previous BCG 
vaccination and current TB infection due to poor specificity in BCG negative people 
and poor sensitivity in children. Meta-analysis proves that previous BCG 




post-vaccination (Richeldi, 2006), while, IGRAs results are independent of BCG 
vaccination (discussed further in chapter 6).  
Absence of an immunization scar can determine the likelihood for TB infection and 
is significantly associated with TB disease severity, which can be related to the level 
of exposure to MTB (Soysal et al., 2005).  
The impacts of BCG on the tuberculin skin test and LTBI results will be further 
discussed in chapter 5; section 5.3. 
1.1.19 Impact of HIV/AIDS on TB & LTBI 
The human immunodeficiency virus (HIV) is the strongest risk factor for the 
development of human tuberculosis among individuals infected with MTB. High 
prevalence of TB/HIV co-infection in various geographical areas and in specific 
population groups has made TB the most common AIDS-diagnostic disease in the 
world, and is compulsory to test for M. tuberculosis. 
The impact of the HIV pandemic is felt all globally and particularly in the many 
resource-poor countries in Sub-Saharan Africa, where two thirds of the world’s TB 
infected population lives. Between 40-80% of TB+/HIV+ patients have pulmonary 
disease in Africa and South America (Raviglione et al., 1992). 
Although TB re-emerged as a major public health problem in the developed and 
industrialized countries due to international migration and the breakdown of health 
services, including TB services, HIV infection is the strongest risk factor with a 
significant increase in the rate of re-activation (rate ratio [RR] 57; 95% C.I.: 26-120) 
and among those older than 50 years of age (RR, 3.8; 95% C.I.: 1.3-11) (Horsburgh 
et al., 2010). TB/HIV co-infection impairs the immune system and increases 
morbidity and mortality rates. The spread of HIV makes TB diagnosis difficult and 
HIV/AIDS epidemics are significantly influencing TB epidemiology due to the 
emergence of immune-suppression and increased susceptibility to TB infection in 





TB high-prevalence areas are also suffering from the HIV/AIDS epidemic creating 
the TB/HIV syndemic and the emergence of drug-resistant strains to anti-TB 
treatment. Evolution of TB strains continues as human demography changes with 
HIV (Basu et al., 2009). For example TB patients in African countries are 
predominantly co-infected with HIV and are disproportionately spreading TB over 
sub-populations associated with new TB epidemics. A total of 36.1 million people 
were living with HIV/AIDS at the end of 2000, 25.3 million (70.1%) living in sub-
Saharan Africa and 5.8 million (16.1%) from South East Asia, with half million 
people dying in 2001 (WHO, 2006), and 1.37 million co-infected new cases 
estimated in the WHO 2007 report (WHO, 2009a).  
Concurrent TB/HIV positive (+ve) co-infection makes the patient less infectious, 
however, a single positive smear sample is considered an important risk factor for 
LTBI progression to the active TB form, and lower lifetime annual risk reaches 7-
10% compared with higher risk reaching 10% among TB+/HIV- (TB positive/HIV 
negative) patient (Balcells et al., 2008; Driver et al., 2006).  
TB/HIV co-infection raises the risk of LTBI re-activation 100-fold, which can be 
qualified using the tuberculin skin test (TST) response and quantified according to T 
cell lymphocyte count. In the industrialized countries HIV+ patients are 60 times at 
higher risk of developing TB from dormant LTBI re-activation compared with being 
six times more likely in TB endemic countries. 
Worldwide, the incidence of TB remains high among the HIV-infected populations 
and this mandates for early diagnosis and treatment. Even though anti-retroviral 
therapy slows the rate of latent re-activation and increases lifespan of hosts,  HIV 
increases the rate of recurrence, even in TB-treated patients, and TB/HIV co-
infection complicates patient management causing diagnostic difficulties, drug 
interactions, adverse drug events, host immune re-constitution (T cell immune 
response), and emergence of drug resistance. MDR-TB cases were detected in 
200,000 out of total 8.8 million newly infected TB patients and in 1.6 million of TB-




HIV is associated with depletion of circulating CD4+ cells and their interferon 
gamma levels. Worldwide, the increment in HIV prevalence raises TB re-activations, 
and early case detection to prevent MTB mutant virulent species and epidemic 
mortalities (Basu et al., 2009). Large effects of HIV infection significantly increase 
the proportion of diagnostic test non-reactors such as TST and IGRAs (Dodd et al., 
2010). HIV/AIDS has a statistically significant association with a low CD4+ T-cell 
count less than 200 cells /µL and is more likely to have normal or minimal CXR 
findings, and requiring other diagnostic tests (chapter 5; sections 5.1; Old diagnostic 
test of tuberculosis). 
Periodic skin testing in primarily negative TST anergic individuals is useful to 
identify high risk groups before active TB disease develops. HIV sero-positive cases 
with/without acid fast bacilli (AFB) positive smear are commonly associated with 
absence or lack of detectable CXR cavitations and are considered less infectious due 
to weak type of cough and age > 40 years with less immunologic resistance 
compared with to HIV sero-negative individuals (Samb et al., 1999).  
A study done in North Nigeria reviewed patient records and revealed that out of 
1,320 HIV/AIDS, those TB co-infected were 10.5% and have predictors of late 
clinical presentations according to WHO classifications and baseline lymphocyte 
CD4+ cell count was less than 200 /µL  thus recommending IGRAs diagnostic tests 
(Iliyasu et al., 2009). Another study done on 247 HIV positively diagnosed patients 
with a decline in CD4+ cell count revealed a decrease in indeterminate results using 
Enzyme-linked immunospot (ELISPOT) assay (Karam et al., 2008).   
In Vietnam, ranked by WHO as 13
th
 among the first 22 high TB-prevalence 
countries, a study of 21,000 TB positive (+ve) patients revealed that urban 
populations are more HIV +ve than rural areas. Another conclusion was that HIV 
+ve patients have 50 % lifetime risk of progressing from LTBI to active disease 
form, compared with only 5-10% of  HIV–/TB+ infected patients, and face higher 
mortality rates reaching 34% in those HIV+/TB+ sputum smear compared with 3% 
for HIV -ve infected persons. This was the only study done in South East Asia that 




prescribed co-trimoxazole (CTX) antibiotic as preventive therapy recommended by 
WHO after noticing Vietnam TB/HIV syndemic spread  (Trinh et al., 2007). 
Non-Mycobacterium tuberculosis infections reduce sputum smear microscopy 
specificity and late clinical stages with increase in risk of opportunistic infections and 
recurrences in individuals previously exposed to TB that have a low CD4+ cell count 
suggestive of immune-suppression states like diabetic mellitus (Iliyasu et al., 2009).   
In Cuba, both DM and alcohol abuse are specific risk factors facilitating re-activation 
of previous TB infection in close contacts (Matthys et al., 2009). One contradictory 
multivariate analysis concludes that past history of TB was independently associated 
with positive TST and high CD4+ cell count (mean CD4+ > 550 +/- 220)  but further 
surveillance studies are required to assess similar results (Britton et al., 2005). 
1.1.20 Tuberculosis diagnosis  
Infectious disease diagnosis is important for differentiation between TB and other 
common infectious and mainly respiratory disorders and between active TB against 
LTBI where both are not only differentiated by INF-γ levels. For the diagnostic 
guideline and criteria’s of TB described in the diagnosis of tuberculosis see chapter 1 
section 1.2, section 1.3 and section 1.4.   
1.1.21 Differential diagnosis 
Any organ can be infected with MTB forming the characteristic ‘tubercle’ 
granulomatous lesion, but TB infection is associated with the respiratory system or 
lungs as the main route of entry (> 80% of occasions). Pulmonary tuberculosis 
should always be included in the differential diagnosis of persons with pulmonary 
signs or symptoms and appropriate diagnostic measures should be instituted (ATS, 
1992). 
1.1.21.1 Differential diagnoses of patchy lesions (Table 1.3) 
Most of the lower respiratory tract infections (e.g. pneumonia) are causes of fever 




underlying malignancy are causing weight loss, night sweats with suppressed 
immunity and pre-disposition to infections such as leukemia and lymphomas. HIV 
infection is associated with opportunistic chest infections and non-Mycobacterium 
tuberculosis manifested as cervical lymph adenopathy (see Table 1.3).  
Table 1.3: Differential diagnoses of pulmonary against extra-pulmonary patchy lesion 
(Medical manual, 2010)  
Pulmonary TB Extra pulmonary TB 
Lung infections: patchy lesion of pneumonia or 
abscess caused by various causative organisms 
(bacterial, viral, fungal, parasitic); e.g., Streptococcus 
pneumonae , Staphylococcus aureus, Mycoplasma 
pneumonae, Pnumocystis carinii pneumonae (PCP), 
viral, e.g. RSV, fungal mycosis e.g.,  histoplasmosis, 
aspergillosis, parasitic e.g. pulmonary echinococcosis, 
Bronchial carcinoma, Other non-infectious diseases 
e.g. silicosis, sarcoidosis, COPD 
TB always considered in any extra 
pulmonary differential diagnoses 
 
1.1.21.2 Differential diagnosis of other-than patchy lesions (Table 1.4)  
Abnormal lung findings can be due to pulmonary tuberculosis or related differential 
diagnosis for other causes (Table 1.4). 
Table  1.4: Differential diagnoses of pulmonary lesion(s) (Arthritis Center, 2009) 
Pulmonary Nodule(s) Pleural Effusion (exudative) 
Infection (TB, fungi, pyogenic abscess) 
Malignancy (bronchogenic, metastasis, lymph 
proliferative diseases) 
Arteriovenous malformations 
Rheumatic disorders (rheumatoid arthritis, 
sarcoidosis, amyloidosis) 
Infection (TB, fungi) 
Malignancy (bronchogenic, metastasis) 
Pulmonary embolism 
Gastrointestinal disease 





1.1.22 Tuberculosis treatment 
The principal goals for tuberculosis treatment are: 1)- to cure the individual patient, 
and 2)- to reduce the transmission of Mycobacterium tuberculosis to the community 
population, therefore, successful treatment has public health benefits through 
prescribing appropriate regimens and follow-up completion of therapy.  
1.1.22.1 Drug category/choice of therapy 
The aims of tuberculosis therapy are to cure the patient’s symptoms and to minimize 
the possibility of transmission of the bacillus to healthy subjects. Adverse effects and 
drug interactions of anti-tuberculosis drugs may result in modification or 
discontinuation of treatment. Successful anti-TB management can restore the quality 
of life, reduce mortality from active TB, prevent case relapse and drug resistance 
development.  
Studies on mycobacterium cell wall bio-synthesis such as mycolic acids and 
mycobactins have facilitated understanding of the mechanism of drug action required 
to design and test new specific anti-mycobacterial agents and to overcome resistance 
problems. Optimization of available therapeutic medication is used to improve drug 
quality and develop new regimens. MTB lipoid cell walls (containing mycolic acids 
and mycolate synthetase enzyme complex) are targeted by specific tuberculostatics 










Table 1.5: Origin of anti-tuberculosis drugs in therapeutic use and their mode of action (Yew 
et al., 2007)  
* means the most effective first line anti-tuberculosis treatment 
1.1.22.2 Treatment schedule 
The primary aim of chemotherapy in pulmonary tuberculosis is to render the sputum 
bacteriologically negative for tubercle bacilli and to effect a bacteriological ‘cure’. 
Human and animal studies demonstrated that TB transmission and host 
infectiousness dramatically decreased within days to weeks from instituting effective 
treatment. 
Active TB cases are treated using the standard short course regimen as prescribed 
(Table 1.5): For the first 2 months a combination of 4 drugs (P), (E), (R), and (I) 
then, for the next 4 months receive (R) and (I). 
The treatment regimen for majority of TB cases is given as  ‘2H3R3Z3E3/4H3R3’, 
i.e. 2-month initial phase of HRZE given 3 times a week, followed by a 4-month of 




Drug Year of discovery 
 
Mode of action 
 
Streptomycin (S) 1944 
 
Inhibition of protein synthesis 
 
Pyrazinamide (P) 1952 
Converted to pyrazinoic acid 
(inhibit protein and RNA 
synthesis) 
* Isoniazid (INH) or (I) 1952 
Inhibit mycolic acid synthesis  




Slow inhibition of RNA 
synthesis (affect lipid and cell 
wall metabolism) 
* Rifampicin (R) 1965 
Inhibition of RNA synthesis 
(bind to bacterial DNA-




Table 1.6: Standard regimens for new TB patients (presumed, or known, to have drug-
susceptible TB) (Medical manual, 2010; WHO, 2010f) 
H = isoniazid, R = rifampicin, Z = pyrazinamide, E = ethambutol, S = streptomycin 
 
Any patient is considered sensitive and cured after completion of prescribed 
therapeutic regimen and shows relief from disease complaints (even though relapse 
rates can reach of 2-3%). Prescribing INH for 9 months or as the new regimen of 
both INH plus rifampicin for 3 months, either is considered as LTBI 
preventive/prophylactic therapy especially for the high-risk groups. Even with free 
treatment prescriptions (45-88%) in the U.S the anti-tuberculosis (anti-TB) results 
were disappointing due to low treatment completeness ratio (16-79%) (Langenskiold 
et al., 2008).    
Age dose-dependent usage of anti-tuberculosis treatment differs worldwide 
according to national guidelines. WHO recommendations for newly diagnosed active 
TB are shown in Table 1.7.  
Table 1.7: Recommended doses of first-line anti-tuberculosis drugs for adults (WHO, 2010f) 




2 months: HRZE(S) 
 





Daily 3 times per week 








Isoniazid (INH) 5 (4–6) 300 10 (8–12) 900 
Rifampicin (R) 10 (8–12) 600 10 (8–12) 600 
Pyrazinamide (P) 25 (20–30) – 35 (30–40) – 
Ethambutol (E) 15 (15–20) – 30 (25–35) – 




Prolonged anti-TB treatment causes a deficiency in serum vitamin D levels and an 
increase in the probability of LTBI and TB re-activation (Talat et al., 2010). 
1.1.22.3 Treatment evaluation 
Successful treatment has been achieved for more than 36 million patients since 1995 
via the WHO strategy for tuberculosis control. Evaluations consider the therapeutic 
outcomes and benefits against adverse effects e.g. INH-induced hepatitis against TB 
clinical improvement need regular follow-up even after therapy completion and 
reduced patient’s anxiety (CDC, 2003; Tissot et al., 2005) (Figure 1.10).  
  
































































Figure 1.10: Example of drug impacts on TB case fatality in England and Wales (Dye, 
2009) (DOA: 26/07/2008) 
Infectiousness does not always end with diagnosis, and PTB relapses are related to 
risk factors such as smoking, non-adherence to regular treatment, and prolonged 
infectiousness. An inadvertent side-effect of expanding TB therapy is an increase in 
TB virulence (Basu et al., 2009). False positive results lead to inappropriate initiation 
of chemotherapy, adverse effects and emergence of resistant MTB strains while false 
negative results lead to miss-diagnosis, facilitating transmission and LTBI 
progression. Both are related to unnecessary resource wastage and overburdening of 




Although combination drug therapy has cured sensitive- and resistant-MTB, still 
some patients fail to respond with serious clinical and epidemiological consequences 
e.g. treatment defaults and failure, with continuous uncontrolled MDR/XDR-TB 
cases in endemic regions such as India (WHO, 2009a).  
1.1.23 Prevention of tuberculosis infection  
The two clinically indistinguishable forms of TB disease entail different prevention 
strategies: primary TB is prevented by strict contact tracing with treatment of 
infected contacts, whereas prevention of re-activation TB is accomplished by 
screening for, and treatment of, latent tuberculosis infection (LTBI). Successful 
preventive measures can be implemented by assigning responsibilities for the control 
programmes, conducting regular TB risk assessments through developing written 
control plans e.g. early detection and treatment of TB-related cases, personal 
protection through population education, laboratory and treatment availability, and 
screening of high risk groups.  
Any control programme must ensure early detection e.g. airborne precautions and 
treatment of both suspected and confirmed diagnosed TB cases. Emphasis is needed 
on periodic guideline revision for each community high-risk group including Group 
1 - indirect exposure to TB patients e.g. HCWs in hospital departments or Group 2 - 
indirect exposure e.g. travellers and preventing occupational TB (CDC, 2008a).  
The setting of goals for future implementation over the 10 years, 2006 – 2015, was a 
crucial step toward TB elimination by assessment of all Stop TB Strategy steps such 
as the goal of revising the TB incidence globalization in 2015 or the role of reducing 
TB prevalence and mortality rates by 50% relative to 1990. The WHO report on 
Global TB Control in 2007 concluded that 2005 targets were met by the Western 
Pacific Region and 26 other countries including high-burden areas; China, 
Philippines, and Vietnam.  
Preventive chemotherapy is defined as the treatment of subclinical, latent infection 




Treatment follow-up is represented by the directly observed treatment, short course 
(DOTS) strategy, as an international recommended step for treatment completion 
since the mid-1990’s for implementation in any TB control programme, especially 
for individuals having new smear-positive or combined smear–negative and with 
extra-pulmonary complications (WHO, 2006).   
Cost-effectiveness facilitates DOTS implementation in 182 countries (cost per 
disability-adjusted life-year (DALY)) implemented in African countries was U.S.$1-
3 and East Asia about less than U.S.$2 and having five essential components: 
political commitment, diagnosis by sputum smear microscopy, reliable drug supply, 
short course treatment with standard first line drug regimens, and TB control offices 
for a recording/notification system allowing assessment of individual patient 
outcomes and overall programme performance (Baltussen et al., 2005) (Figure 1.11). 































PTB falling at 6%/yr
case finding
 
Figure 1.11: Pulmonary tuberculosis in Peru, in the 1980’s and 1990’s 
(http://apps.who.int/tb/surveillanceworkshop/) (DOA: 26/01/2012) 
Successful application of DOTS can achieve TB elimination and LTBI prevention 




In 2006, WHO addressed the new Stop TB Strategy with the following strategic 
steps:  
1. High-quality services of DOTS expansion (free availability of anti-TB treatments 
with direct follow-ups) e.g. in 2004, more than 22 million TB patients treated in 
various 183 countries   
2. Address the issues of TB/HIV co-infection and appearance of severe resistant 
strains treated by DOTS as target elimination by 2015  
3. Strengthen the health system through contribution of national TB control 
programme e.g. planning, management and supply systems  
4. Engage all care providers from public, private, and health-care workers e.g. 
ensure TB case notification and high-quality care service 
5. Empower people afflicted with TB e.g. applying community TB care projects to 
ensure public education and sustained political support, and 
6. Promote research for disease prevention.  
1.1.24 Tuberculosis infection control  
1.1.24.1 Preventing latent TB progressing to TB disease 
Normally people with LTBI never develop active TB disease but some people are 
more likely to do so due to the presence of TB-related risk factors e.g. HIV +ve 
individual, re-infected with TB within last two years, young children, the  elderly or 
those that have been improperly treated for TB. High risk groups require preventive 
treatment prescribed by health care facilities for those holding lower bacterial levels 
(or latent tuberculosis cases).   
1.1.24.2 Infection control within health care settings  
Health care settings need a well designed infection-control programme mainly to 
detect airborne infectious and highly contagious organisms and to provide treatment 




review of guidelines’ and evaluation of programme effectiveness are also needed to 
minimize TB transmission risks. 
1.1.24.3 Preventing exposure to TB while traveling abroad 
Level of knowledge about LTBI/TB disease for traveller’s should be raised through 
regular administrative procedures to limit close contacts or prolonged duration of 
exposures’ to crowded endemic regions, and consulting travel clinics, and personal 
protective devices e.g. facial mask (CDC, 2005a).  
1.1.25 Public health control 
All diagnosed TB cases should be notified to health-related authorities e.g. Ministry 
of Health departments and WHO TB control programs (WHO, 2009a): 
Case - All infectious cases (mainly pulmonary or laryngeal TB) should be; 1- early 
isolated, 2- interviewed, 3- collecting consecutively a three-day sputum samples 
post-discharge, and 4- ensure adequate treatment completion. All these step help 
restriction of index infectiousness. 
Contact - All contacts with an active TB index case should be screened using CXR 
and TST according to the country policy guidelines and repeated for inconclusive 
results before a prophylactic therapy decision is taken. 
Prevention and control - The advice given by the UK Department of Health 
remains similar to that advocated by Sir Robert Philip over 100 years ago: ‘‘The 
most important part of controlling TB is identifying and treating those who already 
have the disease, to shorten their infection and to stop it being passed on to others’’ 




                          
A: Tuberculosis education in school lesson                 .      B: Tuberculosis patients inside cover shelter 
Figure 1.12: Tuberculosis prevention and control programmes in UK, 1940’s 
(http://www.lhsa.lib.ed.ac.uk/exhibits/tales/tuberculosis.html) (DOA: 26/01/2012) 
Diagnosed active TB cases should have follow-up precautions and strict instructions 
to limit transmission of TB contagious bacilli. The WHO Stop TB Control 
programme for TB elimination is an essential target to be reached before 2015, in 
addition to poverty eradication, universal education, reduction of maternal/child 
mortalities, and combating common infectious diseases like HIV/AIDS and malaria. 
Figures 1.13 and 1.14 show the similarities in approach between different centuries.  
 
Figure 1.13: American Red Cross poster campaigning against tuberculosis-Fight tuberculosis on 







Figure 1.14: World TB Day 2011 TB-Elimination: Together We Can!  
(http://www.cdc.gov/tb/events/WorldTBDay/PosterLg_2011.htm) (D0A: 26/01/2012) 
Common examples of control guidelines for TB elimination against spread of 
infection are shown in Table 1.8. 
Table 1.8: CDC tuberculosis classification for immigrants and refugees (CDC, 2008a) 
 
Tuberculosis classification of United States immigrant/refugee 
 




A (TB, infectious) Active TB Positive 
No entry to U.S. until 
treated and smears are 
negative 
B1 (TB, clinically 
active, not 
infectious) 
Active TB Negative 
Report to local health 
department for further 
medical evaluation 
within 30 days of 
arrival in U.S. 
 
B2 (TB, not 
clinically active) 
 
Inactive TB (LTBI) 
Not required unless 
symptomatic 
Same as above 
 
No class (Normal) 
 
Normal Not required None 
AFB = acid fast bacilli 
Researchers are applying state-of-the-art genomic and post-genomic techniques to 




interventions and preventive vaccines. For example risk factor for studies is 
associated with strain clustering was linked to country of origin and previous city of 
residence (Franzetti et al., 2010). 
1.1.26 Diagnosis of tuberculosis-related disorders 
Worldwide, tuberculosis exists at various scales from low incidence to epidemic and 
the disease still remains difficult to diagnose, especially in regions with limited 
resources. The WHO priorities for a TB-free-future stress on improvements of 
diagnostic accuracy with reliable integration of human tuberculosis. National control 
programmes in high prevalence regions are driven towards reducing the burden of 
TB and helping to define end-points in trials of new TB vaccines. Missed diagnoses 
of active TB or that treated prophylactically as LTBI are associated with appearance 
of drug resistant strains (Balabanova et al., 2005).  
Timely diagnosis and treatment is important for the patient morbidity and mortality, 
Tuberculosis diagnosis is 100% accurate for the gold standard test of culturing bacilli 
for 4 to 8 weeks for a definitive bacteriological diagnosis. However, TB still can be 
suspected among any asymptomatic individual that has no specific clinical 
symptom/or sign. Thus identifying a quick and efficient TB diagnostic tool is a major 
global public health priority.  
Clinical interpretation combined with assessment of cost-effectiveness plays an 
important role in LTBI detection and TB control. Significant disagreement between 
diagnostic tests results would necessitate an evidence-based medicine (EBM) for a 
comprehensive technique to support before taking medical decision. False-positive 
diagnoses result in medical service wastage e.g. inefficient resource use and false-
negative diagnoses threaten the public health e.g. by risking the spread of TB 
infection. Differentiated from other TB-related disorders a complete medical 
evaluation for tuberculosis must include a medical history, a physical examination, 
and a radiographic examination (e.g. chest X-ray) and/or microbiological 




1.2 Tuberculosis clinical diagnosis and case 
definition 
A retrospective analysis of respiratory medicine in 2003 concluded that the clinical 
practice with scientific evidence-based medicine (EBM) test results was the major 
goal for early diagnoses and management to improve community health. Various 
diagnostic and disease monitoring tools are not supported by a high quality of 
evidence testing’s e.g. subjective reading of TST positive reaction differs between 
different countries according to TB endemicity which necessitates improvements in 
the diagnostic accuracy of TB and PTB-related clinico-laboratory-radiography 
combinations (Borrill et al., 2003).  
1.2.1 Medical history  
The WHO recommends TB investigations any individual having persistent cough 
more than 3 weeks until proven otherwise, similarly to any chest X-ray cavity as 
probable LTBI until proven otherwise.  
1.2.1.1 Direct history (un-structured interview, face-to-face)  
TB can be diagnosed through passive case detection i.e. detection via symptoms. 
History taking from the subject includes obtaining symptoms of TB and PTB disease 
such as prolonged cough more than three weeks associated with/without chest pain. 
Other generalized symptoms include low-grade remittent fever, chills, night sweats, 
appetite loss, weight loss, easy fatigability. Expectorations such as those producing 
mucoid sputum changing to purulent or hemoptysis (blood) can be considered as a 
clinical predictor in smear-negative TB patients (Kanaya et al., 2001). Other directly 
related medical history includes prior TB exposure or past TB treatment and 
searching for other epidemiological TB-related risk factors such as HIV. For example 
smear-negative PTB cases have lower experience of cough for more than three weeks 
than smear-positive PTB cases (45% vs. 72%) (Tamhane et al., 2009). 




A screening tool facilitates LTBI epidemiological case definition and diagnosis 
(discussed in detail in chapter 4).  
1.2.2 Physical examination  
Medical/ clinical examination looking for physical signs performed to detect subject 
experienced symptoms. Any shared or common finding(s) to other health-related 
disorder¸ like fever, chest pain or productive cough, will complicate TB diagnosis. 
Pulmonary presentations are common in adults, whereas, systemic complications 
(TB dissemination) are noticed in children or immuno-compromized individuals. 
PTB thoracic sequelae involve all parts of the chest and respiratory tract system; 
acute respiratory distress syndrome (ARDS), multiple cystic lesions, extensive 
consolidations, pleural effusions, pneumothorax or empyema. 
Other symptom-based characteristics proposed for active TB diagnosis in children 
are the following predictors: 1) persistent, non-remittent coughing or wheezing; 2) 
failure to thrive despite food supplementation; and 3) fatigue or reduced playfulness. 
Comparative studies testing immune-competency in controls reveal that TB cases 
lose more than 10% of total body weight within short time period, night sweating, 
hypoxemia, abnormal sputum and sometimes auscultation abnormalities. Systemic or 
organ/tissue evaluation and lung examinations by auscultation and percussion help 
limiting TB differential diagnoses and reaching final correct diagnosis.  Case finding 
depends on the various clinical presentation(s) to the health service. Mean duration 
of symptoms (287 days) was longer in subjects reporting coughing with other chest 
symptoms compared to relatively short durations (146 days) from reporting a cough 
alone. The longer the period of symptomatic complaints (> 52 weeks) is associated 
with having high sputum positive grading (3+) and the presence of a sick contact 
within the same household. Smear positive grading was not associated with systemic 
symptom combination compared with significant findings in patients having only 




1.2.3 Laboratory diagnostic testings for tuberculosis 
WHO Stop TB Strategy recommends an evidence-based laboratory identification of 
MTB in TB diagnosis. Result discrepancies reach 58% between clinical findings, 
laboratory results and treatment outcomes, by which international treatment regimens 
can be accurately prescribed after the discovery of reliable diagnostic technique. For 
example, reduced awareness of inconsistent laboratory errors leads physicians to rely 
on radio-graphical findings in TB management resulting in over-diagnosis and 
improper treatment of false positive (FP) TB case (Joshi et al., 2005).  
Nowadays, laboratory case definition depends on the demonstration and isolation of 
MTB from clinical specimens (respiratory or non-respiratory), but is dependent on 
the diagnostic criteria for each country and their health resources. 
1.2.3.1 Microbiological studies  
Microscopic investigation are performed after obtaining samples of body tissue or 
fluid samples using different procedures: Acid Fast Bacilli (AFB) are stained with 
e.g. Ziehl-Neelsen (ZN stain) or Auramine stain (AS), and bacteria can be grown in 
TB growth culture using liquid media (Middle Brook) or solid media (Lowenstein-
Jeensen: LJ). Microbiological diagnosis requires a concentration technique to 
maximize organism numbers and a decontamination procedure to kill other 
contaminating micro-organisms.  
The following examples are commonly accepted international diagnostic tests; 
1.2.3.1.1 Sputum smear sample (SSS) 
Sputum comprises secretions expectorated (the Latin ‘’to spit’’) from respiratory 
airway tracts e.g. mucus and saliva and is abnormally associated with lung diseases 
e.g. coughing blood (hemoptysis) in tuberculosis disease. 
Bacteriology is the smear status of pulmonary cases by which identification of M. 
tuberculosis is made for or any case by culture or other newer methods. Smear-




in their surroundings i.e. considered as the focus for infection targeted for control 
measures and contact investigations. A new sputum smear-positive pulmonary TB 
case is defined by the presence of at least one acid-fast bacillus (AFB+) in at least 
one sputum sample (WHO, 2009a).  
The WHO recommends staining for microscopy (M/S) using ZN stain as the primary 
diagnostic strategy for TB diagnosis in the developing countries (Sadaphal et al., 
2008). Microscopic examination of a sputum smear with ZN stain for AFB is a 100-
year-old method using special bacteriological stain that identifies TB acid-fast 
organisms. It is simple, inexpensive, accessible and cost-effective, and can be used as 
the primary and relatively rapid test for prediction of culture outcomes. 
The limitations of the test are that the test requires a minimum number of 10,000 
organisms/ ml as resolved by detergent concentrations, shows lower sensitivity 
(63%) and specificity (97%), results in pauci-bacillary samples e.g. HIV +ve smear 
sample, and cannot differentiate between MTB and NTM (Tiwari et al., 2007).  
Obtaining insufficient sputum will delay TB diagnosis and requires repeating SS or 
using a forced sputum collection (induced-type collection) (Greenberg et al., 1994).  
A positive sputum sample will denote infectiousness even in an asymptomatic case.  
Infectiousness is also correlated with sputum bacillary numbers (sputum grading) and 
duration of infectiousness e.g. higher grading by sputum smear is usually coincident 
with an individual who has been symptomatic for a longer period. 
Case detection significantly increases with longer SS examination time (10 minutes 
instead of 2 minutes) (Cambanis et al., 2007).   
If sensitivity rose to more than 85% then it is estimated that an additional 400, 000 
individuals could be saved each year globally. Reduction of ZN-phenol decreases 
staining sensitivity and TB detection (Selvakumar et al., 2005). AFB stain of pre-
bronchoscope sputum requires concentration (using sodium hypochlorite) by a 
trained technician to increase SS positivity (Aderaye et al., 2007).  
Any suspected individual is considered non-infected after three consecutive negative 
samples. A definite or relapsed TB case requires two repeated positive specimens or 




Risk factors for SS +ve samples are age (15-44 years), alcohol (delays in seeking 
medical care and TB diagnosis) and male gender (longer exposure) (Godoy et al., 
2004). HIV patients become less infectious in later disease stages of their disease, 
complicating TB detection having SS –ve sample and obtaining MTB culture growth 
(Apers et al., 2003). Such difficulties were revealed in another comparative study 
between four African countries sharing common geographic borders and social life 
due to different HIV prevalence’s of more than 33% e.g. Kenya, Zaire, Zambia and 
South Africa (Samb et al., 1999). 
1.2.3.1.2 Culture and antibiotic sensitivity 
The microbiological culture method is the multiplication of microbial organisms 
using specific growth culture media under controlled laboratory conditions to 
determine the type of infectious organism, and is commonly used for respiratory 
sample pathologies. Microscopic observation of broth culture is rapid, less expensive 
than the new TB diagnostics such as IGRAs and laborious but would be suitable in 
the developing countries (Tiwari et al., 2007). 
The isolation and culture of tubercle bacilli remains the ’gold standard’ for definitive 
diagnosis of tuberculosis with 100% specificity and no missing of any PTB case, but, 
requires four to eight weeks duration for achieving the final results due to slow 
growth of the MTB. Culture is also useful in differentiating MTB from other 
mycobacteria’s. Other limiting factors for isolation are paucibacillary samples mainly 
in childhood lesions and the requirement for more than 100 bacilli to be present in 1 
ml of specimen compared with 5,000-10,000 bacteria of 1 ml SS sample (Aderaye et 
al., 2007). Collection of gastric aspirate or broncho-alveolar lavage (BAL) for smear 
and culture is the most practical method. 
Examples of commonly used MTB culture methods include: 
BACTEC 460 radiometric TB systems (Becton Dickinson Diagnostic Instrument 
Systems, Sparks, MD, USA) widely used and considered as reference standard test in 




Anti-microbial drug susceptibility (ADS) has short MTB detection rate (mean 
reaching 14 days), but there are disadvantages in the high costs and the requirement 
for safe disposal of radioactive waste products (Rodriguez et al., 2007). In a study of 
337 samples examined in Spain comparing BACTEC 460 test and LJ media, 
BACTEC 460 showed higher sensitivity and negative predictive values, respectively, 
(97% versus (vs.) 90%, and 92% vs. 81%) with 100% similar specificities and 
shorter detection time in both SS positive samples (7 days vs. 24 days) and SS 
negative samples (11 days vs. 29 days for LJ media) (Casal et al., 1997). 
The MGIT 960 mycobacterium detection system (Becton Dickinson) is a new 
automated non-radioactive technique that identifies mycobacterium growth using a 
sensor to detect oxygen utilization for intensifying dye fluorescence present in 
detection tubes (Tiwari et al., 2007).  
1.2.3.1.3 Bronchoscopy  
Bronchoscopy is a visualizing technique that can directly examine the inside of 
airways. Bronchoscopy is an invasive test used to view airway abnormalities e.g. 
vascular bleeding, lung tumour biopsy and for therapeutic purposes (e.g. tumour 
surgical therapy, foreign body removal). The procedure shows a high level of 
accuracy level in diagnosing respiratory infections and missed focal abnormal CXR 
findings and guides broncho-alveolar lavage (BAL) to obtain samples confirming TB 
diagnosis even in normal CXR to rule out other possible diagnoses (Rosenthal, 
2003). For example, bronchoscopy diagnosis of complicated endo-bronchial TB 
cases in patients having high C-reactive protein levels (CRP) and small TST 
induration size less than 5-mm  higher than undiagnosed EPTB cases (Araz et al., 
2008).  
Fluids obtained by bronchoscopy are expensive and the procedure can be risky, but 
many lung-based immunological studies rely on bronchoscopy (Breen et al., 2007).  
New hospitals reserve bronchoscopy as a reference diagnostic test for all suspected 
respiratory complaints, and in addition to performing two gastric washes (GW) it is 




presenting with a difficult diagnosis (Dickson et al., 2003). Rare disadvantages that 
have been noticed include airway tears, bleeding, pneumothorax and laryngospasm. 
1.2.3.2 Molecular diagnosis 
1.2.3.2.1 Interferon gamma release assays (IGRAs)  
IGRAs involve two immunological blood tests; QuantiFERON test and T-SPOT .TB 
test using specific antigens to detect LTBI in those previously exposed with MTB 
(Schablon et al., 2009). IGRAs are discussed in section 1.4.2. 
1.2.3.2.2 Nucleic acid amplification test (NAA)  
The newest laboratory tools for the diagnosis of TB are nucleic acid amplification 
(NAA) tests which are performed on direct specimens in several hours. Nucleic acid 
sequences tests are heterogeneous tests using the polymerase chain reaction (PCR) 
technique to amplify and detect mycobacterium NA with superior accuracy. The test 
can be used for respiratory samples and is quick and sensitive. Tests are however 
labour-intensive and specific tests for MTB (e.g. PCR, DNA and RNA probes and 
IGRAs) have a limitation in low-income resource countries due to the expensive cost 
of equipment and consumable reagents. NA targeted sequencing reveals a highly 
accuracy result and replaces other diagnostic tests such as insertion sequence (IS) 
6100 specific for MTB (Campbell et al., 2006). 
Two commercial NAA tests are available that are approved by FDA in 2006 for 
organism identification, speciation, and drug mutational resistance. These include the 
Amplified Mycobacterium tuberculosis direct test (AMTDT, Gen-Probe) with an 
overall sensitivity of 92% and specificity of 99%, and the Amplicor test (Roche 
Diagnostics) (Nolte, 2006). AMTDT can predict culture outcome before making anti-
TB treatment decision, due to positive concordance with AFB staining and increased 
PPV, where both tests show positivity with 99% accuracy (Gallina et al., 2000).   
In Egypt, a prospective study evaluated 50 children at risk from families having a 
positive history of TB and concluded that the Gen-Probe technique could rapidly 




accuracy 98%) (el-Sayed Zaki et al., 2008). Amplicor MTB detects minimal active 
TB disease with 100% specificity but lower sensitivity (73%) (Al Zahrani et al., 
2000). 
1.2.3.2.3 Polymerase chain reaction (PCR) 
PCR is a selective direct amplification technique targeting specific DNA sequences 
and generating millions of copies of particular DNA sequences relying on thermal 
recycling. Primers (short DNA fragments) are complementary to their target region 
enabling selective and repeated amplification. PCR has revolutionized the field of 
infectious diseases as a diagnostic molecular technique since 1984 (e.g. real-time 
PCR) proven with highly sensitive and specific parameters relative to other 
conventional diagnostic methods and as an aid in rapid diagnosis of EPTB patients; 
sensitivity 89 % (75–100 %), specificity and PPV are 100%, NPV 96 %  (91–100 %) 
and test accuracy 97 % (93–100%)  (Queipo-Ortuno et al., 2009).   
PCR is rapid, easy to perform with high sensitivity > 80% and high specificity > 
99%. Better results are also revealed in SS positive smear (96%) than SS negative 
(53%) smear (Roos et al., 1998). Post-sample collection, PCR amplification is 
completed within 2-4 hours and the result detection assay requires another 2-24 
hours.  
Direct PCR methods were targeted at 11 regions of MTB HE7Rv (and absent from 
M. bovis) based on DNA amplification tests applied to 273 sputum samples revealed 
agreement with LJ culture media in comparing DNA purification/DNA 
amplification; 94% with culture results, sensitivity (93%), specificity (96%) and 
perfect concordance between both tests (Pinto et al., 2007).  
Comparative results of sensitivity and mean detection time to other MTB diagnostic 
procedures were respectively; PCR (sensitivity 74%, MDT < one day), LJ culture 
(49%, MDT = 24 days) and BACTEC culture (59%, MDT = 12.89 days). 
Comparison of other 145 samples test sensitivities (sensitivity & specificity) of 
suspected MTB cases for early PTB and EPTB diagnosis were respectively; PCR 




(50% & 20%) (Negi et al., 2005). PCR can also enhance diagnostic ability in pauci-
bacillary infection and atypical tuberculosis presentations. 
A study performed on 120 Tanzanian HIV positive patients testing collected from 
BAL, the sensitivity of both AFB smear (66%) and serology (zero%) against real 
time-PCR higher sensitivity (57-85%) and specificity (91%) in diagnosing active TB 
disease. Another conclusion for the low CD4+ cell count patients is that real-time 
PCR reduces level of contamination, reduces false positive and false negative, and 
diagnoses active MTB in BAL with high sensitivity (85%) and specificity levels 
(91%) (Kibiki et al., 2007).  
In Uganda, sputum PCR (targeting secA1 gene specific to MTB) on 127 HIV -ve 
subjects was shown to be highly sensitive (99%) and specific (88%) for PTB 
detection in comparison with oral wash PCR (73% sensitivity and 88% specificity) 
(Davis et al., 2009).   
A comparison between PCR, AFB staining and AFB growth culture methods on 
1,134 pulmonary samples and 1,839 non-pulmonary samples using estimated 
sensitivities as follows; PCR 77.5%, AFB culture 80%, AFB stain 49% and 
specificity as follows; PCR 100%, AFB culture 100%, AFB stain 99% (Kim et al., 
2008).  
PCR is not useful for testing drug sensitivity and NTM diagnosis.  PCR use is limited 
due to the high cost of the test (U.S.$15 per test) and is not feasible at present in most 
clinical laboratories, is unable to differentiate viable from non-viable AFB, and is not 
useful for drug sensitivity testing and NTM diagnosis, and common false positive 
results are associated with laboratory-introduced contamination (Tiwari et al., 2007). 
Another limiting factor is contamination of samples or the presence of inhibitors 
leading to false-negative or false-positive results. 
1.2.3.3 Other diagnostic tests requiring laboratory analysis  
1.2.3.3.1 Complete blood count (CBC) 
Blood tests such as full blood count, erythrocyte sedimentation rate (ESR) and urine 




definitive diagnostic test but can be used to limit other differential diagnoses e.g. iron 
deficiency normocytic anemia with neutrophilia and lymphopenia are common blood 
findings in cases of active TB disease. New DNA tests are diagnostic for MTB 
bacilli.   
1.2.3.4 Radiological diagnostic tests 
Radiology is the branch of medicine by which the interior of the human body is 
visualized using various forms of radiation. Radiologists utilize an array of imaging 
technologies to diagnose or treat diseases such as ultrasound (US), computerized 
tomography (CT), and magnetic resonance imaging (MRI). Interventional radiology 
is performing medical procedures (usually minimally invasive) with the guidance of 
imaging technologies. Medical imaging is carried out by the radiographer or 
radiological technologist and read by the specialist radiologist. 
Radiological screening is considered as another major diagnostic tool for identifying 
respiratory abnormalities. LTBI detected as post-active pulmonary disease using the 
regular revision guidelines of WHO recommendations, the American College of 
Radiology and UK National Institute of Health and Clinical Excellence (NICE) to 
improve diagnostic test accuracy (MacPherson and Gushulak, 2006).  
1.2.3.4.1 Chest X-ray (CXR)  
See below - section 1.3.1 Radiographical diagnostic test for tuberculosis. 
1.2.3.4.2 Computerized tomography scan (CT scan)   
CT scans or computed axial tomography (CAT) scans were introduced in the 1970s 
as medical imaging methods to generate three-dimensional images and are 
considered as rapid tests for diagnosing and screening of multiple disease entities 
supplementing X-ray results and detecting both acute and chronic changes in lung 
parenchyma. Cavitation is a common sign of LTBI and TB disease activity or miliary 
TB spread (hematogenous-dissiminated small nodules occurs in 2-6% of primary 
TB) (Nakanishi et al., 2009). Other common CT findings of PTB re-activation are 




nodular opacities (tree-in-bud sign), and patchy or lobular opacities of consolidation.  
The main advantage is achieved by reducing super-imposition of structures outside 
the lungs, but hazards of radiation doses and the expensive cost of the computing 
machine limit CT usage.  
CT is indicated for MTB detection in normal or inconclusive CXR and determines 
TB disease activity and complications e.g. 1-3 mm small size nodules. CT is valuable 
for a clinically ill patient having in-conclusive CXR findings for management 
guiding. A study done on 139 HIV +ve patients, CT was superior (69%) more than 
CXR (10%) in detection and exclusion of TB pulmonary complications e.g. severe 
pneumonias or atypical manifestations (Jeong and Lee, 2008). High-resolution CT 
(HRCT) predicts the risk of PTB in SS –ve sample with good reproducibility in 
probable TB cases.    
1.2.3.4.3 Other radiological diagnostic tests 
Magnetic resonance imaging (MRI) has the highest specificity and sensitivity 
indicated according to the country health resource budgets and cost/ benefit ratio.  
Comparison between tuberculosis radiologic and laboratory diagnostic tests are 
detailed accordingly; 
1.3 Radiological diagnostic test for tuberculosis    
1.3.1 Chest X-ray (CXR) 
The WHO recommends in imaging studies using chest radiography to detect chest 
and lung lesion(s) when any ’suggestive appearance of chest TB finding(s)’ is 
considered as probable TB case until proven otherwise.  
Chest radiographic findings and patterns might be most accurately interpreted in 
conjunction with clinical history and specifically prior TB treatment. Even though, 
approximately half of normal healthy individuals do not show a common "expected" 
radiographic pattern of LTBI. Recent primary TB is characterized by lymph 




to TB re-activation(s) are typically located in the lower part of upper lobes or the 
upper part of middle and/ or lower lobes with characteristic cavitatory lesion. 
CXR images are taken for all body anatomy e.g. chest wall, heart, bones, and is still 
considered as the standard rapid test (usually completed within 15 minutes), simple 
(no special preparation), commonly performed, cheap (inexpensive machine), 
excluding other salaries e.g. in a Cambodian survey the total costs of screening 
30,000 subjects was U.S.$550,000 (U.S.$25 per person), non-invasive (painless), 
rare side effects, suitable for medical surveillance and diagnosing and evaluating 
lung response to medical treatment. CXR images expose the body to small doses of 
ionizing radiation to produce an internal image (Glaziou et al., 2008). 
CXR equipment has a fixed box-like apparatus containing X-ray film or an image-
recording digital plate and X-ray producing tube. X-rays are small-burst radiations 
pass through objects to record images. Various films depend on the body part’s 
degree of absorption e.g. bone is more absorbable (appears white) than soft tissue or 
muscle (appears gray) while lung air (appears black) against lung tissue (dark) 
(Figure 1.15). 
Two chest views are taken from the back (poster-anterior; PA) and from lateral side 
(lateral; L). PA is more informative but still using both views show higher diagnostic 
accuracy (OR 3.7) relatively than taking separate PA view (OR 3.09) or lateral view 






Figure 1.15: Procedure of chest X-ray radiography taking postero-anterior (PA) view 
(http://www.radiologyinfo.org/en/pdf/chestrad.pdf) (DOA: 26/01/2012) 
CXR is indicated for any suspected TB chest complaint, such as cough, fever, 
hemoptysis, and shortness of breath but with contra-indications in pregnant women 
(fetus radiation exposure), chest metals (image interference) or risk of cancer (with 
repeated and high radiation dose exposure). In 2000, the American Thoracic Society 
(ATS) and CDC recommend using a single PA radiograph for all TST positive adults 
and children more than 5 years of age, with limitation to lateral radiographs due to 
economics saving U.S.$18 per case and U.S.$72,000 per year and reduction in 
annual case load of 4,000 radiographs and radiation exposure (Meyer et al., 2003).  
Characteristics 
Chest radiographic classifications for TB abnormalities are categorized into five 
broad groups:  




2. Granuloma’s with or without calcification considered likely due to remote TB 
infection (LTBI) and/or is defined as possible active TB. Another three findings 
are considered as consistent with probable active TB:  
3. Apical fibro-nodular disease or multiple non-calcified nodules 
4. Pleural disease or mass in the parenchyma, hilum, or mediastinum, and  
5. Parenchymal lung multiple infiltrates with or without cavitations’.  
CXR can detect chest lesions e.g. cavitatory or nodular lesions, even in the absence 
of another superior diagnostic test like a SS +ve sample, but still cannot exclude TB 
particularly in immuno-suppressed patients, as category (Figure 1.16). 
 
Figure 1.16: Chest X-ray of patient diagnosed with advanced bilateral pulmonary 
tuberculosis showing bilateral pulmonary infiltrate and cavitatory formation 
(http://emedicine.medscape.com/article/230802-diagnosis) (DOA: 26/07/2009) 
Radiological differences between outbreak and non-outbreak cases reported that 
cavitations were not characteristic of outbreak cases. For example the extent of 
cavitations in HIV-positive patients has been directly correlated with CD4+ cell 
counts, and the radiographic changes in the outbreak cases may reflect severe 




nosocomial exposure usually share several characteristics. HIV-positive and 
significantly immuno-compromised and HIV-positive patients, having average mean 
CD4+ cell counts of 119 cells/mm
3
 usually presented with common acute febrile 
illnesses and might harbor of MDR-TB super infection (Sacks et al., 1999). 
Radiological findings of patchy consolidation, nodular opacity, mass-like lesion, 
fibro-calcified lesion and pleural effusion are typical PTB findings and there is a 
significant positive association with foreign-born population from TB endemic 
region (high TB incidence > than 20 cases per 100,000 population) compared to TB 
low endemic areas (low TB incidence < than 20 per 100,000 population) (ACHA, 
2011).  
Periodic CXR screening of LTBI-infected HCWs and for patients previously treated 
is crucial and has been recommended since 1983 by FDA and WHO (Mangura et al., 
1999). Fibrotic lesions are defined as well-delineated radiographic lesions compatible 
with healed tuberculosis (Rieder et al., 1994). 
CXR a routine test for screening immigrants in suspected mid-adolescence having 
pauci-bacillary sputum smear with low risk of TB secondary transmission 
(MacPherson and Gushulak, 2006). Suspected PTB in children is better diagnosed by 
pediatrician’s with a higher specificity and diagnostic accuracy (diagnostic OR 8.3) 
than primary care clinicians (diagnostic OR 2.5) (Swingler et al., 2005).  Prevalence 
of radiologically active TB disease was 33 per 1,000 individuals and higher than 
previous estimates of community radiographic surveys undertaken between 1955-
1957 in India (13.5 to 26.6 per 1,000 populations) (Joshi et al., 2007). 
Statistical parameters  
Chest X-rays show variable statistical characteristics. Usually CXR-tested TB 
suspects and those having ‘any pathology detection’ showed lower sensitivity and 
specificity than those radiographic CXR-tested and diagnosed within the ‘consistent 
for TB’ class.   
CXR statistical finding in scoring ‘TB’ among those suspects having sputum smear 




‘any pathology’ respectively; 92% and 63%. Sensitivity (77%) of scoring ‘highly 
consistent for TB’ among suspected HIV negative was higher than among HIV 
positive suspects (49%) (van Cleeff et al., 2005).  
Poor inter-reader agreements’ of pulmonary parenchymal abnormalities on chest 
radiographs suggests offering a list of differential diagnoses instead of an actual 
diagnosis. Researches in radiographic interpretations should focus on the potential 
lack of consistency in CXR interpretation reporting abnormalities, which can be 
improved with involvement of more radiography readers’. For missing of specific 
difficult radiographic findings, inter- and intra-observer reading is recommended to 
be assessed using kappa (k) agreement value (Bloomfield et al., 1999).  
Overall good intra-reader agreement (k = 0.621) and moderate for inter-reader 
agreement (k = 0.439) improved with repeated training on reading and following 
reporting system of standardized CXR films (Graham et al., 2002). For example, 
experienced radiologists show high intra-observer agreement for reporting presence 
or absence of CXR findings with fewer errors (Tudor et al., 1999).   
Costs 
CXR is a relatively cheap procedure. In Canada 2000, a programme prospectively 
screened for inactive TB tested 250,000 immigrants and showed consistent low-cost 
preventive intervention for young immigrants with 50% high probability of TB 
infection and 10% HIV sero-positivity. The total cost saving per 1,000 populations 
was U.S.$398,870 against U.S.$492,840 using TST screening and the incremental 
cost per case prevented was U.S.$21,580 (Schwartzman et al., 2000).  
In 1979, estimated total expenditure was U.S.$8,200,575 (U.S.$25 per film) if all 
hospitals in USA took radiographs of TST positive employees (Mangura et al., 
1999).  
CXR screening is cost-effective compared to TST and is applied in most countries 
worldwide compared to TST. A study on pilgrims coming from high endemic areas 




(performed within one month before travel to Mecca) were impractical follow-up test  
for TB abnormalities instead of CXR and having higher costs, time consuming of 
administrative infrastructure’s (Al-Jahdali et al., 2003).  
Advantages 
CXR remains the major diagnostic and screening tool for health disorders 
particularly for pulmonary chest abnormalities or for examining lesions, and can 
deliver a rapid test result. A CXR atypical film of an immune-suppressed individual 
e.g. HIV+ve patient is best interpreted by two qualified readers guided by a 
standardized recording policy system and reported from third radiographic reader for 
difficult lesions and discrepant results (van der Werf et al., 2008).   
Characteristic PTB re-activation is commonly manifested as focal or patchy 
heterogeneous consolidation involving the apical and posterior segments of upper 
lobes and either/or both superior segments of lower lobes (Figure 1.17). 
 
Figure 1.17: Postero-anterior CXR of tuberculosis re-activation with cavitations 





Other typical findings include the occurrence of lesion like nodular or linear opacities 
(25%), cavitations (20-45%), hilar or mediastinal lymph adenopathy (5-10%) and 
unilateral pleural effusions (15-20%).  
Characteristic ‘tuberculoma’ is only observed in 5% of PTB cases (Figure 1.15). 
Tuberculoma lesion size is often about 0.5-4 cm diameter with round or oval sharp 
margins and histological central caseous necrosis composed of peripheral histiocytes, 
multinucleated giant cells, and collagen fibers’ (Jeong and Lee, 2008). Large cavities 
are common in right lobes (average 40%) and left lower lobes (30%).  
A past history of PTB can help in differentiating between MTB and NTM pulmonary 
cavitory lesions. Factors predicting PTB cavitations with environmental 
mycobacterias are age less than 50 years history of malignancy large upper lobe 
cavity lesion confined to one lobe and/ or multiplicity of lymph nodes more than two 
(> 2)   (Yang et al., 2007).  
High prevalence of abnormal radiographic finding(s) reflect combinations of 
previous and recent exposure to MTB infection, and so CXR can still identify 
subjects at risk of LTBI progression to active TB until specific INF-γ levels 
measured. For example number of calcified nodules (> 2-5 lesions) and fibrotic 
lesion size of more than two (> 2)  mm in 80% suspected cases are suggestive of 
inactive TB at risk for re-activation within 10 years period compared with contained 
primary lesions due to repeated exposures (van der Werf et al., 2008).    
Another LTBI finding is non-calcified nodular lesion(s) present in mid and/or upper 
lung zones or as pulmonary infiltrates with subsequent PTB (sensitivity 66% and 
specificity 82%) (Linh et al., 2007).  
Reliable risk factor indicators of lung abnormal changes are smokings, ethnic origin 
(African and East Europeans, 90%), symptomatic sputum smear positive sample 
(60%) than negative smears (46%) (Mathez et al., 2007).   
CXR imaging done on any suspected patchy pneumonia and help in epidemiological 




leading to prolonged morbidity, increased mortality and mycobacterium 
transmission. 
Antibiotic prescription (e.g. macrolides treating community-acquired pneumonias) 
without taking CXR during the first health care visit was independently associated 
with health care delays (mean delay = 69 days) compared with CXR imaging (mean 
delay = 15 days) (Golub et al., 2005).  
Limitations 
CXR is an objective method with subjective reading that depends on readers’ 
experience for differentiation between image findings. CXR results can provide 
diagnostic clues with ambiguous analysis e.g. atypical findings in immune-
compromised subjects and with inter-and intra-observer image interpretation 
(Kobashi et al., 2008; Tiwari et al., 2007).  
Limitations in interpretation of various health professionals. For example poor inter-
observer agreement in localizing abnormalities usually detected between TB 
specialists (k = 0.473) and respiratory specialists (k = 0.277) (Jeong and Lee, 2008). 
A study of 805 chest films reveals inter-reader good agreement (k = 0.69) for normal 
CXR finding with excellent intra-reader agreement (k = 0.90). For TB-consistent 
abnormalities, both agreements were good (k = 0.69) and higher for parenchyma 
more than for central structure abnormalities (den Boon et al., 2007). 
Suspected CXR findings only detect high-risk groups but not TB disease activity. 
Other high penetration diagnostic tests e.g. CT scan, detects pulmonary findings and 
can replace CXR. 
Miss-diagnosis is crucial for difficult findings. For example, failure to recognize any 
hilar or mediastinal lymph-adenopathy of primary PTB lesions or over-looking of 
parenchymal abnormalities of dormant bacillary re-activation with failure to detect 
any characteristic LTBI upper lobe nodule opacity or scar can instead be diagnosed 
by CT scan. Initial correct diagnosis of CXR findings in primary TB disease is 
achieved only in 49% and 59% for secondary TB re-activation TB to CT scan correct 




Lateral X-ray film is frequently performed for LTBI evaluation without additional 
benefit in detection of any missed abnormal X-ray findings by PA view, but is still 
useful to rule out other differential diseases like malignancy and NTM. LA adds no 
information in altering TB management e.g. missed calcified granuloma makes no 
treatment changes (Meyer et al., 2003; Swingler et al., 2005). 
CXR performance depends on TB ‘severe’ presentations in addition to co-morbid 
diseases. HIV radiological findings are a significantly independent predictor of TB 
disease and are commonly associated with atypical findings (Geng et al., 2005) 
(Figure 1.18).  
 
Figure 1.18: Chest radiograph of atypical pulmonary tuberculosis (Geng et al., 2005) 
Atypical radiographic findings are associated with a paucity of cavitations, pleural 
effusion, miliary TB, and interstitial lesion patterns. The developing countries are 
facing the spread of a TB/HIV syndemic. In Ethiopia and Uganda, HIV-positive 
patients usually have normal CXR findings are sputum sample smear–negative for 
AFB with a CD4+ cell count less than 200 cells/mm
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 and reduced 
mycobacteriological colony count in comparison with HIV-negative cases (Aderaye 





CXR film (machine, reagents) and inability to relate radiographic findings to results 
of sputum smear results, which add more problems of under- and over-reading 
difficulties. The degree of reader’s agreement depends on the reader professional 
experience and complex interpretation. In a Canadian study, where 973 films were 
read twice by three independent observers, for TB abnormal versus normal findings, 
the intra-reader agreement using five diagnostic categories was moderate to good (k 
= 0.59-0.72, mean 0.636) compared with fair inter-reader agreement (k = 0.44-0.56, 
mean 0.526)  (Zellweger et al., 2006).  
Radiographic appearance cannot be relied on directly to assess presence of 
pulmonary lesions or PTB activity for treatment decision. Out of a total of 8, 995 
immigrants, 630 with demonstrated abnormalities, only 125 subjects with CXR 
findings  had suspected TB lesions and 107 subjects proven active TB disease (90% 
were from African and East European origin) (Mathez et al., 2007).   
Radiographic accuracy is another limiting factor with interpretation errors related 
directly to reporting facilities (poor information communication) and radiology 
experience. CXR is invaluable with low diagnostic accuracy in certain conditions e.g. 
mediastinal lymph adenopathy or other extra pulmonary sites e.g. pleural lesion.  
Radiographic reader complacency can be directly and indirectly related to daily 
reading of plain radiographs, over-reading and missing abnormal findings, reporting 
time and personality type, lack of knowledge, and under-reading/wrong 
interpretations (Tudor et al., 1999).   
Extra pulmonary tuberculosis is considered more infectious than pulmonary 
tuberculosis case regardless of CXR failure to detect EPTB which can be diagnosed 
by history taking of clinical complaint such as severe weight loss, related socio-
economic risk factors and laboratory testing for bacteriological identifications of 
positive sputum smear examination and culture (OR 4.3) (Parimon et al., 2008; 
Zellweger et al., 2006). 
Further clarification for chest X-ray advantages, disadvantages, and limitation are 




1.4 Laboratory diagnostic tests for tuberculosis 
1.4.1 Tuberculin skin test (TST)  
TST has existed without any changes since the late 19
th
 century. The test is 
essentially as described first by Robert Koch in 1890 and as modified by Charles 
Mantoux a French physician who developed Koch’s work for use in diagnosis of 
both active and latent TB infections.  
Definition 
TST is a traditional in vivo skin test to measure an individual’s immune 
inflammatory response delayed type hypersensitivity reaction-4 (DTH-IV) against 
multiple mycobacterial antigens. 
Procedure  
TST is performed using intra-dermal injection of the tuberculin (glycerin extract of 
tubercle bacilli) of a purified protein derivative (PPD); a standardized killed extract 
from cultured TB or mixture of precipitates of more than 200 non-species-specific 
molecules of mycobacterial antigens including M. bovis and non-Mycobacterium 
tuberculosis strains.  
TST is performed by injecting 0.1 ml of tuberculin (100 units/ml) intra-dermally into 
the volar surface of the left forearm followed by a water pool ink mark drawn around 
the injection site for easy  reading after 48-72 hours (but not more than one week). 
Sub-cutaneous injection (instead of intra-dermal injection) gives false-negative 
results and requires an experienced operator nurse to perform the different stage 
patterns; Mantoux screening test; TST (tuberculin sensitivity) and two-step testing 
(which is less common). 
TST results are recorded by measuring the transverse diameter of cutaneous 
indurations (swelling) in millimetres (but not the red erythema) (Zellweger et al., 





Figure 1.19: Mantoux tuberculin skin test showing intra-dermal injection of PPD into 
the forearm (http://www2.cdc.gov/PHTN/tbmodules/modules1-5/m3/3-m-02a.htm) 
 
Figure 1.20: Tuberculin skin result measure induration (swelling) size in millimetres 
(http://www2.cdc.gov/PHTN/tbmodules/modules1-5/m3/3-m-02a.htm) (DOA: 26/07/2008) 
TST results are recorded and reported according to national guideline policy. For 
example, any indurations’ size more than 5-mm diameter is considered as a positive 
reaction in BCG non-vaccinated individuals such as those in the UK or the U.S. 
compared with TB endemic regions as positive more than 10-mm e.g. China or even 




Two common PPD manufactured Aplisol and Tubersol types were injected intra-
dermally in 116 subjects and were then compared with IGRAs to conclude  
agreement of 93% at day 2 (k = 0.80) and 94% at day 7 (k = 0.76). Overall 
agreement for Tubersol was 89% and 86% for Alpisol recorded during same time 
period. Seventh day TST reading can be compared with IGRAs INF-γ level (Tat et 
al., 2005).  
Cost  
TST is cheap and is manufactured from low cost materials. Cost of a single test is 
U.S.$9.79 (£5). 
Advantages 
TST is in widespread use and is the preferred test in developing countries e.g. India 
and Indonesia and worldwide remains the second choice for LTBI diagnosis. TST is 
a simple, cost-effective and confirmatory test in regions having BCG +ve vaccination 
regimens particularly in close contacts to TB infectious index cases. Such tuberculin 
converters to positive result have 5-10% risk of developing active TB after 2-5 years, 
and another 5-10% risk during lifetime period (Al-Orainey, 2009).  
Among 1,885 Tanzanian screened HIV +ve cases, 13 had active TB disease, 1,206 
subjects looked healthy, but all 635 of LTBI subjects (100%) showed a TST response  
more than 5-mm compared with active TB patients (84.6%) and negative results in 
healthy subjects. TST indurations’ is higher in HCWs with radiological lesions 
suggestive of possible active TB e.g. non-calcified nodules and indication for 
periodical TST re-testing (Joshi et al., 2007).  
The mean TST diameter was significantly higher in both active PTB and inactive 
PTB patients compared with healthy individuals (Akbulut et al., 2009).  
For LTBI screening, both NICE and HPA guidelines also recommend performing 
TST during BCG immunization against infectious diseases. CDC guidelines consider 
any TST induration size more than 15-mm as diagnostic sign of LTBI in low-risk 




Screening for LTBI in new expatriates following the 1
st
 positive TST is 
recommended by HPA, but NICE guidelines are limited to compulsory testing in 
large screening programmes linked to health service (HPA, 2008). 
Baseline TST testing is recommended for HCWs to track acquired occupational TB 
and/or tuberculin converter’s associated with previous TB exposure. TST is repeated 
as standard compulsory test for initial negative TST result (e.g. false negative in 
immune-suppression condition). A study on 527 internationally adopted children 
(IAC) at risk of severe TB disease/and LTBI re-activation having low body weights 
and initial negative TST results could detect LTBI in 20% converters to TST 
positivity compared with 47% after two-step repeated TST. BCG scar and/or 
documented immunization (OR 15) are associated with initial TST positive, but 
positivity risk decreases after repeating TST (OR 7) (Trehan et al., 2008).  
Disadvantages/ limitations 
TST subjective reading reduces test specificity and impacts on LTBI detection.  
Diameter results must be read with caution, particularly in vaccinated individuals and 
in endemic regions.  
One-step TST tuberculin reactivity is less reliable in those having induration size 
more than 18-mm even in endemic areas due to BCG positive vaccination and MTB 
shared antigens reducing TST specificity (Tissot et al., 2005). PPD negative result is 
down-regulated in immune-suppressed individuals or those highly anergic with 
‘Koch phenomenon’ post-vaccination.   
In Australia 2004, a prospective study tested the recently culture-proven TB cases 
revealed that both TST induration and specific IFN-γ release were higher in MTB 
infection compared with NTM cases and to other risk factor combinations e.g. 
protein malnutrition, HIV co-infection (Britton et al., 2005). Practical difficulties in 
administration and interpretation give false results. PPD mycobacterium antigen 
mixtures induce painful or scarred indurations’ skin reactions. Biological variability 
may affect TST results between inter-subject e.g. BCG boosting and intra-subject 




indurations’ sizes; more than 5-mm and more than 10-mm are correlated to BCG 
immunization and false positive results (Diel et al., 2008). 
Meta-analysis of TST specificity relating with the injected PPD concentration and 
preparation heterogeneity, reader subjectivity, and variable international cut-off point 
achieve LTBI miss-diagnosis and active TB case loss up to 20-25%. Negative AFB 
smears have negative PPD reactions (induration < 5-mm) compared with positive 
AFB smears (RR = 2.2) (Samb et al., 1999).  
Further clarification for tuberculin skin test advantages, disadvantages, and limitation 
are further discussed in chapter 5 (section 5.2). 
1.4.2 Interferon gamma release assay tests (IGRAs)   
Various TB diagnostic methodologies address the absence of ‘gold’ standard 
diagnostic tests in relation to: 1)- comparison of blood test results to identify true 
positives with active TB,  2)- testing TB true negatives and LTBI free individuals 
(from TB non-endemic areas and without risk factors), 3)- degree of concordance 
with TST results, 4)- positive IGRAs with LTBI exposure risks, and 5)- longitudinal 
follow-up studies for positive IGRAs individuals to  ascertain LTBI progression and 
predict PPV validity in diagnosing LTBI (HPA, 2008).  
LTBI screening includes taking a history of past TB infection and management e.g. 
exposure to index case, incomplete anti-TB course, TB relapse, partial follow-ups or 
radiographic residual changes with calcified nodular granuloma and laboratory MTB 
isolations with rapid IGRAs or PCR diagnostic superiorities (Lalvani et al., 2008). 
In clinical settings, 24 hours is considered a practical period between results 
reporting in relation to established diagnostic accuracy (mean range 85%). 
Assessment of consistent diagnostic accuracy is calculated through measuring the 
kappa agreement value between different procedures using longitudinal studies 





IGRAs are two new diagnostic (blood) tests and are implemented at present in the 
developed countries for detection of LTBI and active tuberculosis. Both tests detect 
the cytokine interferon gamma released from MTB previously sensitized T-
lymphocytic cells. IGRAs use antigenic proteins present in all MTB-complex species 
having peptides; early secretory antigenic target 6 (ESAT-6) and culture filtrate 
protein 10 (CFP-10), which are encoded by a unique genomic segment of MTB 
(stretch of DNA) termed as  ’Region of Difference’ or RD-1 present specifically in 
MTB and M. africanum but not in BCG (M. bovis) or majority of environmental non-
mycobacterium (with exception for M. kansasii, M. marinum and M. szulgai) 
(Andersen et al., 2000; Richeldi, 2006) (Figure 1.21). The loss of RD-1 region from 
M. bovis during virulence attenuation permits production of BCG vaccine. Another 
highly specific antigen TB7.7 (Rv2654) was newly mapped to RD-11 genome by 
which can maximize MTB detection sensitivity, in which TB7.7 unique phage 
insertion was added to the latest version of QuantiFERON (QuantiFERON Gold In-
Tube) test.  
 
 






Figure 1.21: Demonstration of IGRA specific antigen 
(http: //www.rsm.ac.uk/tbscreening07/catanzaro.pdf) (DOA: 26/07/2008) 
Genetic studies reveal both ESAT- 6 and CFP-10 antigens are peptides of 15 amino 




sequences are uniquely restricted to ESAT and CFP proteins of MTB complex 
(Lalvani et al., 2001a).  
Combination of both IGRAs antigens reactivity is significantly higher in active TB 
disease than LTBI (Yew et al., 2009).  
Under in vivo conditions, the RD-1 encoded proteins can cause direct or indirect 
progressive necrosis secondary to interactions between the host cells and bacterial 
proteins but not due to bacterial overloads. Data supports that non-mutant MTB 
bacilli expressing RD-1 can cause dramatic necrosis in mice lungs which is unable to 
make INF-γ (Junqueira-Kipnis et al., 2006). Molecular diagnosis and analysis of 
MTB strains investigated to compare between the past and new TB infections 
according to the country source of origin is the future recommendation.  
Evidence-based study results attest to IGRAs superiority in LTBI detection compared 
with other TB standard diagnostic tests. In Norway, 155 HCWs compared with 48 
healthy controls using both TST and T-SPOT .TB  test to assess risk of acquiring TB 
after recent exposure to PTB positive sputum sample at three different University 
hospitals reveal LTBI prevalence was 3% with low risk of transmission frequency 
(2%) within short duration and IGRAs improve this approach (Storla et al., 2009).  
IGRAs based on RD1-specific antigens are correlated better with exposure intensity 
and BCG independence, and accurately detect LTBI better than PPD-based assays.  
BCG lacks groups of genes (Rv3971 to rv3879) including genes for antigenic 
proteins ESAT-6 and CFP-10 of RD-1 made by MTB early during culture growth but 
with unclear precise action.  
IGRAs assess risk factors of BCG vaccinated individuals. Available commercial 
IGRAs are independent of any previous BCG vaccination and test the immune 
responses against specific TB antigens missing from other mycobacterias’ or BCG 
attenuated bovine TB and are not confounded by the BCG vaccine. 
Indications  
The WHO and National Tuberculosis Program (NTP) recommend international TB 




from NTM infections, diagnosis of case problems in any clinically-related 
differential diagnosis e.g. acute life threatening TB meningitis, diagnosis of 
suspected TB in TST negative result e.g. anergy, organ transplant, repeating IGRAs 
for variable INF-γ level results, and as a marker of treatment cure post-active TB 
treatment or LTBI prophylaxis. IGRAs can be used as a confirmatory test for positive 
or indeterminate TST results read by TB specialist (Al-Orainey, 2009). 
Worldwide examples of implementation of IGRAs 
The UK Health Protection Agency (HPA) recommends the use of IGRAs for LTBI 
detection undertaken at the time of TST reading and for HCWs or those in direct 
contact with immune-compromised patients and those at risk of developing active 
TB disease e.g. testing nurses, laboratory technicians. Other HPA indications for 
IGRAs include use for primary diagnosis of active TB, to confirm diagnosis of 
highly suspected with negative culture result cases, individuals lacking radiological 
and histo-pathological tests, and to help confirmation of final decision after starting 
anti-TB treatment (HPA, 2008). Guidelines of NICE (UK) recommended IGRAs for 
HCWs without known history of BCG vaccination even if free of active TB disease 
or used for active TB diagnosis and ruling out MTB infection. The U.S. CDC 
recommended QuantiFERON testing for all TST positive and negative results 
including evaluation of recent immigrants or sequential test surveillance programmes 
and suggests TST replacement by QuantiFERON test.  
IGRAs can be used as primary tests to rule out LTBI in immuno-compromised 
individuals showing a false negative TST result and in public health investigations.  
Advantages  
IGRAs evaluate TB infection by differentiating LTBI and active TB positive result 
from other differential diagnoses, and excluding non-infected immune-compromised 




LTBI was detected using the ESAT-6 ELISPOT test in 80% of healthy adults for 
contact tracing in high-prevalence areas and this is helpful in assessing LTBI 
prevalence (Lalvani et al., 2001b). 
IGRAs maintain a higher diagnostic sensitivity and specificity for LTBI than TST in 
subjects taking disease modifying anti-rheumatic drugs (DMARDs) for TNF-α 
blockade e.g. rheumatic disease (Lalvani et al., 2008). A follow-up study of 42 
participants in a Dutch supermarket for employee contact investigation in 2005 and 
2006 showed 59% (17/29) as having TST negative result has converted after one 
year to TST positive result. On the other hand, 82% (23/28) have primarily T-SPOT 
.TB test positive result which reverted to negative results compared to only 3% (1/29) 
reversal of QNF-GIT participants. According to the Netherland epidemiology, these 
converted TST results in association with IGRAs negative reversion are not related to 
MTB re-exposure or BCG boosting effects of past TB infection.  
CFP-10 antigen response indicates active bacterial replication, whereas, ESAT-6 
antigen persists as an immunological ’scar’ indicating higher T-SPOT .TB test 
specificity for LTBI detection (Franken et al., 2007).  
ESAT-6 assay detects more positive results in MTB high-risk groups than TST, 
distinguishes asymptomatic NTM infection, and accurately detects recent MTB 
infections in close contacts to index cases and require long term follow-up to 
estimate predictive value of active TB progression (Lalvani et al., 2001b). 
IGRAs reduce false-positive results and avoid LTBI preventive prophylaxis among 
children and the adult population. T-SPOT .TB test is correlated more with the 
degree of exposure (closeness and duration of exposure) than TST. A two-step 
screening approach of contact tracing using TST followed by QNF-G test increases 
LTBI detection and test accuracy (LTBI missing reduced by 30-40% of new case 
expectation because of recent transmission) (Al-Orainey, 2009).  
IGRAs tested on 383 subjects detected positive results in all close contacts 
irrespective of their BCG vaccination. PTB close contacts scoring ELISPOT positive 




indeterminate results in those taking immune-suppressive treatments (Ferrara et al., 
2006).  
In Turkey, another study focused only on 908 pediatrics cases recently exposed to 
household TB index cases, ELISPOT positive children with high INF-γ levels were 
significantly associated with 3-4 fold progression to active TB  compared with non-
significant positive TST results of 2.7 fold  (Bakir et al., 2008). 
A large prospective study done on 626 hospital patients followed up OPDs in the TB 
Prevention and Control Unit in Barcelona, Spain, T-SPOT .TB test positive results 
were significantly higher than QNF-GIT results. Agreement between both IGRAs (T-
SPOT.TB+/QNF-GIT+) was the highest 83.2% (k = 0.66) compared with lower T-
SPOT.TB+/TST+ agreement of 64.5% (k = 0.34) or QNG-GIT+/TST+ agreement of 
58% (k = 0.26 (Dominguez et al., 2008).   
TB infection control with careful follow-up screening is crucial to reduce nosocomial 
infection transmission. Prevalence of LTBI was 77% in Georgian HCWs, detected by 
using combination of QNF test and TST, and was significantly higher than single use 
test (QNF +ve detect LTBI prevalence 66 % and 60 % for TST +ve result). Length of 
employment > 5 years was associated with TST +ve result (OR 5) against QNF +ve 
test (OR 2.26) with moderate agreement of 73% with positive TST > 10-mm (k = 
0.43) (Mirtskhulava et al., 2008).  
LTBI screening in high risk groups using TST and/or IGRAs is cost–effective even 
in low TB incidence areas, but a hybrid strategy is more economical. A study in San 
Francisco on homeless, refugees, intravenous drug users (IDU’s), and immigrants 
implementing QNF test including costs of phlebotomy, laboratory and personal costs 
revealed IGRA cost was only U.S.$33.67 per patient tested for undertaking routine 
TB control programmes (Dewan et al., 2006).  
Excluding indeterminate results, the estimated specificity of IGRAs for LTBI 
detection in low-risk population is still high, ranging between 96-99% compared 
with standard study test parameters TST-/QNF+ result, were detected more in 
subjects born in TB endemic countries (OR 5) than those having both tests negative 




were tested, comparing modified versions of both T-SPOT .TB test (sensitivity 85%, 
specificity 100%) and QNF-GIT (sensitivity 92%, specificity 91%) revealed 
excellent agreement (0.89-0.90) between both IGRAs and each test separately with 
TST, without interfering with delayed type hypersensitivity reaction (Tavast et al., 
2009).  
Limitations 
The main limitation is that IGRAs are expensive (cost; U.S.$37.9, £20-40). 
Indeterminate results can occur when the positive mitogen control fails to react, and 
needs to be interpreted with caution due to absence of stimulable lymphocytes either 
due to pre-analytic error with freezing of blood samples during transportation or due 
to a real absence of living T-lymphocytes in immune defects (Madariaga et al., 2007; 
Zellweger, 2008). In advanced HIV +ve patients with having low CD4+ cell count 
less than 100 cells/mm
3
 both TST and QNF-GIT tests are less sensitive and 
significant relation with indeterminate results e.g. QNF -ve result association (OR 
4.2) (Luetkemeyer et al., 2007).    
The absence of sufficient data to assess serial testing (IGRAs reversion and 
conversion phenomenon) limit IGRAs assessment. Longitudinal (time-period) 
follow-up screening studies are required to approve IGRAs repeatability and 
accuracy assessment.  
The IGRAs test technology has been designed to replace the 115-year-old TST and 
this is the first approved diagnostic tool with superior accuracy to assist in 
elimination of TB globally. The two commercially available IGRAs measure ex vivo 
interferon gamma released from circulating MTB-sensitized T-cell lymphocytes 
correlated with TB exposure. Both IGRAs similarly explore the immune cell 
response against MTB specific antigens and provide quantitative and dynamic 
measurement of immune reaction than TST, in which IGRAs can be added to serial 
screening studies (Richeldi, 2006).  
Meta-analysis studies of published articles revealed IGRAs high statistical 




IGRAs detect both active TB and act as surrogate diagnostic test for LTBI in TB 
high-risk group populations. TST specificity is only higher than IGRAs in BCG non-
vaccinated population (pooled specificity = 0.97 (0.95–0.99), p = 0.032). The overall 
meta-analysis conclusion recommends IGRAs implementation (especially QNF test) 
in BCG vaccinated individuals particularly for infants or in TB endemic countries 
having immunization guidelines of repeating BCG (Veerapathran et al., 2008).   
Newly diagnosed TB cases detected by ELISPOT test (sensitivity 78%) - better than 
QNF-GIT (64%) and with a similar sensitivity detection of TB contacts (Adetifa et 
al., 2007).   
Both IGRAs increase sensitivity and specificity for LTBI detection either combined 
with, or, replacing TST (Pai et al., 2005). 
A study of 425 subjects detected high sensitivity using a combination of TST and 
either IGRA test. A negative result combination (QNF-GIT–/TST–) can exclude 
active TB by 14-fold-time. IGRAs rapid immune-diagnosis of active TB is especially 
required for sputum smear negative and EPTB cases (Goletti et al., 2008).   
IGRAs test help detection of LTBI prevalence and assess TB-related health disorders 
in low-incidence countries and help identification of TB cases in high-risk groups. 
In Gambia - a poor-resource TB-endemic country - both IGRAs respond to MTB 
exposure gradient and are positively associated with increased TST indurations’ size. 
Both IGRAs also diagnose LTBI in TB contacts with similar agreement and 
significant concordance 75% (k = 0.43) (Schablon et al., 2009).  
IGRAs tests are recommended as baseline screening tests for HCWs or new 
immigrants before, and annually after, employment (Bakir et al., 2008).  
IGRAs indeterminate result denotes that the test finding gives no fixed-type 
diagnosis (neither positive nor negative) e.g. 1- insufficient response of the mitogen 
positive control, 2- nonspecific background staining in the wells, 3- nonspecific INF-
γ release by the mononuclear cells in the well (result in high nil-control spot count) 




pregnant). In clinical practice on such occasions, subjects should be screened using 
other available diagnostic tests e.g. sputum routine microscopy or TB growth culture. 
1.4.2.1 QuantiFERON Gold In-Tube test 
Definition  
In vitro and indirect laboratory tests aid in detection of MTB infection using peptide 
cocktail of simulating antigens; QuantiFERON test (QNF), an enzyme-linked 
immunosorbant assay (ELISA) tests uses whole blood involving two specific 
stimulating antigens: 1)- early secretory antigenic target-6 (ESAT-6) and 2)- culture 
filtrate protein-10 (CFP-10). Both antigenic proteins encoded within the ‘Region of 
Difference-1’ (RD-1) are specific to MTB genome.  
The IGRAs test accuracy is improved by choosing antigens absent from BCG 
vaccine and are able to stimulate specifically INF-γ responses.  
The first IGRA version was the QuantiFERON (QNF) test followed by the 
QuantiFERON GOLD (QNF-G) test.   
The latest version replacing the old generation is QuantiFERON Gold-InTube (QNF-
GIT) test and another third specific antigen TB7.7 (Rv2654) encoded by a phage-
inserted region, ‘Regional of Difference-11’ (RD11) is added.  
Assay technology depends on incubating heparinized whole blood over 16-24 hours 
to detect TB infection based on measurement of INF-γ levels (Lalvani et al., 2008). 
The three antigenic proteins have no cross-reaction with PPD and are used in a 
surveillance programme with the two-step TST testing or as screening test for TST 
boosting phenomenon.  
Separated or isolated ESAT-6 and CFP-10 antigens that are used for active TB 
detection reveal lower sensitivity (84%) and specificity (89%) in comparison with 
QNF combined-antigen test (sensitivity 93% and specificity 100%) with 90% 





One ml whole blood is withdrawn and placed in each of two separate heparin tubes; 
one coated with specific antigens (ESAT-6 and CFP-10) and the other serves as 
negative control. Tubes are sealed and incubated at 37 C for 16-24 hours, preparatory 
to centrifugation. During this period, MTB antigens recognized by T-cell 
lymphocytes subsequently secrete INF-γ into the cell supernate against no secretion 
from non-infected T cells. Plasma removal followed by assay of released IFN-γ from 
sensitized T cells and previously exposed to MTB antigens, ESAT-6 and CFP-10. 
ELISA determines INF-γ levels using 200-microlitre plasma sample. After 
stimulation, the plasma supernate can be kept at 2-8 C for 4 weeks or at -20 C for 
three months.  
In the ELISA, monoclonal antibodies determine quantitatively released INF-γ 
concentration levels and are read as international units (IU) using a special Software 
package for result evaluation and interpretation. After correction for negative control 
tube, any value of more than 0.35 IU/ml is considered as the cut-off point for a 
positive result according to the manufacturer guidelines. 
Non-specific INF-γ concentrations found in negative control tube are first subtracted 
from the test result (Kunst, 2005; Pai et al., 2006).  
Characteristics 
The QNF test was approved first by Federal Drug Administration (FDA) in 2001 and 
QNF-G test in 2005 to aid in MTB diagnosis by measuring cell-mediated immune 
reactivity and the latest QNF-GIT approved finally on 10/10/2007.   
The test reported as a comparable diagnostic test, having characteristic high 
sensitivity and specificity in diagnosing both PTB and EPTB, is less reactive to 
atypical MTB, is conveniently administered, has a more objective result and 
interpretation, and is used as baseline test in surveillance health systems allowing 
reliable reporting and research comparison.  
A cross-sectional study done on 800 navy recruits (TST, QNF, and QNF-G) revealed 




compared with estimated QNF (92%) and QNF-G (99.8%). Those having positive 
TST result of more than 10-mm and more than 15-mm were 20–40 times likely 
having discordant results for soldiers born in TB high-prevalence countries due to 
resolved or past old infections, and lower TST specificity and lower QNF sensitivity. 
For example, TST +ve response was more with larger indurations’ size and so a 
combination of both QNF and TST is more specific to detect LTBI than separate 
testing (Mazurek et al., 2007).   
Advantages  
The QNF test is valuable diagnostic test (highly sensitive and specific) and detects 
70% of truly infected active TB and 100% predictor of LTBI at risk of progression 
(Sauzullo et al., 2008).  
The challenge of IGRA positive result without using an invasive procedure permits 
the QNF test to be performed as adjunctive tool for rapid detection of PTB and 
EPTB. Diagnostic accuracy for LTBI detection among exposed contacts is higher 
than TST +ve results. A Norwegian study, performed on 904 asylum seekers, 
detected LTBI prevalence defined by TST as 50% and only 29% by using QNF test. 
Predictors of positive results using QNF and TST more than 15-mm tests are 
associated with ages between 18-29 years, female gender, country of origin and TB 
country background (Asian’s then African’s), and accumulated exposure time. 
Adjusting TST cut-off value to lower indurations’ than 10 or 15-mm will increase 
LTBI prevalence (Winje et al., 2008).   
In Bussan, South Korea, a study done on three TB risk groups concluded that the 
QNG test can be considered as diagnostic tool for LTBI, particularly in BCG +ve 
vaccinated and differentiates vaccinated healthy individual from active TB case 
compared to TST difficulties. Measured INF-γ levels in TB patients was higher 
(INF-γ = 15.5 +/- 4.5 IU/ml) than nurses (high TB risk group) (INF-γ = 11.7 +/- 5.5 
IU/ml) and medical students (low TB risk group) (INF-γ = 1.3 +/- 0.9 IU/ml). Results 
were also significantly correlated with the duration of employment (intensity and 




Multivariate analysis concluded the presence of a significant correlation with 
working duration but contradictory to BCG vaccination. These differences can be 
related to biological factors (participant immunology), BCG vaccination, and 
laboratory-related errors (Ozdemir et al., 2007).  
The QNF test can detect LTBI in BCG +ve individuals with low TB exposure risks 
(Lee et al., 2009; Taggart et al., 2001). In Hamburg, Germany, a study followed 601 
contacts diagnosed as having AFB +ve smear and MTB culture-positive, 40% were 
TST –ve at 5-mm cut-off against 11% QNG test –ve result. LTBI progression rate to 
active TB disease was detected better by QNF test (14%) than TST (2%). BCG 
vaccinated subject were 12 times higher to have TST +ve (OR 12.5) and 6 times to 
be foreign–born (OR 5.8) whereas QNF test positivity is BCG vaccination 
independent (OR 1.14) (Diel et al., 2008). 
Limitations 
QNF test results revealed low sensitivity for LTBI/TB diagnosis in those with low 
CD4+ cell count e.g. advanced immune-suppressed individual or HIV/AIDS 
(Balcells et al., 2008). Processing of whole blood for 12 hours is considered a major 
limitation, weakening the QNF test with un-acceptable positive INF-γ levels.  
In a study done on 270 active TB subjects, the QNF-GIT indeterminate result rate 
was 3.5% after treatment associated with risk factors e.g. age > 60 years, being 
female gender, and ethnic origin due to decreased T cell response (Chee et al., 2008). 
In another multivariate analysis, QNF-G positivity had no significant association 
with exposure durations due to the masking effect of age but still detected accurately 
all true LTBI infections in healthy individuals (Harada et al., 2006). 
Disadvantages 
QNF test repeatability and accuracy need longitudinal re-assessment screening 
studies on large sample sizes. Among 63 subjects tested in California using two-step 




specificity 98%, unexpected false-reversion (32%) and false–conversion rates 
(6.95%) were revealed (Perry et al., 2008).  
Further clarification for QNF-GIT advantages, disadvantages, and limitation are 
further discussed in chapter 6 (section 6.1). 
1.4.2.2 T-SPOT .TB test    
Definition   
ELISPOT (enzyme-linked immunospot assay) test was first developed by Cecil 
Czerkinsky in 1983 based on modified version of ELISA immunoassay to enumerate 
B cells secreting antigen-specific antibodies with identification and enumeration of 
cytokine-producing cells at the single cell level. ELISPOT assay used to measure 
released IFN-γ. 
The second IGRA test is T-SPOT .TB assay produced only by Oxford Immunotec 
Ltd. (Oxford, UK) and approved by FDA in 2006. T-SPOT .TB test is an in vitro 
diagnostic assay measures specifically IFN-γ released from sensitized T-cell 
lymphocytes (LMCs) following isolation, washing and exposure of peripheral blood 
monomorphonuclear cells to MTB antigens, ESAT-6 and CFP-10. Appearance of 
spots in the test well represents MTB-sensitized T-cell and is interpreted after 
comparison with negative and positive control wells (Kunst, 2006; Pai et al., 2006). 
Each visualized spot represents secretory products of responding reactive cells. 
Unlike QuantiFERON ELISA test, T-SPOT .TB test does not determine INF-γ level.  
Procedure 
T-SPOT .TB assay is based on ELISPOT methodology and requires isolation and 
incubation of standardized 250,000 LMCs in each of the test wells.  
In vivo sensitized T-cells from blood circulation are incubated ex-vivo overnight to 
re-encounter MTB antigens to release the INF-γ cytokine from the sensitized T-




The manufacturer recommends 4 ml blood withdrawal (2 ml in children) and assay 
performed within the first eight hours after sampling. LMCs are separated from 
blood on Ficoll gradient then placed in microtitre wells already surface-coated with 
antibody against INF-γ. Antigens are then added for comparison with a positive 
control (phythaemagglutinin; or PHA) followed by incubating the plate at 37 C for 
16-20 hours and adding of a second enzyme-conjugated antibody against INF-γ and 
chromogenic substrate where bound enzyme cleaves the substrate [translator’s 
correction] and a coloured spot forms. Each counted spot is read visually or using 
magnifying glass, or rarely by using specific plate-reader. The accepted cut-off point 
for positive result is more than > 5 spots. The positive mitogen control normally 
gives at least 20 spots. If the negative control plate gives an apparent positive result 
(non-specific stimulation) then the positive control spots plate should show at least 
twice higher than the number of negative control spots.   
Characteristic  
The T-SPOT .TB test is a new technology designed to specifically and quantitatively 
detect activated T effecter cells. It is highly sensitive, provides a rapid result (< 24 
hours), is convenient, objective and accurate in assessing the cellular immune 
response against MTB infection, and is used as screening tool to identify community 
TB and LTBI risk groups.  
Advantages 
The T-SPOT .TB test was introduced to increase TB and LTBI diagnostic rates and   
as a useful screening tool with immune-epidemiological evidence of high diagnostic 
accuracy to detect TB-related disorders at community level.  
ELISPOT responses in advanced HIV positive patients are independent of CD4+ cell 
count.  
The T-SPOT .TB assay has negative association with history of anti-TB treatment. 
After two weeks of therapy in 270 patient culture +ve proven results, a statistical 




positive assay show higher sensitivity in 254 cases (94%) compared with positive 
QNF-GIT test in 224 patients (83%)  (Chee et al., 2008).  
In UK, February 2001, one student in a secondary school diagnosed as being sputum 
smear positive and PTB CXR positive cavitations after which 1,128 other contact 
students tested with TST only detected 69 active TB secondary cases and 254 LTBI 
infected students. Between May and June in 2001, another school outbreak involved 
535 students from one infectious index case and diagnosis was based on conventional 
criteria (clinical assessment, radiological CXR and Heaf test yield LTBI of 24%). A 
combination of TST and ELISPOT tests revealed high agreement (k = 0.72). 
ELISPOT +ve result was significantly associated with direct time-exposure to the 
index case (OR 2.5). ELISPOT positive results in LTBI-presumed students have 
higher Heaf grades with longer exposure durations to MTB than ELISPOT negative 
students (Ewer et al., 2003).  
Positive reversion to negative result occurred post anti-TB curative and preventive 
chemoprophylaxis (Chee et al., 2008). A silicosis patient is an indication for T.SPOT 
.TB testing, especially in TB endemic countries due to aggravating risk factor 
combinations (Leung et al., 2008). Similar indications for use in hemo-dialysis 
patients (chronic renal failure) or cutaneous anergy and insensitive TST (Passalent et 
al., 2007). 
Close contacts of recently MTB-infected patients require follow-up to estimate 
predictive values of developing active TB disease. Screening study on close contacts 
a jail in Texas, USA, found LTBI prevalence rates of 19% using T-SPOT .TB test 
against 8.5% using TST and lower false-positive results (Porsa et al., 2007).  
Disadvantages/limitations 
There are difficulties in LTBI detection and discrimination between LTBI and active 
TB disease due to an increase in immune-compromised disorders. The discordance 
reflects the limitation of the IGRAs tests for implementation. The UK National 
Institute for Health and Clinical Excellence (NICE) guidelines 2006 approve a 




T.SPOT.TB-/TST+ (10-27%). IGRAs are considered an inadequate replacement to 
TST for LTBI detection (Janssens et al., 2007).  
Further clarification for T-SPOT .TB test advantages, disadvantages, and limitation 
are further discussed in chapter 6 (section 6.2). 
1.5 Aim and outline of the thesis 
The overall aim of the thesis is to study the challenges in tuberculosis prevention in 
the State of Kuwait during 2010, through early detection and management of latent 
tuberculosis infection and tuberculosis disease suspicion. The magnitude of the TB 
disease problem (morbidity, resistance and death) prompts more investment in 
clinical, epidemiologic and operational research in TB. Failure and weakness of the 
health care system to suspect and early diagnose TB-related suspects to reduce re-
activation risks and active TB case development argues for a need for revising case-
finding strategies which can directly result in reduction of non-infectious (LTBI) and 
infectious (active) TB cases and better TB control. Identification of latent 
tuberculosis infection cases (as ‘suspect TB’) can be facilitated by building a 
classification tree using epidemiological-radiographic-laboratory test results 
(epidemiological suspect and diagnostic test results). The approach adopted in the 
thesis is outlined below;  
Chapter I introduces an overview discussion of latent tuberculosis and tuberculosis 
disease definition, diagnosis, and management.  
Chapter II assesses the trends of tuberculosis morbidity and mortality representing 
TB health-related status of the community residents of both Kuwaitis’ and non-
Kuwaitis’ in the State of Kuwait.  
Chapter III describes the thesis methodology of the project steps: A- new immigrant 
interview using questionnaire, and B- describe implementation of the four 
tuberculosis diagnostic tests on the same immigrant: two old tests; chest X-ray and 




Chapter IV discusses LTBI-epidemiological suspicion and investigates risk factors 
through clarification of the questionnaire epidemiological variables with estimations 
of LTBI point-prevalence. 
Chapter V discusses LTBI-laboratory diagnostics and evaluates the performance of 
the two old tuberculosis diagnostic tests; chest X-ray and tuberculin skin test, and the 
effect of BCG vaccination on Mantoux diagnostic test results.  
Chapter VI evaluates the performance of the two new tuberculosis IGRAs diagnostic 
tests; QuantiFERON Gold In-Tube and T-SPOT .TB tests for diagnosis of LTBI 
cases. 
Chapter VII building a classification tree of evidence-based laboratory diagnostic 
criteria for detection of LTBI and ‘suspect tuberculosis’ cases. 
Chapter VIII identifies evidence-based predictors for LTBI. 
Chapter IX discusses the cost effectiveness of immigrant’s  chemo-preventive 
screening. 
Chapter X describes general discussion and recommendations.  
Thesis Output: Recommendations to modify institutional infection control and 
occupational health policy with comparison of the effectiveness of a new model 
versus the old screening policy to speedily predict highly ‘suspect TB’ (secondary 
case re-activations), TB prevention using prophylactic chemotherapy and save 
human and economic costs.   
Thesis Conclusion: The project result finally permits development of a screening 
algorithm aimed at achieving 100% sensitivity for confirmed LTBI and ‘suspect TB’ 
case with the highest possible positive predictive value (PPV) for physician-






2 Chapter Two 
Assessment of tuberculosis-related health status of all 





This chapter presents the health system and standard health policy for diagnostic era 
and control of tuberculosis in Kuwait. This work assesses retrospectively the 
epidemiological trends of tuberculosis morbidity, mortality and related fatality by 
gender and nationality associated with international migration into the State of 
Kuwait, and the policy measures followed to control migration patterns. The work 
described in this chapter presents a descriptive analysis of the trends in TB morbidity 
and mortality, and risk factors-tuberculosis disease association, in the current 
demographic infrastructure of Kuwait residents according to nationality and gender. 
Demographic data were obtained from the Kuwait national records over a 26-year-





2.1.1 The State of Kuwait  
Kuwait lies at the northwestern corner of the Arabian Gulf and covers an area of 
17,820 square kilometres (Km
2
) (11,073 square miles). It shares a 222-kilometre 
(138-mile) border with Saudi Arabia to the south and southwest, and a 242-kilometre 
(150-mile) borderline with Iraq to the north and west. Kuwait has a population 
density of 171.21 persons per Km
2
 with an urban population rate of 97 percent 
allocated all over the country towns, including the capital city, Kuwait City, were 
majority of people are located along the Arabian Gulf Sea, toward the south (Figure 
2.1). The currency is the Kuwaiti Dinar (K.D.). Following decades of in-house 
family disputes and on-going conflicts with the Ottoman Empire, in 1899 Britain 
agreed to manage foreign relations until Kuwait gained independence in 1961. 
Kuwait's agricultural development is very limited, having an extremely hot climate 
and a dominant desert topography and with the exception of fish. It is almost entirely 
dependent on imported food. During the late 1940s, the extent of Kuwait's oil 
resources became obvious and the long-term potential of the petroleum industry was 
realized, now having a modern and well-developed infrastructure. Kuwait has several 
major electric power-generating plants providing the country with drinking water 
through desalination operations and removing salt from seawater. The chief exports 
are oil, oil-related products and fertilizers whereas imports are food and livestock, 
















Figure 2.1: International map of the State of Kuwait 
(http://www.worldatlas.com/webimage/countrys/asia/kw.htm) (DOA: 26/01/2012) 
2.1.2  Kuwait population residents 
The population of Kuwait refers to the total number of inhabitants, of which a third 
are natives, divided unequally across the country’s six governorates: Al ‘Asimah, 
Hawalli, Al Farwaniya, Mubarak Al-Kabeer, Al Jahra and Al Ahmadi (Figure 2.1). 
Immigrants represent 70% of the total population. The total population of Kuwait 
(nearly 3.5 million) is composed of Kuwaitis: non-Kuwaitis in ratio of 1:2.5, and is 
considered a good example of a non-endemic country with a TB incidence of 35 per 
100,000 populations (WHO, 2010e). The population growth rate (PGR) is estimated 
to be 3.44 per 1000 person. The annual crude birth rate of Kuwait is 21.88% while 
the annual crude death rate is 2.42 deaths per 1000 persons. According to the 
estimation census made on December 2004, the total population was 2,644,777 with 
a total of 942,892 Kuwaiti’s compared with 1,118,911 Kuwaiti’s out of 3,484,881 
when counted on December 2009 (HVS, 1984-2009). A similar distribution has been 






MK = Kuwaiti males, FK = Kuwaiti females, TK = total Kuwaiti’s, MNK =non-Kuwaiti males, FNK = non-Kuwaiti 
females, TNK = total non-Kuwaiti’s, MT = total males, FT = total females, GT = grand total  
Figure 2.2: Chart represents the distribution of Kuwait residents by gender and nationality 
through three different decades (1980’s, 1990’s and 2000’s) (HVS, 1984-2009) 
Migration is increasing annually all over the world. Immigration having travel-
associated negative health impacts and in particular affecting TB non-endemic 
regions. The net migration rate (NMR) of Kuwait is around 15.65%, ranking third 
worldwide in 2010 (Factbook, 2011). 
Table 2.1: Net Migration Rate of Kuwait (2000-2011) estimated) (Factbook, 2011)  
 
The main immigration ‘pulling’ or ‘in-migration’ factor is the need for a labour force 
which is similar to all developed and non-endemic low incidence countries (Figure 
2.3) (Shah, 2007). 









































Figure 2.3: Chart represents the total labour force (age 15 years and above) and 
distribution by nationality in Kuwait, 1985-2007 (Shah, 2007) 
The second driver for immigration is family re-unions/visits, followed on third by 


















Asians = includes all Asians, Arabs = includes all Arab nationalities 
Figure 2.4: The distribution of non-Kuwaiti population by nationality or broad 




2.1.3 Impact of migration on LTBI & TB  
With the increase in migration, immigrants are in particular need of close monitoring 
and screening programmes to tackle TB transmission and to ensure effective general 
public health. Migration is a major risk factor with public health risk on infectious 
diseases epidemiology. Population-demographic changes are related to contact-
exposure and importation of LTBI/active TB from high- toward low-prevalence 
regions such as return visits and re-exposure risks (McCarthy, 1984). An individual’s 
geographical history (immigration and foreign travel, destinations, travel-exposure 
durations) is important in any assessment, as well as consideration of age and general 
health of traveler’s including risk of type of job/work (Freeman et al., 2010). 
Immigration demographics indicate that Asians, Blacks, and Hispanics bear the 
greatest burden of TB and screening of immigrants can protect community public 
health in nations of low TB incidence. Western Europe faces irregular migration of 
TB cases a phenomenon that has increased during the past two decades and is 
investigated using routine medical examination and migrant screening (MacPherson 
and Gushulak, 2006). The incidence of tuberculosis in the country of birth is crucial 
to predict variation in demographic structure changes which can be used to focus and 
target TB elimination and prevention efforts toward the high-risk TB groups 
(Watkins et al., 2002). Worldwide, and in Kuwait in particular (where the number of 
immigrants has doubled the Kuwaiti indigenous population), it is essential to 
understand the drug susceptibility of M. tuberculosis, especially in low TB 
prevalence regions due to the risks of uncontrolled immigration and high travel of 
hosts (Saif Alfaresi and Hag-Ali, 2010). 
Despite national and WHO international recommended guidelines for the diagnosis 
and treatment of both LTBI and TB disease,  health care workers still lack alertness 
and have poor knowledge of TB added, to which can be added under-estimation of 




2.1.4 Arabian Gulf countries’ health policies 
Countries have different responsibilities and legal obligations towards various types 
of international migrants, these responsibilities being restricted by international 
human rights laws, national laws and labour organizations. Regardless of the reason 
for migration, fears of the consequences of uncontrolled migration on national public 
health has led to restrictive immigration procedures been followed, as a compulsory 
requirement for immigration e.g. obtaining a visa requires prior health examination 
from an immigrant’s mother country, and such workers are only admitted on a 
temporarily for specified periods.  
2.1.5 Kuwait’s health and anti-tuberculosis policy 
A global expansion of TB control programmes for immigrant populations in Kuwait 
has achieved a significant decrease in TB-harboring immigrants from countries of 
high TB incidence. International collaboration between TB immigration screening 
programmes and national TB programmes within the countries of origin offer 
benefits to both immigrant-source and immigrant-receiving countries (Alvarez et al., 
2011). Kuwait Ministry of Health has been proactive in committing support and 
financial resources for health system maintenance for example funding TB epidemic 
control programmes utilizing both national governmental and non-governmental 
efforts in collaboration with the Stop TB Partnership through adequate follow-ups, 
sufficient information handling procedures, and authorities’ coordination (Oxlade et 
al., 2009). Kuwaiti governmental support to the Ministry of Health has successfully 
improved the health care system and increased the quality of human life, for example 
offering a free and accessible health care service with compulsory notification of any 
infectious disease within the country. An increased movement of people through 
travel and immigration has stressful effects on public health responses and associated 
with transmission threats of international communicable diseases (Coker, 2004). The 
budget for the National Programme for Tuberculosis (NPT) in Kuwait was increased 
to U.S.$6 million for 2011 (compared with U.S.$4 million in 2006) (WHO, 2010b). 
Worldwide, TB screening programmes for immigrants can take place in three ways: 




occurs at the point of entry into the host country and at airports or other transit 
migrant centres; and, thirdly, through post-arrival screening after entry to the host 
country in transitioning centres such as Immigration Centres. In Kuwait, the 
Department of Public Health guidelines specify infectious diseases control through 
both steps one and three for TB screening before official entry of immigrants to the 
State.   
Policy measures and governmental efforts in Kuwait manage migration, family re-
unification and permit authorized movements through obligatory legislation and 
serious measures that serve to safeguard workers’ rights. Immigrants have no right to 
remain in Kuwait in the destination country beyond the period of authorized 
employment. A balanced migration policy means bringing the immigration level 
down towards the emigration level. Kuwait operates an ‘entry points based system’ 
that includes a compulsory visa known in Arabic language as ‘Kafalah’ followed by 
employment-limited authorization and issue of the obligatory civil identification 
card, which is is provided only after the person has been awarded a certificate 
reporting a post-examination ‘normality report’ issued by the Tuberculosis Control 
Unit (TCU), a sub-division from Department of Public Health. The entry report 
includes results of six diagnostic tests: HIV/AIDS, hepatitis B and C, malaria, 
filariasis and a chest X-ray (CXR). New immigrants are tested at one of four 
immigration centres; Al Asma’a, Al Farwaniya, Al Jahra or Al Fahaheel, and test 
results are transferred to the Department of Public Health for final approval of entry.  
A positive test result is used as an indication for isolation of the immigrant and 
treatment before deportation. Within the Tuberculosis Control Unit, any suspected 
CXR tuberculosis case is further tested with the tuberculin skin test; positivity is an 
indication for further diagnostic testing such as sputum culture and antibiotic 
sensitivity to rule out active TB prior to admission for treatment and rejection. 
2.1.6 Kuwait notification system 
In 2009, Kuwait's population totaled 3,484,881 with an increase of 47% of human 
immigration, compared with 1,786,616 in 1984 (Kuwait Times, December 07, 2009). 
Almost 60% are foreign residents looking for jobs, with an estimated 70% being 




expatriates and new immigrants coming into the country per day. Each immigrant 
should be registered within one month after been offered a temporary viza before 
entry to the country. 
A strict notification system provides accurate assessments of the national health 
system and care services, and missed or lost cases are not an issue. By law, any 
suspected infectious diseases, including TB cases, are only diagnosed and treated in a 
governmental hospital. The overall case detection rate for TB in Kuwait is 100%, 
compared with only 70% in the South East Asia Region (WHO, 2010c). In European 
industrialized countries such as Norway, Ireland and Great Britain, a detected rise in 
incidence of TB since 2001, among young foreign-born subjects belonging to 
immigrant families from high-incidence countries, is due to increases in national TB 
notification rates (Dahle et al., 2007). 
All tuberculosis death and hospital discharge rates can be safely used for comparative 
purposes of the health status and communicable diseases trends either national 
(within Kuwait) and/or international (worldwide). Surveillance systems can 
determine causes of death (mortality) and discharge (morbidity) as potential sources  
for detecting improvements in TB diagnosed case rates (Home, 1984). With high 
coverage of the Ministry of Health, Kuwaitis’ regular national surveillance and 
establishment of tuberculosis reference centres (e.g. TCU) add elements of control to 
both diagnosis and management. Accurate registration data are available and 
accessible without the need for morbid rate estimations. The slowing of the decrease 
in TB rates all over the world and in Kuwait can be largely attributed to persistence 
of LTBI/TB in foreigners’ and foreign-born populations. The rate of TB is usually 
nearly 2 to 5 times higher among non-Kuwaiti residents than among the Kuwaiti 
population, and TB is most prominent in the Asian populations (HVS, 1984-2009; 
Jassal and Bishai, 2010).  
2.1.7 Strengths and limitation of health policy system 
Strict notification of any diagnosed and admitted TB individual to the Ministry of 
Health authorities in Kuwait is essential. Any suspect and diagnosed TB cases should 
be admitted. No admission, diagnostic testing or management is allowed except in 




or Infectious Disease hospital, and then transferred to or admitted directly to, 2)- 
Tuberculosis Curative Unit. All admissions represent all the cases of tuberculosis in 
the country, and thus incidence and prevalence can be calculated from these hospital-
based data.  
Limitations appear because of the absence of a central database able to differentiate 
newly diagnosed (incident) cases from old re-admitted cases i.e. re-admission is 
considered as a new case. TB stigmatization may lead to the preference of some 
residents, even Kuwaitis, to be managed outside the country. Such cases can be 
missed with absent diagnosis in the issued death certificate. Wrong diagnosis due to 
language barriers and miss-diagnosis may occasionally occur e.g. in prison or field 
workers in the desert due to case accessible difficulties. 
2.2 Aims and objectives 
Assess the morbid trends of tuberculosis disease of all residents in Kuwait during the 
last three decades. 
2.3 Methodology 
Tuberculosis data between 1984 and 2009 were collected from the annual 
publications of the Department of Health Information and Vital Statistics (HVS). 
Morbidity and mortality rates were calculated accordingly using Microsoft Office 
Excel 2003 (©Microsoft Corp etc), and figures were drawn using Microsoft Office 
Excel 2007 (©Microsoft Corp etc). 
2.4 Results 
2.4.1 Trends in tuberculosis morbidity (1984-2009) 
Population morbidity and mortality in Kuwait can be identified through study of all 
residents who are influenced by infectious diseases and by the endemic tuberculosis 
of the foreign migrant’s according to the geographic distributions and related socio-
demographic backgrounds. Tuberculosis case admission is taken according to the 




hospital occurs for implementation of diagnostic-related-procedures. Tuberculosis 
morbidity rates representing tuberculosis prevalence over a 26-year-period (1984-
2009) in Kuwait were calculated as percentages of tuberculosis hospital discharges 
per 1,000 population (almost equal to prevalence) and tuberculosis hospital 
discharges per 1,000 hospital discharges (which represents the burden on hospitals). 
All rates been tested for two demographic population characteristics (gender and 
nationality), and were calculated as represented as the following: 
2.4.1.1 Tuberculosis hospital discharges per 1,000 total population 
during a 26-year-period (1984-2009) (Figure 2.5, Appendix 1 - Table A) 
The overall morbidity trends of TB discharges per 1,000 populations have declined 
gradually from 0.49 in 1984 to 0.29 in 1989. Post Iraqi invasion a steady continuous 
fluctuation trend reaching average of 0.26 until 1999, then declined to 0.08 per 1,000 
populations until 2004 is observed. A sudden increase in the TB morbidity trend has 
occurred since 2005 (0.22 per 1,000 populations) and continued almost at the same 
rate until 2009. The highest calculated rate after invasion was 0.29/1000 population 
in 1993, 1996 and 1997, whereas, the lowest value rate of 0.07/1000 population was 
demonstrated in 2001, 2003 and 2004. In general, males and non-Kuwaitis’ rates 

















































































































































Figure 2.5: Trends in tuberculosis hospital discharges per 1,000 population by gender and 
nationality reported in Kuwait, 1984-2009 (MK = Kuwaiti male, FK = Kuwaiti female, MNK = 
non-Kuwaiti male, FNK = non-Kuwaiti female, N/A = data not available) 
2.4.1.2 Tuberculosis hospital discharges per 1,000 total hospital 
discharges during a 26-year-period (1984-2009) (Figure 2.6, Appendix 
2 - Table B), 
In general there was a decline between 1984 and 2004, with two steady periods; the 
first was between 1989 and 1996 and the second one, at a lower level, between 2000 
and 2004. Then the trend sharply increased until 2009. All non-Kuwaitis’ rates have 
been continuously rising since 2005, where males reached 7.59 and females 4.61 in 
2009, compared with rates of only 1 for Kuwaitis. Non-Kuwaitis always had higher 
rates (nearly double) than those of Kuwaitis and also male rates were comparatively 
higher than those of females. The highest calculated rates after the invasion were 
























































































































































 Figure 2.6: Trends in tuberculosis hospital discharges per 1,000 hospital discharges by gender 
and nationality reported in Kuwait, 1984-2009 (MK = Kuwaiti male, FK = Kuwaiti female, MNK 
= non-Kuwaiti male, FNK = non-Kuwaiti female, N/A = data not available) 
2.4.2 Trends in tuberculosis mortality (1984-2009) 
Tuberculosis mortality status representing the tuberculosis deaths over a 26-years-
period in Kuwait. All rates been tested also for two demographic population 
characteristics (gender and nationality), and were calculated as represented as the 
following: 
2.4.2.1 Tuberculosis cause-specific mortality rate per 100,000 
populations (TB CSMR/100 000 population) during a 26-years-period 
(1984-2009) (Figure 2.7, Appendix 3 - Table C)  
Tuberculosis cause-specific death rate is defined as the annual total number of deaths 




The overall mortality trends reveal tremendous sharp declines of TB cause-specific 
mortalities per 100,000 populations in all CSMR annual rates from 2.63 in 1984 to 
0.64 in 1989. Post-1990 a steady continuous fluctuating trend reached averages of 
less than 1 until 2009. A sudden reversal with double increase in TB morbidity trends 
has occurred since 2008 from 0.56 to 1.16 for Kuwaitis’ mortalities and 0.54 to 0.85 
for non-Kuwaitis per 1,000 populations. The highest calculated rate after invasion 
was 1.17/100 000 populations in 1995, whereas the lowest value of 0.39/100 000 
populations was calculated in 1998. Non-Kuwaiti females rates averaged around 
one/100 000 populations after no cases in 1993. In general, male and Kuwaitis’ rates 










































































































































Figure 2.7: Trends in tuberculosis cause-specific mortality rates (CSMR) by gender and 
nationality reported in Kuwait, 1984-2009 (MK = Kuwaiti male, FK = Kuwaiti female, MNK = 
non-Kuwaiti male, FNK = non-Kuwaiti female, N/A = data not available)  
2.4.2.2 Tuberculosis case fatality rate (tuberculosis deaths per 100 
tuberculosis hospital discharges (TB deaths/100 TB hospital 




On average, the overall trends of TB case fatality rates were below 5% of total TB 
discharges during the 26-years-period, with intervene by a sharp incline of average 
10% between 2000 and 2004, followed by decline to rates below 5%. Kuwaiti’s 
suffered higher case fatalities than non-Kuwaitis. There was a sharp increase in 
Kuwaiti fatalities from 5.56% in 2008 to 11.02% in 2009, compared with a 0.5% 
increase for non-Kuwaitis (from 2.65% in 2008 to 3.06% in 2009). Males Kuwaiti’s 
have markedly higher case fatalities than females (Figure 2.8).  
 
Figure 2.8: Trends in tuberculosis case fatality rates by gender and nationality reported in 
Kuwait, 1984-2009 (MK = Kuwaiti male, FK = Kuwaiti female, MNK = non-Kuwaiti male, FNK = 





















































































































































International economic migration flows are continuously increasing all over the 
world from low socio-economic regions towards richer countries, where the majority 
of immigrants are looking for economic opportunities and economic globalization. 
Mobility of the world’s population is rapidly becoming a key determinant of 
infectious disease epidemiology. Prevalent screening using definitive intervention 
and cost-effective procedures for agreed diagnostic criteria toward health restoration 
are pre-requisites.  
Tuberculosis, hepatitis and HIV/AIDS are predominantly detected in Asian and 
African immigrants. Tuberculosis epidemiology differs according to the infection 
pressures in different countries, with consequent variable probability of development 
of tuberculosis disease: the greater duration of exposure and the length of time spent 
in close contact with high-risk populations, the greater the risk of latent TB infection 
and late-appearing clinical disease (McCarthy, 1984). Immigrants from TB-endemic 
countries play a role as sources of tuberculosis infection, particularly within migrant 
communities due to contact patterns of the migrant communities (Lillebaek et al., 
2002; Rieder et al., 1994). Follow-up screening of high-risk groups at entry for the 
burden of immigrant-associated tuberculosis (active infectious and inactive non-
infectious) (Coker et al., 2006) is needed, together with efficient intervention 
programmes  (Liu et al., 2009) and follow up targeting of TB contacts (Mulder et al., 
2009) for anti-TB and preventive therapy. Screening among migrants will lead to 
earlier case detection, shortened symptom duration, and reduction by 33% of MTB 
infectiousness and hospitalization. Cooperation among countries should reduce 
political differences and facilitate the development of improved screening 
programmes. 
 
The demographic infrastructure and population health status of Kuwait has been 
changing over the last four decades and is associated with the global changes in 
trends of communicable diseases and the overloads of health care services. There are 
common worldwide TB-associated demographic risk factors such as gender, place of 




gender difference exists, men showing a higher reported case notification rate of 
tuberculosis than women, necessitating active case finding and strengthening of 
primary health care (Buu et al., 2010; Sharma and Kumar, 2010). 
The direct indicators of the burden of tuberculosis are prevalence (indicating the 
number of people suffering from the disease at a given point of time) and annual 
mortality (indicating the number dying each year). Both of these rates respond 
quickly to improvements in control, as timely and effective treatment reduces the 
average duration of disease (thus decreasing prevalence) and the likelihood of dying 
from TB (thus reducing mortality rate e.g. cause-specific and proportionate mortality 
rate defined as TB death cases per 100%). Worldwide there were 5.8 million notified 
cases of TB in 2009 and a case detection rate of 63% (ranges, 60 - 67%) compared 
with 61% in 2008 (WHO, 2010d). 
Kuwait shows a similar worldwide picture for all TB mortality and morbidity trends. 
These rates represent TB burden and overloads on Ministry of Health and Kuwait 
population. Substantial rate declines of mortality and morbidity burden of TB in 
Kuwaitis relative to non-Kuwaitis could be due to improved socio-economic 
conditions and life expectancy and disappearance of old, healed but untreated TB 
(Horsburgh
 
et al., 2010). This reflects advances in the general hygiene which can 
justify the implications of improvements in TB control and having lower drug-
resistant MTB strains compared with those regions under continued health overloads 
(Hickson, 2009; Mangtani et al., 1995; Oxlade et al., 2009).
 
 
A mild and slow annual rise of 100,000 was achieved in the total population below 
two millions until 1998 (total 2,027,103), but since 2005, a total growth increments 
have reached an annual growth of 300,000. There has been a large increase of 
immigrants into Kuwait (the majority from low-social class migrants) since 2004. In 
2005, out of total 1,893,602 non-Kuwaitis, 38.6% were of TB endemic Asian origin 
e.g. India, Indonesia, Bangladesh, the Philippines (HVS, 1984-2009). 
 
Disproportionate over-estimation of hospital discharges and morbidity can be due to 
recurrent discharges for the same TB case and comparison between different 
nationalities should be cautious. Similarly, international mobility and long-term 




than >40 cases/100000 population/year) are potentially at risk of contracting TB 
because Kuwaiti people have high exposure probabilities to MTB and infectious 
cases, which have raised the Kuwaitis’ case fatality ratios. This has been associated 
with re-exposure and spread of other external infectious diseases to Kuwait 
community e.g. malaria or HIV/AIDS (McCarthy, 1984). 
The relative frequency of exogenous re-infection against endogenous re-activation is 
still ambiguous and undetermined. Kuwaitis’ higher case fatalities can be related to 
combinations of multiple morbid risk factors for affection by both internal and 
external environmental factors, which are complicating TB elimination and 
weakening assessment of control programme outcomes (Lienhardt et al., 2002b).  
2.5.1 Common ecological factors 
2.5.1.1 Biological factors 
2.5.1.1.1 Age  
Higher trends of TB mortality and morbidity in the elderly than younger adults is an 
increasing problem in many countries, associated with age-related decline in 
immunity and increasing longevity of LTBI occurs particularly in the developed 
world, whereas, other statistically proved risk factors predominating in the 
developing countries such as poverty, malnutrition and tobacco smoking (WHO, 
2009).  
A strong association between aging and TB development with excess/rise of TB 
morbid indicators is usually noticed in younger women and older men due to decline 
in macrophages, which are the host’s anti-TB defence mechanism. Older ages, and 
usually in males above 45 years, show higher re-activation risk of dormant LTBI, as 
immunity weakens and BCG vaccine efficiency flare-ups (Gajalakshmi et al., 2009; 
Kolappan et al., 2007). Clinical improvement in response to treatment was less 




2.5.1.1.2 Gender  
In Kuwait, the reversal shift to female predominance since 1999, having the highest 
rate values for all tuberculosis discharge per 1,000 population rates, might be due to 
predominance of female immigrants employed for in-house jobs e.g. housemaids and 
cooks, with overcrowding and prolonged exposure-contacts and difficulty in hiding 
TB morbidity symptoms due to stigma-social anti behaviors and public ignorance 
(Courtwright and Turner, 2010; Juniarti and Evans, 2010; Svensson et al., 2011) in 
contrast to male predominance all over the world revealed by the study of Neyrolles 
and Ouintana-Murci (2009), which should be encountered for research 
recommendations according to the needs of Kuwaiti’s environment to household 
immigrants. The significance of household crowding and associated-risk of 
prolonged contact is observed in Kuwaiti’s household disease transmission. The 
impact of stigma on social behaviours and TB diagnosis and treatment has serious 
socio-economic consequences, particularly for women, and is commonly associated 
with fear of infection, TB diagnostic delay and treatment non-compliance 
(Courtwright and Turner, 2010; Juniarti and Evans, 2010).
 
For example, in 2009, 
tuberculosis discharge per 1,000 population rate of female non-Kuwaitis was 0.35% 
compared with 0.24%, 0.12% and 0.09% for the non-Kuwaiti males, Kuwaiti males 
and Kuwaiti females respectively which could be a specific recommendation for 
further research about the needs of Kuwaiti’s environment to household immigrants. 
Waning of anti-tuberculosis immunity in old age (above 50 years) compared with 
younger groups with LTBI is a potential biological mechanism for an increase in 
LTBI re-activation (Horsburgh et al., 2010).  
2.5.1.1.3 Sex hormones 
Sex differences are based on infectious disease epidemiology. Worldwide, TB is a 
leading cause of mortality among women, but higher morbidity rates and worse 
outcomes are reported more inr men. Protection/susceptibility to MTB and related-
mortality rates is correlated with sex hormones. High sex steroids are less protective 




2008). Special care for high risk groups of old and reproductive ages is crucial for a 
successful TB control programmes to be considered. 
2.5.1.1.4 Host genetics  
Tuberculosis is a disease with a genetic predisposition. Pre-existing differences in 
strain genetic background, rural-urban cluster strains and innate immune response 
differences are related to compensatory changes of morbid trends which been found 
to play a role in the emergence and spread of acquired drug-resistant MTB strains, 
and which is a man-made problem (Borrell and Gangeux, 2011; Crampin et al., 
2009). Host genetic factors determine differential susceptibility to infection and 
disease outcome because of human’s genetic variation associated with sex-specific 
effects and complex susceptibility to pulmonary TB (Neyrolles and Quintana-Murci, 
2009; WHO, 2009). 
2.5.1.2 Socio-economic-cultural factors 
2.5.1.2.1 Income  
Combined socio-economic factors are complicating TB elimination and  are affecting  
control programme outcomes commonly noticed in the developing countries 
(Lienhardt et al., 2002b). Low social class, overcrowding, illiteracy and 
under/malnutrition are all related to immune-suppression (CD4+ counts less than 200 
cells/mm
3
) with anergic DTH-IV immune responses against TB-concomitant 
infections and LTBI re-activations (Pai et al., 2005).  
2.5.1.2.2 Stigmatization  
Cultural epidemiological approaches are useful for TB control, such as treatment ad-
herence, determinants of default and impacts on behaviour of gender-specific 
features of stigma (Weiss et al., 2008). TB stigma is an important barrier to health-
seeking behavior, delays in TB diagnosis, treatment non-compliance that necessitates 
health intervention instruments and consequently hinders the control and 
management of all infectious diseases. Identification and evaluation of causes and 




reviewed by Courtwright and Turner (Coutwright and Turner, 2010). Perception of 
TB infection and self-isolation from TB diagnosis due to secrecy and shame are 
barriers for males in seeking care due to risks of unemployment and income loss 
(Wieland et al., 2010). Reversed rate percentages of tuberculosis discharges per 
1,000 populations toward feminization such as females and marital status or male 
and sexual contact (Kip et al., 2011; Weiss et al., 2008).  
2.5.1.2.3 Behavioural factors 
Population mobility is a major factor in globalization of public health threats. 
Internationally, significant increases in travel-related respiratory and vector-borne 
infections are potential risks for introduction of airborne droplet transmission into 
non-endemic countries, and numbers of travellers’ deaths are still under-estimated.  
Importation of immigrant pathogenic strains can influence local population strains 
over extended time periods (Dahle et al., 2007). 
Smoking with exposure to toxic substances is the major behavioural and 
occupational risk factor that is increasing all over the world including Kuwait (Rao et 
al., 2011). Tobacco smoking/addiction can be the cause of LTBI re-activations, and 
the three-fold-rise in TB case fatalities due to smoking addiction since the last decade 
(Jeon and Murray, 2008; Wen et al., 2010), which is also related to different ethnic 
backgrounds (Wang and Shen, 2009). 
2.5.1.2.4 Socio-economic factors  
Socio-economic risk factors have direct and indirect impacts on TB transmission, 
which consequently add more barriers toward the health care sectors. Risk factors 
including age, gender, daily contacts and various genetic polymorphisms should be 
targeted by any surveillance programme.  
Although changes in the immune system during aging lead to increased susceptibility 
to mycobacterial infections and re-activation of latent foci, TB is still associated with 
younger ages in developing countries, independently of HIV status. This may be 




and shorter life expectancies in comparison with industrialized countries (Solari et 
al., 2008). 
2.5.1.2.5 Virulence of Mycobacterium tuberculosis infecting strain 
Emergence of drug resistant tuberculosis is a serious public health problem newly 
appearing in non-endemic countries, which requires strengthening tuberculosis 
control and improving monitoring of therapy. MTB spoligotyping is suitable for the 
broad evidence-based epidemiological investigation of tuberculosis patients. 
Linkage between immigrant geographic origin and MTB genotypic strains varied 
significantly with clinical picture presentations and raised TB mortality and case 
fatality rates in non-endemic countries (Thuong et al., 2008). The predominance of 
foreign-born genotypic and drug-resistant strains varies significantly with differences 
in severity and clinical picture presentations, to which Kuwaitis are sensitive, and in 
which more pulmonary TB develops in males compared with females, in contrast to 
which there are more extra-pulmonary complications in females than in males 
(Ladefoged et al., 2011; Svensson et al., 2011).  
2.5.1.2.6 Nutritional factors 
Environmental effects such as nutritional status or living on traditional farms or 
parasitic (helminthes) infections are known risk factors to affect the immune system 
in early (neonatal) life with consequences for later disease outcomes or for responses 
to BCG vaccination in infancy (Djuardi et al., 2010). Vitamin D deficiency and 
related anemia (e.g. iron deficiency anemia) are common in females all over the 
world due to poor nutrition and high susceptibility to MTB with low antimicrobial 
immunity increases LTBI and TB probabilities’ (Neyrolles and Quintana-Murci, 
2009; Talat et al., 2010).   
Re-activations are commonly related to impairment of the immune system, caused by 
poverty (low income and property ownerships), and alcohol and drug abuse, leading 




related debilitating medical conditions, poor eating habits and inadequate nutrition 
with vitamin deficiency (LoBue et al., 2010b).  
Predominance of diabetus disease and cardiovascular diseases in Kuwait is related to 
under-nutrition according to age and gender (Dye et al., 2011). Diabetics have more 
severe clinical TB infections, which require large controlled and longer treatment, 
and are more likely to develop MDR-TB than non-diabetics (Chang et al., 2011). 
Overweight as important risk factor and related-drug resistance is an important 
outcome for the binomial TB-DM in which diabetics are unaware of DM and TB 
risks (Jeon and Murray, 2008). 
2.5.1.3 Risk factor combinations 
The relative frequency of exogenous re-infection against endogenous re-activation is 
still ambiguous and undetermined.  
Tuberculosis exposure is affected by internal and external environmental risk factors. 
Previous history of TB infection is a common risk factor, which can be integrated as 
‘PTB suspicion’, which is also help TB diagnosis higher than the CXR performances 
(Wu et al., 2009). Common additional risks are prevalence of TB infection within 
exposed populations, presence of infectious source, air density carrying TB droplet 
nuclei, duration of exposure to infected polluted air and quality of indoor/outdoor air 
ventilation (filtration).   
Close contact and proximity of jail inmates raise HIV and TB possibilities due to 
overcrowding, shared respiratory ventilation buildings (> 12 hours) and poor living 
conditions, facilitating MTB transmission to others from undetected active TB cases. 
Environmental conditions and proximity to contagious index cases (> 8 hours) can be 
considered as barriers for TB control programmes e.g. hospital wards, aircraft (Al-
Jahdali et al., 2003; Demkow et al., 2008).  
Variability in the median period from immigrant arrival until diagnosis of TB is 
related to both immigrant origin and site of TB lesion e.g. Asians infected with extra-
pulmonary disease have a shorter median time-period before diagnosis, which can be 




exposure to other immigrants during or after travel (Cowei and Sharpe, 1998). Public 
transportation of overcrowded immigrants and increased exposure-time represents an 
additional occupational risk factor for LTBI re-activation and TB infection. 
For example a Kuwaiti family living in overcrowded place (close-contact exposure) 
and having housemaid coming from TB endemic country (long exposure durations 
with new LTBI/TB suspect immigrant) in addition to poor eating habits or 
under/malnutrition such as vitamin D deficiencies (Talat et al., 2010), and having 
immune-suppression (weak immune responses) against MTB facilitate LTBI re-
activations mainly in smokers’ and diabetic patient or complaining from other 
debilitating conditions (LoBue et al., 2010b; Pai et al., 2005).  
2.6 Conclusions 
Notification rates of tuberculosis in Kuwait, standardized for gender and nationality, 
have declined between 1984 and 1990, but the decline has decreased since 2009.  
Kuwait infrastructure has changed substantially and awareness of socio-demographic 
changes may speed-up diagnosis of tuberculosis. The annual rise and TB burdens of 
non-Kuwaiti population are overloading the health care system and medical service.  
Overcoming higher rates of TB morbidity of non-Kuwaitis in comparison with those 
of the Kuwaitis population constitute a serious public health issue that warrants 
urgent evaluation and re-structuring of the tuberculosis control programme through 
highly-qualified surveillance system and strict quantification and reduction of TB 
stigmatization. Fluctuation of declining and increments in the overall national TB 
rates, coupled with the persistence of disproportionately high TB rates among 
foreign-born non-Kuwaitis, suggest the need for a re-doubling of public health efforts 
aimed at the eradication of TB in Kuwait. Tuberculosis-associated immigration can 
be limited through verification of new screening guidelines for diagnostic testing to 





1- To control and further reduce TB incidence and prevalence, both nationally and 
locally, public health professionals must urgently and effectively target high-risk 
sub-populations through: 
2- Adequate surveillance systems allowing the identification of population segments 
having a particular excess risk of tuberculosis compared with the general 
population, and the screening for tuberculosis and infection with Mycobacterium 
tuberculosis;  
3- Applying diagnostic guidelines to improve immigration and related 
communicable disease control/prevention strategies can contribute to a reduction 
in TB morbid trends due to breaking of Mycobacterium tuberculosis transmission 
chain.  
4- Improvement in screening of immigrants for TB upon arrival to Kuwait, public 
health efforts and re-enforcing awareness of TB risks, transmission, diverse 
manifestations to limit diagnostic delays in the health services; 
5- Availability of cost effective new diagnostic tests (interferon gamma release 
assays; IGRAs) which assist in screening of high-risk groups for LTBI, enabling 
effective preventive chemo-prophylaxis;  
6- Reduction of structural and behavioural barriers in health systems by filling the 
gap of lack of knowledge regarding migrants' exposure to risk factors, morbidity, 
and psychosocial needs;   
7- Careful planning, pilot testing, enhanced information sharing, practitioner 
training, and ongoing programme evaluation;  
8- Using Kuwait electronic health records (EHRs) evolution of prospective 
surveillance detection of latent TB infection;  





3 Chapter three 




3.1 Ethics and responsibilities  
A field trip was undertaken to Kuwait in August-November 2008 to achieve 
agreement for the project implementation. Project approval was guided by the 
Permanent Coordination Committee for Medical and Health Researches in their 11
th
 
meeting on Tuesday, 28/10/2008, where they discussed and approved the 
methodology for the research protocol: ‘The Challenges of Tuberculosis Prevention 
through Early Detection of Latent Tuberculosis Infection in New Immigrants to The 
State of Kuwait’. The Scientific Research Committee approval is considered as 
ethical clearance for conducting the research and was followed by official documents 
sent to the involved ministry departments for permission and facilitating the 
researcher’s mission. 
Scientific requirements involved the followings; 
 Recommendation official letter from the University of Edinburgh external 
supervisor: Professor Sue Welburn 
 Agreement of head of Public Health department   
 Project methodology (the preliminary methodology agreed on) 
 Data collection sheet (questionnaire) of participants in English language 
(Appendix 5) 
 Screening tool result sheets; chest X-ray (Appendix 6), tuberculin skin test 
(Appendix 7) and both IGRAs; QuantiFERON Gold In-Tube test (Appendix 8) 
and T-SPOT .TB test (Appendix 9) 
 Participant informed consent; both in English (Appendix 10) and Arabic 
(Appendix 11) languages  
 Researcher adoption pledge; both in English (Appendix 12) and Arabic (Appendix 
13) languages and  
 Letter signed by researcher, detailing that the Ministry of Health will not be 
financially supporting the project. 
Permission has been granted to facilitate with allowance for data collection and 




during registration Al’ Farwaniya Immigration Centre and TB Control Unit (two 
different departments of Ministry of Health in Kuwait).  
3.2 Role of authority 
The project responsible authorities; Ministry of Health in the State of Kuwait and the 
University of Edinburgh in Scotland have thoroughly facilitated and organized all the 
steps of research implementation with no interference with project data. The author 
declares no competing interests. The author follows direct administrative supervision 
in the project field to improve quality of work and has no authority to interfere with 
the entry to Kuwait of any immigrant having positive result(s) and/or latent 
tuberculosis infection diagnoses. The researcher provided research staff with basic 
background information about the study and project step follow-ups. Each potential 
participant in the project screening was adequately informed of the aims, methods 
and sources of funding of the screening, any possible conflicts, the institutional 
affiliations of the researcher and the study benefits and potential risks. On request, 
immigrant has all human rights to be informed about his/her research extra- (non)-
compulsory test results of both interferon gamma release assays and/or tuberculin 
skin test but not chest X-ray (the ordinary test) results. 
3.3 Study methodological design  
A review on methodology of various published studies employed for detection of 
latent tuberculosis infection and active tuberculosis disease cases was carried out in 
order to overview the general picture of tuberculosis worldwide. The findings of the 
review formed the basis and context for the development of the methodological 
design and the screening of the new immigrants to Kuwait as follows. 
3.4 Study design 
The research followed an observational, randomized and repeated-measure, 




3.5 Study duration 
The study period was four months from February to May 2010, research being 
conducted during four working days (Sunday to Wednesday).  
3.6 Study population 
The study permitted involvement of any new immigrant entering through Al 
Farwaniya Immigration Centre in Kuwait during February and May 2010. Project 
implementations were preceded by a preliminary clarification of all research steps 
and the four tuberculosis diagnostic test procedures. An adoption pledge was signed 
by the researcher (Appendix 12; English or Appendix 13; Arabic) followed by 
participants’ verbal or signature of written participant consent (Appendix 10: English 
or Appendix 11; Arabic). 
3.7 Sample size calculation 
Sample size was calculated using the basic national records statistics of Kuwait and 
systemic review of international latent tuberculosis infection (LTBI) statistics and 
annual reports of the World Health Organization as follows (Horsburg, 2004; HVS, 
1984-2009; WHO, 2008b; WHO, 2010d): 
 Average total daily immigrants entering Kuwait = 400 - 700 (average 500) 
individuals per day 
 Average total immigrants entering Kuwait per year = 500 x 25 days/month x 12 
months/year = 150,000 immigrants per year  
Excluding non-working days and holidays, the average of 120,000 (between 80,000 
and 150,000) immigrants are legally entering the country as a newly immigrants and 
the majority enter occupied in the labour force as employee workers more than 
family re-unions. The prevalence of latent tuberculosis infected individuals in the six 
billion populations infected with Mycobacterium tuberculosis worldwide is five to 




activation to the active tuberculosis disease form and further distributing tuberculosis 
infection. The mid-point average is seven and a half percent (7.5%), and was taken to 
represent LTBI prevalence. Using the Win EpiScope statistical package (Thrusfield 
et al., 2001), the estimated sample size required for project implementation reveals 
the following values (Table 3.1):  
Table 3.1: Sample size calculation using Win Episcope 2.0 statistical package programme 
(Thrusfield et al., 2001) 
 
The lowest accepted and calculated sample size was one hundred and sixty seven 
participants to estimate prevalence with a specified 95% confidence interval of 
‘True’ implies correction for a test’s sensitivity and specificity of 3.51% and 11.49%. 
The size was increased to one hundred and eighty immigrants with the availability of 
screening diagnostic tests (n = 180). 
3.8 Study selection 
During their compulsory registration at the Immigration Centre, new expatriates were 
randomly chosen as one in every thirty four new immigrants without selection bias. 
All eligible participants were approached to enroll in the study after accepting the 
informant consent and after being briefed on their interviewee rights.  
3.9 Inclusion criteria 
Any healthy adult new immigrant aged between eighteen and sixty years of age was 
simultaneously eligible for inclusion and invited to participate. Other 
epidemiological or tuberculosis risk factor differences were not considered as 
limiting factor such as gender, nationality, ethnic origin, past history of TB infection 
or metabolic disease(s).  
Average immigrants 
















120,000 7.5 2 95 667 
120,000 7.5 3 95 297 




3.10 Exclusion criteria 
Any immigrant was excluded from the study if: 
1. He/she refused to participate and/or refused consent agreement,  
2. There was an absolute language barrier with difficulty in contact even with the 
help of a third party (e.g. a nurse capable of translating),  
3. He/she was newly diagnosed as having acute infectious disease within the last six 
months before entry to Kuwait e.g. presenting signs and/or symptoms of active 
TB, acute hepatitis or HIV/AIDS, 
4. He/she was at increased risk of adverse reaction(s) to tuberculin skin test e.g. skin 
allergy or venepuncture e.g. blood disorders like hemophilia or sickle cell 
anemia, or was a severely malnourished (thin wasted) individual,  
5. He/she had a history of previous positive tuberculin skin test result less than 6 
months prior to entry and enrollment, and  
6. He/she missed follow-up for a tuberculin skin test reading result after five days. 
3.11 Tuberculosis screening tools  
For each new immigrant, all of the following screening diagnostic tools were 
performed including an interview for data collection using a structured questionnaire 
(Appendix 5) followed by applying another three tuberculosis diagnostic tests on top 
of the ordinary chest X-ray; tuberculin skin (prick) test and both interferon gamma 
release assay (IGRAs) tests: 1- QuantiFERON Gold In-Tube test (QNF-GIT) and 2- 
T-SPOT .TB test.  
3.12 Study setting 
3.12.1 Al Farwaniya Immigration Centre 
Out of the four immigration centres covering the whole of Kuwait (Al ‘Asimah, Al 
Fahaleel and Al Jahra), Al Farwaniya Immigration Centre had been chosen randomly 
for immigrant screening. Al Farwaniya Immigration Centre is located in Al 




of Kuwait (covering 907,321 out of the 3,442,945 total population in 2009) (HVS, 
2009), with a non-Kuwaiti predominance and with up to 200-300 worldwide new 
immigrants being tested daily during five working days per week.  
Immigrant registration and numbering (standard daily procedure) described as; 
Project procedure’s  
After expatriate ordinary registration and following WHO guidelines for diagnostic 
test implementation (Chiang et al., 2009; WHO, 2002a), all new immigrants were:  
 Freely allowed to choose whether or not to participate in the study, 
 Informed of the research procedures and risks,  
 Protected from any harm related to testing procedures,  
 Protected from stigma associated with tuberculosis,  
 The only one able to know the results of his/her own diagnostic tests, and   
 His/her right to abstain from participating or to withdraw consent at any time 
without reprisals.  
The following Figure 3.1, Figure 3.2 and Figure 3.3 clarified the project steps. After 
their ordinary administrative registration (Step 1), all participants were randomly 
selected and invited to participate after they provided informed consent (written or 
verbal; Appendix 10 and Appendix 11) followed by (Step 2) were data gathering 
through confidential face-to-face interview using epidemiological and LTBI risk 
factor assessment questionnaire (Appendix 5). An expert and highly-qualified data 
collector speaking four languages was trained for data extraction to obtain 
tuberculosis-related answers (Step 2). One interviewer was used to obviate inter-rater 
variation. When there was a complete language barrier the immigrant was excluded.   
Then participant will enter the nursing room (Step 3) to perform the routine post-
entry and ordinary diagnostic tests for any new immigrant including; 1- withdrawal 
of routine blood sample for screening by the virology polymerase chain reaction 




filariasis, and 3- intramuscular (IM) anti-meningitis chemoprophylaxis versus 
meningococcal disease.  
 
Figure 3.1: Flow diagram representing the strategic plan for screening the 180 new immigrants 
to Kuwait in Al Farwaniya Immigration Centre (Step 1: immigrant registration), (Step 2: data 
collection), (Step 3: nursing room), (Step 4: Chest X-ray room), IGRAs = interferon gamma 
release assay tests including both QuantiFERON Gold In-Tube test (QFT-GIT), T-SPOT .TB 
test)  
Apart from the listed compulsory tests in the nursing room and (Step 3) started by the 
following: first measurement of both body weight and height, followed secondly by 
withdrawal of both IGRAs blood samples on the same PCR prick, then thirdly 
administration of the tuberculin skin test and fourthly checking for scar of BCG 
vaccination. Finally, in (Step 4) immigrants were referred to radiography for taking 
ordinary compulsory chest X-ray. As usual all radiographic pictures were 
electronically transferred to Tuberculosis Control Unit (TCU) for the medical staff to 





Figure 3.2: Case management of new immigrants at Steps (1 to 4) in Al Farwaniya 
Immigration Centre in Kuwait 






Expatriate  results 








Figure 3.3: Immigrants case management in the nursing room; 1- measurement of body 
height/weight, 2- blood withdrawal of interferon gamma release assay (IGRAs) samples, 3- 
tuberculin skin test administration (prick test) and BCG scar detection 
IGRAs blood samples were transferred within 30 minutes to TCU. The total time for 
management of each case was between 45 and 60 minutes and three to four 
participants were interviewed per day within four working days during the four 
months of the study. 
Step 1 
This began with random selection of any registered immigrant and invitation to 
participate after he/she provided informed consent and preliminary agreement for 
participation (written or verbal; Appendix 10 and Appendix 11) after being given an 
explanation of all field examination testing, and adoption pledge primarily signed by 
the researcher (Appendix 12 and Appendix 13). 
Step 2 
  




This involved contact between the data interviewer and participant using as pre-
designed and pre-tested identical questionnaire developed following a literature 
review of all potential risk factors of LTBI/TB disease (Appendix 5). The 
questionnaire will be discussed in thorough in chapter 4. 
Step 3 
In the nursing room the following examinations and test procedures were performed: 
1. Body weight (in Kilogram) and height (in centimetre) were measured and 
recorded on the tuberculin skin sheet (Appendix 7) 
2. Peripheral venipuncture and venous blood of IGRAs tests were withdrawn as: 
one sample of 8 ml heparinized blood tube for the T-SPOT .TB test (further 
discussed in 3.12.2.1.1) and three samples of 1 ml heparinized blood tubes for the 
QuantiFERON-TB Gold In-Tube test (QFT-GIT) (further discussed in section 
3.12.2.1.2) and  
3. Tuberculin skin (prick) test using the Mantoux technique was performed 
according to recommendations of the WHO-Kuwait tuberculosis standards for 
mass screening of Mycobacterium tuberculosis infection, where: 
The testing nurse administered exactly five Tuberculin Units of 0.1 ml of purified 
protein derivative (PPD) as 5TU of tuberculin  (Tubersol: Sanofi Pasteur Ltd, 
Toronto, Ontario, Canada), which was intra-dermally slowly injected in the 
superficial skin layers (Mantoux technique) using one-ml disposable tuberculin 
syringes, on the volar surface of the mid-anterior left forearm. The left forearm was 
chosen by convention to avoid errors in allocating the test site during reading. 
However, in case of scarring (e.g. previous BCG) on the left forearm, the test was 
given on the right forearm (Figure 3.3, Figure 3.4, and Figure 3.5). Each participant 
was carefully examined for the presence of a Bacille de Calmette Guerin (BCG) scar 





Figure 3.4: Injecting five tuberculin units (5TU) of a Mantoux skin test 
(http://en.wikipedia.org/wiki/Tuberculosis_diagnosis) (DOA: 26/01/2012) 
 
Figure 3.5: Measuring the size of induration using flexible calliper after 46-72 hour post-
application of 5 tuberculin units (http://en.wikipedia.org/wiki/Tuberculosis_diagnosis) (DOA: 
26/01/2012) 
Within 48 and 72 hours, both readers (the administrative nurse and researcher) 
double checked and identified the margins of transverse induration of the TST site by 
carefully palpating the edges of the reaction for measurement. A small flexible 
caliper (15 cm length ruler calibrated in millimetre) was used to measure any firm 
and well circumscribed induration or soft well-defined margin swellings. Care was 
taken not to measure erythematous skin reaction. The readers also asked and 
examined the immigrant for the presence of any adverse reactions in the test site such 




individual’s vaccination status and was looked for on both arms from the shoulder 
region to the wrist, because of differences in international vaccination schedule.  
In accordance with the American Thoracic Society and Centers for Disease Control 
and Prevention guidelines (ATS and CDC, 1999; CDC, 2005c; CDC, 2010b, Farhat 
et al., 2006) and Department of Public Health (Ministry of Health in Kuwait), either 
with or without history of prior BCG, positive tests were defined as those for which 
were transverse diameters of the palpable hardened areas with an induration size of 
10 millimetre (≥ 10-mm) (further discussed in chapter 5) and finally, 
Step 4 
Chest X-ray was performed in the radiography room by expert radiographers’. 
Postero-anterior (PA) graphs were taken as an ordinary test and copied by CXR 
printer machine. Excluding one Syrian female due to pregnancy contraindication, 
chest radiographs of the 179 participating individuals were then read by three 
different pulmonologists and re-read by another two qualified reader radiologists’ 
guided by a standardized recording policy, for purpose of interpretation, recording 
and reportation for the presence of discrepant abnormal findings’ in a specific chest 
X-ray recording sheet (Appendix 6) which is further discussed in chapter 5 (van der 
Werf et al., 2008).   
After collection of blood samples, both IGRAs heparinized tubes were transported 
within 30 minutes of collection in an insulated covered icebox to the tuberculosis 
central laboratory of Kuwait in Tuberculosis Control Unit for rapid sample 
processing after collection. 
3.12.2 Tuberculosis Control Unit (TCU)  
The Public Health department, through the Tuberculosis Control Unit belongs to 
Sabah Health Area within Al ‘Asimah governorate and is considered as a central 
office for directing the national tuberculosis programme (NTP) working hard to bring 
tuberculosis under control where TB screening in the chosen policy using CXR and 




usually ascertained by the TB Curative Unit and Al-Rashed Centre for Respiratory 
diseases and Allergy. Further detailed management procedures are taken such as 
repeating several CXR's, taking three consecutive morning sputum samples for acid 
fast bacilli (AFB) examination, culture and drug sensitivity and other advanced 
investigations for complicated cases e.g. broncho-alveolar lavage (BAL), lung 
biopsy, lung bronchoscopes. 
The function of the TB Control Unit includes the following:  
 Screening referrals from: A- The centre of examination of expatriates, B- The 
general Medical Council, C- The centre for examination of food handlers, D- 
Contacts from the TB Curative clinic, E- Contacts of diagnosed and confirmed TB 
case in hospitals 
 Laboratory examination of sputum samples referred from all clinics and hospitals.  
 Screening of referrals of suspected TB, thoracic and extra thoracic TB before they 
are referred to the TB Curative Unit 
 Receives and process all TB disease notifications from all sources of notification 
in the country, register all cases and ensure application of the direct observational 
therapy, short course (DOTS) strategy  
 Processes TB notifications and implements contact investigation.  
In addition to daily interpretation of average 1,000 to 1,500 chest radiographic 
interpretations over the six different governorate medical centre’s, TCU has the 
central laboratory for tuberculosis interferon gamma assays (IGRAs) testing in 
Kuwait.  
3.12.2.1 Tuberculosis central laboratory  
Manipulation and analysis of IGRAs blood samples was performed according to the 
manufacturer’s instructions for tube preparation at the central and only tuberculosis 


















Figure 3.6: Laboratory processing of interferon gamma release assay (IGRAs) samples in the 
central tuberculosis laboratory of Kuwait (QNF-GIT = QuantiFERON Gold In-Tube test) 
Both ex vivo IGRAs were employed to identify Mycobacterium tuberculosis 
infection and described accordingly: 
3.12.2.1.1 T-SPOT .TB test   
The commercial T-SPOT .TB assay (Oxford Immunotec Ltd, Oxford, United 
Kingdom) used the collected peripheral venous blood into cell preparation tubes 
(Becton Dickinson, Franklin Lakes, NJ). A new biomarker test using ESAT (early-
secreted antigenic target 6-kDa protein) and CFP-10 (culture filtrate protein 10), 
stand out as suitable antigens inducing an interferon-gamma (IFN-γ) secreting, T-
cell-mediated immune response to MTB infection. 
Principle procedure of T-SPOT .TB test (Oxford Immunotec Ltd, Oxford) 
(Figure 3.3, Figure 3.6, Figure 3.7, Figure 3.8, Figure 3.9); 
Tuberculosis Central Laboratory 
Tuberculosis central laboratory 




1) A precoated INF-γ cytokine in ELISPOT plate was seeded with peripheral blood 
mononuclear cells (PBMCs) per well and incubated with media with no antigen 
(as a negative control), peptide antigens derived from ESAT-6 (labeled panel A), 
peptide antigens derived from CFP-10 (labeled panel B), M. tuberculosis H37Rv 
PPD, or phytohemagglutinin (PHA as a positive control) in a 5% CO2 
atmosphere at 37°C for 16 to 24 hours  
2) Peripheral blood mononuclear cells (PBMC’s) were separated from a whole 
blood sample and washed to remove any sources of background interfering 
signal.  
3) PBMC’s were incubated with the antigens to allow stimulation of any sensitized 
T-lymphocytic cells present in the blood sample.  
4) Secreted INF-γ cytokine was captured by specific antibodies on the layer 
membrane (which forms the base of the well), and the cells and other unwanted 
materials were removed by washing.  
5) A second antibody, conjugated to alkaline phosphatase (ALP) and directed to a 
different epitope on the cytokine molecule, which is able to bind to the INF-γ 
cytokine captured on the membrane surface, was added.  
6) Any unbound conjugate was removed by a second washing.  
7) Then a soluble substrate was added to each well; this was cleaved by bound 
enzyme able to form a spot of insoluble precipitate at the reaction site. Each read 
spot represents a footprint of an individual cytokine-secreting T-cell. Evaluating 
the number of spots obtained provides a measurement of the abundance of M. 
tuberculosis sensitive effecter CD4+ T-cells in the participant peripheral blood 










Figure 3.7: The main laboratory steps of T-SPOT .TB test (http://www.oxfordimmunotec.com/96-
UK) (DOA: 26/01/2012) 
T-SPOT .TB test result was counted as spots from T-lymphocytes sensitized to M. 
tuberculosis antigens and delineated captured interferon gamma. Following the 
manufacturer’s recommendations, results were then interpreted by subtracting the 
spot count in the negative (NIL) control from the spot count in Panel A (containing 






Figure 3.8: Interpretation of T-SPOT .TB test; ESAT-6 (early secretory antigen target-6), CFP 
10 (culture filtrate protein-10) (http://www.tbtestingservices.com/TB%20Testing) (26/01/2012) 
The test was interpreted as positive if individual displayed response as either or both 
panel A or panel B had six or more spots more than the negative control (> 6 CFU; 
colony forming unit), and this number was at least twice the number of spots in the 
negative control. The test was considered to have failed if the negative control spot 
count was more than ten spots (> 10 spots) or if there were less than twenty spots (< 
20 spots) in the positive control and both panels A and B was nonreactive according 
to the criteria above. Spots were counted manually and with ELISPOT magnifying 
glass reader (Figure 3.8, Figure 3.9). 
 
Figure 3.9: A positive T-SPOT .TB test result of either panel A or panel B or both had six or 
more spots than the negative control (spot forming unit represents sensitized T-lymphocyte to 




Spots were enumerated and double-checked by two observers (the laboratory 
technician and laboratory head manager) using a stereomicroscope apparatus and 
spots manual counting, and the mean spot count was interpreted as the final test 
result. 
3.12.2.1.2 QuantiFERON-TB Gold In-Tube test (QFT-GIT) 
The QFT-GIT is an indirect, bimolecular, blood test able to measure the cell-
mediated immune response of MTB-infected (LTBI case) individuals. Stimulation of 
effector T cells in the whole blood with a specific antigen(s) or mitogen, followed by 
simple quantification of the resulting IFN-γ in the plasma is the basis of 
QuantiFERON test.  
Principle procedure of QuatiFERON Gold In-Tube test (Cellestis 
Limited, Carneige, Melbourne, Victoria, Australia) (Figure 3.3, Figure 3.6, 
Figure 3.10) 
The test specially used the designed three blood collected tubes (one aliquots ml 
blood each) that had been coated with Mycobacterium tuberculosis specific antigens 
(ESAT-6, CFP-10 and TB7.7), along with a negative and a positive control tubes. 
The previous three TB-specific antigens are encoded within two regions of the M. 
tuberculosis genome, which are deleted from all BCG strains and most non-
tuberculous mycobacterial (NTM) species (with the exception of M. kansasii , M. 
marinum and M. szulgai), and for which QNF-GIT is highly specific for detecting 
MTB infection. Stimulation of T-lymphocytes in whole blood with the three highly 
specific antigens results in cytokine gamma interferon (IFN-γ) production only in 
those infected with M. tuberculosis (Figure 3.10); 
1) Three evacuated blood collection tubes (one ml blood each) were used for the ex 
vivo QuantiFERON-TB Gold In-tube assay and testing was performed according 
to the manufacturer’s instructions (Cellestis Ltd, Carnegie, VIC, Australia): the 
first tube contained heparin alone (Nil tube, negative control), the second tube 




control), and the third tube contained M. tuberculosis-specific antigens, including 
ESAT-6, CFP-10, and TB7.7 (TB antigen tube).  
2) After mixing, the tubes were incubated upright for 20 hour at 37 ° C before 
plasma was harvested and stored frozen at -20 ° C until further analysis. All 
analyses were performed within five days. 
3) An enzyme linked immunosorbent assay (ELISA) was then used to measure 
quantitatively the amount of IFN-γ present in each of the three tubes (Nil control, 
TB-Antigen, Mitogen control) (Figure 3.10).  
4) The results were calculated using specific QFT-GIT Software provided by 
manufacturer (Cellestis Limited, Carnegie, Australia).  
 
Figure 3.10: The main laboratory steps of QuantiFERON Gold In-Tube test (QFT-GIT) 




According to the manufacturer’s specifications, any immigrant blood sample was 
considered highly likely to have previous M. tuberculosis infection if containing the 
IFN-γ concentration of the TB-Antigen tube above the test cut-off, which is more 
than or equal 0.35 international unit per millilitre (> 0.35 IU/ml), or more than or 
equal ≥ 25% in the unstimulated negative control INF-γ value sample. Indeterminate 
results were defined by the ELISA apparatus as either: 1)- a negative control 
(unstimulated sample) INF-γ level of more than 8.0 IU/ml or 2)- a positive control 
INF-γ response of 0.5 IU/ml or less with a TB antigen minus a negative control INF-
γ response of either less than 0.35 IU/ml or less than 25% of the negative control 
value. 
3.13 Work quality control  
Quality assurance in LTBI prevalence screening aims at: 1- ensuring the highest 
sensitivity and specificity in case detection, 2- ensuring the quality of the data 
collected, and 3- reducing potential selection and information bias. 
All screening step components require particular attention to ensure that safety was 
paid to immigrants’ health and test procedure safety through strict follow-up and 
completeness of documented data. The research investigator was responsible for 
provincial coordination, fieldwork organization and quality control through 
coordination of the implementation process, and manipulated and reviewed daily all 
collected data to ensure legible, complete and consistent recording (Chiang et al., 
2009). The investigator and helping staff adhered rigorously to the study. Direct 
close monitoring was the responsibility of the researcher.  
3.14 Safety warnings and precautions 
Laboratory technicians conducting IGRAs tests followed strict precautions when 
handling material of human origin and all blood samples were considered potentially 
infectious. Handling of blood samples and assay components, their use, storage and 




biohazard safety guidelines or regulations. Care was also taken when working with 
chemicals considered as potentially hazardous. 
3.15 Identification of latent tuberculosis infection  
From a systemic literature review, a new laboratory categorization was invented for 
defining latent tuberculosis infection using a scoring system for the results of four 
tuberculosis diagnostic tests and epidemiological associated risk factors predicting 
suspect tuberculosis carriers. 
3.16 Laboratory-related diagnosis of LTBI   
Based on a literature review, the researcher constructed a definition terminology 
based on a new scoring system as the basic backbone to predict asymptomatic LTBI 
cases with a high suspicion of TB before active TB development. The following 
descriptive table describes a new laboratory classification of diagnostic testing’s, 
which can be considered as a new categorized diagnostic criterion for LTBI case 
definition and as the ’paradox of the gold standard’, in addition to TB risk factors 












Table 3.2: Categorization criterion for latent tuberculosis infection case definition using a 
combination of four-tuberculosis diagnostic tests and results scores 
 
CXR = chest X-ray, TST = tuberculin skin test, QFT-GIT = QuantiFERON Gold In-Tube test,  
T-SPOT .TB = T-SPOT .TB test, LTBI = latent tuberculosis infection 
 
*Risk defined according to Thrusfield, M. (2007)  
 
Categorization of the case-risk of LTBI (Table 3.3) and the case diagnosis definitions 














LTBI case definition* 
Old (Standard) New 
CXR TST QFT-GIT T-SPOT .TB 
- - - - 1 Negligible 
+ - - - 2 Low 
- + - - 3 Low 
- - + - 4 Low 
- - - + 5 Low 
+ + - - 6 Average 
+ - + - 7 High 
- + + - 8 High 
+ - - + 9 High 
- + - + 10 High 
- - + + 11 Extremely high 
+ - + + 12 Extremely high 
- + + + 13 Extremely high 




Table 3.3: Definition of risk (Thrusfield, 2007) 
‘Likelihood’ means probability, the state or fact or being likely, ‘Likely’ means probable, such 
as might will happen or be true, to be reasonably expected  
Positivity of tuberculosis diagnostic test results was defined accordingly, and a 
negative test result meant exclusion of LTBI case as not fulfilling the positive-result 
criteria (Table 3.4).  
Table 3.4: Definition of test positivity of the four-tuberculosis diagnostic tests for latent 
tuberculosis infection  
 
1 
Positive test definition will be further explained for each test in chapters five and six 
(comparison of diagnostic testing)  
 
LTBI case diagnosis 
 
Definition 
Negligible (of ‘likelihood) 
 
Need not to be considered, Insignificant (of ‘likelihood’), 
means unimportant (c.f. ‘significant) 
 
Low (of ‘likelihood’) 
 
Less than average, coming below the normal level 
 
Average (of ‘likelihood’) 
 
The usual amount or extent 
 
High (of ‘likelihood’) 
 
Extending above the normal or average level 
 
Extremely (of ‘likelihood’) 
 
Outermost, further from the centre, situated at either end; the 
highest or most extreme degree of anything 













Induration size more than or equal 10 millimetre (≥10-
mm) 
QuantiFERON Gold In-tube test
4 ¥ 
 
INF-γ value cut-off more than or equal 0.35 
international unit per millilitre (≥ 0.35 IU/mL) 
T-SPOT .TB test
5 ¥ 
Either or both panel A or panel B had six or more spots 






Radiological finding interpreted as abnormal result consistent with LTBI (probable TB) which 
is further subdivided using a scoring system (score I, II, III and IV) according to the readers’ 
final interpretation and conclusion of chest X-ray reading (nodular lesion and/or fibrotic lesion 
and/or cavitatory/granulomatous lesion with/or without calcification and/or other parenchyma 
lung infiltrates and/or  pleural or parenchyma disease (Jeong and Lee, 2008; Linh et al., 2007; 
Ralph et al., 2010; van Cleef et al., 2005; van der Werf et al., 2008; Yang et al., 2007)   
3
 The criterion for classifying positive TST reaction is that any reaction of more than or equal 
10-mm (> 10-mm) of induration will be considered as positive in recent immigrants (within the 
last five years) from high-prevalence countries according to The American Thoracic Society and 
Centers for Disease Control and Prevention guidelines (ATS and CDC, 1999; CDC, 2005c; 
CDC, 2010b, Farhat et al., 2006) and Department of Public Health (Ministry of Health-Kuwait) 
4 
Follow manufacturer’s specification for positive result of QuantiFERON Gold In-Tube test 
(Cellestis Limited, Chadstone, Melbourne, Victoria, Australia)  
5 
Follow manufacturer’s specification for positive result of T-SPOT .TB test (Oxford Immunotec 
Limited, Abingdon, Oxford, United Kingdom) 
¥ 
Any indeterminate reaction of interferon gamma release assays (IGRAs) was considered as a 
negative test result  
3.17 Epidemiological-related diagnosis of LTBI 
Epidemiological variable- and socio-demographic-questionnaire was structurally 
performed before gathered and tested for identification of statistical associations 
between exposure risk factors of LTBI and ‘suspect TB’ cases (see chapter 4).  
3.18 Data management and statistical analysis 
Data were collected prospectively and then entered into a computerized SPSS 
database for analysis using the Statistical Package for Social Sciences Software, 
version 17.0 (SPSS 17.0, SPSS Inc., Chicago, IL, USA) (SPSS 17.0, 2008). All 
recorded questionnaire data were double entered on daily basis by two data entry 
specialist and revised finally by the researcher checking for discrepancies between 
the two entries to ensure accuracy. Data were expressed and entered as number for 




quantitative variables were also given an interval value to determine qualitative 
variable, for example immigrant’s age of 27 years was entered differently as: a- 
quantitatively (exact age 27 years) and/or b- qualitatively as (25- which means lie 
between 25 and 30 years).  
The sensitivity of a test is defined as the proportion of true positives detected by the 
test, which represents the probability of the test to produce a positive result in true 
positives, classified using a ‘Gold Standard’ test (this is the internationally accepted, 
but slow, demonstration of growth of Mycobacterium tuberculosis in culture). On the 
other hand, the specificity of a test is the proportion of true negatives that are 
detected by the test; which represents the probability of the test to produce true 
negative result with using the ‘Gold Standard’ test to classify true status (Knapp and 
Miller, 1992).   
The positive predictive value (PPV) of a LTBI diagnostic test defines the probability 
of LTBI in new immigrant with positive result (T+׀B+), therefore represents a 
proportion of immigrants with positive test result in total 180 immigrants with that 
the positive result is a true positive, whereas, the negative predictive value (NPV) 
describes the probability of not having LTBI in immigrant with a negative LTBI 
diagnostic test results (T-׀B-), therefore also represents a proportion of immigrants 
without LTBI with a negative diagnostic result in total of 180 immigrants with 
negative test results (TN/TN+FN). Both predictive values vary and largely dependent 
on the prevalence of LTBI in the examined 180 recent immigrants (Simundic, 2008; 
Thrusfield, 2007).    
Table 3.5 shows the outcomes of a test in relation to the gold standard true positive 
status, and the equations to calculate the sensitivity, specificity, positive predictive 








Table 3.5: Outcomes of a diagnostic test and equations (Simundic, 2008; Thrusfield, 2007) 
 
True positive (TP) - with LTBI with the value of diagnostic test results occurring 
above the cut-off, 
False positive (FP) - without LTBI with the value of diagnostic test results occurring 
above the cut-off, 
False negative (FN) - without LTBI with the value of diagnostic test results occurring 
below the cut-off, and 
True negative (TN) - with LTBI with the value of diagnostic test results occurring 
below the cut-off. 
Frequencies and percentages were used in chapter 4 to summarize the socio-
demographic characteristics and the estimated prevalence of diagnosed LTBI was 
calculated using all the four trial diagnostics. The prevalence of LTBI was estimated 
by dividing the number of participants with positive result of the diagnostic test by 
 








TP FP TP+FP 
Test  
Negative 
FN TN FN+TN 
Total TP+FN FP+TN TP+FP+FN+TN 
 
Equations 
Sensitivity = TP/(TP+FN) 
Specificity = TN/(FP+TN) 
Positive predictive value (PPV) = TP/(TP+FP) 




the total number of study participants who had undergone the research study. The 
combined prevalence of LTBI was estimated by dividing the number of participants 
who tested positive using all the four diagnostic tests by the total number of study 
participants who had the results for all the four tests.  
Categorical variables were analyzed using a Likelihood ratio (LLR χ2) when 
Pearson’s chi square is inappropriate for small sample [defined as the ruling-in 
diagnosis or the ratio of expected test probability result in subjects with LTBI to the 
subjects without LTBI; [LR+ = (T+׀B+) / (T+׀B-) = sensitivity / (1-specificity)], to 
measure the diagnostic accuracy and to compare the proportions of target outcomes 
in which can link the pre-test and post-test probability of LTBI in each immigrant. 
Likelihood ratio for negative test result (LR-) defined as the ruling-out diagnosis 
[LR= (T-׀B+) / (T- ׀B-) = (1-sensitivity) / specificity)] and denotes the ratio of the 
probability that a negative result will occur in subjects with the disease to the 
probability that the same result will occur in subjects without the disease. Non-
parametric measure of correlation statistics of non-normally distributed continuous 
variables were analyzed using a Kruskal-Wallis (KW χ
2
) test, which corresponds to 
one-way analysis of variance, and it is related to the median and interquartile ranges 
(IQR) (Thrusfield, 2007). 
Agreement between diagnostic test results (positive or negative) was assessed using 
Cohen’s Kappa (k) coefficient (Altman, 1991) and implemented in SPSS version 
17.0 (SPSS 17.0, 2008). Agreement of test results was based on the analysis of the 
Kappa statistics using the computer programme SPSS version 17.0. 
Kappa value = (A-E)/ (N-E) 
A = ∑all positives and negatives common to both techniques 
E = (∑positives)/N + (∑negatives/N) 
N = the total number of immigrant participants tested by the four techniques  
A Kappa value can lay between 0 and 1, where 0.80-1 means very good agreement 




0.40: fair agreement; and < 0.20: poor agreement. A negative Kappa value indicates 
that the two tests agreement is less than expected by chance (Altman, 1991).  
Confidence interval (CI) is a measure of location (or an interval estimate of sample 
parameter) that indicates an estimated reliability. Also defined as a range of values 
has a specified probability of including the true value of the risk factor variable, if the 
research studies are repeated. C.I. created at the 95% level indicates that 95% of the 
time properly constructed confidence intervals should contain the true value of the 
tested variable using Confidence Interval Analysis Software (C.I.A., 2000). This 
corresponds to hypothesis testing with p-values, with a conventional cut-off for p of 
less than 0.05 (Knapp and Miller, 1992). The p-value is the probability of obtaining 
an actually observed test results which often rejects the null hypothesis when the p-
value is less than 0.05 and 0.1 (or the significance level), by which the result is 
statistically significant due to rejection of null hypothesis. P-value allows assessment 
of the role of chance (or whether or not the findings are ‘significantly different’ or 
‘not significantly different’ from the reference value) (Thrusfield, 2007).  
The range of data set is simply a possible limit of spread and is defined as the 
difference between the highest and lowest values. Concentrating more on the middle 
portion of distribution, is the interquartile range (IQR), also called midspread, which 
is defined as the difference between the upper (Q3 or the 75
th
 percentile) and the 
lower (Q1 or the 25
th
 percentile) quartile values. IQR uses the middle 50% of data 
that equals to the length of the box in a box plot and is not affected by outliers or the 
extremes. The IQR is used to build box plots, simple graphical representations of a 
probability distribution. Semi-interquartile range (SIQR) is half the interquartile 
range (Knapp and Miller, 1992, Thrusfield, 2007). 
Questionnaire quantitative variables were drawn as box-and-whiskers plots diagrams 
using SPSS version 17.0 (SPSS 17.0, 2008), whereas, the spread sheet were 
visualized as figures and charts of the qualitative variables were drawn using 




3.19 Pilot study 
The researcher coordinated all study steps having direct supervision on all involved 
project staff (screening team) to identify any practical difficulties and how to tackle 
them. The researcher and involved project staff companion carried out a pilot study 
to clarify the field steps using only the project questionnaire and tuberculin skin test 
followed by ordinary chest X-ray reading (Step 1-4; described in Figure 3.1) and to 
test the study protocol form on a random sample (five new immigrants) over two 
days in Al Farwaniya Immigration Centre. Major limitation in administration and 
data collection for future facilitations were identified. Participant agreement and 
follow-up for TST reading result were the main addressed difficulties tackled during 
the project implementation and diagnostic interventions.  
3.20 Study outcome 
The objective of the study is to assess the accuracy of tuberculosis diagnostic tools in 
diagnosing latent tuberculosis infection and to identify major epidemiological risk 
factors of latent tuberculosis infection and re-activation transmission. Consequently, 
a new guideline for LTBI identification/diagnosis using results of the four anti-
tuberculosis diagnostic tests was proposed.   
3.21 Study output 
To envisage the study outputs being published in medical journals such as The 
Lancet, British Medical Journal (bmj), eMedicine, European Respiratory Journal 
(ERS), PLoS ONE, BMC Infectious Diseases and American Thoracic Society (ATS). 
3.22 Study data review and source 
The project study searched identical strategy and selection criteria for previous data 
identified from Pubmed and other reviews such as the Lancet, bmj, PLoS ONE, 
BMC Infectious Diseases, eMedicine, The International Journal of Tuberculosis and 




the American College of Chest Physicians, The New England Journal of Medicine, 
The Journal of Infectious Diseases, National Insititute for Health and Clinical 
Excellence (NICE), and the American Thoracic Society and Center of Disease 
Control and Prevention (ATS and CDC), from 1928 to 2011 (including keywords: 
tuberculosis diagnosis, latent tuberculosis infection, interferon gamma release assay 
(IGRAs) , QuantiFERON test, T-SPOT .TB test, tuberculin skin test, chest X-ray). 
Epidemiological and tuberculosis risk factors were searched from 1920 to 2011 
(including keywords: tuberculosis diagnostic criteria, latent tuberculosis infection, 
migration, BCG, smoking, socio-economic condition). The search includes only 
studies published in English and relevant to tuberculosis diagnostic testing.  
3.23 Study strength 
All enrolled new immigrants were completely screened in officially authorized 
tuberculosis Immigration Centre (Department of Public Health-Ministry of Health in 
Kuwait) they are legally and compulsory registered before entry to Kuwait. Random 
sample selections from recent expatriates assumed to be healthy immigrants on entry, 
who come from many countries (14 different nationalities) with different TB risk 
exposures thereby increasing external validity. Testing four different TB diagnostic 
tests, on the same subject, at the same time, strengthens the research in an area that 
had not previously been investigated. The central and only TB laboratory of TCU in 
the country was responsible for IGRAs processing. Follow-up and immigrant 
compliance was 99%.  
3.24 Limitations of the study 
The absence of a gold standard test to compare the four diagnostic tests can be 
considered as a limiting factor. Another limitation is the small sample size which 
might constrain generalization of the results to a larger population and wider 
community. Thirdly, there were no previous data on LTBI prevalence in immigrants 
or Kuwait residents for comparison. Fourthly, all questionnaire answers and obtained 
data were based on immigrants’ memory or hiding past history, and related 




result in under- or over-estimation of the actual effects of the selected risk factors 
(Saqib et al., 2011). Fifthly, refusal in research participation was high for the family 
re-union immigrants who account for 10-20% of Kuwaitis’ expatriates, and limit 
result comparisons to other immigrants.  
3.25 Study plan and key results 
The basic laboratory of the four different latent tuberculosis infection diagnostic tests 
and their results been implemented on the 180 new expatriates arriving to Kuwait 
during February and May 2010 is described in the following Figure 3.11.  
 
Figure 3.11: Flow diagram representing the four diagnostics of latent tuberculosis infection and 





3.26 Conclusion  
Prevention of tuberculosis-related health disorders depend on early case detection 
and rapid intervention. Absence of a gold standard diagnostic tool for both LTBI and 
TB cases complicates tuberculosis prevention. This is a research study that can be 
used to design both qualitative and quantitative mass screening programme, 
supported with evidence-based statistical findings able to confirm the research 
hypotheses in strengthening the health system and medical care services. 
3.27 Study recommendation and future plans 
Regular literature reviews evaluating IGRAs and tuberculosis diagnostics, in addition 
to raising health resources for TB elimination requires multiple shared tasks between 
the Kuwaiti community and public health system through facilitating a new 
diagnostic strategy of TB interventions using IGRAs tests as compulsory tests would 





4 Chapter four 
Assessment of the evidence-based epidemiological 
characteristics and predictive risk factors for 






The convergence of several infectious disease epidemics, such TB, HIV, influenza 
and non-communicable health epidemics such as tobacco smoking, during the 21
st
 
century have promoted worsening outcomes for TB (Jianming et al., 2009). 
Tuberculosis must be considered as an inter-related risk factors-disease that needs to 
be addressed through combinations of social, economic, environmental interventions. 
The continuous rises in notifications and incidence of TB in non-endemic countries 
(including Kuwait) are predominantly observed in foreign-born immigrants from TB 
endemic regions. Inadequate screening due a lack of data on LTBI prevalence and 
related risk factors complicates TB control as illustrated by a recent UK study 
(Pareek et al., 2011).   
Since there is no gold standard for the diagnosis of LTBI, other measures such as 
using an epidemiological gradient of risk factors can be used to evaluate laboratory 
diagnostic tests (Brodie et al., 2008, Ewer et al., 2003; Lalvani et al., 2001b).  
Studies concerning the performance of such epidemiological characteristics are 
needed to assess diagnostics validity, build public acceptance and implementation by 
clinicians, impacting on the decision to isolate LTBI prior to progression to active 
TB disease (Solari et al., 2008). Tuberculosis diagnostics and screening can be 
supported by high quality evidence-based epidemiological (risk factor assessment) 
screening tools to improve LTBI case definition. Careful screening and identifying 
symptoms by the medical staff raises the performance of chest X-rays performed for 
routine admission and reduces re-activation of TB cases (Barnes et al., 1988; 
Feingold, 1977). A structured interview is a common screening tool which can 
correlate exposure to TB contacts as surrogate markers for LTBI, and explores the 
differences between treated, against missed, TB cases (Chee et al., 2008; El-Sony et 
al., 2002; WHO, 2007b).   
Multi-factorial epidemiological (disease) models consider the interactions of 
biological, cultural, ecological, and politico-economic factors in explaining TB 




resurgence of tuberculosis, including the interaction between biomedical, political, 
cultural, and economic factors which point to the analytical challenges achieved by 
combination of variable disease transmissions with global addressing of 
environmental conditions such as exposure risk and the socio-cultural surroundings 
(Dean and Fenton, 2010). 
Social determinants and tuberculosis risk factors  
Measures of socio-economic status (SES) and exposure to various risk factors for 
tuberculosis are included in the screening study for two main reasons; first to 
establish the prevalence in different socio-economic groups, and secondly to estimate 
the prevalence of exposure and determine the association between specific risk 
factors and LTBI/TB disease. Ecological studies based on the analysis of populations 
have shown wide-ranging differences that explain causal relationships associating 
common risk factors to the prevalence of LTBI/TB (Shetty et al., 2006).  Even with 
95% curative rates of MTB bacilli there are still TB resurgences’, spreading this 
disease in socially crowded and disadvantaged adults, such as immigrants from 
endemic countries (Elender et al., 1998; Ho, 2004). Monitoring risk factors facilitates 
our understanding of the distribution and causes of TB prevalence/epidemics in high-
risk groups and helps target interventions (Glaziou et al., 2008; Salazar-Vergara et 
al., 2003; WHO, 2007b). 
4.2 Aim 
To examine and describe the epidemiological risk factors for suspects harbouring 
latent tuberculosis infection through sample-based screening.  
4.3 Objective 
To identify the exposure risk(s) for latent tuberculosis infection through comparative 
evaluation of socio-demographics and health-related risk behavior in healthy new 





All of the selected 180 new immigrants were interviewed over a period of four 
months (February to May 2010). Written informed consent was obtained from all 
participants, which was preceded by adoption pledge signed by the investigator.  
4.5 Data collection 
A standard risk factor questionnaire interview in English (Appendix 5) was designed 
that comprised twenty five quantitative variables and forty three qualitative variables 
to obtain information as regards socio-economic status and to collect data such as 
BCG vaccination status, previous exposure to TB patients and clinical conditions 
related to chest/lung diseases. Such data facilitates understanding of the distribution 
and causes of TB prevalence/epidemics in Kuwait and facilitating future control 
(Glaziou et al., 2008; Salazar-Vergara et al., 2003; WHO, 2007b).   
4.6 Reliability and validity 
Questionnaires were pre-tested on a small pilot study (five immigrants), before 
starting surveillance to resolve any identified difficulties such as language barrier. 
The information gained was used to improve immigrants’ communication and 
follow-up cooperation. 
4.7 Statistical analysis  
Association of socio-demographic data and risk factors with the results of LTBI 
screening were measured by the Likelihood ratio (LLR χ
2
 (d.f.)) test. The Kruskal-
Wallis (KW χ
2
 (d.f.)) test was used to calculate and compare non-normally distributed 
variables for overall significance of risk factors. Excel 2007 was used to draw the 
qualitative variables using the graph and chart of data percentages and SPSS 17.0 
Software programme (SPSS 17.0, 2008) to build box-and-whiskers plots diagrams of 
the quantitative variables. Analyses of risk factor variables and diagnostic test 




using C.I.A. Software (2000) and a p-value of less than 0.05 was considered as the 
level of statistical significance. Statistical formulas are detailed in chapter 3; section 
3.18 (Materials and Methods). 
4.8 Results 
The questionnaire was divided into nine divisions (A to E) according to the 
epidemiological characteristics comprising both the socio-economic status and the 
tuberculosis-related risk factors (data collection questionnaire; Appendix 5). 
4.8.1 Socio-demographic characteristics 
The socio-economic variables of the 180 immigrant participants according to latent 




Table 4.1: The distribution of socio-demographic characteristics according to latent tuberculosis infection categories of 180 new immigrants to 

















































n % n % n % n % n % n % n % 
Age group 
(years) 




25- 26 28.89 9 25.00 0 0 1 25.00 7 15.22 1 25.0 44 24.44 
30 22 24.44 12 33.33 0 0 2 50.00 9 19.57 1 25.0 46 25.56 
35- 14 15.56 6 16.67 0 0 0 0.00 10 21.74 0 0.0 30 16.67 
40- 8 8.89 2 5.56 0 0 1 25.00 8 17.39 0 0.0 19 10.56 
45- 2 2.22 1 2.78 0 0 0 0.00 6 13.04 0 0.0 9 5.00 






















M 76 84.44 25 69.44 0 0 1 25.00 34 73.91 1 25.00 137 76.11 LLR χ2(4)= 
14.008 
0.007 
F 14 15.56 11 30.56 0 0 3 75.00 12 26.09 3 75.00 43 23.89 
Nationality 




Syria 1 1.11 0 0.00 0 0 0 0.00 0 0.00 1 25.00 2 1.11 
India 35 38.89 8 22.22 0 0 0 0.00 19 41.30 1 25.00 63 35.00 
Pakistan 1 1.11 0 0.00 0 0 0 0.00 0 0.00 0 0.00 1 0.56 
Sri Lanka 3 3.33 2 5.56 0 0 1 25.00 0 0.00 0 0.00 6 3.33 
Philippines 8 8.89 12 33.33 0 0 2 50.00 13 28.26 0 0.00 35 19.44 
USA 1 1.11 0 0.00 0 0 0 0.00 0 0.00 0 0.00 1 0.56 
Poland 1 1.11 0 0.00 0 0 0 0.00 0 0.00 0 0.00 1 0.56 
Indonesia 0 0.00 1 2.78 0 0 0 0.00 0 0.00 0 0.00 1 0.56 
China 0 0.00 1 2.78 0 0 0 0.00 0 0.00 0 0.00 1 0.56 
Ethiopia 5 5.56 1 2.78 0 0 1 25.00 6 13.04 1 25.00 14 7.78 
Nepal 14 15.56 5 13.89 0 0 0 0.00 7 15.22 1 25.00 27 15.00 
Venezuela 1 1.11 0 0.00 0 0 0 0.00 0 0.00 0 0.00 1 0.56 
North 
Korea 
0 0.00 0 0.00 0 0 0 0.00 1 2.17 0 0.00 1 0.56 
Marital 
status 




married 48 53.33 22 61.11 0 0 4 100.00 35 76.09 3 75.00 112 62.22 
widow 1 1.11 0 0.00 0 0 0 0.00 0 0.00 0 0.00 1 0.56 
divorce/sep
arate 





















Continued Table 4.1 
 
Ethnicity 




Black 6 6.67 1 2.78 0 0 1 25.00 6 13.04 1 25.00 15 8.33 
White 1 1.11 0 0.00 0 0 0 0.00 0 0.00 0 0.00 1 0.56 
Caucasian 21 23.33 6 16.67 0 0 0 0.00 0 0.00 1 25.00 28 15.56 
Other 1 1.11 0 0.00 0 0 0 0.00 0 0.00 0 0.00 1 0.56 
Education 




primary 8 8.89 2 5.56 0 0 0 0.00 7 15.22 1 25.00 18 10.00 
Intermediate 7 7.78 4 11.11 0 0 0 0.00 6 13.04 2 50.00 19 10.56 
secondary 25 27.78 10 27.78 0 0 0 0.00 13 28.26 0 0.00 48 26.67 
diploma 14 15.56 6 16.67 0 0 1 25.00 3 6.52 0 0.00 24 13.33 
university & 
above 


































<50 9 10.00 0 0.00 0 0 0 0.00 1 2.17 1 25.00 11 6.11 
50- 18 20.00 7 19.44 0 0 1 25.00 9 19.57 1 25.00 36 20.00 
100- 35 38.89 19 52.78 0 0 1 25.00 23 50.00 1 25.00 79 43.89 
250- 16 17.78 3 8.33 0 0 0 0.00 2 4.35 0 0.00 21 11.67 
500- 7 7.78 2 5.56 0 0 0 0.00 3 6.52 0 0.00 12 6.67 
1000 and 
more 
























1-4 31 34.44 11 30.56 0 0 2 50.00 14 30.43 1 25.00 59 32.78 
LLR χ2(8)= 
6.586 
0.582 5-10 52 57.78 20 55.56 0 0 2 50.00 31 67.39 3 75.00 108 60.00 
>10 7 7.78 5 13.89 0 0 0 0.00 1 2.17 0 0.00 13 7.22 
Total 
family size 


























































































































The overall median age of the immigrants was observed to be 31.5 years with an 
interquartile range (IQR) of 11 years and the semi-interquartile range (SIQR) of 5.5 
years. The minimum age of participants was 20 years and the oldest immigrant in the 
study was aged 56 years. Older median ages were observed in the ‘extremely high’ 
LTBI group at 37 years  (IQR = 11 years) and in the ‘high’ LTBI at 32.5 years (IQR = 
13 years), compared with the ‘negligible’ LTBI at 30 years (IQR = 11 years) and ‘low’ 
LTBI at 31 years (IQR = 10 years), with a statistically significant difference between all 
age classes for the five different LTBI groups (KW χ
2
 (4) = 25.741, p < 0.001) (Figure 
4.1, Table 4.1).  
 
Figure 4.1: Box-and-whiskers plots show an increasing of the median age (years) in terms to latent 




The majority of participants were aged between 20 and 45 years (92.22%).  Similarly, 
members of the ‘negligible’ LTBI group were aged between 20 years and 40 years 
88.89% (80/90). The majority of the ‘extremely high’ classifications were aged between 
25 and 50 years 86.95% (40/46) and between 20 and 40 years for the ‘low’ classification 
of LTBI 88.89% (32/36). These differences were statistically significant (LLR χ
2
 (24) = 
38.244, p = 0.033). (Figure 4.2, Table 4.1).    
 
 
Figure 4.2: Percent distribution of the age groups (years) according to latent tuberculosis infection 




The response rate of participation in the study was higher for male immigrants 76.11% 
(137/180), with ‘negligible’ LTBI as 84.44% (76/90) followed by the ‘extremely high’ 
LTBI immigrants at 73.91% (34/46) and ‘low’ LTBI participants in 69.44% (25/36). The 
gender difference was statistically significant (LLR χ
2
 (4) = 14.008, p = 0.007) (Figure 
4.3, Table 4.1).  
 
Figure 4.3: Percent distribution of gender according to latent tuberculosis infection categories of 





Statistically significant differences were detected between nationality and LTBI case 
categories. Most of the immigrants in this study 77.22% (139/180) came from counties 
endemic of TB, broken down as follows; Indians 35%, Filipinos 19.44%, Nepalis 15%, 
Ethiopians 7.78% and Sri Lankans 3.3%. Egyptians represented the majority of 
immigrants coming from non-endemic countries: 14.44% (26/180) (LLR χ
2
 (52) = 72.522, 
p = 0.032) (Figure 4.4, Table 4.1).  
 
Figure 4.4: Percent distribution of the nationality according to latent tuberculosis infection 




Marital status was not observed to be significantly associated with LTBI-defined 
immigrants, the composition being: married 62.22% (112/180) and single 35.56% 
(64/180) (LLR χ
2
 (12) = 13.368, p = 0.343) (Figure 4.5, Table 4.1). 
 
Figure 4.5: Percent distribution of the marital status according to latent tuberculosis infection 






A statistically significant association was found between ethnic groups and LTBI 
defined categories. The majority of LTBI defined immigrants were Asians 75% 
(135/180), classified as ‘extremely high’ for LTBI in 86.96% (40/46) and ‘negligible’ 
LTBI in 67.78% (61/90). There were 15.56% (28/180) Caucasians, comprising 
‘negligible’ LTBI in 23.33% (21/90) and ‘low’ LTBI in 16.67% (6/36). There were 
8.33% (15/180) Blacks, divided equally between ‘negligible’ in 6.67% (6/90) and 
‘extremely high’ in 13.04% (6/46) (LLR χ
2
 (16) = 26.478, p = 0.028) (Figure 4.6, Table 
4.1).  
 
Figure 4.6: Percent distribution of the ethnic origin according to latent tuberculosis infection 




The level of education was not a statistically significant risk factor for LTBI and 
‘suspect TB’ cases. The majority of participants had graduated from secondary school 
and higher levels of education 73.33% (132/180), compared to 26.67% (48/180) of those 
graduated from intermediate school and lower levels (which was divided equally in all 
LTBI participant groups). For example Filipino participants commonly had diploma and 
university qualifications 81.11% (31/36) compared to Nepali’s 74.07% (20/27) that were 
graduated and had intermediate school qualifications and lower levels (LLR χ
2
(20) = 
25.245, p = 0.192) (Figure 4.7, Table 4.1). 
 
Figure 4.7: Percent distribution of the education status according to latent tuberculosis infection 




Total immigrants occupied in their mother country were 90.55% (163/180), with overall 
median duration of total employment was 6.5 years (IQR = 9, SIQR = 4.5). The longest 
duration of work experience was for the ‘extremely high’ LTBI classification as 10 years 
(IQR = 11.3) compared to lower number of years of work experience for the ‘negligible’ 
LTBI as 5 years (IQR = 7) or the ‘low’ LTBI as 7 years (IQR = 7.8) with no statistical 
significant difference (KW χ
2 
(4) = 7.276, p = 0.122) (Figure 4.8, Table 4.1) 
 
Figure 4.8: Box-and-whiskers plots of the average duration of employment (years) in the mother 
country according to latent tuberculosis infection categories of 163 employed new immigrants to 




LTBI categories were not statistically significantly different with the average total 
income per month in the mother country for those employed immigrants in 92.78% 
(167/180). The majority of employed immigrants (20%) received between U.S.$50 and 
U.S.$100, and 43.89% received between U.S.$100 and U.S.$250. Only 6.11% of 
immigrants received less than U.S.$50, compared with 4.44% who received more than 
U.S.$1000 (LLR χ
2
 (24) = 31.551, p = 0.139) (Figure 4.9, Table 4.1).  
 
Figure 4.9: Percent distribution of the total income (U.S.$) in the mother country according to latent 
tuberculosis infection categories of 163 employed new immigrants to Kuwait during February and 




The overall median income of the employed participants in their mother country was 
U.S.$136 (IQR = 174, SIQR = 87). The lowest salary was U.S.$22 and the highest 
U.S.$4,452. The highest overall median income was in the ‘low’ LTBI group: 
U.S.$188.50 (IQR = 128) versus U.S.$l35 (IQR = 110) in those with ‘extremely high’ 
LTBI, and U.S.$134 for ‘negligible’ LTBI participants (IQR = 196) (KW χ
2
 (4) = 3.532, p 
= 0.473) (Table 4.1).  
Sixty percent (108/180) of immigrant homes in their mother country contained one to 
ten persons, 32.78% (59/180) had family sizes of between one and four persons and 
7.22% had family sized in excess of more than ten individuals there was no statistically 
significant differences (LLR χ2(8) = 6.586,  p = 0.582). The majority 67.39% (31/46) of 
immigrants in five to ten person households belonged to the ‘extremely high’ category, 
followed by 57.78% (52/90) were belonging to the ‘negligible’ LTBI and by 55.56% 
(20/36) were from the ‘low’ LTBI group (Figure 4.10, Table 4.1). 
 
Figure 4.10: Percent distribution of the total family size (subjects) according to latent tuberculosis 




The overall median number of family individuals living within the same place in the 
mother country was five (IQR = 3) and was the same for all classified LTBI groups 
except for ‘high’ LTBI, which had a median of four (IQR = 3). The minimum number of 
individuals was two, and the maximum was 30 (KW χ
2
 (4) = 2.962, p = 0.564) (Figure 
4.11, Table 4.1). 
 
Figure 4.11: Box-and-whiskers plots of the total family size living within the same house in the 
mother country according to latent tuberculosis infection categories of 180 new immigrants to 
Kuwait during February and May, 2010 
The overall median number of total living rooms within the same living place in the 
mother country was two (IQR = two, SIQR = one), and the lowest number of living 
rooms was one versus the highest number of ten, but with no statistically significant 
difference (KW χ
2




bedrooms in the same house in the mother country was two (IQR = two, SIQR = one). 
The lowest bedroom number was one versus the highest sleeping rooms of seven in all 
LTBI groups with statistical significance at 10% (KW χ
2
 (4) = 8.977, p = 0.062) (Table 
4.1).  
The median number of general crowding index (G.C.I.) (denoted by the number of co-
residents per living room (Baker et al., 2000)) of immigrants was 2.083 (IQR = 2, SIQR 
= 1), and the highest was found in the ‘extremely high’ LTBI as 2.58 (IQR = 2.38) and 
the lowest index in the ‘low’ LTBI group as 2.08 (IQR = 2.25). The lowest household 
crowding index was 0.50 versus the highest G.C.I. value was 13.0, but without statistical 
significant difference (KW χ
2
 (4) = 2.731, p = 0.604)   (Figure 4.12, Table 4.1). 
 
Figure 4.12: Box-and-whiskers plots of the general crowding index (G.C.I.) according to latent 




The overall median number of sleeping crowding index (S.C.I.) (denoted by the number 
of co-residents per sleeping bedroom (Baker et al., 2000)) of immigrants was 2.333 
(IQR = 1.25, SIQR = 0.625), and the highest S.C.I. was found in the ‘extremely high’ 
LTBI group, with a value of 2.67 (IQR = 1.88) and the lowest index was found in the 
‘low’ LTBI group, with a value of 2.00 (IQR = 1.33). The minimum S.C.I. number was 
1.00, and the highest was 13.0 (KW χ
2
 (4) = 5.906, p = 0.206). No statistical significant 
difference was observed (Figure 4.13, Table 4.1).   
 
Figure 4.13: Box-and-whiskers plots of the sleeping crowding index (S.C.I.) according to latent 




4.8.2 Risk factors for Mycobacterium tuberculosis infection 
The susceptibility of immigrants to Mycobacterium tuberculosis infection in their 
mother countries and relation with transport routes and sanitary systems according to 




Table 4.2: Distribution of transport routes and sanitary systems in the mother country according to latent tuberculosis infection categories of 





























n % n % n % n % n % n % n % 
Feasible access to 
medical 
health care service 













60- 12 12.6 1 25.0 0 0 0 0.0 3 6.5 0 0.0 18 10.0 
120- 1 1.1 0 0.0 0 0 0 0.0 0 0.0 0 0.0 3 1.7 


























TB exposure in mother country: Transport routes 
 



































Continued Table 4.2 
 
Presence of sanitary system (sanitary condition of living area in mother country) 




























4.8.2.1 Access to health care services 
Medical care systems in the participants’ mother countries were  accessible to almost 
all 99.44% participants except for one ‘low’ LTBI case, but with no statistical 
significant difference  (LLR χ
2
 (4) = 3.241, p = 0.518). Duration time taken to reach 
the health care services in mother country within less than one hour was answered by 
86.1% immigrants’, compared to 10% of participants who were able to reach medical 
services between one and two hours. 3.9% of immigrants have difficulties to reach 
health care services for more than two hours (LLR χ
2
 (12) = 8.079, p = 0.779). 
Average median duration (minutes) of access to medical care services was 15 
minutes (IQR = 20, SIQR = 10) for all participants, and those defined as ‘high’ LTBI 
cases scored the longest time to reach within 30 minutes (IQR = 8) (KW χ
2
 (4) = 
5.970, p = 0.201). The minimum duration of accessibility was 2 minutes and the 
maximum time to reach health services was 150 minutes (Figure 4.14, Table 4.2).  
 
Figure 4.14: Percent distribution of the average duration (minutes) to health care services in the 
mother country according to latent tuberculosis infection categories of 180 new immigrants to 




4.8.2.2 Transport routes 
The greatest (99.44%) of transport routes used by immigrants in the remote country 
was on foot which was similar to all LTBI participant groups but without statistical 
significant difference for LTBI development (LLR χ
2
 (4) = 1.392, p = 0.846). 46.11% 
of immigrants rode a bicycle and/or tricycle and/or motorcycle, and these were 
usually found in the ‘negligible’ LTBI category in 53.33% and the ‘extremely high’ 
LTBI in 39.13%, which showed statistical significance at 10% level (LLR χ
2
 (4) = 
8.052, p = 0.090). 75.56% of immigrants were using microbuses (e.g. Chapini in the 
Philippines) and/or bus and/or train, separated more in the ‘high’ LTBI 100% and the 
‘extremely LTBI’ 80.43% versus 73.33% of the ‘negligible’ group. Exposure and 
closed environmental contact revealed statistical significant association (LLR χ
2
 (4) = 
14.884, p = 0.005). Only 37.78% of participants also used cars (LLR χ
2
 (4) = 3.858, p 
= 0.426) (Table 4.2).  
4.8.2.3 Sanitary systems 
The presence of sanitary systems and proper sanitary conditions within houses in the 
mother country can be determined by the water supply system. The majority of 
participants 70.56% (127/180) utilized the water tap and water gallon (small tanks) in 
their home country and 25% of immigrants were and/or also using a water pump or 
pump well. Only 4.44% of participants were utilizing imported water storage in their 
living places (LLR χ
2
 (8) = 7.836, p = 0.450) (Figure 14.5, Table 4.2). Also 95% of 
immigrants reported having proper sewage systems in their living places and houses. 
However, significant association between sanitary system was not significant (LLR 
χ
2





Figure 4.15: Percent distribution of the water supply systems used in the mother country 
according to latent tuberculosis infection categories of 180 new immigrants to Kuwait during 
February and May, 2010  
4.8.3 Entry to and living conditions in the State of Kuwait 
Study immigrants living conditions pre- and post-entry to Kuwait are presented in 






Table 4.3: Distribution of immigrants’ living conditions in Kuwait according to latent tuberculosis infection categories of 180 new immigrants to 








































22 24.44 8 22.22 0 0 1 25.00 2 4.35 0 0.00 33 18.33 




































































room with good 
ventilation 






room without good 
ventilation 




















Median (IQR) 3.00 (2) 3.00 (3) -- (--) 1.00 (2) 2.50 (2) 3.00 (6) 3.00 (2) 






in Kuwait  
(day) 
Median (IQR) 11.00 (18) 11.50 (16.5) -- (--) 19.00 (21.5) 12.50 (12.25) 8.50 (13.5) 11.5 (17) 






12.78% (23/180) of participants had past history of previous residence in Kuwait, 
with male predominance (73.91%) and the majority were belonging to the 
‘negligible’ LTBI 14.44% (13/90) and the ‘extremely high’ LTBI groups 15.22% 
(7/46) (LLR χ
2
(4) = 3.353, p = 0.501) (Table 4.3). The overall median duration since 
the last entry/visit to Kuwait was two years (IQR = 3). The minimum duration was 
before one year and the maximum was 23 years, but was not significantly different 
between groups (KW χ
2
 (10) = 14.258, p = 0.162). The median duration of registration 
post-entry to Kuwait was 11.5 days (IQR = 17), which was nearly the same for the 
‘negligible’ and ‘low’ LTBI, but was longer for those ‘high’ LTBI immigrants 19 
days (IQR = 21.5) and ‘extremely high’ 12.5 days before registration (IQR = 12.25) 
(KW χ
2
 (4) = 1.551, p = 0.818) (Table 4.3). Only 2.2% (4/180) immigrants had 
entered the country without the ordinary CXR testing having been performed in their 
mother countries (LLR χ
2
 (4) = 2.919, p = 0.572). Additional tests including sputum 
smear and microscopy (M/S) were performed on 5.55% (LLR χ
2
 (4) = 10.562, p = 
0.032), tuberculin skin test (PPD test) performed for 7.8% (LLR χ
2
 (4) = 3.578, p = 
0.466), and only 9.4% immigrants did a forced cough test (LLR χ
2
 (4) =7.667, p = 
0.105) (Table 4.3).  
The purpose of in-put migration according to the proposed occupation in Kuwait was 
subdivided into the following jobs: First came to work in house-related jobs 
(working as housemaid, driver, cooker and guardian/gardener) were 47.22%, and the 
majority of new immigrants belong to the ‘extremely high’ LTBI group in 58.7% 
(27/46). Second immigrants entered to join manual working jobs were 33.89%, with 
the majority also belongs to the ‘extremely high’ in 36.96% (17/46), and thirdly 
those came to work as non-manual workers were 18.33% (33/180), and the majority 
belong to the ‘negligible’ LTBI group in 24.44% (22/90). Statistical significant 
difference was associated between immigrant’s occupational jobs in the country and 
LTBI development (LLR χ
2








Figure 4.16: Percent distribution of proposed stratum occupation in Kuwait according to latent 
tuberculosis infection categories of 180 new immigrants to Kuwait during February and May, 
2010  
The overall median number of individuals living in the same room as the 
participating immigrant in Kuwait was three individuals (IQR = two, SIQR = one). 
The minimum number of accompanying people was one with a maximum of 12 (KW 
χ
2







86.66% of immigrants reported closed, well-ventilated bedrooms, compared with 
13.33% of immigrants living with poor ventilation (LLR χ
2
 (5) = 6.131, p = 0.294) 
(Figure 4.17, Table 4.3).  
 
Figure 4.17: Percent distribution of the ventilation condition within the living region in Kuwait 
according to latent tuberculosis infection categories of 180 new immigrants to Kuwait during 
February and May, 2010  
4.8.4 Knowledge about tuberculosis  
High levels of TB awareness is crucial for the success of treatment and 
prevention/control efforts in high risk populations, and represents a key challenge for 
public health initiatives. Association of presentations with chest TB in patients 
remains controversial, even more so in asymptomatic LTBI cases. Table 4.4 shows 
the immigrants’ clinical knowledge about TB disease and describes the general 




Table 4.4: Distribution of immigrant’s tuberculosis knowledge according to latent tuberculosis infection categories of 180 new immigrants to 
Kuwait during February and May, 2010 
 
 






















(n=180) Likelihood ratio p-value 
n % n % n % n % n % n % n % 
General knowledge 
Correct 68 75.56 28 77.78 0 0 4 100.00 45 97.83 3 75.00 148 82.22 
LLR χ2(4)=16.103 0.003 
Incorrect 22 24.44 8 22.22 0 0 0 0.00 1 2.17 1 25.00 32 17.78 
Cough 
Yes 68 75.56 28 77.78 0 0 4 100.00 44 95.65 2 50.00 146 81.11 
LLR χ2(8)=24.553 0.002 No 2 2.22 3 8.33 0 0 0 0.00 2 4.35 1 25.00 8 4.44 
Unknown 20 22.22 5 13.89 0 0 0 0.00 0 0.00 1 25.00 26 14.44 
Hemoptysis 
Yes 55 61.11 24 66.67 0 0 3 75.00 38 82.61 3 75.00 123 68.33 
LLR χ2(8)=22.590 0.004 No 14 15.56 7 19.44 0 0 1 25.00 8 17.39 0 0.00 30 16.67 
Unknown 21 23.33 5 13.89 0 0 0 0.00 0 0.00 1 25.00 27 15.00 
Fever 
Yes 57 63.33 26 72.22 0 0 3 75.00 40 86.96 2 50.00 128 71.11 
LLR χ2(8)=22.032 0.005 No 12 13.33 5 13.89 0 0 1 25.00 6 13.04 1 25.00 25 13.89 
Unknown 21 23.33 5 13.89 0 0 0 0.00 0 0.00 1 25.00 27 15.00 
Night sweating 
Yes 32 35.56 15 41.67 0 0 1 25.00 21 45.65 1 25.00 70 38.89 
LLR χ2(8)=15.726 0.046 No 37 41.11 15 41.67 0 0 3 75.00 24 52.17 2 50.00 81 45.00 
Unknown 21 23.33 6 16.67 0 0 0 0.00 1 2.17 1 25.00 29 16.11 
Generalized weakness 
Yes 56 62.22 26 72.22 0 0 2 50.00 36 78.26 3 75.00 123 68.33 
LLR χ2(8)=24.435 0.002 No 13 14.44 5 13.89 0 0 2 50.00 10 21.74 0 0.00 30 16.67 





Average LTBI category is zero (means no detected cases), (-) means cannot be computed by SPSS Software programm 
 
 
Continued Table 4.4 
 
Weight loss/wasted 
Yes 54 60.00 25 69.44 0 0 2 50.00 39 84.78 3 75.00 123 68.33 
LLR χ2(8)=24.824 0.002 No 15 16.67 6 16.67 0 0 2 50.00 7 15.22 0 0.00 30 16.67 
Unknown 21 23.33 5 13.89 0 0 0 0.00 0 0.00 1 25.00 27 15.00 
Vomiting/diarrhea 
Yes 38 42.22 17 47.22 0 0 1 25.00 21 45.65 2 50.00 79 43.89 
LLR χ2(8)=17.087 0.029 No 31 34.44 13 36.11 0 0 3 75.00 24 52.17 1 25.00 72 40.00 
Unknown 21 23.33 6 16.67 0 0 0 0.00 1 2.17 1 25.00 29 16.11 
Body pain (bone/joint) 
Yes 28 31.11 8 22.22 0 0 1 25.00 11 23.91 1 25.00 49 27.22 
LLR χ2(8)=18.626 0.017 No 41 45.56 21 58.33 0 0 3 75.00 34 73.91 2 50.00 101 56.11 
Unknown 21 23.33 7 19.44 0 0 0 0.00 1 2.17 1 25.00 30 16.67 
Other symptom(s)/sign(s) 
Yes 3 3.33 1 2.78 0 0 0 0.00 3 6.52 0 0.00 7 3.89 
LLR χ2(8)=22.038 0.005 No 66 73.33 30 83.33 0 0 4 100.00 43 93.48 3 75.00 146 81.11 




Immigrants were asked indirectly about TB to prevent stigma and misperceptions 
(Wieland et al., 2010). Not a single participant was able to answer all TB questions 
correctly. However, out of 180 immigrants interviewed, general knowledge about TB 
was high with statistical significant difference (LLR χ
2
(4) = 16.103, p = 0.003).  A 
total of 82.22% (148/180) of immigrants heard about TB disease and at least 
correctly defined tuberculosis as a ‘dangerous infectious respiratory disease’ and 
these were distributed more in the ‘high’ and ‘extremely high’ LTBI groups. 
Common clinical symptoms of TB answered as ‘yes’/‘unknown’ were distributed as 
follows: cough 81.11%/14.44% (LLR χ
2
(8) = 24.553, p = 0.002), fever  71.11%/15%  
(LLR χ
2
 (8) = 22.032, p = 0.004), generalized weakness and weight loss (or wasted) 
68.33%/15% (LLR χ
2
 (8) = 24.435, p = 0.002), and hemoptysis 68.33%/15% (LLR χ
2
 
(8) = 22.590, p = 0.004).  
Tuberculosis symptoms were less frequently identified as vomiting/diarrhea 43.98% 
(LLR χ
2
 (8) = 17.087, p = 0.029), night-sweats 38.89% (LLR χ
2
 (8) = 15.726, p = 
0.046), and body pains (bone/joints) (LLR χ
2
 (8) = 18.626, p = 0.017) or other 
complaints such as TB orbital swelling (LLR χ
2
 (8) = 22.038, p = 0.005) (Table 4.4). 
4.8.5 Sources of tuberculosis knowledge 
General information about tuberculosis was explored through immigrants’ answers 
about their various sources of the infection and disease knowledge, as shown in 
Table 4.5. Common sources of knowledge were associated with the defined LTBI 
categories, and distributed as TB knowledge in the mother countries within the 
study/learning areas (e.g. school/class and close friends) (LLR χ
2
 (4) = 11.512, p = 
0.021), and/or public shared talks and external communications (community and 
social networking) (LLR χ
2
 (4) = 11.236, p = 0.024). LTBI categories were also 
defined for immigrants who stated that television and reading advertisements in 
newspapers/magazines as sources of knowledge with significant association (LLR χ
2
 
(4) = 15.275, p = 0.004). Medical campaigns and posters were also important sources 
of TB knowledge dissemination, which were significantly different across the LTBI 
categories (LLR χ
2




Table 4.5: Distribution of tuberculosis knowledge sources according to latent tuberculosis infection categories of 180 new immigrants to Kuwait 
during February and May, 2010 





















(n=180) Likelihood ratio p-value 
n % n % n % n % n % n % n % 
Family/Relative Yes 37 41.11 16 44.44 0 0.00 1 25.00 26 56.52 1 25.00 81 45.00 LLR χ2(4)=4.380 0.357 
Study area (e.g. school/friend subject) Yes 30 33.33 16 44.44 0 0.00 4 100.00 23 50.00 1 25.00 74 41.11 LLR χ2(4)=11.512 0.021 
Work peer/close contact Yes 32 35.56 17 47.22 0 0.00 3 75.00 22 47.83 1 25.00 75 41.67 LLR χ2(4)=4.887 0.299 
Public shared talks Yes 67 74.44 29 80.56 0 0.00 3 75.00 44 95.65 3 75.00 146 81.11 LLR χ2(4)=11.236 0.024 
TV/Newspaper advertisement Yes 61 67.78 27 75.00 0 0.00 4 100.00 43 93.48 3 75.00 138 76.67 LLR χ2(4)=15.275 0.004 
Medical campaign/Poster Yes 41 45.56 24 66.67 0 0.00 4 100.00 34 73.91 3 75.00 106 58.89 LLR χ2(4)=16.627 0.002 
Other source(S) Yes 10 11.11 5 13.89 0 0.00 0 0.00 8 17.39 1 25.00 24 13.33 LLR χ2(4)=2.555 0.635 
Example(s) of other knowledge source 
Friend/Relative 1 1.11 0 0.00 0 0.00 0 0.00 1 2.17 0 0.00 2 1.11 
LLR χ2(28)=24.124 0.675 
Hospital 5 5.56 0 0.00 0 0.00 0 0.00 1 2.17 1 25.00 7 3.89 
Internet 0 0.00 3 8.33 0 0.00 0 0.00 2 4.35 0 0.00 5 2.78 
Internet & journal 1 1.11 1 2.78 0 0.00 0 0.00 1 2.17 0 0.00 3 1.67 
Internet & public 0 0.00 1 2.78 0 0.00 0 0.00 0 0.00 0 0.00 1 0.56 
Journal 1 1.11 0 0.00 0 0.00 0 0.00 1 2.17 0 0.00 2 1.11 
Public 2 2.22 0 0.00 0 0.00 0 0.00 2 4.35 0 0.00 4 2.22 





On the contrary, association of the defined LTBI groups and the TB knowledge from 
close contacts of immigrant’s families or relatives were not statistically significant 
(LLR χ
2
 (4) = 4.380, p = 0.357) or occupational close contacts such as work peer (LLR 
χ
2
 (4) = 4.887, p = 0.299), which might be due to TB stigma and symptoms hiding. 
Networking sources such as internet also revealed insignificant association (LLR χ
2
 
(4) = 24.124, p = 0.675) (Table 4.5).  
4.8.6 Risk of tuberculosis exposure and contact 
Using degree of exposure to TB as a surrogate for LTBI, epidemiological risk factors 
correlate with TB exposure. 
4.8.6.1 Risk of travel or work outside 
Risks of tuberculosis-associated exposure-contact transmissions of MTB bacilli for 
the 180 new immigrants according to latent tuberculosis infection defined categories 






Table 4.6: Distribution of tuberculosis travel and work risk factors according to latent tuberculosis infection categories of 180 new immigrants to 





























Yes 43 47.78 18 50.00 0 0 3 75.00 20 43.48 2 50.00 86 47.78 
LLR χ2(4) = 
1.654 
0.799 









No 53 58.89 19 52.78 0 0 1 25.00 28 60.87 2 50.00 103 57.22 
Work 
outside in : 







2 2.22 2 5.56 0 0 1 25.00 1 2.17 0 0.00 6 3.33 
Non-
endemic 
















Average LTBI category is zero (means no detected cases), (-) means cannot be computed by SPSS Software programme  
 









No 82 91.11 35 97.22 0 0 4 100.00 44 95.65 4 100.00 169 93.89 
Travel 
and/or 
 visit to : 







3 3.33 0 0.00 0 0 0 0.00 0 0.00 0 0.00 3 1.67 
Non-
endemic 















Out of the total 180 participants, 42.78% (77/180) had worked outside their mother 
countries for at least one year. 31.11% of immigrant workers employed in non-
endemic regions, such as Gulf countries, and were distributed mainly in the ‘low’ 
LTBI group 38.89% and ‘extremely high’ LTBI 30.43%. Immigrants working 
previously in endemic regions constituted only 8.33%, and were distributed mainly 
in the ‘negligible’ LTBI 11.11% (LLR χ
2
 (12) = 10.541, p = 0.569) (Figure 4.18, Table 
4.6).  
 
Figure 4.18: Percent distribution of working history outside the mother country according to 
latent tuberculosis infection categories of 180 new immigrants to Kuwait during February and 




Only 6.11% (11/180) of immigrants had travelled outside their mother countries, and 
all fell the ‘negligible’ LTBI group 8.89% (LLR χ
2
 (4) = 3.220, p = 0.522). 
Immigrants travelled to both endemic and non-endemic regions, but only 5% been 
travelled to endemic countries versus 3% travelled to non-endemic regions only 
(LLR χ
2
 (12) = 8.334, p = 0.759). The overall median duration of travel or visit was 
less than 4 weeks (IQR = 3, SIQR = 1.5). The minimum travel duration was one 
week and the longest was 20 weeks. The differences were not statistically significant 
between LTBI categories (KW χ
2
 (2) = 1.244, p = 0.537) (Figure 4.19, Table 4.6). 
 
Figure 4.19: Percent distribution of travel history outside the mother country according to 
latent tuberculosis infection categories of 180 new immigrants to Kuwait during February and 




4.8.6.2 History of environmental (inside household and outside 
household) contacts 
Screening of household contacts, which has been prioritized in industrialized 
countries, merits serious consideration as a means of interrupting transmission in 
high-burden settings. The distribution of environmental contacts inside- and outside 
households of the immigrants in their mother countries according to latent 




Table 4.7: Distribution of environmental exposure contacts in the mother country according to latent tuberculosis infection categories of 180 new 
immigrants to Kuwait during February and May, 2010   




















n % n % n % n % n % n % n % 
Average number of 
daily contact to inside 
same households 




3-5 33 36.67 11 31 0 0.00 0 0.00 20 43.48 2 50.00 66 36.67 
6-10 5 5.56 3 8 0 0.00 0 0.00 1 2.17 0 0.00 9 5.00 
>10 0 0.00 1 3 0 0.00 0 0.00 0 0.00 0 0.00 1 0.56 
Duration of contact to 
inside same households 
(hours) 
1-5 1 1.11 1 3 0 0.00 0 0.00 4 8.70 0 0.00 6 3.33 
LLR χ2(8)= 
11.361 
0.182 6-10 30 33.33 8 22 0 0.00 1 25.00 17 36.96 0 0.00 56 31.11 
>10 59 65.56 27 75 0 0.00 3 75.00 25 54.35 4 100.00 118 65.56 
Average number of 
daily contact to outside 
non-households 




3-5 23 25.56 7 19 0 0.00 3 75.00 16 34.78 1 25.00 50 27.78 
6-10 38 42.22 12 33 0 0.00 0 0.00 14 30.43 0 0.00 64 35.56 
>10 15 16.67 13 36.1 0 0.00 0 0.00 12 26.09 2 50.00 42 22.78 
Duration of contact to 
outside non-households 
(hours) 




1-5 4 4.44 2 6 0 0.00 0 0.00 2 4.35 1 25.00 9 5.00 
6-10 49 54.44 21 58 0 0.00 2 50.00 17 36.96 1 25.00 90 50.00 




The average number of daily contacts within households was not significantly 
associated with LTBI categories. 57.78% of immigrants had daily contacts to either 
one and/or two individuals or 36.67% between three and five subjects. The details of 
those exposed to three and/or five subjects were distributed as follows; ‘extremely 
high’ LTBI in 43.48%, ‘negligible’ LTBI in 36.67% and ‘low’ LTBI in 31% (LLR χ
2
 
(12) = 10.869, p = 0.540) (Figure 4.20, Table 4.7).  
 
Figure 4.20: Percent distribution of average number of daily contacts with inside household 
individuals in the mother country according to latent tuberculosis infection categories of 180 





In all LTBI categories, the average duration of contact to individuals inside 
households for more than 10 hours was recorded in 65.56% of immigrants and 
between six and ten hours was observed in 31.11%. No significant differences were 
detected between LTBI categories and duration of contact inside households (LLR χ
2
 
(8) = 11.361, p = 0.182) (Figure 4.21, Table 4.7).  
 
Figure 4.21: Percent distribution of duration (hours) of daily contacts with inside household 
individuals in the mother country according to latent tuberculosis infection categories of 180 





The average number of immigrants’ daily contact to outside (non-household) 
environment was not significantly associated with LTBI development. 35.56% of 
immigrants had daily contacts to either six and/or ten individuals outside homes, or 
27.78% contacted between three and five subjects. The details of those 22.78% 
participants who were exposed to more than ten individuals were divided as follows; 
‘negligible’ LTBI in 16.67%, ‘low’ LTBI in 36.1% and ‘extremely high’ LTBI in 
26.09% (LLR χ
2
 (16) = 22.613, p = 0.124) (Figure 4.22, Table 4.7). 
 
Figure 4.22: Percent distribution of average number of daily contact to outside households 
according to latent tuberculosis infection categories of 180 new immigrants to Kuwait during 




For all LTBI categories, the duration of contact to individuals outside households 
was significantly associated at the 10% significance interval. 50% of participants had 
contacts to outside environment between six and ten hours and other 38.89% of them 
spent more than ten hours outside their households (LLR χ
2
 (12) = 20.285, p = 0.062) 
(Figure 4.23, Table 4.7). 
 
Figure 4.23: Percent distribution of average duration (hours) of daily contact to outside 
households according to latent tuberculosis infection categories of 180 new immigrants to 
Kuwait during February and May, 2010  
4.8.6.3 History of direct contact to diagnosed tuberculosis patient  
Table 4.8 lists the direct contact of immigrants to diagnosed tuberculosis patients in 




Table 4.8: Distribution of direct contact with diagnosed tuberculosis patient according to latent tuberculosis infection categories of 180 
new immigrants to Kuwait during February and May, 2010 





















n % n % n % n % n % n % n % 
Have been infected 
or contacted with 
TB case 
Yes 5 6 0 0 0 0 0 0 6 13 0 0 11 6.11 LLR χ2(8)= 
13.799 
0.087 
Unknown 10 11 4 11.11 0 0 0 0 1 2 0 0 15 8.33 
If Yes, TB disease 
was diagnosed by 
medically qualified 
staff 

































Yes 3 3 0 0 0 0 0 0 3 7 0 0 6 3.33 LLR χ2(8)= 
8.671 
0.371 
Unknown 2 2 0 0 0 0 0 0 3 7 0 0 5 2.78 
Cured 
Yes 3 3 0 0 0 0 0 0 4 9 0 0 7 3.89 LLR χ2(8)= 
7.476 
0.486 
Unknown 2 2 0 0 0 0 0 0 1 2 0 0 3 1.67 







Continued Table 4.8 
Failure 
Yes 1 1 0 0 0 0 0 0 2 4 0 0 3 1.67 LLR χ2(8)= 
6.088 
0.637 
Unknown 3 3 0 0 0 0 0 0 2 4 0 0 5 2.78 
Relapse 
Yes 1 1 0 0 0 0 0 0 2 4 0 0 3 1.67 LLR χ2(8)= 
8.971 
0.345 
Unknown 3 3 0 0 0 0 0 0 4 9 0 0 7 3.89 
Resistance 
No 86 96 36 100.00 0 0 4 100.00 40 87 4 100.00 170 94.44 LLR χ2(4)= 
8.890 
0.064 
Unknown 4 4 0 0 0 0 0 0 6 13 0 0 10 5.56 
DOTS 
Yes 0 0 0 0 0 0 0 0 1 2 0 0 1 0.56 LLR χ2(8)= 
9.985 
0.266 
Unknown 4 4 0 0 0 0 0 0 5 11 0 0 9 5.00 
Rifampicin 
Yes 3 3 0 0 0 0 0 0 3 7 0 0 6 3.33 LLR χ2(8)= 
8.671 
0.371 
Unknown 2 2 0 0 0 0 0 0 3 7 0 0 5 2.78 
Pyrizanamide 
Yes 3 3 0 0 0 0 0 0 3 7 0 0 6 3.33 LLR χ2(8)= 
8.671 
0.371 
Unknown 2 2 0 0 0 0 0 0 3 7 0 0 5 2.78 
INH 
Yes 3 3 0 0 0 0 0 0 3 7 0 0 6 3.33 LLR χ2(8)= 
8.671 
0.371 
Unknown 2 2 0 0 0 0 0 0 3 7 0 0 5 2.78 
Ethambutol 
Yes 3 3 0 0 0 0 0 0 3 7 0 0 6 3.33 LLR χ2(8)= 
8.671 
0.371 
Unknown 2 2 0 0 0 0 0 0 3 7 0 0 5 2.78 
Other treatment 
e.g. streptomycin 



















Average LTBI category is zero (means no detected cases), (-) means cannot be computed by SPSS Software programme 
 
 

































6.11% (11/180) of participants admitted a previous history of direct contact with a 
diagnosed TB patient(s), 13% (6/46) in the ‘extremely high’ LTBI group and 6% 
(5/90) in the ‘negligible’ LTBI group. 85.55% (154/180) denied any contact, and 
8.33% (15/180) reported ‘unknown’ contact. Differences were not statistically 
significant (LLR χ
2
 (8) = 13.799, p = 0.087) (Table 3).  
There were no statistically significant difference in relation to LTBI categories as 
follows; all contacted TB patients were diagnosed by a medically-qualified health 
care service in their mother country (LLR χ
2
 (4) = 8.561, p = 0.073), and 90.9% 
(10/11) had received prescribed anti-tuberculosis chemotherapy (LLR χ
2
 (4) = 6.993, p 
= 0.136). The overall median duration of disease complaints of their infected 
contacts before tuberculosis diagnosis was 13 months (IQR = 12 months) (KW χ
2
 (1) 
= 0.077, p = 0.782) (Table 3). 
The anti-TB therapy was reported for the following regimen courses in relation to 
LTBI categories; completed treatment course 3.33% (LLR χ
2
 (8) = 8.671, p = 0.371), 
complaints cured 3.89% (LLR χ
2
 (8) = 7.476, p = 0.486), treatment default 5.56% 
(LLR χ
2
 (4) = 8.890, p = 0.064), treatment failure (LLR χ
2
 (8) = 6.088, p = 0.637), 
treatment relapse (LLR χ
2
 (8) = 8.971, p = 0.345), and DOTS follow-up 0.56% (LLR 
χ
2
 (8) = 9.985, p = 0.266).  No history of TB treatment resistance was recalled by the 
immigrants (LLR χ
2
 (4) = 8.890, p = 0.064). 3.33% of participants know about the 
treatment of TB and recalled using a full course of anti-TB drugs (rifampicin, 
pyrizanamide, INH, ethambutol).  2.78% answered ‘unknown’ about treatment (LLR 
χ
2
 (8) = 8.671, p = 0.371). Only 4.44% of immigrants reported absence of adverse 
effects of anti-TB treatment (such as fever, vomiting/diarrhea, hepatitis, orange urine 
discoloration) of their TB patients (LLR χ
2
 (8) = 13.799, p = 0.111) (Table 3). 
4.8.6.4 The stigma of tuberculosis  
The distribution of TB stigma and risk factors of immigrant’s exposure to 





Table 4.9: Distribution of tuberculosis exposure risk factor according to latent tuberculosis infection categories of 180 new immigrants to 
















Can not be judged 
(n=4) 
Total 
(n=180) Likelihood ratio p-value 
n % n % n % n % n % n % n % 
Previous history of 
contact with TB 
diagnosed patient 
Yes 30 33.33 15 42 0 0 2 50.00 24 52.17 2 50.00 73 40.56 
LLR χ2(8)= 
7.877 
0.446 No 48 53.33 17 47 0 0 2 50.00 20 43.48 2 50.00 89 49.44 
Unknown 12 13.33 4 11 0 0 0 0.00 2 4.35 0 0.00 18 10.00 
In-door close contact 
Yes 4 4.44 1 3 0 0 0 0.00 9 19.57 0 0.00 14 7.78 LLR χ2(4)= 
11.047 
0.026 
No 86 95.56 35 97 0 0 4 100.00 37 80.43 4 100.00 166 92.22 
Out-door close 
contact 
Yes 19 21.11 9 25 0 0 1 25.00 16 34.78 1 25.00 46 25.56 LLR χ2(4)= 
2.906 
0.574 
No 71 78.89 27 75 0 0 3 75.00 30 65.22 3 75.00 134 74.44 
Average number of 
daily contact to inside 
same household 
diagnosed TB 




3-5 33 36.67 11 31 0 0 0 0.00 20 43.48 2 50.00 66 36.67 
6-10 5 5.56 3 8 0 0 0 0.00 1 2.17 0 0.00 9 5.00 
>10 0 0.00 1 3 0 0 0 0.00 0 0.00 0 0.00 1 0.56 
Average number of 
daily contact to inside 
HH diagnosed TB 
Median 
(IQR) 








Average LTBI category is zero (means no detected cases), (-) means cannot be computed by SPSS Software programme 
 
 
Continued Table 4.9 
Duration of contact to 
inside same 
households (hours)) 
1-5 1 1.11 1 3 0 0 0 0.00 4 8.70 0 0.00 6 3.33 
LLR χ2(8)= 
11.361 
0.182 6-10 30 33.33 8 22 0 0 1 25.00 17 36.96 0 0.00 56 31.11 
>10 59 65.56 27 75 0 0 3 75.00 25 54.35 4 100.00 118 65.56 
Average number of 
daily contact to 
outside non-
households 




3-5 23 25.56 7 19 0 0 3 75.00 16 34.78 1 25.00 50 27.78 
6-10 38 42.22 12 33 0 0 0 0.00 14 30.43 0 0.00 64 35.56 
>10 15 16.67 13 36.1 0 0 0 0.00 12 26.09 2 50.00 42 22.78 
Average number of 
daily contact with 
NHH diagnosed TB 
Median 
(IQR) 




Duration of contact to 
outside non-
households (hours) 




1-5 4 4.44 2 6 0 0 0 0.00 2 4.35 1 25.00 9 5.00 
6-10 49 54.44 21 58 0 0 2 50.00 17 36.96 1 25.00 90 50.00 




All immigrants were re-questioned about history of previous contacts with TB 
diagnosed patients. The results revealed statistical insignificant difference for 
association between LTBI stigma and those immigrants  answered ‘yes’ in 40.56% 
(73/180) compared to those immigrants who answered as ‘no’ 49.44% (89/180) or 
those answered as ‘unknown’ in 10% (18/180) (LLR χ
2
 (8) = 7.877, p = 0.446). 50% 
of immigrants belonging to the ‘high’ and ‘extremely high’ LTBI groups were daily 
exposed to infected subjects compared to less percentage of the rest groups (Figure 
4.24, Table 4.9).   
 
Figure 4.24: Percent distribution of 'previous history' contacts with diagnosed tuberculosis 
patients in the mother country according to latent tuberculosis infection categories of 180 new 




Indoor close contacts to diagnosed TB patients were significantly associated with 
LTBI risk development in 7.78% (14/180) of participants (LLR χ
2
 (4) = 11.047, p = 
0.026). Those participants were belonging to the ‘extremely high’ LTBI group 
19.57% (9/46) than those of the ‘negligible’ LTBI group 4.44% (4/90) (Figure 4.25, 
Table 4.9).  
 
Figure 4.25: Percent distribution of indoor close contacts to diagnosed household tuberculosis 
patients in the mother country according to latent tuberculosis infection categories of 180 new 






On the other hand outdoor close contacts to diagnosed TB patients were not 
significantly associated with LTBI suspicion in 25.56% (46/180) of participants, the 
majority belonging to the ‘extremely high’ LTBI group in 34.78% and 25% of 
participants in each of  the ‘low’ and ‘high’ LTBI groups (LLR χ
2
 (4) = 2.906, p = 
0.574) (Figure 4.26, Table 4.9).    
 
Figure 4.26: Percent distribution of previous history of outdoor contacts with tuberclosis 
diagnosed patients in the mother country according to latent tuberculosis infection categories of 





The average number of daily contacts to household (inside) diagnosed patient in the 
mother country was not significantly associated with development of LTBI. Contact 
with one TB patient to inside the living sites was answered by 36.67% (66/180) of 
immigrants, and the majority was belonging to the ‘extremely high’ LTBI in 43.48% 
and ‘negligible’ LTBI in 36.67%. Comparatively, 5% had contact with two TB 
patients and only 0.56% of immigrants had contact with three TB patients (LLR χ
2
 
(12) = 10.869, p = 0.540) (Figure 4.27, Table 4.9). 
 
Figure 4.27: Percent distribution of the average number of daily contacts with diagnosed 
tuberculosis patients inside household individuals in the mother country according to latent 





The overall median number of daily contacts to inside household diagnosed TB 
patients in the mother country was one subject (IQR = one). The lowest number of 
contacts with TB diagnosed patients was one, whereas the maximum was four (KW 
χ
2
 (4) = 2.958, p = 0.565) (Table 4.9). 
The average period of contact with those having TB patients inside households was 
not significantly associated with LTBI categories. Including immigrants without 
history of exposure to TB patients and participants who have daily contact of less 
than one hour were both composed 90% (162/180) of sample size, and were 
represented equally for all LTBI group participants (LLR χ
2
 (12) = 14.630, p = 0.262). 
Immigrants had average duration of exposure of one hour duration to an inside TB 
contact (IQR = 1, SIQR = 0.5) (KW χ
2
 (4) = 2.958, p = 0.565) (Figure 4.28, Table 
4.9). 
 
Figure 4.28: Percent distribution of average duration of daily contacts with diagnosed 
tuberculosis patients to inside household individuals in the mother country according to latent 




Average number of daily contacts to diagnosed patient outside households in the 
mother country was not significantly associated with development of LTBI and TB 
suspicion. 29.44% (53/180) of participants had external contact to one non household 
TB patient, compared to 6.11% of immigrants had contact with more than one TB 
patients. ‘Extremely high’ LTBI group was the predominant group had external 
contacts to various TB patients (LLR χ
2
 (12) = 7.808, p = 0.800) (Figure 4.29, Table 
4.9).  
 
Figure 4.29: Percent distribution of the average number of daily contacts with diagnosed 
tuberculosis patients to outisde household individuals in the mother country according to latent 





Including immigrants with no history of external contacts and those had daily 
external contacts with non-household TB patients of less than one hour were detected 
in 96.11% (173/180), compared to only 3.33% who spent daily between one and five 
hours with predominance of the ‘extremely high’ LTBI group (LLR χ
2
(8) = 7.285, p  
= 0.506) (Figure 4.29, Table 4.9). The overall median number of daily external 
contacts to non-household diagnosed TB patient in the mother country was one TB 
case (IQR = one contact). Lowest number of contacts was one, and highest number 
was four (KW χ
2
 (4) = 4.150, p = 0.386) (Table 4.9). 
4.8.6.5 Risk factors for progression of infection to active tuberculosis 
Multiple risk factors associated with progression of M. tuberculosis toward the active 
form of tuberculosis disease can be sub-divided into the categories detailed below. 
4.8.6.5.1 History of infectious and non-infectious (chronic) disorders 
The past history of catching infectious and/or chronic non-infectious disorders 







Table 4.10: History of infectious and chronic non-infectious disorders according to latent tuberculosis infection categories of 180 new 

















































(n=180) Likeilhood ratio p-value 
n % n % n % n % n % n % n % 
Skin 
allergy 
Yes 5 5.56 4 11.11 0 0 1 25.00 1 2.17 0 0.00 11 6.11 LLR χ
2
(4)=4.934 0.294 




Yes 3 3.33 2 5.56 0 0 0 0.00 4 8.70 0 0.00 9 5.00 
LLR χ2(8)=12.777 0.120 
Unknown 9 10.00 1 2.78 0 0 0 0.00 0 0.00 1 25.00 11 6.11 
Asthma 
Yes 2 2.22 4 11.11 0 0 0 0.00 0 0.00 0 0.00 6 3.33 
LLR χ2(8)=12.394 0.134 
Unknown 2 2.22 0 0.00 0 0 0 0.00 3 6.52 0 0.00 5 2.78 
HIV/AIDS No 90 100.00 36 100.00 0 0 4 100.00 46 100.00 4 100.00 180 100.00 - -- 
Hepatitis 
Yes 1 1.11 1 2.78 0 0 0 0.00 2 4.35 0 0.00 4 2.22 
LLR χ2(8)=6.954 0.542 
Unknown 4 4.44 4 11.11 0 0 0 0.00 6 13.04 0 0.00 14 7.78 
Silicosis 
Yes 0 0.00 1 2.78 0 0 0 0.00 0 0.00 0 0.00 1 0.56 
LLR χ2(8)=12.433 0.133 
Unknown 82 91.11 26 72.22 0 0 2 50.00 41 89.13 3 75.00 154 85.56 













               
Average category = means zero (no detected cases)  
 
Continued Table 4.10 
Cardiovasc
ular disease 
Yes 3 3.33 0 0.00 0 0 0 0.00 4 8.70 0 0.00 7 3.89 
LLR χ2(8)=8.546 0.382 
Unknown 0 0.00 0 0.00 0 0 0 0.00 1 2.17 0 0.00 1 0.56 
Blood 
disorder 
Yes 0 0.00 1 2.78 0 0 0 0.00 1 2.17 0 0.00 2 1.11 
LLR χ2(8)=6.479 0.594 
Unknown 0 0.00 1 2.78 0 0 0 0.00 0 0.00 0 0.00 1 0.56 
Other 
disease  
Yes 6 6.67 4 11.11 0 0 0 0.00 2 4.35 0 0.00 12 6.67 LLR χ
2


















Most of the immigrants in the study described different past histories of disease 
exposure but with no statistical significant differences between past history of 
contacting previous chronic disorders (infections/non-infectious) and LTBI 
categories. The majority of complained of skin allergies 6.11% (LLR χ
2
(4) = 4.934, p 
= 0.294), malaria 5% (LLR χ
2
(8) = 12.777, p = 0.120), cardiovascular disorders 3.89% 
(LLR χ
2
(8) = 8.546, p = 0.382), asthma 3.33% (LLR χ
2
(8) = 12.394, p = 0.134), DM 
2.22% (LLR χ
2
(4) = 2.422, p = 0.659) and 2.22% admitted catching hepatitis during 
childhood (LLR χ
2
(8) = 6.954, p = 0.542). All immigrants denied any past history of a 
diagnosis of HIV/AIDS.  
72.22% of immigrants (predominantly male) admitted to drinking alcohol in their TB 
endemic and mother countries; Philippinos 48.57% (17/35), Nepali’s 38.26% (11/28) 
and Indians 14.28% (9/63). Those participants were distributed without significant 
difference as ‘negligible’ LTBI 28.89% (26/90), ‘low’ LTBI group 33.33% (12/36) 
and ‘extremely high’ LTBI 19.57% (9/46) (LLR χ
2
 (4) = 5.705, p = 0.222) (Table 
4.10).  
Up to 11.66% (21/180) of immigrants had a current history of taking pharmaceutical 
agents, and 6.66% (12/180) had a history of cardiovascular disease and diabetes 
mellitus constituted. Participants having past history of surgical procedure were 
18.89% (34/180) (LLR χ
2
(4) = 3.522, p = 0.475). Participants with a current history of 
taking regular pharmaceutical therapy (mainly skin anti-allergic steroids) were 
11.67% (21/180) (LLR χ
2
 (4) = 5.039, p = 0.283) (Table 4.10). 
4.8.7 Body mass index (weight-for-height measure) 
Body Mass Index (BMI) is a nutritional indicator and measure of health and body 
composition. BMI is calculated by dividing a person's weight in kilograms (kg) by 
the height in metres squared (m
2
). The normal BMI lies between 18.50 and 24.99, 
representing a healthy range. A BMI lower than 18.50 is considered underweight, 
compared with overweight subjects (BMI 25.00-30.00) and obese individuals (BMI 




A strong association between extremes of relative body weight and the TB burden 
level has been well characterized all over the world. Common inverse relationship is 
detected between BMI and TB incidence, and within the BMI normal and overweight 
ranges 18.50 and 30.00 kg/m
2
, respectively (Lonnroth et al., 2010). The distribution 
of BMI according to the latent tuberculosis infection classification of the 180 






Table 4.11: Distribution of body mass index (BMI) according to latent tuberculosis infection categories of 180 new immigrants to Kuwait 
























Extremely High  
 
(n=46) 













 n % n % n % n % n % n % n % 
<18.50 (Underweight) 7 7.78 2 5.56 0 0 0 0.00 4 8.70 0 0.00 13 7.22 
LLR χ2(12)= 
8.722 
0.726) 18.50-24.99 (Normal weight) 50 55.56 21 58.33 0 0 1 25.00 28 60.87 4 100.00 104 57.78 
25.00-30.00 (Overweight) 27 30.00 11 30.56 0 0 2 50.00 12 26.09 0 0.00 52 28.89 
>30.00 (Obesity) 6 6.67 2 5.56 0 0 1 25.00 2 4.35 0 0.00 11 6.11 
BMI Median (IQR) 24.12 (6) 24.06 (5.23) - - 27.09 (6.16) 23.04 (4.71) 22.51 (5.78) 24.017 (5.48) 






The majority of new immigrants 57.78% (104/180) were lying within the normal 
weight-for-height measures and BMI ranges (18.50-24.99 kg/m
2
) in comparison to 
28.89% (52/180) been overweight immigrants (25.00-30.00 kg/m
2
) and 6.11% were 
obese (more than 30.00 kg/m
2
). Only 7.22% (13/180) of participants were 
underweight and the majority belongs to the ‘extremely high’ LTBI group 8.70% 
(4/46) and ‘negligible’ LTBI 7.78% (7/90) (LLR χ
2
 (12) = 8.722, p = 0.726) (Figure 
4.30, Table 4.11).  
 
Figure 4.30: Percent distribution of body mass index on the latent tuberculosis infection case 





The overall median BMI of all immigrants was normal and equals 24.017 kg/m
2
 
(IQR = 5.48, SIQR = 2.74) but with no statistical significance difference toward 
LTBI development (KW χ
2
 (4) = 3.912, p = 0.418), except for associated high BMI 
for the ‘high’ LTBI group as 27.09 (IQR = 6.16). The minimum BMI was 14.70 
kg/m
2
 versus the highest BMI value was 36.83 kg/m
2
 (Figure 4.30, Figure 4.31, 
Table 4.10).  
 
Figure 4.31: Box-and-whiskers plots of the distribution of body mass index (BMI) according to 





4.8.8 History of smoking and smoking behavioral habits 
Assessment of smoking as a risk factor, according to latent tuberculosis infection is 




Table 4.12: Distribution of smoking according to latent tuberculosis infection categories of 180 new immigrants to Kuwait during February and 
May, 2010 
 





























Ex-smoker 12 13.33 7 19.44 0 0 0 0.00 9 19.57 0 0.00 28 15.56 






52 57.78 16 44.44 0 0 1 25.00 23 50.00 0 0.00 92 51.11 LLR χ2(4) 
=9.135 
0.058 
Never smoke 38 42.22 20 55.56 0 0 3 75.00 23 50.00 4 100.00 88 48.89 
Starting age of 
smoking (years-
range) 
Never smoke 38 42.22 20 55.56 0 0 3 75.00 23 50.00 4 100.00 88 48.89 
LLR χ2 (24) 
=29.286 
0.210 
<20 15 16.67 5 13.89 0 0 0 0.00 8 17.39 0 0.00 28 15.56 
20- 22 24.44 6 16.67 0 0 0 0.00 2 4.35 0 0.00 30 16.67 
25- 9 10.00 3 8.33 0 0 1 25.00 5 10.87 0 0.00 18 10.00 
30- 3 3.33 1 2.78 0 0 0 0.00 5 10.87 0 0.00 9 5.00 
35- 1 1.11 1 2.78 0 0 0 0.00 3 6.52 0 0.00 5 2.78 




Continued Table 4.12 



























78 86.67 29 80.56 0 0 4 100.00 37 80.43 4 100.00 152 84.44 
LLR χ2 (24) = 
13.875 
0.949 
<20 3 3.33 0 0.00 0 0 0 0.00 0 0.00 0 0.00 3 1.67 
20- 3 3.33 1 2.78 0 0 0 0.00 1 2.17 0 0.00 5 2.78 
25- 3 3.33 4 11.11 0 0 0 0.00 5 10.87 0 0.00 12 6.67 
30- 2 2.22 1 2.78 0 0 0 0.00 1 2.17 0 0.00 4 2.22 
35- 1 1.11 1 2.78 0 0 0 0.00 1 2.17 0 0.00 3 1.67 
>40 0 0.00 0 0.00 0 0 0 0.00 1 2.17 0 0.00 1 0.56 
























Never smoke 38 42.22 20 55.56 0 0 3 75.00 23 50.00 4 100.00 88 48.89 
LLR χ2 (12) = 
10.073 
0.610 
<1 4 4.44 3 8.33 0 0 0 0.00 1 2.17 0 0.00 8 4.44 
1-2 9 10.00 1 2.78 0 0 0 0.00 2 4.35 0 0.00 12 6.67 
3-5 15 16.67 3 8.33 0 0 0 0.00 4 8.70 0 0.00 22 12.22 
6-10 8 8.89 5 13.89 0 0 0 0.00 6 13.04 0 0.00 19 10.56 
















































































<5 15 16.67 4 11.11 0 0 0 0.00 7 15.22 0 0.00 26 14.44 
5-10 14 15.56 7 19.44 0 0 0 0.00 5 10.87 0 0.00 26 14.44 
>10-20 5 5.56 1 2.78 0 0 1 25.00 6 13.04 0 0.00 13 7.22 













<5 9 10.00 1 2.78 0 0 0 0.00 3 6.52 0 0.00 13 7.22 
5-10 6 6.67 1 2.78 0 0 0 0.00 3 6.52 0 0.00 10 5.56 




Smoking habits were significantly associated with those participants having positive 
history of smoking during life period in 51.11% (92/180) compared to those who 
never smoke in 48.89% (88/180). The relationship between smoking and LTBI 
categories was close to significance at 5% (LLR χ
2
 (4) = 9.135, p = 0.058) (Figure 
4.32, Table 4.12).  
 
Figure 4.32: Percent distribution of past history of smoking during life according to latent 







51.11% of participants had positive history of smoking, in which current smokers 
were 35.56% (64/180) and ex-smokers were 15.56% (28/180). The majority of 
current smokers belonged to the ‘negligible’ LTBI 44.44% and ‘extremely high’ 
LTBI group 30.43%. On the other hand, the majority of ex-smokers were belonged to 
‘extremely high’ LTBI 19.57% and ‘low’ LTBI group 19.44% (LLR χ
2
 (8) = 13.303, p 
= 0.102) (Figure 4.33, Table 4.12). 
 
Figure 4.33: Percent distribution of smoking history according to latent tuberculosis infection 





The starting age for smoking was not significantly associated with LTBI 
categorization, where the majority 32.2% (58/180) had started smoking below the 
age of 25 years. The majority of ‘extremely high’ LTBI started smoking at young 
ages below 20 years and older ages above 30 years (LLR χ
2
 (24) = 29.286, p = 0.210) 
(Figure 4.34, Table 4.12).  
 
Figure 4.34: Distribution of starting age groups by smoking history according to latent 
tuberculosis infection categories of 180 new immigrants to Kuwait during February and May, 
2010  
The overall median age of starting smoking was 22 years (IQR = 10, SIQR = 5). The 
median starting age for the ‘negligible’ LTBI group was 21.5 years (IQR = 8 years, 




starting smoking was 8 years, versus the maximum of 40 years. However the 
differences for LTBI categorization were not statistically significant (KW χ
2
 (3) = 
2.313, p = 0.510) (Table 4.12).  
The age at which smoking stopped was not significantly associated with LTBI 
categorizations. 6.67% of ex-smoker participants had stopped smoking between the 
ages between 25 and 30 years, and predominantly were from the ‘low’ and 
‘extremely high’ LTBI groups (11%) (LLR χ
2
 (24) = 13.875, p = 0.949) (Figure 4.35, 
Table 4.12).  
 
Figure 4.35: Percent distribution of stopping age groups by smoking history according to latent 





The overall median age at which smoking stopped for all immigrants was 28 years 
(IQR = 9, SIQR = 4.5), and the stopping age for the ‘extremely high’ LTBI was 29 
years (IQR = 9) and similarly for the ‘low’ LTBI group at 28 years (IQR = 8). The 
minimum age of stop smoking was 19 years and the maximum 43 years (KW χ
2
 (2) = 
2.363, p = 0.307) (Table 4.12). 
Excluding non-smokers, current smokers were used to smoke for longer durations of 
more than 10 years in 17.22%, and were high (longer duration) for the ‘extremely 
high’ LTBI in 21.74% and the ‘low’ LTBI group in 17.78%. Immigrants smoked 
between 6-10 years were answered by 10.56%, which was detected in the ‘extremely 
high’ LTBI 13.04% and the ‘low’ LTBI group in 13.89% (LLR χ
2
 (12) = 10.073, p = 
0.610) (Figure 4.36, Table 4.12). 
 
Figure 4.36: Percent distribution of duration of current smoking by smoking history according 
to latent tuberculosis infection categories of 180 new immigrants to Kuwait during February 




The overall median duration of current smoking was 4 years (IQR = 2, SIQR = 1), 
and was the same for all LTBI categories. The minimum duration of smoking was 
one year versus the maximum duration of five years started at older ages (KW χ
2
 (3) = 
4.227, p = 0.238) (Table 4.12). The overall median duration of ex-smoking was 3.5 
years (IQR = 7, SIQR = 3.5). The minimum duration of ex-smoking was less than 
one year versus the maximum duration of 29 years before stopping at older ages 
(KW χ
2
 (2) = 1.261, p = 0.532) (Table 4.12). 
Smokers showed the following preferences (Table 4.12):  
‘Manufactured’ cigarettes in 40.56% (predominantly by the ‘negligible’ LTBI group 
in 44.44% and ‘extremely high’ LTBI in 39.13%), with no significant differences 
(LLR χ
2
 (4) = 5.228, p = 0.265), 
Chewing ‘tambacco tobacco’ in 11.11% and were preferred by ‘extremely high’ 
LTBI in 15.22% (LLR χ
2
 (4) = 6.525, p = 0.163),  
‘Birri’ or ‘cigar’ 0.56% each was represented by ‘negligible’ immigrant case (LLR χ
2
 
(4) = 1.392, p = 0.846), and smoking ‘Shisha’ (or ‘Qedo’) in 2.78% and majority were 
from the ‘negligible’ LTBI group in 4.44% (LLR χ
2
 (4) = 3.828, p = 0.430). 
The number of cigarettes smoked per day was similar for those who smoked up to 10 
cigarettes per day (14.44% of participants). The ‘negligible’ LTBI participants prefer 
to smoke less than 5 cigarettes were 16.67% compared to 7.78% who preferred to 
smoke more than 20 cigarettes per day. The ‘low’ LTBI group prefers to smoke 
between 5-10 cigarettes 19.44%, whereas those ‘extremely high’ LTBI participants 
preferred smoking between 10 and 20 cigarettes per day were 13.04% and were 
higher than the rest LTBI groups. However, statistical significance between number 
of smoking cigarettes and LTBI development was absent (LLR χ
2
 (16) = 19.446, p = 





Figure 4.37: Percent distribution of the frequency number of smoking cigarettes per day 
according to latent tuberculosis infection categories of 180 new immigrants to Kuwait during 
February and May, 2010  
For those who smoked other than cigarettes, the frequency number of smoking habits 
was mainly less than 5 times per day. The ‘negligible’ LTBI group was 20% and 
higher among the other LTBI groups and the ‘extremely high’ LTBI participants 
were 15.21%. However, the frequency of smoking other than cigarettes has 
insignificant statistical difference with LTBI diagnosis (LLR χ
2
 (12) = 8.322, p = 
0.759) (Figure 4.38, Table 4.11). Cigarette smoking was preferred by 79.34% (73/92) 
of smokers versus chewing ’tambaco tobacco’ and/or smoking ‘birri’ were preferred 
by Indians 21.73% (20/92), whereas, ‘shisha’ smoking was preferred by Egyptians 
5.43% (5/92). A preference of other smoking habits such as ‘pedis’ (manual 





Figure 4.38: Percent distribution of the frequency number of smoking habits other than 
cigarettes per day according to latent tuberculosis infection categories of 180 new immigrants to 
Kuwait during February and May, 2010 
4.9 Discussion 
4.9.1 Study screening questionnaire (structured interview)  
Questionnaires are a research screening tool, pioneered by Sir Francis Galton (1882-
1911),  consisting of multiple questions designed to gather information  for statistical 
analysis of respondents’ responses and early detection of all health-related disorders 




assess TB chronic disease re-surgence due to latency re-activation, and to help in 
continuous case-finding using acceptable examination tests and ensuring 
confidentiality as important component of management strategies (WHO, 2007b). 
Questionnaire should be universally arranged, then can be used as a rapid, cheap and 
objective (verbal) screening tool for data collection and preceded by participant’s 
ethical agreement. A well designed, standardized, confidential, case sensitive should 
be carefully arranged with unbiased questionnaires to describe the epidemiological 
and demographic variables and related diagnostic test results. Final statistical 
analysis also facilitates public interaction between the community and health systems 
(Glaziou et al., 2008; Long et al., 2008).  
There are common worldwide TB-associated demographic risk factors, in addressing 
epidemiological determinants of health in the prevention and control of tuberculosis,. 
Global TB health can be determined by relating occupational variables (e.g. 
occupation and job category, years of exposure) and non-occupational variables (e.g. 
age, gender, place of birth, education level, nationality, ethnic origin) to the immune 
response indicators (e.g. BCG scar, TST indurations, and IGRAs results).  
Individual-level determinants, including high-risk behaviors, are major drivers of 
disease transmission. The patterns and distribution of infectious diseases in the 
population are influenced by a dynamic interplay between the prevalence of the 
infectious agent, the effectiveness of preventive and control interventions, and a 
range of social and structural environmental factors (Dean and Fenton, 2010; 
Kruijshaar and Abubakar, 2009).  
Modified questionnaire construction from previous population surveys is crucial for 
screening success, and should be designed using clear and precise questions. 
Questionnaire should also be culture-oriented, reasonable, administered with 
responsibility, avoiding re-call bias, hierarchically ordered (simple questions 
followed by complicated issues), and links between TB with other socio-economic 
factors (van der Werf et al., 2008). Using a previously validated questionnaire help to 




The importance of the questionnaire data and screening re-in forces the aims and 
objectives, and the likelihood of associations will provide useful information for 
interpreting the results for detecting the future trends of TB (WHO, 2007b). 
Descriptive analysis of questionnaire data facilitates knowledge of characteristics of 
immigrants that are sampled, by which precise population- and individual-level 
factors that are associated with LTBI and risks of re-activation progressions can be 
identified. This knowledge assists in the development of targeted diagnostic 
guidelines before testing immigrants and high risk groups (Freeman et al., 2010).   
4.9.2 Epidemiological risk factors for latent tuberculosis 
infection  
Tuberculosis prevalence screening in a representative sample of the population offers 
a unique opportunity for collecting additional data on socio-economic status and risk 
factors for TB and health care-seeking behaviours. Information about these factors 
will contribute to wide arrays of epidemiological knowledge and estimating of the 
prevalence of TB more precise. Additional questions on the socio-economic status 
and epidemiological risks supported with another feasibility study to assess the 
additional time and resource requirements (WHO, 2007b).   
Communities’ tuberculosis rates are heavily influenced by the social, environmental 
and epidemiologic context, emphasizing that socio-economic status and related risk 
factors are important determinants of epidemiologic trends. Seven main components 
of access to which factors can be assigned: availability, adequacy, acceptability, 
accessibility, affordability, health beliefs and medical/non-medical costs 
(Mackenbach et al., 2008; Wieland et al., 2010). Risk factor variables were grouped 
into demographic, socio-economic, life style behavioral factors and personal health-
related factors/living conditions.  
Accordingly risk factor variables and socio-economic-demographic, and life style 
behavioral factors and personal health-related factors for Mycobacterium 
tuberculosis infection among new immigrants to Kuwait was grouped in our 




4.9.2.1 Socio-demographic characteristics  
Socio-economic status is a significant risk for LTBI/TB susceptibility. TB has 
enormous public health and economic implications in high-burden countries. There is 
therefore an urgent need to provide targeted interventions, particularly for individuals 
most at risk of TB, to gain better knowledge about the distribution of TB in the 
population, as well as a better understanding of what factors are driving the TB 
epidemic in a given setting.  
4.9.2.1.1 Age 
Aging and process of increasing in TB incidence are positively associated. As 
growing older then populations are at higher risks of TB infection and complications 
(Dye et al., 2011; Mahomed et al., 2011; Wen et al., 2010). The prevalence of 
infection increased with age in both men and women in the middle reproductive ages 
(Gopi et al., 2005). Latent TB was statistically significantly associated with older 
ages due to longer duration of exposures and co-morbidities of other diseases. In 
addition to atypical presentations and delayed diagnosis of LTBI, elderly people are 
also associated with LTBI/TB and even deterioration of successful TB control 
(Abuaku et al., 2010; Dye, 2006; Shetty et al., 2006). Old age is a major risk factor 
for LTBI due to the longer duration of direct or indirect contact to MTB, associated 
with unemployment and malnutrition or longer consumption of unpasteurized dairy 
products (Bradshow et al., 2011; Gomes et al., 2011; Kip et al., 2011; Sia et al., 
2010).  Older age groups have higher rates of LTBI prevalence and positive IGRAs 
than younger groups, possibly due to waning immunologic reactivity (Winston and 
Navin, 2010), associated with negative/indeterminate results in active TB patients 
(Hang et al., 2011). TB risk is positively associated with increasing adult age most 
strongly in individuals from low-income geographic countries e.g. Africa and Asia 
(Goldhaber-Fiebert et al., 2011; Li et al., 2010; Mahomed et al., 2011). 
The median age (31.5 years) of our research findings was of the average age risk for 
LTBI development, which is also similar to similar age ranges (more than 35 years) 




On the contrary Kik et al. (2009) showed no association between increasing age or 
gender as risk factors for positive diagnostic testing’s of LTBI using TST, and both 
IGRAs. Similarly, Hill and colleagues (2008) also found no significant association 
between various age groups and gender or ethnicity with positive IGRAs in 2,348 
Gambian contacts to diagnosed TB patients (Hill et al., 2008). 
4.9.2.1.2 Gender 
Males bears a higher burden of TB; this is supported by higher prevalence rates in 
our study, which could be explained by a variety of other predisposing factors, such 
as higher case notification or smoking (Abuaku et al., 2010; Feng et al., 2011b; 
Goldhaber-Fiebert et al., 2011; Gopi et al., 2005; Mahomed et al., 2011; Rafiza et 
al., 2011; Wen et al., 2010). Being a female ‘housewife’ with a low level of 
schooling education was a significant explanatory variable for East Asian endemic 
countries such as the Philippines, Bangladesh and India (Kip et al., 2011; Rutherford 
et al., 2010; Weiss et al., 2008; Winje et al., 2008). Other studies did not find any 
correlation between age or gender and LTBI (Boccia et al., 2009; Caley et al., 2010; 
Carvalho et al., 2005; Kik et al., 2009). The QFT-GIT-based prevalence of LTBI was 
not significantly associated with gender or age (Legesse et al., 2011). Kik and others 
(2009) also found no association between age and gender in immigrants from 
endemic countries (Kik et al., 2009). 
4.9.2.1.3 Nationality 
Country of origin is important in determining risk of latent TB (Mankia et al., 2011). 
LTBI screening and intensive contact tracing, both followed by compulsory LTBI 
prophylaxis is needed to reduce TB in high-risk ethnic groups (O'Donnell et al., 
2010). Similar to the findings here, the immigrants’ country region of birth is 
considered as a high influential explanatory factor (independent variable) for LTBI 
cases, which is related to MTB exposures in their geographic residence, in addition 
to poor regions within endemic countries (Carvalho et al., 2005; Lavigne et al., 2006; 
Sun et al., 2010). TB exposed immigrant close contacts were influenced by prior 
and/or recent exposure of immigrants to TB in the mother country of origin in the 




2011). Our results relating LTBI and the country of origin and being born in high 
incidence (endemic) countries has been observed in other studies (Kik et al., 2009; 
Saracino et al., 2009; Winje et al., 2008). 
4.9.2.1.4 Civil status/gender 
Being married was a predominant common risk factor for having LTBI/TB in our 
study. Married females with excessive housework commonly experience TB 
diagnosis/treatment delays (Yimer et al., 2009). An Italian study on new immigrants 
revealed a similar gender risk association (Carvalho et al., 2005). No association 
between LTBI and gender was detected by Rafiza et al. (2011). 
4.9.2.1.5 Ethnic and religious status  
Ethnicity provides important clues to genetic and cultural differences that predispose 
to LTBI and needs further exploration using MTB genotypes. Ethnicity is defined 
biologically and culturally (lifestyle) factors, and is related to country of origin and is 
strongly associated with TB in which further studies of genome-linkage MTB 
susceptibility among non-endemic countries residents are warranted  (Ladefoged et 
al., 2011; WHO, 2010i).  
Certain ethnic groups are more susceptible to TB infection than others. LTBI 
prevalence among blacks and mixed race groups is significantly higher than other 
races, and is associated with environmental and host factors and co-morbid 
conditions (Mahomed et al., 2011; Rutherford et al., 2010). Muslim, black and non-
Hispanic white races are predisposed to LTBI, re-activations and HIV (Kip et al., 
2011; O'Donnell et al., 2010). Other ethnic groups are less vulnerable to LTBI, 
associated with genetic and cultural differences.   
Cultural beliefs and attitudes can determine the differences between positive 
compliance toward anti-TB treatment and negative responses against LTBI 
prophylaxis (Carvalho et al., 2005). Additionally, educational levels and ethnicity are 
reported predictors of positive TST and LTBI suspicion (Minodier et al., 2010).  




religion and LTBI development in immigrant populations. LTBI screening and 
intensive contact tracing, both followed by compulsory LTBI prophylaxis, is needed 
to reduce TB in highly risk ethnic groups (O'Donnell et al., 2010).  
4.9.2.1.6 Educational level 
Education offers a practical strategy for helping society to deal with TB. Higher 
levels of education and health are significantly protective against TB morbid trends, 
observed from the differences among people access/interpret/benefit/respect 
knowledge about LTBI/TB disease (Mackenbach et al., 2008; Shetty et al., 2006).  
Education highlights the misperceptions about TB transmission and severity, helps 
the distinction between asymptomatic LTBI and active TB form (Geng et al., 2005; 
Wieland et al., 2010). Low levels of education are predictive for positive TB tests 
(Mahomed et al., 2011; Wen et al., 2010) and are also related to HIV stigma (Kip et 
al., 2011). Choosing alternative self-treatment behaviors and seeking allopathic 
medicine is related to time delays for diagnosis particularly in low-income endemic 
countries, due to compromised health system operation and referral patterns (Portero 
et al., 2002; Weiss et al., 2008). In contrast to previous findings, and consistent with 
our results, higher levels of various education were not associated with LTBI 
suspicion due to short delays in TB patient diagnosis/management (Jurcev-Savicevic 
and Kardum, 2011). Lack of such associations was also found by Carvalho et al. 
(2005) and Rafiza et al. (2011).  
4.9.2.1.7 Occupation 
Individuals coming in direct contact with TB infected people are at high risk of 
LTBI, which is commonly seen in the occupational nosocomial infection in health 
care workers, such as nurses in hospital wards and TB treatment units (Rafiza et al., 
2011). The type of hospital job category and duration of years in the health care 
profession are significantly associated with latent tuberculosis infection (Cagalayan 
et al., 2011). On the other hand, inability to work is a known major cause of 
increased poverty and low socio-economic status (Mauch et al., 2011). 
Unemployment is strongly associated with LTBI/TB risk (Sia et al., 2010) and 




1995; Shetty et al., 2006), mainly in unemployed or homeless individuals. On the 
opposite, both poverty and low SES in low resource countries increase MTB 
propagation and disease poor conditions which reduce working opportunities and 
raise poverty levels (Geraldes Santos Mde et al., 2007). 
4.9.2.1.8 Employment 
In contrast the research results presented here, longer duration of exposure(s) to an 
index case for more days was significantly associated with carrying MTB bacilli and 
showing positive IGRAs (Bradshow et al., 2011). Years served in the health care 
profession were significantly associated with positive QNF-GIT but not TST 
(Cagalayan et al., 2011). Furthermore, length of time in employment or profession 
can be used as a proxy measure for increased likelihood of occupational exposure to 
TB in immigrants (Eum et al., 2008). Pai and colleagues (2005) reported that the 
years served in the health care services (more than 5 years versus less than one year) 
had a statistically significant effect on both positive TST and QTF results. 
A health system delay of more than seven weeks was positively related to 
unemployment status and illiteracy (Pantoja et al., 2009). High prevalence of LTBI 
was detected among Georgian HCWs, and a longer duration of employment 
increased MTB carrier risks (Mirtskhulava et al., 2008). Our findings show that the 
duration of employment was not significantly associated with LTBI diagnosis 
because risk of infection depended primarily on the duration of exposure to a person 
with infectious TB disease inside/outside and concentration of infectious droplet 
nuclei in the air. A similar finding was also reported by Cagalayan et al. (2011) and 
Rafiza et al. (2011). 
4.9.2.1.9 Income and social status 
Even though there still no internationally agreed standard definition, accepted 
indicators of socio-economic status are median household income and expenditure, 
crowding, level of education, and housing quality. Household income in private 
occupied dwellings is a measure of total household income adjusted for household 




defined. Income-health inequalities and residents of resource-poor neighborhoods are 
at greater risk of adverse health outcomes, compared with residents of more affluent 
neighborhoods (Mackenbach et al., 2008). 
Total household income is reflected in socio-economic status through the type of 
housing and LTBI exposure risks (Shetty et al., 2006). Low-income and poverty with 
social inequalities determines and threatens TB outcomes, and are closely associated 
with the socio-economic status of the population (Geraldes Santos Mde et al., 2007; 
Mahomed et al., 2011; Weiss et al., 2008). Geographical economic barriers add risks 
to vulnerable people for MTB transmission and disease progression, such as charges 
for health services and lost incomes. Financial barriers and access to TB health care 
are of immigrant’s concern in the developing countries, in which the service policy 
makers are requested for facilitated interventions (Dean and Fenton, 2010; Long et 
al., 2008; Sia et al., 2010; Wei  et al., 2009). The length of health-seeking and total 
anti-TB therapeutic costs in poor communities are directly related to the length 
(delays) of health seeking behaviour and catastrophic health expenditure (Pantoja et 
al., 2009). A direct relationship between SES factors and TB treatment outcomes 
exists because of the financial burden and the quality of case management. 
Challenges of facilitated health system to equalize the poverty with the country SES 
inequalities (Muniyandi and Ramachandran, 2008). Income level is associated with 
the choice of health care provider (Charles et al., 2010) and factors affecting 
treatment success (Xu et al., 2010). In contrast, high income and wealthier household 
socio-economic conditions were associated with higher levels of education about TB 
knowledge (Portero et al., 2002) and prevalence of TB infection in urban regions 
(Boccia et al., 2009). The participants in this study were considered to be of average 
income and more educated, and fit these associations. 
4.9.2.1.10 Total individuals living in the same place (family size) 
The low SES is ecologically related to household crowding and is a sign of low 
income/poverty linked with deprivations and high TB incidence. The proportion of 




additional bedrooms) has association with the prevalence of certain infectious 
diseases and tuberculosis (Baker et al., 2000).  
The number of house residents is significantly associated with the presence of self-
reported latent or active TB, either currently or during their past household residence 
(Larcombe et al., 2011). Average family income defines economic status differently, 
depending on the number of family members. Crowding in country of birth and 
related housing quality of migrants is an important variable for tuberculosis risk 
(Mangtani et al., 1995; WHO, 2007b). Overcrowding is independently associated 
with TB infection (Boccia et al., 2009), and poor standards of housing conditions 
(Muniyandi and Ramachandran, 2008; Pantoja et al., 2009). High rates of TB 
infection are observed in household contacts with longer duration of intense exposure 
(infectiousness of two years) in high prevalence countries (Lin et al., 2008; Sia et al., 
2010). Family size is associated with CXR cavitation status in TB cases (WHO, 
2007a). Similarly, treatment delays of TB patients were independently associated 
with an increase in the household size (Sabawoon et al., 2011). 
These research findings on the contrary revealed no significant associations between 
family member size and LTBI development, because the majority of immigrants 
were coming from average income conditions in their mother countries. 
4.9.2.1.11 Urbanization (general crowding index/sleeping crowding 
index) 
Household density is known as both an indicator of low socio-economic status and as 
a risk factor associated with high morbidity and mortality risks. Social discrimination 
and poverty, overcrowded housing, poor sanitation and malnutrition are all major 
risk factors combinations for LTBI development and facilitating MTB re-activations’ 
during the initial years of residency after migration in urban and industrialized 
countries (McKenna et al., 2005). Immigration of young foreign-born adults is the 
dominant factor of urbanization and TB epidemiology in low-incidence and high-
income countries. TB prevalence is higher in urban overcrowded (social mixing with 
infected case) populations, associated with low housing quality compared with 




TB risks and household crowding was strongly detected in Europe and adverse 
negatively associated with schooling and urban location (Goldhaber-Fiebert et al., 
2011). Similar findings were also noticed in Philippino’s immigrants due to their 
living in high-density urban areas having high socio-economic status, still are at 
higher risks of LTBI than rural areas because of closed-ventilation environments 
(Boccia et al., 2009). In India, even with presence of access to health services, still 
the risk of TB infection is expected to double between 2010 and 2030 due to 
increased urbanization to nearly 600 million people (Lalvani et al., 2001a). Recent 
similar findings of raised TB rates due to urbanization associated with rise in body 
mass index and spreading of diabetes mellitus in Korea (Dye et al., 2011), and rises 
in body weight as concluded by Goldhaber-Fiebert et al. (2011). Effective socio-
economic markers and overcrowding indices to identify those at risk of LTBI/TB can 
be observed in residence of shared cooking facilities in urbanizing community 
(Shetty et al., 2006). 
The profile of social determinants-of-health framework in public health should be 
verified and able to identify suspected immigrants for screening which proved 
significantly by Satcher D. (2010). Our data demonstrated that household crowding, 
a correlate of low socio-economic status, might be associated with LTBI 
development (Baker et al., 2000) which needs further analytic studies. Even though 
all medical centres were accessible in mother countries to all sample participants, 
still risk factor predictors of LTBI need further assessment.  
4.9.2.2 Risk factors for Mycobacterium tuberculosis infection 
4.9.2.2.1 Access to health care services 
Health-seeking behaviors are associated with knowledge of key symptoms and/or 
signs, perceived curability, and to perception of TB services without barriers and 
ethical confidentiality and cultural-related stigma. Health-system barriers in 
accessing tuberculosis care cause delays in timely diagnosis/treatment, resulting in 
continued MTB transmission. Access is a pre-requisite for utilization of health care 
services. Lack of TB infrastructure and financial resources is crucial and a reason for 




2010). Lower accessibility and difficult access to the health care services and follow-
up programmes, with lack of resources (mainly in rural areas), should be managed 
through improvements of the nearest residence to free public health centre services 
(Ladefoged et al., 2011).  
Health care systems in the mother country were accessible to almost all participants 
because the majority were coming from urban settings with few obstacles to reaching 
public and/or private medical centres to treat patient health disorders and tested by 
TB diagnostics and managements. Income-related inequalities are important in health 
self-assessment and promotion of seeking health care (Mackenbach et al., 2008). 
Despite educational background and family income the immigrants’ in this study 
showed intentional health-seeking behavior for TB symptoms and discouragement of 
self-treatment toward better health care services. A similar conclusion was also 
concluded by Portero et al. (2002). Illness-costs of immigrants were identified as the 
main barrier from health care seeking for symptoms management (Aye et al., 2010). 
Poor access to health facilities and limited awareness of TB within most communities 
and health seeking behavior was shown by Gele et al. (2009), which is not a problem 
for recent expatriates in Kuwait. Short travel distances and distance times are 
positively associated with attendance at, and satisfaction in, public health services 
with various reasons of attendance (Nteta et al., 2010), in addition with non-
adherence/loss of follow-up due to social stigma and adverse effects (Gust et al., 
2011). This can be due to inefficient diagnostic facilities and from incompetent 
health care providers (Saqib et al., 2011).  
4.9.2.2.2 Transport routes 
The research results support the qualitative possibility of MTB transmission and 
LTBI development on transfer close overloaded machine such as cars, buses or 
trains, but without defining risks of LTBI development quantitatively (Edelson and 
Phypers, 2011; Ling et al., 2011). The risk of contact transmission during 
transportation when persons with active tuberculosis travel on public transport routes 




contacts because of the use of small travel tools e.g. chapini (small buses) and related 
positive IGRAs. 
4.9.2.2.3 Sanitary systems 
Socio-hygienic conditions should be regularly studied to analyze associations with 
related morbid disorders (both infectious and non-infectious conditions). Better 
sanitation using centralized water supply through sewer chlorinated system limits 
public health disorders. Poor sanitation is associated with TB mainly in low-income 
countries due to poverty, over-crowding, homelessness of irreversible increasing 
population growths (Baker et al., 2008; Lienhardt et al., 2005) with no town 
resettlement/poor living conditions and without access to running water, bathrooms 
or flushing toilets (Ladefoged et al., 2011). Re-emergence of tuberculosis imposes 
public health threats and had received global attention. Inadequate sanitary 
infrastructure and an improper sewage system can continue to be a problem 
necessitates raising the population hygiene through supplement of a new water 
supply system and disinfection of sewage water.  
McKenna et al. revealed significantly a correlation between MTB re-activation and 
poor sanitary conditions of new immigrants to urban areas (McKenna et al., 2005). 
However, our findings revealed no significant relationships between the sanitary 
system and development of LTBI risks. Similarly, Grafein et al. (2011) recently 
found no association, using IGRA (QNF-GIT), between LTBI and age, gender, years 
of schooling, fieldwork, mobility/travel duration and access to health care. 
4.9.2.3 Entry into and living conditions in the State of Kuwait 
Return visits to Kuwait concerning re-exposure risks added to the country pre-entry 
regular screening can prove immigrants remained uninfected (McCarthy, 1984). 
Early immigrants’ registration within short period after entry (median duration was 
11.5 days), proved no missing of recent expatriates and representing strict 
notification system in Kuwait in comparison to worldwide countries having weak 




Kuwait were from endemic (Asian) countries and immigrants targeted with easy 
follow-up should be considered. 
Longer duration of registration post-entry increases the risks of exposure-contact and 
risk of developing LTBI and TB disease within first 12 to 24 months of exposure, 
especially from those highly suspicious TB immigrants (Ling et al., 2011).  
Compared with Kuwait short duration of post-entry registration, Richard and 
colleagues (2005) results detected delay of 35 days from entry to the reply through 
mailed letter and 70 days until immigrant’s first clinic visit in Canada (an example of 
developed country with high immigrants).  Even with no significant association, new 
immigrants had high risk of exposure contact due to sharing a bedroom with other 
subjects (which can be an index case) in Kuwait and co-habitation in small closed-
room environments, aggravating LTBI re-activation/transmission, and which was 
also observed by Sia et al. (2010). 
Positive association can be detected if repeat LTBI diagnostics after period of 
exposure time. The majority of proposed occupations in Kuwait was significantly 
associated with longer duration of exposures within house-related jobs and closed 
communities. Also the new living trends of Kuwaiti’s such as renting small flats 
have more risks of contacting and infection from the ‘extremely high’ LTBI groups. 
In-migration pulling factors to Kuwait such as house-related jobs and manual 
workers constituted the major daily expatriates which belong significantly to the 
‘extremely high’ group and TB suspicious cases. On the contrary few immigrants 
entered as non-manual occupants were belonging to the ‘negligible’ LTBI group. 
Consequently populations of non-endemic countries are at greater risk of acquiring 
TB due to repeated contacts with LTBI and MTB transmission from the immigrant 
workers and MTB carriers (Edelson and Phypers, 2011; Fronteira and Ferrinho, 
2011). 
Ventilation frequency and airflow influence respiratory infections and TB spread in 
the TB mother countries. Consequently, after entry to Kuwait, air handling and 
ventilation are important to prevent airborne transmission. Larcombe and colleagues 




residents and the presence of latent and active TB disease. Thesis necessitates 
investigation of the environmental factors surrounding the epidemiological 
characteristics followed by educating the community population regarding the 
importance of air ventilation especially in urban developed countries. 
4.9.2.4 Knowledge about tuberculosis disease 
A number of factors, including socio-economic and lack of information concerning 
TB, play a key role in governing the health seeking behaviour of patients with TB 
symptoms (Yimer et al., 2009). The relevance of distress patterns with respect to TB 
non-specific symptoms is a common public interest (Weiss et al., 2008). Poor 
knowledge of TB prevents migrant patients voluntarily seeking TB care post-entry to 
non-endemic countries, which is the case in the majority of admitted TB foreign-born 
patients (Wei et al., 2009). Immigrants were primarily asked indirectly about latent 
TB to ignore barriers of misperceptions and low awareness of TB infection (Wieland 
et al., 2010). On the contrary, the majority (95%) of the study subjects had contact 
with the nearest medical provider within a reasonable period of time following any 
complaints. A common feature in urbanized regions is the health seeking behaviours 
and looking for medical opinion from the facilitated medical care services (Charles et 
al., 2010; Yimer et al., 2009). 
Absence of typical respiratory- and non-respiratory symptoms reduces clinical 
suspicion with consequent delayed diagnosis of LTBI/TB and increases in TB 
morbidity/mortality due to probable re-activation risks (Feng et al., 2011).  
The symptoms/signs of PTB are usually non-specific but typical presentations, such 
as unexplained body weight loss, remain as important factors to remind medical care 
physicians to consider a diagnosis of tuberculosis. Accurate education about 
tuberculosis was defined as having knowledge about respiratory MTB airborne 
transmission when coughing or sneezing (Khandoker et al., 2011), which was 
significantly related to the level of immigrants’ education (Portero et al., 2002), as 




4.9.2.4.1 Respiratory symptoms   
The presence of a chronic cough more of than three weeks, dyspnoea and hemoptysis 
are clear TB symptoms, and are independently associated with overall PTB mortality 
(Feng et al., 2011; Portero et al., 2002). Delay in diagnosis due to non-considered TB 
symptoms by the people and/or health care providers is proved in endemic countries 
such as Pakistan (the 8
th
 TB burden country). Diagnostic delays (up to median delays 
of 8 weeks) related to lower detection rates can be significantly improved through 
early suspicion and accurate diagnostic tests (Saqib et al., 2011). A longer diagnostic 
delay is associated with under-estimated TB symptoms such as complaints of 
coughing and losing body weight (Jurcev-Savicevic and Kardum, 2011). Immigrants 
(~54%) sought treatment from governmental hospitals for coughing of more than 
three weeks were missed, mainly due to symptomatic under-estimations and 
knowledge of coughing as a mode of transmission, and was correlated with medical 
and community education levels (Kar and Logaraj, 2011; Portero et al., 2002).  
However Garfein et al. (2011) concluded absence of a significant association 
between LTBI development and TB knowledge (symptoms and transmission), but 
not due to difficult access to health care service.   
4.9.2.4.2 Constitutional symptoms 
The presence of constitutional symptoms represents higher disease severity and is 
associated with increased risk of PTB death. Weight loss (wasting), prolonged fever, 
anorexia, and malaise, generalized weakness, and hyperhidrosis were clear 
constitutional complaints that  are significantly associated with clinical complaints of 
PTB mortality, and which force the immigrant community toward health-seeking 
behavior were all significantly associated. Similar findings were shown by Feng et 
al. (2011), Garfein et al. (2011) and Portero et al. (2002).   
Gaps in the knowledge of M. tuberculosis biology and its interaction with the human 
host need further research. Aye et al. (2010) proved the community members’ belief 
in TB as an inherited and normally incurable disease. Background knowledge on 
tuberculosis and social support could show a positive impact on the perception of 




worker with the same native language as the immigrant to raise the educational level 
about LTBI/TB. Level of TB knowledge was 66% and the majority usually answered 
’I do not know’ about previous TB vaccination unless asked about the reason of BCG 
scar presence (Ailinger et al., 2004). TB knowledge is correlated with delay of TB 
diagnosis according to geographical location, e.g. median delay was 74 days in India 
compared to 60 days in Bangladesh and 33.5 days in Malawi (Weiss et al., 2008). 
4.9.2.5 Sources of tuberculosis knowledge 
Worldwide, the media is a source of health education and information about TB, 
especially in endemic countries suffering from the disease burden’s consequences 
(Khandoker et al., 2011; Wandwalo and Morkve, 2000). Communication and social 
mobilization activities in TB control result in multiple benefits including bridging 
pre-existing gaps between the health system and the community through support and 
coordination of general health services stakeholders. Community settlement provided 
with social support and raised TB knowledge permit positive self-perceptions of 
health care even for undocumented immigrants (Carvalho et al., 2005).  
Enhancement of TB knowledge, attitudes and behaviors build-up community 
efficacy to combat TB. Also socio-economic factors should be supported by the 
design of TB information campaigns and by prioritizing public health interventions 
about TB (Portero et al., 2002). Standardized data collection and the presence of a 
health-care workers with the same native language as the immigrant assist in 
identifying the gaps in knowledge between immigrant communities and providers of 
TB care for medical campaigns and implemented projects with successful 
engagement of treated patients (Carvalho et al., 2005; Kamineni et al., 2011). 
Time delays to diagnosis are the most important obstacles to the control of the 
infectious cases and TB epidemic, and need to be shortened (Uys et al., 2007). Total 
delay includes time delay to TB diagnosis, patient delay and health care system delay 
(Sreeramareddy et al., 2009; Yimer et al., 2009). Factors contributing to delayed 
access to medical care include socio-economic status and related personal health 
such as poverty and type of health seeking behaviours (Aye et al., 2010). To reduce 




especially in the less-educated segments of the population and within endemic 
countries, in particular (Jurcev-Savicevic and Kardum, 2011).   
Factors, such as access to media, improve correct knowledge about TB, especially in 
daily viewers of television, and by daily reading of newspaper/magazines and 
listening to radio (Khandoker et al., 2011). A main source of TB knowledge is radio 
messages and television advertisements (Portero et al., 2002). Television is reported 
to be the main source of information supporting TB knowledge and teaching (Kar 
and Logaraj, 2011).   
Designing and implementing interventional programmes, based on levels of 
community education and using the media to disseminate TB knowledge, is urgently 
needed, particularly among women. For example the belief that TB is inherited is 
significantly associated with a non-formal education. Advice from family members, 
relatives and/or friends were not significant in this study but has been shown to be 
significant in endemic countries e.g. Philippines (Portero et al., 2002). 
4.9.2.6 Risk of tuberculosis exposure  
Public health authorities are considering attention to the travel clinics for LTBI 
screening of international travelers. Immigrants use multiple transport facilities in 
low-income and TB endemic regions. Understanding the overlapping nature of TB 
epidemics, and their social and structural determinants, is key to designing and 
implementing effective prevention campaigns. TB infection is frequent among 
travelers to high incidence-countries, especially in those long-term travelers and/or 
those involved in work due to longer exposures, such as health care providers. 
Association with travel across borders suggests the potential for TB transmission, 
which can be acquired in their mother countries or recently from exposure during 
travel. Contact tracing of public transport routes for travel considering the proximity 
to TB index cases and the duration of exposure and other confounding risk factors 
(Edelson and Phypers, 2011).  
Close-contacts are considered a high-risk setting for transmission of MTB bacilli, 




Commuting transport difficulties and longer distances from health care services and 
missing follow-up visits such as using multiple buses can lead to incomplete or 
failures of INH-prophylaxis in those LTBI diagnosed close-contacts to PTB 
(Machado et al., 2009). 
Immigrants arriving from high TB incidence countries are at higher risk than the 
general population for developing active TB disease, particularly in the first two to 
five years after arrival (McKenna et al., 2005). However, risks of TB exposure 
cannot be indicative of those immigrant ‘minorities’ able to travel or work outside 
their low-income mother countries. Similar findings by Grafein et al. (2011) indicate 
the risk of direct exposure to MTB and spreading TB during migration. On the 
opposite arrivals from TB endemic region was not significantly associated with MTB 
carrying or LTBI suspicion (Mendez-Echevarria et al., 2011). Our research results 
also revealed no significant associations between LTBI presence and risks of travel 
or working outside in endemic countries.  
LTBI and false-positive TST’s were apparent in travelers in high-incidence 
countries. There remains uncertainty of which travelers’ might benefit from pre- or 
post-travel TST screening. Mantoux test conversion is likely to over-estimate the risk 
of LTBI and MTB infection in the low-prevalence populations due to low positive 
predictive values (Freeman et al., 2010). 
4.9.2.6.1 History of environmental (inside household and outside 
household) contacts 
The burden of TB disease among household contacts is always studied and represents 
an opportunity to target transmission-interruption interventions from the index cases. 
Individual risk behaviors influence the probability of contact with other infected or 
infectious individuals and affect delays in TB diagnosis with further MTB 
transmission. Higher prevalence of latent infection due to cumulative exposure in 
high burdens of TB is still unclear and is the topic for future researches to detect risks 




Contact tracing is integral in tuberculosis management and usually begins with the 
nearest first-degree relatives such as the household contacts to peripheral contacts 
previously diagnosed to have LTBI or active TB. Common factors significantly 
associated with latent TB infection are history of living in the same house with close 
family members or friends who had active tuberculosis (Rafiza et al., 2011). 
Diagnosis of LTBI and TB among immigrants and their contacts can prevent TB 
transmission among communities in rural with low-incidence areas that have limited 
resources for contact investigations. Other studies performed among close contacts in 
different settings have shown a better correlation of both IGRAs with recent 
exposure and closeness of contact, in comparison with TST unable to detect risks of 
previous MTB infection (Adetifa et al., 2007; Brodie et al., 2008; Ewer et al., 2003; 
Lalvani et al., 2001b). 
High- and medium-priority contact tracing and diagnostic investigation to identify 
cases of active and latent TBI is an important component of the WHO 
recommendations for tuberculosis control all over the world. National policies and 
guidelines can be facilitated through evaluation and revision of diagnostic 
interventions. LTBI/TB is highly prevalent in TB households (Sia et al., 2010). 
Contact screening using approximate risk-based assessment depends on 
infectiousness of TB index cases, susceptibility of contacts and intensity of exposure. 
Based on exposure time among tuberculosis contacts, IGRAs conversion to abnormal 
results can be detected after exposure. IGRAs can accurately and more specifically 
discriminate LTBI compared with the less sensitive TST, based on risk of TB 
exposure (Jong Lee et al., 2010).  
Even with absence of significance in these research findings for environmental 
exposure either inside or outside households, the longer duration of daily exposure to 
outside contacts in endemic countries can add risk factors to LTBI development and 
MTB carrying which was significantly associated in those exposed outside for more 
than 10 hours. A similar association of duration-contacts in adults was commonly 
found to be latently infected with MTB in a high TB burden endemic regions where 




suspicion’ (Mahomed et al., 2011). The same findings were also recently elsewhere 
(Edelson and Phypers, 2011; Fronteira and Ferrinho, 2011; Ling et al., 2011). 
In contrast, our study’s final results revealed that previous contacts and exposures to 
the index case did not appear to increase the positive likelihood of TB diagnostic 
testing. Risk factors of positive IGRAs and TST were not associated with TB 
infection in the past and previous or recent household close contacts (high risk of 
exposure) to index cases. The previous conclusions were similar in other publications 
(Bradshow et al., 2011; Kik et al., 2009; Rafiza et al., 2011). Also Shanaube and 
colleagues recently revealed lack of strong associations between either positive TST 
or QFT-GIT result with risk factors related to household infectivity and MTB 
transmission (Shanaube et al., 2011). 
4.9.2.6.2 History of ‘direct contact’ with diagnosed tuberculosis 
patient  
MTB airborne transmission plus crowding are associated risks of close and intimate 
family contact with an infectious open TB patient and consequent LTBI development 
in the lower age groups. Intimate family close-contact with a household TB case 
represents a significant risk factor for young children (less than five years) mortality 
in a low-income country due to longer exposure duration (Gomes et al., 2011).  
Household crowding can be related to the number of people residing in a household, 
and exceeding any adequate services provided to the occupancy members such as 
absent additional bedrooms. Elevated risk of TB morbid trends and incidence can be 
reduced through improvements in measures of household crowding in endemic 
countries. Higher levels of direct close contact with diagnosed and treated active TB 
case are significantly increases with risk of contracting MTB infection. A closer 
relationship, such as indoor households and mixing of students in the same class 
room, increase risks of both MTB infections and LTBI diagnosis (Caley et al., 2010; 
Ewer et al., 2003; Sia et al., 2010).   
Previous history of TB infection is a common risk factor which can be integrated as 
suspected LTBI even without performing chest X-ray (Crampin et al., 2009; Wu et 




develop LTBI which necessities mandatory follow-up and monitoring to provide 
treatment and reduce the risk of active TB occurrence. For example positive IGRAs 
are more likely to develop re-activation active TB disease which can be prevented 
(Huang et al., 2010; Mendez-Echevarria et al., 2011). 
In-door activity related to housing condition and resident health are correlated. 
Winter (cold) seasonality of increased humidity and low airflow is positively 
associated with high rates of TB case notifications during summer and spring (Fares, 
2011). MTB transmission is associated with crowding and lacking of adequate 
ventilated housing. The health of immigrants within overcrowded living places 
reflects householder’s health, where the small, overcrowded rooms increase the risk 
of LTBI and re-activations (Larcombe et al., 2011). Living in the same house with 
TB patients is a known risk factor due to shared ventilation air space and close 
(direct or indirect) contact with each other where high and low LTBI risk groups 
identified. Contacts of known TB cases are known to contribute greatly to TB disease 
burden in certain settings. It is possible that the true number and prevalence of LTBI 
cases was underestimated due to death of active TB disease after infected from 
contact-exposure achieved by Hill and colleague findings (Hill et al., 2008). For 
example, in West Africa, up to 45% of newly diagnosed TB cases have a known TB 
contact (Lienhardt et al., 2005). Positive ELISPOT results were significantly 
associated with direct exposure within weeks of exposure to index case, which 
results in LTBI-presumed students having higher TST grades due to longer durations 
of exposure to MTB than ELISPOT negative school students (Ewer et al., 2003). 
Pertero and others showed no correlation between knowledge about the level of 
contagiousness (length of exposure) to the socio-economic and demographic data 
(Portero et al., 2002). In endemic countries alternative solutions to allopathic 
medicine are found and are related to time delay, complicating help-seeking behavior 
in urban regions (Weiss et al., 2008). 
This research showed an absence of a significant association between past history of 
contacting previous TB infection, which is usually a major cause of resurgence or 




recommend further MTB genotyping. On the contrary, no association was found 
between previous TB history and clinical presentation of PTB (Feng et al., 2011b).  
Regarding the standard chemotherapy of TB (four different drugs plus the length 
duration of 9 months) proved in the interviewed participants without significant 
association due to incomplete knowledge about infected patients, except answering 
correctly about treatment default and/or resistance. Both Portero et al. (2002) and 
Rafiza et al. (2011) found no associations with having previous anti-tuberculosis 
treatment - similar to our findings.  
Unfavorable factors can lead to adverse outcomes of TB treatment, and complicate 
MTB transmission and the appearance of resistant strains. Socio-demographic risk 
factors such as age, gender, migration status, alcoholism, smoking, lower educational 
and income levels, unemployment, non-supervised treatment, medical staff attitude 
towards patients, treatment of other concomitant diseases and HIV infection, 
presence of hemoptysis or other side effects of anti-TB drugs can complicate 
treatment (Abuaku et al., 2010; Santha et al., 2002). A treatment delay of 30 days 
was considered as a performance indicator for TB control programmes in high-TB-
burden countries (ATS and CDC, 1999; Lin et al., 2008; Yimer et al., 2009). 
4.9.2.6.3 Stigma of tuberculosis  
Recent exposure surrogate measures such as gradient of recent exposure have been 
used to evaluate IGRAs, which correlate better with an exposure gradient (Brodie et 
al., 2008, Ewer et al., 2003; Lalvani et al., 2001b). Exposure to TB patient can 
estimate the probability of having a positive QNF-GIT result and can be function of 
related risk factors (Mendez-Echevarria et al., 2011). For example positive IGRAs 
can determine latent TB infection in foreign-born immigrants and also reflect prior 
TB exposure in the country of origin (Kik et al., 2009).  
Stigma is assumed to be due to its airborne transmission and the close link to poverty 
and general community rejection (Cramm et al., 2010; Wei et al., 2009; WHO, 
2005). The increased level of indirect exposure usually did not translate to increased 




exposure to an open active TB case such as student exposure in a classroom has more 
risk than ‘far’ direct exposure to teachers (Caley et al., 2010; Ewer et al., 2003). On 
the contrary Garfein et al. (2011) findings revealed no prediction of significant 
association between LTBI detection or ever contact to TB patient. 
Sleeping in proximity to a TB case in a different house or different room was not 
significantly associated with an positive ELISPOT test or Mantoux test, even though 
five to six percent of positive TB diagnosis case contacts can develop TB within two 
years (Hill et al., 2008). 
Stigmatization of TB is a multi-targeted barrier to TB control, having direct 
relevance to health-seeking behavior and negative impacts at three levels; 1)- 
individual level (shame, afraid from death penalty, employment), 2)- family level 
(transmission stigma, blamed rejection, isolation) and 3)- society level (geographic 
TB endemicity marking, cultural perception and attitudes associations such as 
TB/HIV ‘the dirty disease’ association) (Courtwright and Turner, 2010; Cramm et 
al., 2010; Kipp et al., 2011; Wieland et al., 2010). In this study private secrecy was 
lessened during deep questioning in face-to-face interviews.  
TB stigma is associated with community avoidance of seeking care to treat their 
symptoms/complaints and consequent high morbidity/mortality burdens. The 
presence of TB stigma in both patients and community members, worldwide (and 
Asian endemic countries in particular), suggests that intervention is required to 
combat TB stigma by simply improving the knowledge and raising the education 
levels about TB disease and co-infection consequences (Kip et al., 2011). Richard 
and colleagues (2005) in a Canadian study on 760 new immigrants revealed 22% 
reported previous adequate TB treatment that reflects incomplete documentation at 
the initial pre-immigration evaluation and delays in clinical data completion.  
34.44% of immigrants felt the need to maintain confidentiality even though they 
already had contacted TB patients due to stigma in the mother countries and more 
important is unemployment risks in high-income countries and Kuwait (Kamineni et 
al. 2011; Kar and Logaraj, 2011). Fear of infected with and/or dying from incurable 




the social isolation coming from TB diagnosis are manifestations of community 
perception experiences with TB in their native countries and directly related to TB 
stigma in answering the interview questions (Courtwright and Turner, 2010; Cramm 
et al., 2010; Kip et al., 2011; Wieland et al., 2010).  
Engagement with new immigrants showed barriers to TB testing, including low 
awareness and lack of knowledge about latent TB, in addition to miss-perceptions 
related to TB including secrecy, shame, fear, and isolation. Similar findings were 
observed by Wieland et al. (2010). 
Community education providing scientific understanding of TB disease and 
consequent LTBI development should be an international request toward TB control. 
Similar results were recommended by Juniarti and Evans (2010) to implement 
stigma-reducing programmes and strategies able to stop the spread of MTB to the 
family and community. Patient diagnostic delays were found associated with an 
increase in the household size, TB social isolation stigma, diagnostic barriers with a 
longer time to reach a private health-care facility and default chemotherapy 
(incomplete treatment), initial seeking of alternative services and self-treatment 
through traditional health providers (Courtwright and Turner, 2010; Cramm et al., 
2010; Dean and Fenton, 2010; Kip et al., 2011; Sabawoon et al., 2011; Wieland et 
al., 2010).   
Reduction of tuberculosis-associated stigma, encouraging public-private healthcare 
services, encouraging LTBI case-finding with recording of symptoms and screening 
of contacts, improving diagnostic capabilities is requested. Worldwide general 
education for a better understanding and acceptance of TB with its associated 
infection risks can improve the ‘social isolation process’, and should be done at 
individual, family, and community levels. 
Cultural factors associated with TB stigma among TB patients e,g, being an old 
female and Muslim is different and cannot be compared within the same community 
members such as old female with low education levels without the effects of low TB 





TB stigma is considered to be a major limitation of the thesis study, but reflecting the 
barriers and involved difficulties in carrying out a high-profile and large-scale 
screening of new immigrants in the future. Important collected variables such as past 
history of TB infection or contact to infected TB patient or duration of exposures are 
completely relied on immigrant’s recall bias. Similar to Kipp et al. (2011) our 
research findings would recommend to document and grade the level of TB stigma 
and accurately identify risk factors related with stigma. These are important steps 
towards developing interventions to reduce TB stigma.  
4.9.2.7 Risk factors for progression of infection to active tuberculosis 
4.9.2.7.1 History of infectious and non-infectious (chronic) disorders 
Trends in TB burden can be determined by TB case detection and cure rates, and also 
by numerous other biological, social and economic factors. To ensure rapid declines 
in TB burden, countries should consider the risk factors or range of health-related 
outcomes associated with TB prevalence such as HIV, smoking, malnutrition, 
cardiovascular diseases, diabetes mellitus, alcoholism, crowding and indoor air 
pollution, or the length (delays) of diagnostic and treatment in health-seeking 
patterns (Dean and Fenton, 2010; Muniyandi and Ramachandran, 2008; WHO, 
2008). The importance of geographic and socio-economic location on TB morbidity 
and mortality rates, for example TB mortality, is an indicator of social health that is 
affected by cultural beliefs and behaviors toward TB. A Geographic Information 
System (GIS) is essential analytical tool allowing epidemiologists to work to 
eliminate TB, to consider and recognize difficult data allowing public health 
practitioners to recognize geographic dimensions and their incorporation within the 
new health policy plans. Shetty et al. (2006) negate any significant correlation 
between history of infectious and non-infectious diseases with immigrants SES. 
TB-related morbid trends can be caused by interactions with other infections, and 
observed prevalence and incidence can be due to other non-TB causes (Gomes et al., 
2011). The global trends and adverse health impact of HIV and sexual disease 




challenges for controlling community morbidity and mortality trends, with 
devastating fiscal and emotional costs to individuals, families and societies (Dean 
and Fenton, 2010). Underlying co-morbidities such as immune compromization have 
been frequently reported as independent predictors of tuberculosis morbidity and 
mortality (Bradshow et al., 2011). Thesis study results were not associated with 
infectious and non-infectious diseases as immigrants entered as healthy individuals.  
Various inter-related leading risk factors are significant clinical predictors of 
development of tuberculosis, due to the presence of co-morbidities of other disorders 
e.g. malnutrition, smoking, alcohol consumption or chronic disorders e.g. 
cardiovascular diseases and malignancy (Shetty et al., 2006). This can be related to 
regional, ethnic and cultural causes (Fares, 2011; McKenna et al., 2005; Sia et al., 
2010). A significant relationship was established between smoking habits and 
alcoholism with subsequent development of TB in positive HIV individuals 
(Dhungana et al., 2008), which, however, was not detected in our research results.  
Drinking alcohol and chronic disorders such DM and cardiovascular diseases were 
not significant factors with LTBI. No effect of those risk factors on TB were reported 
by Shetty et al. (2006) and Feng et al. (2011b). Common positive relationships 
between positive medical history and TB history and higher mortality trends were 
revealed by Wen et al. (2010).  
Diabetes mellitus  
Diabetes mellitus (DM) is associated with an increased risk of LTBI re-activation 
and TB disease and should be an important target for intervention and efforts to 
diagnose, detect, and treat both LTBI and DM that have a beneficial impact on TB 
control. Jeon and Murray (2008) noted that nearly 60% were unaware of diabetes and 
related TB risks. 
Epidemiologic transitions classically involve shifts from infectious to non-
communicable diseases, still one billion individuals are currently living in 
developing (Asian) countries with important relationships of both TB and diabetes 




contracting TB, MTB re-activation and related symptoms than non-diabetics, 
particularly among males in lower income countries. Rising DM prevalence is related 
to nutritional status (higher BMI) and higher TB incidence (Dye et al., 2011). 
Unawareness of immigrants of their diabetes and TB risks should be addressed (Jeon 
and Murray, 2008). Co-morbidities such as liver disease and cancer associated with 
old ages increases risks of LTBI/TB (Abuaku et al., 2010; Dye, 2006).  An 
immigrant’s denial of smoking or drinking may be due to denial since the majority of 
subjects were coming from restricted Asian cultures, and TB stigma might be under-
estimated (Cramm et al., 2010).   
Pharmaceutical and surgical therapy  
Pharmaceutical treatments were not significantly associated with TB risks because 
healthy immigrants were not taking medical treatments such as corticosteroids, 
immunosuppressive treatment or anti-hypertensive’s (Belard et al., 2011; Ladefoged 
et al., 2011). Self-reporting and related environmental differences are difficult to be 
globally standardized and the research trials should focus separately according to 
each country environment and TB morbid trends. 
4.9.2.8 Body mass index (BMI) (weight-for-height measure) 
Changing body mass index is directly related to TB morbidity and a low BMI is a 
risk determinant for tuberculosis. Nutritional status is useful for predicting LTBI and 
prognosis of tuberculosis patients. Falling BMI (defined as less than 18.5 kg/m
2
) is 
associated with higher risk of developing TB (Hang et al., 2011; Shetty et al., 2006). 
Adverse effects of malnutrition due to MTB infection can cause a rapid rise in TB 
incidence due to suppression of the systemic immune response and aggravating 
infection (Dye et al., 2011). Wasting is a prominent feature in developing 
tuberculosis with incompletely known underlying mechanisms that might be due to 
immune-endocrine disturbances linked to the consumption wasting status. Ralph and 
colleagues (2010) revealed an association between proportions of affected lung and 
CXR cavitary lesion with decreasing BMI category. Dye and colleagues revealed 
opposite findings and these risk factors positively reduced TB incidence especially in 




Ladefoged and colleagues recently achieved significant association between 
malnutrition and TB, but without significance association between lower BMI and 
TB risk (Ladefoged et al., 2011).  
Developmental factors of population growth and changes in demographic factors e.g. 
rural-urbanizations is related to raising incidence of obesity, and diabetes mellitus 
and TB. Low BMI patients had nearly a 10-fold increase in mortality, but overweight 
or obese patients were associated with reduced mortality (Wen et al., 2010). A 
similar positive association comparing the income of world continental regions and 
their diabetes prevalence’s with overweight (BMI more than 25 kg/m
2
) was revealed 
by Goldhaber-Fiebert et al. (2011).  
Latent TB carriers are asymptomatic healthy, having normal BMI complicating the 
issue of MTB carrier suspicion, and necessitates high specificity diagnostic tests. Our 
findings revealed no direct correlation between BMI and the healthy asymptomatic 
LTBI immigrants. Even with no significant association, our results revealed that BMI 
can be a good predictor of LTBI and relative TB risk, but without declaring the 
mechanism of nutritional status effects. Similar findings were reported by both 
Lonnroth et al. (2010) and Rafiza et al. (2011). 
4.9.2.9 Smoking   
Chest infections (including tuberculosis) and tobacco smoking are the two major 
causes of respiratory disease and death. Smoking and its chronic cumulative effects 
are a risk factor for TB which increases susceptibility of the human host and cough-
bacillary transmissions from infectious individuals. In the world tobacco smoking 
ranks fourth among the top ten leading risks for human health and annually causes 5 
million deaths. Even though smoking is the single biggest preventable cause of death, 
there are still an estimated that 1.3 billion smokers (1 billion of them are men) and 
about 15 billion cigarettes are smoked daily out of 5.5 trillion cigarettes produced 
globally worldwide.  
Smokers are at risk of dying from TB (Kolappan et al., 2002). Ten million deaths by 




smoking and tuberculosis are preventable killers, both are considered as major public 
health concerns with geographic overlap between a high prevalence of cigarettes and 
smoking and societies with high LTBI and TB cases (Pat et al., 2007). Annually, five 
million deaths are caused by smoking, compared with two to three million deaths 
from TB (Lin et al., 2007), and globally, one-third of smokers and one-fifth of TB 
prevalence cases are measured in the East Asian countries, commonly in urban areas 
(WHO, 2009a). Smoking is determined to be the main risk factor for loss of years of 
healthy life (disability-adjusted life years or DALYs) in industrialized countries and 
also among the ten principal risk factors in low-income countries (WHO, 2002b). 
Smoking has long been associated with low survival in individuals infected with TB 
and smokers are at increased risk of infections with severe forms of tuberculosis and 
other respiratory diseases such as pneumonia (Lin et al., 2007). Wen et al. (2010) 
conclude that combination (interaction) effect of smoking and previous TB history 
reveals increased TB mortality than either smoking or TB history alone. Once a 
smoker quits smoking, the nine-time higher TB mortality in smokers is reduced to 
that similar to non-smoker mortality.    
Smoking is a rapidly growing global epidemic. Even though still causing up to 9% of 
all deaths due to adverse effects on local and systemic parts of the immune system, 
skin and soft tissues and directly on the respiratory tract, an estimate of 10 million 
adult deaths from all causes in 2030 will be tobacco-related mortality particularly in 
resource-poor countries of Asia, Africa and South America. Worldwide China is the 
largest country for production and consumption of tobacco (Liu et al., 1998). A 
recent modeling study revealed that if China reduced both smoking and solid fuel use 
added to maintaining 80% of DOTS coverage and TB control, would reduce the 
annual TB incidence of 14%–52% by 2033 (Hsien-Ho et al., 2008). Adverse effects 
of smoking are commonly due to inhibition of T cell–mediated immune pathways 
which produce INF-γ, IL-2, and TNF-α (Pai et al., 2007b). 
The prevalence of adults’ reported history (current or previous) of tuberculosis was 
higher among smokers (mainly bidi smokers) than in those who never smoked. 
Smoking increases the incidence of clinical tuberculosis, predominantly in males and 




related-diseases and losing natural life expectancy (Gajalakshmi et al., 2003). Similar 
associations were revealed by Kolappan and Gopi (2002). Lin and colleagues, 
showing a rise of two-fold in the risk of tuberculosis in 17,700 current Taiwanese 
smokers, and a significant dose-response relationship with number of cigarettes 
smoked per day and packs per year (Lin et al., 2009).   
4.9.2.9.1 Non-beneficial effects of smoking on tuberculosis 
The shared clinical picture of symptoms and signs of both smokers and TB patient’s 
makes it difficult to differentiate among both due to deep cough similarities. The 
presence of tobacco smoke-associated diseases such as chronic obstructive 
pulmonary disease (COPD) can reduce immunity and masks the physical signs of TB 
due to similar aggravating complaints and raised disease severity (Awaisu et al., 
2010). Cigarette smoking exposure has been shown to reduce IFN-γ production of 
the lung CD4+ T cells by more than 80% compared with no inhibition on splenic T  
cells and/or without decreasing the number of CD4+ or CD8+ but causing lower 
macrophage intracellular killing of MTB, reducing resistance and immunity against 
tuberculosis with increased bacterial burden (Feng et al., 2011). Also the 
immunosuppressive effects of tobacco smoke result from a turning off of the 
production of pro inflammatory cytokines such as tumor necrosis factor alpha (TNF-
α) and attenuates the systemic inflammatory responses with consequent re-activation 
of latent tuberculosis, a physiological mechanism termed the ‘chronic anti-
inflammatory pathway’ (Wang et al., 2003).    
4.9.2.9.2 Physiological mechanisms of smoking that predispose 
infection  
Cigarette smoking is a known substantial risk factor for important bacterial and viral 
infections having common physiological mechanisms of smoking predisposal to 
infection. Firstly, the mechanical and structural changes of the lung physiology of 
nicotine major toxic compounds turn off the macrophage production of TNF-α, 
thereby rendering smokers susceptible to the progression of latent TB infection and 
active TB development (Arcavi et al., 2004; Kopallan et al., 2007; Wang et al., 




increases susceptibility to and aggravate tuberculosis infection and pulmonary 
tuberculosis, and both have common epidemiological and clinical links (Gajalakshmi 
et al., 2003; Liu et al., 1998). Both smoking and pulmonary tuberculosis can damage 
the lungs by reducing the immunological (cellular and immunoglobulins) levels and 
impairing the phagocytic activity of macrophages and natural killer cells and together 
with MTB bacilli induces apoptosis of alveolar macrophages (Pat et al., 2007). 
In this study the risk of smoking for the development and diagnosis of LTBI and TB 
suspects was evaluated. Here we have evaluated the risk of smoking to develop latent 
tuberculosis infection among new immigrants from tuberculosis endemic countries, 
by using a risk factor questionnaire to assess tobacco smoking and habits. 
The negative public health impacts of smoking are increasing risk and morbid rates 
of burden TB disease among the high- and low-resource countries (Arcavi et al., 
2004). A tuberculosis control programme should address the benefits from 
interventions of reducing tobacco as a potential preventive measure with emphasis on 
transmission limitation to reduce global burden of TB sustainability due to numerous 
smoking implications of: 1- active and passive cigarette smoking and risk factor of 
exposure, 2- development of re-activation dormant TB and 3- progression of primary 
TB, and 4- increased severity of cavitary disease and death in TB cases (den Boon et 
al., 2007; Gajalakshmi et al., 2003; Kolappan et al., 2002; Lin et al., 2007; Pat et al., 
2007).  
Susceptibility to smoking is a known predictor of smoking onset and smoking rates 
are usually higher among older school students due to increased susceptibility, 
especially in males from low-income countries (Guindon et al., 2008). Ng et al. 
(2008) revealed that 30% of diagnosed ex-TB patients never been asked about their 
smoking behaviours. Similar findings were detected in 50% of TB diagnosed patients 
only received messages about a general advice to quit smoking without explanations 




4.9.2.9.3 Socio-demographic associations with smoking 
Socio-demographic status of TB patients such as gender, overcrowding, nutritional 
vulnerability and associated chronic non communicable disease is particularly 
relevant in a country in economic transition (Shetty and Shemko, 2006). Both 
smoking, obesity and inequalities of TB-related mortality are common among men 
with a lower level of education (Mackenbach et al., 2008). All forms of tobacco use 
are an independent risk factor for low body mass index (Pendekar and Gupta, 2007). 
Similar significant findings were achieved by He and colleagues observed that male 
smokers had an increased prevalence of TB disease compared with non-smokers (He 
et al., 2010). 
 Smoking is sex-linked especially in South East Asia (Guindon et al., 2008).  
Smokers (especially males) are less adherent to TB treatment and are at higher risks 
of treatment default, added consequently to persistent TB infectivity and raising their 
families infectivity due to passive smoking of householders within the households 
(Lavigne et al., 2006). 
Our research findings revealed a significant association between smoking history and 
LTBI risks. However another multivariate analysis study on an Indian population 
showed absence of smoking effects on LTBI (Shetty et al., 2006). 
4.9.2.9.4 Changes of chest X-ray in smokers with tuberculosis 
Risks of TB morbid trends due to tobacco smoking are observed worldwide. 
Regardless of the specific types of TB outcomes, exposure to tobacco smoke is 
consistently associated with TB risks. Compared with people who never smoke, 
smokers have an increased risk of positive latent TB infection, of having active TB, 
and of dying from TB (Lin et al., 2007). 
Smoking affects the clinical manifestations of TB and increases the occurrence of 
upper zone involvement (cavitary and miliary disease) due to down regulation of 
TNF-α production from the macrophage and decreased immune response (Altet-




developing cavitary TB lesions (Altet-Gomez et al., 2005; Kherad et al., 2009). 
Neither associated abnormal changes were detected in our research CXR findings.  
The prevalence of TB among current- (40%) and ex-smokers (14%) in diagnosed TB 
patients was compared to non-smokers (Awaisu et al., 2010). Tobacco smoking has 
significant impacts on treatment adherence of LTBI (less compliance), and is also 
associated with treatment failure, default, and relapse after successful anti-TB 
treatment (d'Arc Lyra Batista et al., 2008; Kolappan et al., 2002; Ng et al., 2008; 
Pradeepkumar et al., 2008; Santha et al., 2002). The association between smoking 
and TB deaths remained significant even after including alcohol use (Pednekar et al., 
2007). Except for associated factors of being a female and a non-smoker, socio-
economic profile such as age, region of birth, and nicotine dependence among 
smokers were not associated with adherence to LTBI treatment (Lavigne et al., 
2006). Extra supervision should be focused on smokers to ensure compliance with 
LTBI and anti-TB treatment. 
On the contrary Feng et al.’s (2011b) results revealed no significant associations 
between smoking and clinical presentation of PTB. Also Kik et al. (2009) revealed 
no significant association between those had smoked and immigrants having positive 
TST and both IGRAs. 
Cohort studies are valuable and show the smoking effects of increasing TB morbid 
risks, been examined among ex-smokers through defining related risk factors (Jee et 
al., 2009), such as tobacco smoking and related LTBI diagnosis (den Boon et al., 
2005) and/or with TB disease (Kolappan et al., 2002) and/or TB relapses due to non-
adherence to anti-tuberculosis treatment and increased infectiousness (Wang et al., 
2009). Doll and colleagues conclusions proved on follow-up study for 40 years on 
British doctors that death from infectious diseases and PTB was significantly 
positively associated with cigarette smoking habits (number of cigarettes and current 
smoking) than non-smokers and ex-smokers stopped at younger ages (less than 35 
years) (Doll et al., 1994). Similar to increased TB mortality in active smokers, 
passive exposure to second hand tobacco smoke in the household also predisposes to 




among Indian male smokers and non-smokers together, smoking causes half of all 
deaths from TB (Gajalakshmi et al., 2003).  
4.9.2.9.5 Smoking habits 
Understanding the tobacco use, habits, attitudes and behaviours of newly diagnosed 
TB patients is of paramount importance in individualizing smoking cessation 
intervention via behavioural therapy and in designing effective educational 
intervention programmes for the prevention of TB through reducing treatment failure 
and TB recurrence or other poor consequences (Awaisu et al., 2010). Studying the 
behaviour of smokers and likelihood for TB infection prolongation within 
communities is difficult due to the socio-economic confounding.  
Diagnostic delays of TB are associated with smoking habits, both ex-smoking and 
current smoking, and consequent complications to advanced poor conditions (Jurcev-
Savicevic and Kardum, 2011). Ex-smoking and past history of smoking, in 
comparison to current smoking, was specifically associated with evidence of LTBI 
heterogeneous groups (Shetty et al., 2006). 
The impact of TB on smokers in the community is also related to hazardous lifestyles 
and living conditions (Altet-Gomez et al., 2005). Classification of smoking 
behaviours is difficult; lifetime amount of smoking habits, amount and duration in 
years, recall bias and lack of objective standards are considered limitation barriers.  
For example measurement of body biomarkers (e.g. nicotine) in children can 
determine exposures to environmental tobacco smoke (ETS). Interactions between 
smoking and adverse effects of other environmental factors was observed due to 
impairment of T-helper cell immune maturation (Huttunen et al., 2010), and from 
ETS which are toxic, irritant and directly toxicogenic and contains up to 4,500 free 
radical compounds (e.g. formaldehyde and acrolein) (Perez-Padilla et al., 2010).  
Immigrants who ‘ever smoked daily’ were having significant positive QFT-GIT 
results relative to insignificant TST results adjusted for country of origin and recent 




Lin et al. (2007) meta-analysis concluded that exposure to repairable pollutants from 
tobacco combustion (dose-response relationship) increases the risk of TB infection 
even among those exposed to passive smoking e.g. exposure of children to household 
smoker parents. Pendekar and Gupta’s (2007) study revealed that smoking - 
particularly bidi smoking (the commonest Indian smoking type) - is a known 
important risk factor with higher probabilities of tuberculosis mortalities than 
smoking cigarettes (Pendekar and Gupta, 2007).  
4.9.2.9.6 Smoking and tuberculosis dose-response relationship  
It is very difficult to evaluate the significance of smoking e.g. dose-dependent effects 
are inconsistently reported, but recent conclusion by Wen et al.’s (2010) revealed the  
presence of association between dose-response relationship of smoking quantity and 
the intensity of TB infection and mortality (Wen et al., 2010). 
Tobacco smoking is positively associated with TB prognosis and health outcomes 
(active disease and morbid trends) in smokers compared with the non-smoking 
population. Raised risks of TB deaths among smokers with respiratory TB (PTB) 
were linked to a dose-response-time relation between the numbers of daily cigarettes 
consumed (pack-years) and duration of tobacco use e.g. age of starting smoking 
(Gajalakshmi et al., 2003; Liu et al., 1998; Wang et al., 2009).   
Tobacco smoking, which has substantially increased in the developing countries for 
the last four decades, is associated with positive TST results and a positive pack-
years (dose-response) relationship in LTBI cases. den Boon et al.’s (2005) results 
showed that smoking of more than 15 pack-years is associated with positive 
tuberculin reactivity. 
The research study was unable to confirm a strong statistically significant association 
between smoking and latent tuberculosis infection. Behaviors of tobacco use 
(addiction) are difficult to change and need to be tackled carefully. Smokers’ 
utilization of tobacco products at a young age increases risks of LTBI suspicion. 
Smoke-free environments are linked to public community’s protection from 




4.9.2.9.7 Recommendations for smoking follow-ups 
 Smokers need extra-supervision to ensure compliance with LTBI treatment and 
reduce risks of developing active disease.  
 Tobacco manufacturing should be stopped.  
 Monitor tobacco use and regular prevention policies. Repeated brief cessation 
advice is a feasible and inexpensive addition to routine TB case management. 
 Multifaceted action is required to improve biomass smoke-related illnesses 
coupled with accurate tuberculosis diagnosis and case management (Hopewell et 
al., 2006).  
4.10 General discussion of LTBI risk factors  
Latent tuberculosis and epidemiological risks 
To estimate the prevalence of exposure to specific TB risk factors in the population, 
the relative association between the various predominating factors and LTBI/TB 
disease should be determined. To understand the reasons for change in TB 
prevalence over time, it is important to know the change in the exposure of the 
population to risk factors for TB, such as malnutrition, smoking, diabetes, indoor air 
pollution, and crowding in relation the low socio-economic status. Repeated LTBI 
prevalence surveys provide a platform for monitoring the change in prevalence of 
such risk factors over time. The evidence for a causal link between these and other 
risk factors is varied and the relative risk of TB associated with these predictive 
factors cannot be specifically established, and is likely to vary across populations 
because of effect modification related to a varying mixture of risk factor exposures. 
Measurement of risk factor exposures necessitates extra questions during data 
collection (e.g. the questionnaire, clinical history of other disorders). Therefore 
targeted screening and laboratory diagnostic testing’s should follow utilization of 
assessment tool (e.g. screening questionnaire) able to diagnose ‘identifiable’ or 
‘predictive’ risk factors to accurately suspect and diagnose LTBI. Random sub-




the prevalence of exposures to various risk factors in the high-risk groups and 
population (WHO, 2007b).  
Study strengths and limitations 
The risk factors studied were associated with MTB exposure and can be 
generalizable to other situations and cultural settings for large samples. This study is 
limited in that all the information that was collected was self-reported influenced 
mainly by recall bias and TB stigma.  
4.11 Conclusions 
Social determinants of health should be addressed in the design of TB information 
campaigns and in prioritizing tuberculosis public health interventions. Tuberculosis 
remains a disease of the socio-economically disadvantaged living in overcrowded 
environments. The project results proved to be a valuable instrument to assess 
foreign-born socio-economic situations and LTBI risk factors, which can be a 
research tool to help to tackle barriers to diagnostics and management for 
tuberculosis control in Kuwait (Mauch et al., 2011). 
4.12 Study recommendations 
1- Investigate the causes associated with development of latent tuberculosis among 
different high-risk groups and recent immigrants to improve the efficacy of 
screening programmes. 
2- Consider new expatriates (mainly adolescents) from deprived communities an 
important target group for educational interventions and diagnostic testing’s by 
tuberculosis control programmes in low-burden settings (Mahomed et al., 2011). 
3- Investigate strictly the contacts of high-risk groups such as targeted active case 
finding is useful to limit MTB transmission within non-endemic populations. 
4- Enhancement of financial resources and decentralization of medical services, 
especially in low income counties to facilitate the implementation of TB control 




Using a combination of the significant epidemiological risk factors associated with 
LTBI and ‘TB suspect’ diagnosis and the laboratory combination of diagnostic 
testing’s, the outline of evidence-based detection of latent tuberculosis cases in 






5 Chapter five 
Evaluation of the performance of chest X-ray and 
tuberculin skin test for diagnosis of latent 





Latent tuberculosis case is defined as normal healthy immigrants with normal CXR 
and abnormal TST and/or both abnormal IGRAs in the absence of any signs or 
symptoms of active TB infection. Individual’s harboring the dormant Mycobacterium 
tuberculosis bacilli and defined as latent tuberculosis cases are difficult to be 
clarified as radiological possibility and bacteriological certainty unless post-
dormancy bacillary re-activations. Screening of risk groups and immigrants coming 
from TB-endemic regions is mandatory, worldwide in countries with a TB low 
prevalence. Weakness of the standard screening policy and loss of MTB carriers are 
associated with raised morbidity and mortality trends. Absence of a gold standard or 
accurate laboratory identification for diagnosing the human tuberculosis except 
isolation of cultured M. tuberculosis had unavoidable consequences of delayed 
diagnosis and uncontrolled spread of TB. For example, even using prescribed LTBI 
prophylaxis for asymptomatic ‘suspect TB’ cases without a sound diagnostic result 
or with laboratory errors and improper management of false positives is associated 
with a rise of new MTB resistant strains and uncontrolled transmission which 
disrupts public health. Even with various TB diagnostic tools (pre-arrival and post-
arrival) and diagnostic precautions such as testing for TB using CXR and PCR for 
HIV and hepatitis and availability of free treatment policy, still there is an increase in 
the number of undiagnosed LTBI and leakage of ‘suspect TB’ subjects. 
Serious TB morbidity/mortality impedes improvements of new diagnostic tests with 
high accuracy and effective managements. There are still no published data regarding 
the use of either interferon gamma release assays as a compulsory diagnostic test for 
immigrant screening coming from high-to-low TB prevalence countries. Even though 
interferon-γ tests for screening of risk groups is a promising way of detecting LTBI 
with few false positives, it is limited geographically by the funding resources of the 
health care system. 
Without prompt clinical suspicion and diagnosis, and proper isolation and adequate 




associated TB will afflict other patients and pose a health hazard for health care 
systems (Freeman et al., 2010; He et al., 2010; Schablon et al., 2009). 
The WHO recommends effective TB control, but diagnosis necessitates early 
detection and management of LTBI individuals at high risk of re-activation and 
progression to active TB disease forms (Hussein, 2007). For example, treatment of 
LTBI is a major component of national strategies for elimination, for instance in the 
United States (Eisenberg and Pollok, 2010). Accurate and early diagnosis of TB 
infection is crucial but difficult with an inability to recognize the epidemiology of 
various MTB species and process effective strategies to limit disease spread. A 
correctly diagnosed case is defined as a culture-positive patient and, worldwide, is 
used as the gold standard diagnosis, but, results are only achieved after 4-8 weeks, 
which is critical for both the patient (e.g. disease complications) and community (e.g. 
increased risks of transmission). 
Diagnostic tools can help clinicians to reach a diagnosis or be used to predict the 
probability of a health event or LTBI and guide decisions to isolate and 
prophylactically treat suspected MTB carriers. The ‘gold standard’ diagnostic or 
reference test should meet a critical criterion supported by a body of evidence and 
utilization of the reference as a gold standard by the relevant medical specialty 
community. It should attain both high sensitivity and specificity. Due to the clear 
limitations of MTB culture, a new schedule needs to be able to diagnose dormant 
LTBI before active TB flare-ups (commonly pulmonary TB) (Richman, 2008).  
In Kuwait case detection and notification rates for all forms of tuberculosis is very 
high, reaching 89% (77-100%) in 2009 (WHO, 2011b). All new immigrants are 
accessible at the authorized entry port for implementation of screening procedures; 
direct interview and the four (two old and two new) diagnostic tests are available. 
The aim of chapter five is to assess interventions and evaluate the performance of the 
two old tuberculosis diagnostic tests ordinarily used for diagnosis of latent 
tuberculosis infection carriers, and the effect of Bacille Calmette-Guérin (BCG) 




5.1 Chest X-ray 
5.1.1 Introduction 
Chest radiography is one of the diagnostic methods for differentiating between LTBI 
and PTB disease and is an indication of medical evaluation for individuals with 
positive results of other TB diagnostic tests - in particular close contacts to infected 
TB patients or persons with calcified granulomas, nodular or fibrotic lesions 
consistent with old TB. 
The absence of a gold standard diagnostic for tuberculosis makes chest radiography 
the cheapest, rapid, most accessible radiological screening test all over the world, as 
the first line diagnostic approach for chest and lung abnormal findings. Multiple 
reasons necessities to perform chest radiography for asymptomatic individuals: first 
to exclude active TB disease; secondly, to assess the evidence of prior TB and other 
associated relative re-activation risks which can help in guiding treatment decisions; 
and thirdly, to provide a baseline for future comparisons and further research. 
Worldwide in developed countries, as part of WHO recommendations, ‘post-landing 
surveillance’, ordinary chest X-ray remains the central tool in screening for TB 
among migrants in most world programmes because radiography offers benefits for 
screening large numbers of people within high prevalence regions (Rieder et al., 
1994).   
Advanced TB cases usually reveal marked clinical, radiological improvements and 
conversion of laboratory-positive test results to negative results. Nevertheless, gross 
radiological changes, including cavitations, can persist (Douglas et al., 1956) as can 
the presence of acid fast bacilli in sputum smears (Barnes et al., 1988). Hospital-
admitted PTB are often interpreted as a predominant consolidation (the primary 
lesion) and other pulmonary lung changes such as effusion, reticular fibrosis, 
excluding cavitations (Wu et al., 2009). In contrast, LTBI suspect carriers are 
asymptomatic healthy with no exact diagnostic chest X-ray findings.  
However sensitivity and specificity of the CXR for diagnosis of active pulmonary TB 




1988; Cohen et al., 1996). Because of low specificity, if diagnosis among TB 
suspects (i.e. TB-like symptomatic patient) is based only on CXR, this would lead to 
a substantial proportion (~ 40%) of over-diagnosis.  
LTBI detection as post-active pulmonary disease is regularly revised using WHO 
guideline, the American College of Radiology and UK National Institute for Health 
and Clinical Excellence (NICE) to improve diagnostic test accuracy (MacPherson 
and Gushulak, 2006). LTBI is defined by CXR findings as being an asymptomatic 
condition with typical evidence of past TB abnormalities having: 1- pleural 
thickening, 2- upper lobe linear or nodular scarring images, 3- calcified nodules 
(granulomas), 4- non-calcified nodules, 5- fibrotic scar with/without reduction in 
volume of upper lobe(s), 6- cranial retraction of pulmonary tissue, 7- calcified 
mediastinal and hilar lymph nodes, 8- diaphragmatic tenting, and 9- blunt costo-
phrenic angle. Calcified nodules size (commonly between 3-10-mm) and/ or number 
(between 2 and 5) are typical characteristics for LTBI (Ralph et al., 2010). 
5.1.1.1 Merits of chest X-ray  
Performance and diagnostic accuracy of chest radiography can be evaluated for TB 
in humans in the absence of a reference test and of a comparative assessment with 
other diagnostic tests. The utility of CXR is well established in TB diagnosis and 
clinical monitoring. Problems in CXR reporting arise from the heterogeneous CXR 
manifestations of pulmonary TB (e.g. primary versus post-primary disease, adults 
versus children, immuno-competent versus immuno-compromised) and to 
inaccuracies inherent in CXR performance and interpretation including limited inter-
observer or intra-observer agreement on CXR findings (Ralph et al., 2010).  
Although with limitations of CXR sensitivity and specificity reading discrepancies, it 
remains a pivotal tool for diagnosing chest infections and tuberculosis. Routine 
admission CXRs are common and applied in hospitals serving populations where TB 
is common (Barnes et al., 1988). 
 Annual follow-up screening for active TB cases should be considered seriously to 




screening healthy but high risk immigrants at entry points to non-endemic countries. 
Radiographic findings play an important role in the clinical diagnosis as a significant 
predictor of PTB, even in HIV positive cases (Kanaya et al., 2001; Tamhane et al., 
2009). A healed calcified lesion in chest radiographs is typical of primary lung 
exposure to mycobacteria and TB infection (Parrish et al., 1998).  
5.1.1.2 Limitations of chest X-ray  
Radiography is an important diagnostic procedure in the absence of MTB culture; 
however, inaccurate interpretation of well-performed CXR can impact case detection 
and depends on experience and interpretative skills of the reader to exclude LTBI 
suspects (Bloomfield et al., 1999). Missing PTB and LTBI findings can be due to 
lack of consistency in reporting and other limitating factors such as clinical training 
of medical house staff, excessive workloads and the specialty of attending physicians 
(Wu et al., 2009).  
CXR does not play a major role in facilitating PTB diagnosis, with consequent 
delays in diagnosis and treatment. Missed abnormal radiographic findings play an 
important role in patient’s survival relative to rises in hospital mortalities and 
exposure of the surrounding community to TB infection with public hazards e.g. 
medical staff, health care workers, in-house close contacts (Wu et al., 2009). Joshi 
and others concluded that the majority of asymptomatic HCWs in a high TB-
incidence country region showed abnormal radiographic findings, reflecting a 
combination of recent and past MTB exposures that are not explained by 
demographic, occupational or immune response factors (Joshi et al., 2007). Limited 
association was seen between clinical presentation and radiological features of PTB 
mortalities (Feng et al., 2011b).  
Grading of radiological positive findings of LTBI/suspect TB is not standardized due 
to heterogeneous and inaccurate interpretations of radiographic manifestations of 
PTB. A standard, simple, numerical risk score, validated against ‘suspect TB’ 
radiographic outcome of new immigrants in repeated data sets is still lacking, but 
case validation is still dependent on medical staff experience. Therefore a simple 




and colleagues (2010) classified abnormalities according to the location (upper, 
middle or lower lobe) and the type of lesion (cavities, alveolar, reticular, miliary). 
They constructed a CXR severity grading system in adults with smear-positive PTB 
which was correlated with clinical and microbiological severity and response to 
treatment, concluding that cavitary disease show significant relationship between 
radiological and biological parameters and the 2-month sputum AFB density.   
A normal chest radiograph should not exclude latent TB and clinicians are requested 
to take care of TB past history for individuals coming from endemic regions (Mankia 
et al., 2011). The proportion of lung affected (cavitations and/or fibrotic infiltrate) is 
an important measure in many TB CXR grading methods. Creating a CXR score 
including cavitations and socio-demographics LTBI risk factors such as nationality 
and smoking also can be considered. Higher scores indicate a greater suspicion of 
LTBI and assessment of other TB diagnostics is necessitated which are similar to our 
research study testing’s. 
5.1.2  Aim 
To assess the accuracy of chest radiography (the standard tuberculosis diagnostic 
test). 
5.1.3 Objective and sub-objectives 
To assess the diagnostic performance of CXR in diagnosing LTBI in healthy humans 
with absence of a reference standard test as: 
1. Evaluate the performance of chest X-ray in diagnosis of latent tuberculosis 
infection 
2. Introduction of a new chest X-ray scoring system and recording sheet to improve 
diagnostic performance of latent tuberculosis infection  





Excluding one Syrian pregnant housewife, postero-anterior (PA) chest X-ray films 
for 179 new immigrants were interpreted for evidence of abnormalities indicative for 
LTBI and TB. CXR hard copies were read independently and blindly by highly-
qualified medical staff (three pulmonologists) and re-read by two radiologists. 
Comments on abnormal findings were recorded in a separate CXR recording sheet 
(Appendix 6) to interpret the final results and stage scoring (the detailed 
methodology is discussed in chapter 3). 
5.1.4.1 Radiological Criteria for LTBI Diagnosis 
Based on a literature review, a frame scoring system was constructed to predict LTBI 
and TB suspect requiring further diagnostic test(s).  
Radiological findings interpreted as an abnormal result consistent with LTBI 
(probable TB) were further subdivided using a scoring system according to the 
readers’ final interpretation and conclusion of chest X-ray reading (nodular lesion 
and/or fibrotic lesion and/or cavitatory /granulomatous lesion with/or without 
calcification and/or other parenchyma lung infiltrates and/or pleural or parenchyma 
disease).  A risk scoring system was introduced to report on the CXR results using a 
four point scoring system (score I, II, III and IV) to identify predictors of LTBI 
suspect for re-activations’: I: No pathology, II: Pathology not consistent for LTBI, 









Table 5.1: Chest X-ray scoring system for classification of LTBI categories (Jeong and Lee, 
2008; Linh et al., 2007; Ralph et al., 2010; van Cleef et al., 2005; van der Werf et al., 2008; 
WHO, 2011c; Yang et al., 2007)  
LTBI = latent tuberculosis infection, CXR = chest X-ray, score I = negative and free from 
abnormalities, score II = at least fibrosis less than 1 cm size and/or nodule size of less 5 mm, 
score III = at least fibrosis of 1 cm or more size and/or nodule of 5-mm or more size 
with/without calcification and/or cavitary granulomatous lesion, score IV = score III plus 
and/or other parenchyma lung infiltrates and/or pleural or parenchyma disease. 
 
A normal CXR was defined as clear lung fields with no abnormality detected. An 
abnormal CXR was any lung (including pleura) abnormality detected, including 
opacities, cavitation, fibrosis, pleural effusions, calcification(s) or any unexplained or 
suspicious shadow (WHO, 2011c). 
The score I was labeled as ‘normal’ (‘no LTBI’ or ‘negative’), whereas, ‘abnormal’ 
(or ‘positive’) CXR results was considered score II ‘suspect LTBI’ (or ‘atypical’), 
score III as ’high suspicion of LTBI’ and score IV were labeled as ‘extremely high 
suspicion of for LTBI’. Scores III and IV are also considered as ‘typical’ LTBI 
abnormal lesions and ‘definite LTBI diagnosis’ for score IV. 
5.1.5 Data analysis 
Sensitivity and specificity (Knapp and Miller, 1992) were calculated using SPSS 
version 17.0 Software statistical package. The frequency of positive findings 
identified separately of the PA radiographs on the basis of the final interpretations 
CXR result CXR score Case definition 
Final 
interpretation 
No pathology I No TB Normal 
Pathology not 
consistent with LTBI 
II Suspect LTBI Abnormal 
Pathology consistent 
with LTBI 
III High suspicion of LTBI Abnormal 
Pathology highly 
consistent with LTBI 




(CXR stage scoring) and positive findings. Agreement between readers was assessed 
by using the kappa coefficient statistic. A Kappa value of 0.20 or less indicated 
‘poor’ agreement; a kappa value of 0.21–0.40, ’fair’ agreement; a kappa value of 
0.41–0.60, ’moderate’ agreement; a kappa value of 0.61–0.80, ’good’ agreement; and 
a kappa value of 0.81–1.00, ’excellent’ agreement (Altman, 1991). 
5.1.6 Results 
5.1.6.1 Interpretation of chest X-ray radiographs 
The distribution of chest radiographic findings according to chest X-ray readers’ 
final comments were as follows (Table 5.2). 
Table 5.2: Distribution of chest X-ray findings following a new scoring system of 180 new 
immigrants to Kuwait during February and May, 2010   
CXR score I = normal, score II = suspect LTBI, score III = highly suspect LTBI, score IV = 
extremely high (definite) LTBI, TCU = Tuberculosis Control Unit (medical staff), Pulmonologist 
(3) = three respiratory specialists    
All of the 180 new immigrants entered Kuwait after being accepted as healthy. 
Chest X-rays were performed on 179 of the expatriates. One immigrant - a 
pregnant Syrian female was excluded, with a temporary certificate issued until 
childbirth. 
The distribution of CXR results of the 180 immigrants that were interpreted by the 
TCU medical staff opinion and the three pulmonologists according to the defined 
LTBI case categories did not revealed any statistical significant association. LTBI 





TCU Pulmonologist (3) Radiologist A Radiologist B 
n (%) n (%) n (%) n (%) 
I Normal 179 (100%) 179 (100%) 166 (93%) 168 (94%) 
II Abnormal 0 (0%) 0 (0%) 7 (4%) 2 (1%) 
III Abnormal 0 (0%) 0 (0%) 4 (2%) 9 (5%) 




20.112%, ‘average’ in 0.00%, ‘high’ in 2.23%, ‘extremely high’ in 25.7%, and 
‘cannot be judged’ were 1.68% (LLR χ
2
 (4) = 7.882, p = 0.096) (Table 5.3, page 287).  
Even with detection of abnormal findings in the lung shadows, the three 
pulmonologists independently interpreted all the 179 CXR films as normal (score I) 
(LLR χ
2
 (4) = 7.882, p = 0.096). Based on the dichotomous classification (TB-related 
abnormalities or not), pulmonologists and both radiologists were concordant in 
89.94% (161/179) cases having normal results. The estimated prevalence of LTBI 
suspected cases detected by both radiologists was 10.06% (18/179) compared with 
zero prevalence by both the TCU staff and the three pulmonologists. There were 
observed statistical significant differences comparing the results of both radiologists’ 
according to the defined LTBI case categories (LLR χ
2
 (8) = 52.584, p = < 0.001) 
(Figure 5.1).  
 
Figure 5.1: Distribution of chest X-ray agreement interpretations by both radiologists' 
(radiologist A and radiologist B) according to latent tuberculosis infection categories of 180 new 




5.1.6.2 Chest X-ray findings of both radiologists 
Excluding the TBU chest X-ray results, fibrotic changes and nodular lesions were 
commonly detected by all radiography readers (the three pulmonologists and two 
radiologists). On the contrary chest X-ray films reviewed by the two radiologists 
revealed different opinions. Table 5.3 reveals the difference of CXR results and CXR 
score of both radiologists (radiologist A and radiologist B) according to LTBI case 
categories. The differences of abnormal findings were in scoring of the observed 
lesions, which were more size-specific when interpreted by each radiologist 
differently. All findings were statistically significant as shown by the different p-




Table 5.3: Radiologists interpretation following the scoring system of categories for LTBI case definition of 180 new immigrants to Kuwait during 
February and May, 2010 
Score I = No pathology, Score II = Pathology not consistent with LTBI, Score III = Pathology consistent (significant) for LTBI, Score IV = Pathology highly consistent (highly significant) for LTBI, (-) = 




















Extremely High  
 
(n=46) 









n % n % n % n % n % n % n % 
Radiologist A  
(CXR result) 
 
Normal 90 50.28 28 15.642 0 0 1 0.56 44 24.58 3 1.68 166 92.22 
LLR χ2(8)= 
42.006 
<0.001 Abnormal 0 0.00 8 4.469 0 0 3 1.68 2 1.12 0 0.00 13 7.22 
No CXR 0 0.00 0 0.000 0 0 0 0.00 0 0.00 1 0.56 1 0.56 
Radiologist A 
(CXR score) 




II 0 0.00 5 2.793 0 0 1 0.56 1 0.56 0 0.00 7 3.89 
III 0 0.00 2 1.117 0 0 2 1.12 0 0.00 0 0.00 4 2.22 
IV 0 0.00 1 0.559 0 0 0 0.00 1 0.56 0 0.00 2 1.11 
No CXR 0 0.00 0 0.000 0 0 0 0.00 0 0.00 1 0.56 1 0.56 
Radiologist B 
(CXR result) 
Normal 90 50.28 31 17.318 0 0 2 1.12 42 23.46 3 1.68 168 93.33 
LLR χ2(8)= 
28.823 
<0.001 Abnormal 0 0.00 5 2.793 0 0 2 1.12 4 2.23 0 0.00 11 6.11 
No CXR 0 0.00 0 0.000 0 0 0 0.00 0 0.00 1 0.56 1 0.56 
Radiologist B 
(CXR score) 




II 0 0.00 1 0.559 0 0 0 0.00 1 0.56 0 0.00 2 1.11 
III 0 0.00 4 2.235 0 0 2 1.12 3 1.68 0 0.00 9 5.00 
IV 0 0.00 0 0.00 0 0 0 0.00 0 0.00 0 0.00 0 0.00 
No CXR 0 0.00 0 0.000 0 0 0 0.00 0 0.00 1 0.56 1 0.56 
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Radiologist A’s final interpretation reveals ’normal’ LTBI finding in 92.22% and 
’abnormal’ CXR findings of LTBI prevalence in 7.22% (13/180) subjects. The 
details of these abnormal cases were as follows; ‘low’ LTBI suspicion in 4.47%, 
‘high’ LTBI suspicion in 1.68%, and ‘extremely high’ cases in 1.12% (LLR χ
2
 (8) = 
42.006, p < 0.001) (Table 5.3).  
Concerning LTBI scoring, radiologist A described cases with score II (pathology not 
consistent with TB) in 3.89%, score III (pathology consistent with TB) in 2.22% and 
score IV (pathology highly consistent with TB) in 1.11%. Radiologist A’s results 
reveal more score II for the ‘low’ LTBI cases, and was recorded as fibrosis (fibrotic 
infiltrates) of less than 1cm and/or nodule size less than 5-mm (LLR χ
2
 (16) = 46.593, 
p < 0.001) (Figure 5.2, Table 5.3). 
  
Figure 5.2: Chest X-ray interpretation of radiologist A according to stage scoring system and 
latent tuberculosis infection (LTBI) categories of 179 new immigrants to Kuwait during 
February and May 2010  
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By contrast radiologist B’s final interpretation reveals ‘normal’ CXR results in 
93.33% and ‘abnormal’ CXR findings were detected in 6.11% (11/180). The details 
of these abnormal cases were as follows; ‘low’ LTBI suspicion in 2.79%, ‘high’ 
LTBI in 1.12% and ‘extremely high’ in 2.24% (LLR χ
2
 (8) = 28.823, p < 0.001) 
(Table 5.3).  
Concerning LTBI scoring, radiologist B only found cases with score II in 1.11% and 
score III in 5.00% with no score IV cases. Radiologist B interpreted more score III 
abnormal findings, and which was in common described as nodule more than 5-mm 
and/or fibrotic infiltrates more than 1cm (LLR χ
2
 (12) = 29.751, p = 0.003) (Figure 5.3, 
Table 5.3). 
 
Figure 5.3: Chest X-ray interpretation of radiologist B according to score staging system and 
latent tuberculosis infection (LTBI) categories of 179 new immigrants to Kuwait during 
February and May 2010    
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5.1.6.3 CXR reader agreement 
Based on the dichotomous LTBI classification (TB-related result), kappa agreements 
were calculated as follows (Table 5.4). 
Table 5.4: Inter-reader’s agreements of chest X-ray interpretation for 179 new immigrants to 
Kuwait during February and May, 2010 
a = cannot be computed by SPSS 17.0 Software, (---) = already present, TCU = Tuberculosis Control 
Unit staff, Pulmonologists (3) = three respiratory specialists 
CXR films, with the exception of one pregnant female, were interpreted as normal 
results by both TCU staff and the three pulmonologists with 100% concordance 
(kappa = 1.00).  The level of agreement in terms of CXR diagnostic outcome was 
different. Both radiologists were more likely to give a positive diagnosis in 
identification of LTBI prevalence having ‘moderate’ inter-reader agreement (k = 
0.505) (Altman, 1991). 
Diagnostic lesions of LTBI suspects such as fibrotic infiltrates of more than 5 mm 
and nodular size of more than 1 cm were the most common forms of parenchymal 
lesions, and particularly in the lower lobes of the right lung fields were differently 
detected and interpreted by all the radiographic readers’, but with different final 
scoring of both lung lesions as follows; pulmonologist A (LLR χ
2
(16) = 15.193, p = 
0.511), pulmonologist B (LLR χ
2
(24) = 16.655, p = 0.863), pulmonologist C (LLR 
χ
2
(24) = 19.321, p = 0.735), radiologist A (LLR χ
2
(52) = 58.328, p = 0.254) and 
radiologist B (LLR χ
2
(40)  = 41.091, p = 0.423). No calcified nodules were detected by 




TCU Pulmonologists (3) Radiologist A Radiologist B 
Pulmonologists (3) 1.00 --- --- --- 
Radiologist A 









Chest radiography provides useful information regarding disease extent and progress 
without an agreed-upon, validated system regarding the severity of CXR 
abnormalities. The purpose of this research is to introduce a scoring system to 
improve the radiographic diagnostic performance/detection of LTBI and TB 
suspects. Clear documentation of adequate diagnosis could potentially reduce the 
number of unnecessary entries, which would make TB prevention programmes and 
CXR reading more efficient and cost-effective. The goal of performing CXR in the 
TB screening programmes prior to employment and after entry of the immigrant’s is 
to search for chest radiographic findings suggestive of active TB or evidence of 
LTBI lung changes. Abnormal radiographic finding’s were fibrotic non-calcified 
lesions of 2 cm and larger, or large cavitation(s) more associated with MTB 
transmission (Eisenberg and Pollok, 2010; Lin et al., 2008). Our research finding still 
revealed nodular sizes more than 1 cm as indicative of prior MTB exposure. Our 
research finding revealed that more than 1 cm is still indicative of prior MTB 
exposure.  
Leakage of suspected TB cases due to missed diagnosis were detected by our 
research findings and such leakage is known limiting factor of TB control for 
decades all over the world. Similar findings were reported by (Barnes et al., 1988; 
Feingold, 1977).  
5.1.7.1 Scoring system 
Testing helpful predictors of the presence or absence of LTBI aids construction of a 
TB predictive model using meaningful CXR LTBI scores, in addition to other 
diagnostic tests, and epidemiological risk factors related to past TB clinical history 
(Cohen et al., 1996). The benefit of a combined scoring system is detection of 
LTBI/TB suspects better than readers’ experience. It predicts abnormal changes 
frequently compared with the biased expected lung changes of one reader and which 
also affected by inter- and intra-rater differences (usually fair or poor agreement). 
Severity risk factor measures are needed to reduce the limitation factors such as 
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nationality and past history of TB infection or smoking. Solari and colleagues’ 
analysis of covariates reveals that patients with previous episodes of PTB are more 
likely to present hemoptysis and cavities on the CXR even in the absence of MTB 
(Solari et al., 2008).  
The research introduces a new four point scoring system, using scores II, III, and IV, 
and which represents abnormal CXR results consistently with suspicion of LTBI 
pathologies. The system was able to show correlation with baseline epidemiologic 
(socio-demographic) factors and other diagnostic test results. Scoring changes is 
important to decide before and follow-up after LTBI prophylaxis and active TB 
management, which improve early diagnosis and prediction of MTB harboring 
subjects. Similar to our findings, multiple raters’ also permit reduction of under- and 
over-diagnosis of abnormal lung fields (Ralph et al., 2010; van Cleef et al., 2005).  
5.1.7.2 Chest X-ray interpretation 
Specific abnormal CXR changes for definite diagnosis of LTBI/TB is still absent. 
Research studies adopt a screening criterion for specific definition of ‘TB suggestive 
CXR findings’ had difficult application, similar to the majority of those 
bacteriologically confirmed cases were belonging to ‘non-TB suggestive CXR 
abnormality’ (WHO, 2011c). 
Subjective reader interpretation and related miss-diagnosis and miss-leading of 
LTBI/TB management is restrictive barriers for TB control. The need for a national 
or universal international standard system for reporting CXR in LTBI and pulmonary 
TB is acknowledged by the health care systems. Fibrotic lesions of less than 5 mm 
are defined as well-delineated radiographic lesions compatible with non-endemic 
regional ‘healed’ tuberculosis, but not in endemic countries (< 1 cm) (ATS, 2000).  
CXR interpretations represent readers’ subtlety but still are questionable. Familiarity 
of TB disease and interpretation experiences of chest radiographic findings are both 
crucial for LTBI/TB diagnosis which limits the community population with threatens 
of infection transmission. Our thesis research findings greatly suggest that chest 
radiographs read by non-radiologists are of extremely low achievement in TB 
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screening programmes. A recent similar conclusion also has been reached by 
Eisenberg and Pollock (2010). 
‘Intentional over-reading’ is defined as CXRs read by interpreters who are unable to 
classify radiographic films as normal (or considered wrongly as abnormal) (WHO, 
2011c).  
Interpretations for abnormal CXR findings by two independent readers reveal 
statistical significance in achieving more accurate findings (Gopi et al., 2005). All 
radiological screening programmes are subject to interpretation error. Experience and 
the number of interpreters have been shown to affect interpretation. Standardized 
interpretation should be a goal of all screening programmes using CXRs. Zellweger 
and colleagues (2006) demonstrated that experience in reading CXRs for possible 
active TB among asylum seekers can play a significant role in the reproducibility of 
the reading. Although not done within an immigrant TB screening programme, it has 
been suggested that TB specialists had better interpretation accuracy in detecting TB 
related abnormalities. If films are digitized at each site and transmitted electronically 
to a central reading site, all interpretation can be done by a designated panel of TB 
radiology experts with an increase in the accuracy of diagnosing active and inactive 
PTB (Zellweger et al., 2006). 
Even though there is confusion among radiologists and clinicians regarding the 
actual definition of an ‘abnormal chest radiograph consistent with prior TB’, the 
American Thoracic Society and the Centers for Disease Control and Prevention still 
recommend CXR fibrotic infiltrates more than 5 mm (not 10 mm) in non-endemic 
countries as positive result with high re-activation risks requiring further testing’s. 
For example the ATS and CDC (ATS, 2000) stated that both ‘nodules and fibrotic 
lesions’ (with no comments on their size) suggest increased TB re-activation risk 
compared with opposite findings of other published results (Jasmir et al., 2002). 
Inter-rater agreement on cavitations and confluent consolidations are interpreted with 
higher agreement and are associated with higher AFB density in sputum of 
pulmonary TB patients and worse lung function than for non-cavitary disease (Palaci 
et al., 2007; Raplh et al., 2010). 
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The typical findings of re-activation of LTBI disease characteristically include 
cavitations and/or infiltrates in the lower parts of upper lobe and/or within the upper 
parts of lower lobe lung fields, below hilar and parahilar regions (Farman et al., 
1986). Cavitary lesions give rise to greater clinical suspicion than alveolar infiltrates 
and mass lesions in asymptomatic subjects who might suffer of average delays of one 
month before LTBI/TB diagnosis and treatment (Wu et al., 2009). Size of 
cavitations’ can be used for discriminate accuracy as the best new marker and 
advantageous without aids for CXR assessment (Ralph et al., 2010). Nevertheless, no 
single interpreted CXR of the participants revealed any LTBI diagnostic lesion 
(cavitations’) even in those with positive IGRAs result. 
The chest X-rays showed high frequencies of fibrotic infiltrates and nodular 
calcifications characteristic of LTBI radiographic findings for an early compatible 
primary infection (Lee et al., 2011). Other common radiographic abnormalities of 
PTB patients on/without treatment are cavity formation, lobar/segmental 
consolidation and bilateral involvements (Feng et al., 2011b). On the contrary, our 
research findings were significantly associated with the inability to detect most of 
these common LTBI abnormal changes by all five film readers’. 
Calcified nodular lesions and calcified mediastinal lymph nodes (and enlarged size) 
represent a common main site of MTB in latent tuberculosis, and is considered as an 
old, healed tuberculosis lesion with high re-activation risks (Lee et al., 2011). 
Radiologists could accurately interpret the nodules as an LTBI risk factor. Similar 
findings were also found by Eisenberg and Pollok (2010) and Horsburgh et al., 
(2010).  
Similar to the research radiologists interpretation, Graham and colleagues (2002) 
obtained the same inter-reader’s agreement (k = 0.53, ‘moderate’= 0.40-0.60). Our 
radiographic findings emphasized chest radiographic evaluation by experienced CXR 
radiologists and TB specialists. Similar approaches and findings were obtained by 
Richard et al. (2002).  
Reducing CXR inter-reader variability is facilitated by interpretation by at least two 
or three certified radiologists. The contradictory findings of sharing medical 
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pulmonologists’ and radiologists’ add little CXR performance to be considered as a 
diagnostic test in excluding LTBI or prior history of TB affection, which had proved 
similarly by Eisenberg and colleagues. For example, confusion is common regarding 
the definition of ‘abnormal CXR consistent with prior TB’ and the relative 
significance of non-calcified fibrotic lesions of varying sizes. The findings greatly 
suggest that single test-strategy using only chest radiograph yield low positive 
finding’s in LTBI/TB immigration screening and/or in pre-employment setting 
(Eisenberg and Pollok, 2010).   
5.1.7.3 Chest X-ray radiography 
A CXR result depends on the intensity and presentation of TB disease, which in turn 
is influenced by a range of other factors such immuno-suppression and atypical 
findings e.g. HIV/AIDS. Other factors -such as CXR film (quality), functioning CXR 
machine and the reagents in addition to reader experience and interpretation skills 
making CXR subject to intra- and inter-reader variation - delay PTB diagnosis. The 
degree of readers’ result concordance, inter-reader variability and LTBI sensitivity 
are highly dependent on the quality of the films. Radiography and CXR is also 
unable to distinguish 'smear-positive TB' from 'smear negative TB', whereby all 
factors can contribute to interpretation and therefore over- and under-diagnosis (van 
Cleeff et al., 2005; WHO, 2011c).  
The useful of CXR in providing information regarding lung shadows and disease 
extents is still not enough due to lack of a standard and validated grade system for the 
severity of radiographic abnormalities even in bacteriologically proved PTB.  
One postero-anterior radiographic (PA) view is sufficient for TB screening of pre-
employment individuals instead of the lateral (LA) view, the latter providing no 
additional diagnostic value (Eisenberg et al., 2009), but still, chest radiography yield 
low level of changes in detection of LTBI, and provide no assistance to prioritize a 
decision for LTBI treatment (Eisenberg and Pollok, 2010). Also elimination of the 
acquisition of LA for screening of asymptomatic individuals never caused 
radiologists to change decisions made on the PA view and would therefore reduce 
radiation exposures (Eisenberg et al., 2009). 
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5.1.8 Study strengths and limitations 
The research study is innovating new suggestions such as: 
1. Introduction of a high-quality CXR recording sheet (Appendix 6). 
2. Multiple interpretations from various independent chest radiographic readers’, of 
TB-related specialists and radiologists, and simultaneously compared to results 
issued by the authorized staff of Tuberculosis Control Unit. 
The research study faces barriers such as absence of standardized definition to 
ascertain radiographic appearance of LTBI.  
5.1.9 Conclusions 
Due to lack of a universal standard and accepted reporting system of chest 
radiography, then: 
1. Review of published guidelines regarding specific radiographic findings of re-
activation risks provides no assistance to prioritize LTBI diagnosis/treatment.  
2. Chest X-ray is a weak screening tool for detection of abnormal TB-related and 
latent tuberculosis findings, with consequently, 
3. Missing diagnosis of latent tuberculosis and entry to the country (leakage) of 
LTBI and suspected TB immigrants. 
4. The inherent problem of inter-rater differences in radiographic assessment and 
the low rates of clinician-radiologist agreement between reporters on CXR 
findings can be solved. 
5. Chest radiography provides no assistance in deciding which individuals to 
prioritize for LTBI chemoprophylaxis unless supported by another specific 
diagnostic test such as IGRAs which need introduction of a new well-defined 
scoring system. 
5.1.10 Recommendations 
Chest radiography diagnostic performance can be improved by the following:  
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1- Use of the new, simple and well-defined CXR scoring system which is 
fundamental for higher correct diagnosis of LTBI/TB. Also the scoring system 
should be revised after implemented on similar study on large sample size of high 
risk group. 
2- Chest radiographic readers need consensus radiographic training to reach 
maximum inter-rater agreements.  
3- Radiologists’ should be part of CXR decision-makers for TB reporting. An effort 
to harmonize interpretation and chest X-ray reporting is needed. 
5.2 Tuberculin Skin Test 
The second standard diagnostic test for latent tuberculosis infection is the tuberculin 
skin test (TST). 
5.2.1 Introduction  
Detection and monitoring of tuberculosis infection is essential to control its spread. 
Targeted tuberculin skin testing and drug therapy to prevent latent M. tuberculosis 
infection from progressing to overt disease are important TB elimination strategies, 
particularly in low-incidence countries. The tuberculin skin test has been used 
effectively for detection of previous MTB infection and LTBI for more than 100 
years, despite few drawbacks such as variability and subjectivity in test application 
and reading, and false positive or false negative results.  
5.2.1.1 Tuberculin skin test history 
The tuberculin skin test was first described by Robert Koch in 1890, but developed 
by Charles Mantoux, a French physician in 1907 who gave the test its eponymous 
name, or PPD for Purified Protein Derivative. Tuberculin is a glycerol extract of the 
bacillus, with PPD introduced in 1934 in its standardized version. Later, in 1939, 
PPD-S was produced by Seibert and Glenn, and remains as the standard dose of 5 
tuberculin units (0.1ml) is injected intradermally. In the UK, Mantoux test used 
different type of 2TU (tuberculin RT23) of SSI {Staten Serum Institute} dissolved in 
0.1ml solution (CDC, 2011; MoH, 2005).  
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5.2.1.2 Immunological reaction 
The TST (skin test reagent) reaction for diagnosis of mycobacterial infection is 
caused by a localized delayed-type hypersensitivity (DTH) versus the injected PPD 
at the site of injection, which are tuberculin’s composed of a crude mixture of heat-
denatured proteins derived from cultures of M. tuberculosis. The relationship of PPD 
responses to the immune T-lymphocytes’ release interferon gamma (INF-γ) in 
peripheral blood after presentation to MTB antigens remains unclear. BCG 
vaccination alters the interpretation of a positive PPD, and therefore TST 
interpretation depends on the presence or absence of previous BCG. 
5.2.1.3 Tuberculin skin test interpretation 
Manifestation of a positive TST represents reactive type-IV delayed hypersensitivity 
reaction. TST induration between 5- and 10-mm can persist for up to 25 years after 
BCG vaccination (Burl et al., 2010). The interpretation of the test is based on an 
individual’s epidemiological risk factors for TB infection and disease progression. 
There is an inherent relationship between PPD and local prevalence of LTBI. 
Geographic and racial differences can determine exposures to mycobacteria other 
than Mycobacterium tuberculosis (NTM) and the host immune status. TST 
conversions can be false positives in a low-risk travel population, even in absence of 
exposure to MTB (Freeman et al., 2010). A common confounder, which affects TST 
reactivity, is prior vaccination with the compulsory Bacille Calmette-Guérin vaccine, 
the strain and dose of BCG used, and method of vaccine administration or age of 
vaccination.  TST cannot be positive in certain biological factors due to suppression 
of type-IV delayed hypersensitivity and T-lymphocytes such as malignancies and 
viral infections (e.g. HIV) (LoBue et al., 2010). Chan and colleagues (2008) 
concluded in their longitudinal study of 783 children in Taiwan vaccinated with BCG 
at birth that 10-mm induration should be an optimal ‘cut-off’ for children younger 
than 7 years of age, with 21-mm being more appropriate for the first year of life 
compared with only 5-mm ‘cut-off’s in non-endemic countries. 
5.2.1.4 Merits of the tuberculin skin test  
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In addition to the routine diagnostic and screening methods, the tuberculin skin test is 
still used for the last 100 years worldwide (NICE, 2006). TST is still the most 
common technique for diagnosing LTBI infection, even among BCG-vaccinated 
populations, because of low cost, easy application and interpretation, and is still used 
to screen contacts of active TB patients and other populations at high TB risk (ATS, 
2000). TST use is based on purified protein derivative (PPD), is inexpensive and 
easy to perform for identification of MTB-infected subjects. 
TB skin testing at immigrant entry centres that serve large foreign-born populations 
can be effective.  Li and colleagues (2010) detected LTBI prevalence of positive TST 
in 24.4% (higher among foreigners) in BCG-vaccinated which help to target TST 
testing before immigrant’s chemoprophylaxis. 
TST is currently a standard and reliable test for immune-diagnosis of TB infection 
(Lin et al., 2008). For persons with LTBI having normal immune responsiveness, 
TST sensitivity can approach 100%. The specificity is approximately 99% in 
populations with less antigenic cross reaction in those without history of BCG 
vaccination or exposures to other mycobacterial organisms (ATS and CDC, 1999). 
Positive TST in contacts of a TB patient is indicative of LTBI and was detected (2.4 
times higher) than in contacts without history of exposure to TB patient was 
observed by Lin and colleagues (2008). Controlling TB in the US follows reports of 
the Institute of Medicine which recommends compulsory TST for all immigrants and 
treating LTBI prophylactically before US entry (legal green card). Hill and 
colleagues concluded their study on 2,348 household Gambian contacts to sputum 
smear TB diagnosed patients that either positive TST or T-SPOT .TB test was 
sufficient indication for preventive treatment without replacement of the Mantoux 
test by an ELISPOT test (Hill et al., 2008). 
5.2.1.5 Disadvantages of the tuberculin skin test  
The TST is inadequate for a confident diagnosis or exclusion of LTBI/TB infection 
(low sensitivity and specificity), but is currently used as the standard second choice 
after abnormal CXR to detect LTBI even without differentiating past and present TB 
infection. TST sensitivity (which is poor in children) is affected by several factors 
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such as the interval post-infection, desensitization and observer variation, whereas, 
the specificity (which is poor in adults) is influenced by previous sensitization (result 
of exposure to M. avium, M. paratuberculosis and environmental mycobacteria) and 
by skin tuberculosis (Monaghan et al., 1994). Independent risk factors for a positive 
TST reaction in household contacts were detected more in those having longer 
affection of TB index case and suffer from treatment delays (Lin et al., 2008). 
Uncertainty of past history of previous BCG vaccination might affect the 
interpretation of TST reactions and the likelihood options of the effective treatments. 
Factors affecting TST reaction are commonly related to two factors; vaccine and 
dose (some contain bacillary virulence and produce different sensitivities) and time 
of TST reading (Horwitz et al., 1972). A meta-analytical study proved that previous 
BCG administration increased the likelihood of TST false-positive results up to 15 
years post-vaccination (Richeldi, 2006) while interferon gamma release assay 
(IGRAs) results are independent of BCG vaccination (discussed in chapter 1 section 
1.4.2; IGRAs). TST is not helpful in identifying (if positive reaction) or excluding (if 
negative result) latent TB infection in patients taking immune-suppressive treatments 
(Mankia et al., 2011). 
5.2.1.6 Contradictory responses 
5.2.1.6.1 False-positive reactions 
False-positive reaction can be defined as positive TST induration with no history of 
infection with M. tuberculosis. The causes of false-positive results can include, but 
not be limited to, infection with non-Mycobacterium tuberculosis (especially in low 
prevalence non-endemic countries) or previous BCG vaccination or prior TST testing 
(Farhat et al., 2006). Two-step TST testing measures conversion reading (negative-
to-positive reaction) of more than 72 hours but is less reliable in BCG vaccinated 
individuals (Lalvani et al., 2001b; Tat et al., 2005). Another confounding factor is 
tobacco smoking, associated with positive TST reaction in LTBI cases and need to be 
further studied (den Boon et al., 2005).  
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5.2.1.6.2 False-negative reactions 
Absence of a TST reaction in persons infected with M. tuberculosis can result from; 
cutaneous anergy, recent TB infection (within 8-10 weeks of exposure), very old TB 
infection, very young age (less than 6 months old), recent live-virus vaccination 
(such as measles) or recent viral illnesses (such as hepatitis and chickenpox), or 
overwhelming TB disease. Also incorrect TST administration and reaction 
interpretation can also reduce a negative result (Bergamini et al., 2009; Jong Lee et 
al., 2010). For example the Heaf test was discontinued in UK after observed of small 
test head fragments were found at the injection sites (Zellweger et al., 2006). Low 
rates of positive TST might be associated with under-estimation and subjective 
interpretation, which should rely on the readers’ experience (Chang et al., 2010). 
Hardy et al. (2010) showed that a higher cut-off point for a positive TST (> 15-mm) 
lead to missing cases of LTBI  
5.2.1.6.3 Booster phenomenon 
Skin test conversion from primarily negative TST reactions to positive result due to 
loss of early immunologic reactivity to MTB. This can represents an immunologic 
boosting phenomenon of previous MTB infection after subsequent repeated TST 
within short period of time (2-24 weeks). The initial test stimulates the immune 
system of a previously infected with MTB due to the ability of their immune system 
to react against the second test, known as ‘booster effect’. The ‘two-step method’ to 
be repeated in one to three weeks is recommended (Al Mazrou, 2004; CDC, 2010b). 
Boosting can even occur two years after the first TST.   
5.2.2 Aim 





To assess the diagnostic performance of TST in diagnosing LTBI in healthy humans 
with absence of a reference standard test as: 
1. Evaluate the performance of tuberculin skin test in diagnosis of LTBI and 
‘suspect TB’ cases 
2. Introduce a new recording sheet for tuberculin skin test evaluation 
5.2.4 Methodology  
The skin was injected with 0.1 mL (5 tuberculin units [TU]) of Tubersol® 
(Connaught Laboratories, Willowdale, Ontario, Canada) using the Mantoux method 
to the 180 participants’ volar forearm. The diameters of the resulting wheal reactions 
were measured within 48 and 72 hours after puncture (not more than 5 days) after 
application. Induration size on the volar forearm was measured in millimetres (mm) 
using a flexible reading ruler. All the results obtained were double-interpreted (nurse 
and researcher) and recorded as either positive (if ≥ 10-mm) and negative result (< 
10-mm). Both body weight and body height were measured to calculate body mass 
index (BMI).  Arms were checked for the presence of a BCG scar.   
5.2.4.1 Scoring criteria of tuberculin skin test reaction 
Following the Ministry of Health (Kuwait) and the American Thoracic Society and 
Centers for Disease Control and Prevention guidelines (ATS and CDC, 2000), a TST 
response was defined as a skin test reaction to antigens (PPD) derived from 
Mycobacterium tuberculosis. A positive TST was defined as an induration reaction to 
PPD of more than or equal 10-mm cut-off point for LTBI diagnosis. The TST result 
was confirmed after double interpretation by both the nurse and the researcher. Any 
adverse reactions at the injection site during TST manipulation and result 
interpretation were recorded. All results were been documented in the TST recording 
sheet by the nurse (Appendix 7). The LTBI scoring system was graded according to 
Mantoux reaction size induration (mm) (Table 5.5).  
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Table 5.5: Tuberculin skin test response and scoring system of latent tuberculosis infection 
reaction (ATS and CDC, 2000; CDC, 2005c; CDC, 2010b, MoH, 2010)  
A positive TST reaction is defined as any reaction of more than or equal 10-mm (> 
10-mm) of induration in recent immigrants (within last 5 years) from high-
prevalence countries. A reaction of more than 5-mm (> 5-mm) of induration was 
considered positive in those coming from non-endemic countries and/or with a 
history of recent contacts of infectious TB cases and/or persons with fibrotic changes 
on chest radiographs consistent with prior TB. Also a reaction of more than 15-mm 
(> 15-mm) of induration was accepted as positive in immigrants with no known risk 
factors for TB (ATS and CDC, 2000; CDC, 2005c; CDC, 2010b) 
5.2.5 Results  
98.33% (177/180) fulfilled the inclusion criteria for TST results. The TST results of 
three excluded immigrants were as follows: two participants came on day 7 (Indian 
electrician male and Nepali housemaid female) and one participant did not return for 
TST reading (Ethiopian housemaid female) (Table 5.6).  
Table 5.6: Results of tuberculin skin test performed to 180 new immigrants to Kuwait during 
February and May, 2010 
Mantoux response at 48-72 
hours (until 120 hours) 
Score Grade LTBI Reaction 
0 0 Negative 
<5 1 Reactive 
5 - <10 2 Borderline 
10 - <15 3 Positive 
15 - <20 4 Highly positive 
> 20 5 Definite 
TST result Number of immigrants (%) 
Included TST within 24-72 hours (until 120 hours) 177 (98.33%) 
Excluded TST (follow-up after 5 days) 2 (1.11%) 
Excluded TST (lost follow-up) 1 (0.55%) 
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A modified ‘cut-off’ point value of TST induration was proposed for classifying TST 
results into cutaneous grading and scoring system of LTBI diagnosis in healthy 
adults. The frequency of LTBI reactions in the new immigrants including the three 
missed follow-up participants are shown in Table 5.7.    
Table 5.7: Skin test response and score frequency of latent tuberculosis infection of the 180 
new immigrants to Kuwait during February and May, 2010  
Modified ‘cut-off’ point value of TST induration was more than 10-mm, score (-) = no score for 
excluded case (due to missed follow-up or result reading after 5 days), mm = millimetre induration 
(diameter size swelling) 
Applying the tuberculin skin test responses’ according to the LTBI case category 
classification showed the significant statistical differences as shown by the different 




Score grade LTBI diagnosis Final result n (%) 
0 I Negative (no reaction) Normal 170 (96.04%) 
1 - < 5 II Normal (reactive) Normal 6 (3.38%) 
5 - < 10 III Borderline Normal 1 (0.05%) 
10 - < 15 IV Positive Abnormal 0 (0.00%) 
15 - < 20 V Highly positive Abnormal 0 (0.00%) 
> 20 VI Definite Abnormal 0 (0.00%) 
Excluded - Cannot be judged - 3 (1.66%) 
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Table 5.8: Distribution of tuberculin skin test results according to latent tuberculosis infection categories of 180 new immigrants to Kuwait during 
February and May, 2010  
Average LTBI category is zero (means no detected cases), Missed = excluded case due to missed follow-up or came after 5 days for TST result reading  



















n % n % n % n % n % n % n % 
TST follow-
up 
Normal 90 100.00 36 100.00 0 0.00 4 100.00 46 100.00 1 25.00 177 98.33 LLR χ2(4)= 
26.017 
<0.001 
Missed 0 0.00 0 0.00 0 0.00 0 0.00 0 0.00 3 75.00 3 1.67 
TST score 
Score I (<5) 90 100.00 36 100.00 0 0.00 3 75.00 46 100.00 1 25.00 176 97.78 
LLR χ2(8)= 
33.865 
<0.001 Score II (5-9) 0 0.00 0 0.00 0 0.00 1 25.00 0 0.00 0 0.00 1 0.56 













5 5.56 0 0.00 0 0.00 0 0.00 1 2.17 0 0.00 6 3.33 
5-9 (Reactive-
Borderline) 
0 0.00 0 0.00 0 0.00 1 25.00 0 0.00 0 0.00 1 0.56 
Missed 0 0.00 0 0.00 0 0.00 0 0.00 0 0.00 3 75.00 3 1.67 
TST adverse 
reaction 
No 90 100.00 36 100.00 0 0.00 4 100.00 46 100.00 1 25.00 177 98.33 LLR χ2(4)= 
26.017 
<0.001 
Missed 0 0.00 0 0.00 0 0.00 0 0.00 0 0.00 3 75.00 3 1.67 
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The comparison between TST follow-up results (normal versus missed cases) 
according to LTBI case categories showed a statistically significant difference (LLR 
χ
2
 (4) = 26.017, p < 0.001) (Table 5.8). Distribution of the TST stratified cutaneous 
induration size according to the defined LTBI case categories revealed the following: 
healthy participants having normal results with no skin reaction (zero mm) were 
94.44% (170/180), in comparison to participants who had small reactive reaction 
(between 1 and < 5-mm) in 3.33% (6/180) or those having normal response with 
borderline reaction (between 5 and < 10-mm) in 0.56% (1/180) (one Sri Lankan 
housemaid female) (LLR χ
2
 (12) = 37.947, p < 0.001) (Figure 5.4, Table 5.7 and Table 
5.8). 
 
Figure 5.4: Distribution of tuberculin skin test reaction and cutaneous induration (millimetre) 
according to latent tuberculosis infection categories of 180 new immigrants to Kuwait during 
February and May, 2010 
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According to the Mantoux reaction, the prevalence of LTBI in all the included new 
immigrants was zero% (0/177) using the ordinary TST method. Applying the 
classification criteria of LTBI, all participants were belonging to the normal results 
of score I (zero = negative reaction) and score II (= < 5-mm induration) in 97.78% 
(176/180). Immigrants had score III (5-9-mm induration) were 0.56% (1/180) with 
no observed positive abnormal reaction above the modified ‘cut-off’ value (> 10-
mm) (LLR χ
2
 (8) = 33.865, p < 0.001) (Figure 5.5, Table 5.7 and Table 5.8). 
 
Figure 5.5: Distribution of tuberculin skin test score according to latent tuberculosis infection 
categories of 180 new immigrants to Kuwait during February and May, 2010  
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Absence of adverse reactions was noticed in all participants due to proper 
administration of TST by the head nurse and the research strictly addressed 
notification of any future complications or swelling reactions and enforce of further 
follow-ups (LLR χ
2
 (4) = 26.017, p < 0.001) (Table 5.8).  
5.2.6 Discussion 
The TST has been the only established screening method for tuberculosis for over a 
century. Although the TST is inexpensive, easily available and accessible and is the 
preferred test in most TB-prevalent settings, it has recognized limitations, including 
subjective interpretation, false positivity, cross reactivity with non-tuberculous 
mycobacteria, administration errors and the requirement for two visits. In addition to 
these limitations, low diagnostic accuracy and the unavailability of better screening 
tests in resource-limited settings makes MTB transmission difficult to control. Still 
the diagnosis of latent TB infection is currently based on the century-old tuberculin 
skin test even though a positive reaction can result from previous infection by MTB, 
BCG vaccination or cross-reactions with nontuberculous mycobacteria. Used as the 
second choice standard test after CXR, TST results help clinicians to estimate 
accurately the risk of TB re-activation for patients and reinforce treatment adherence 
for LTBI (Horsburgh et al., 2004).  
The TST cannot distinguish between previous BCG vaccination and TB infection 
due to poor specificity in BCG-negative people and poor sensitivity in children. A 
meta-analysis proves that previous BCG administration increases the likelihood of 
TST false-positive results up to 15 years post-vaccination (Richeldi, 2006) while the 
interferon gamma release assay results are independent of BCG vaccination (will be 
further discussed in chapter 6). Similar to these results Chang et al. (2010) concluded 
that an increased TST reaction was associated with previous BCG vaccination. Meta-
analysis of 56 studies reveals similar findings of a higher reaction risk versus 5 TU 
PPD (Wang et al., 2002). With the exception to those who have never been 
vaccinated TST reactions of up to 18-mm in diameter are likely to be the result of 
prior vaccination, rather than old TB infection and no need for preventive 
chemotherapy (Tissot et al., 2005). BCG vaccinated individuals above the age of one 
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year produce more frequent, more persistent and larger TST reactions (Farhat et al., 
2006).  
The effect of BCG on the TST reaction is observed mainly in the first years after 
BCG administration. Previous BCG vaccination and the boosting phenomenon were 
significantly associated with positive TST and reactions miss-interpretations (Chang 
et al., 2010; Wang et al., 2002). The proportion of prior BCG-vaccinated individuals 
having positive TST results reaches 90% (Horwitz et al., 1972). TST induration 
between 5- and 10-mm persists for up to 25 years after BCG vaccination, depending 
on several factors; 1- strain and dose of BCG used, 2- method of vaccine 
administration, 3- the timing of vaccination, 4- number of BCG vaccinations 
administered, 5- cross-reactivity with other environmental mycobacteria, 6- age of 
vaccination and other associated factors such as nutritional status and genetic factors 
(Burl et al., 2010).  A positive TST result in children below 5 years of age, especially 
if they are not BCG-vaccinated, must be taken as evidence of TB infection (Mendez-
Echevarria et al., 2011). The presence of a false negative TST because of poor T cell 
function can be detected in small children. 
In contrast to previous findings, my results of tuberculin skin tests showed no 
statistically significant association between previous BCG vaccination and presence 
of a BCG scar in relation to LTBI categories. A history of BCG vaccine is not a 
contraindication for tuberculin skin testing or treatment for LTBI in persons with 
positive TST results. TST reactions should be interpreted regardless of BCG 
vaccination history (CDC, 2010b). Absence of positive TST reactions in our study 
strengthens the inference that BCG is not interfering with TST interpretation even 
though 86.11% (155/180) of participants had already been vaccinated against TB 
with BCG around pre-school ages (discussed further in the next section 5.3; BCG). 
Similar related finding we rerecorded by Minodiier and colleagues (2010), namely 
that a positive TST is more likely to be related to an increased duration of TB 
exposure in the TB-endemic country of birth rather than to previous BCG 
vaccination. 
The TST should not be used to overlook CXR findings. Data suggest that cases of 
LTBI can potentially be missed due to the high ‘cut-off’ point (> 10-mm) for a 
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positive TST in non-endemic countries such as Kuwait, with consequent missing of 
LTBI immigrant cases. The size of TST reactions might remains the same without 
increase in most immigrants, could be due to medium or high level of allergic 
responses against low virulent organisms and able to ’burns out’ or kill the invading 
bacilli. The situation recommends TST re-testing to follow the natural history of 
BCG vaccination (Horwitz et al., 1972). However risk factors for positive TST is 
increased due to longer hours of MTB exposures in endemic countries.  
5.2.6.1 Is TST no more a ‘second choice’ for LTBI detection? 
Although TST is an important tool for detecting TB infection and has been well-
studied all over the world to detect LTBI, it is not a ‘gold standard’. TST positive 
results can be considered as clinical predictors only for smear-negative TB patients 
(Kanaya et al., 2001), and the TST is an imperfect tool for detecting latent or active 
tuberculosis infected with viable MTB organisms.  
Others have also found that the TST is imperfect as a routine screening test for BCG-
vaccinated or other persons at low risk for TB infection such as low prevalence 
regions and Kuwait (CDC, 1995). Variability of TST reactions and interpretation 
ambiguity do not allow dependence on TST result for LTBI/TB management. An 
updated report of CDC proved that neither the presence of induration reaction nor the 
TST size will provide exact protection against TB disease or to determine whether 
the reaction is due to TST or previous BCG (CDC, 2006).   
Because the majority of immigrants received BCG at older pre-school ages, our 
negative TST findings support the theory that minimal TST indurations in vaccinated 
individuals if BCG was administered in infancy during the post-vaccination period 
(especially more than 10 years) versus more persistent and larger TST reactions in 
those who received BCG after infancy (Crampin et al., 2009; Farhat et al., 2006).  
The study results suggested that the diagnostic use of TST should be improved to 
detect MTB infection by modification of the ‘cut-off’ point values for adults and in 
particular healthy immigrants coming from TB-endemic regions. On the contrary 
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Zhang et al. (2010) concluded that 10-mm induration should be used as the ‘cut-off’ 
point in endemic countries. 
The possibility of cross-reaction of the TST with BCG vaccination in BCG-
vaccinated populations attenuates TST specificity in diagnosing tuberculosis. The 
TST reveals a significant association with individual’s BCG status (which is 
compulsory in all TB endemic and Asian countries) in having significantly lower 
specificity and diagnostic accuracy than IGRAs blood tests in identification of LTBI 
and MTB infection (Richeldi et al., 2009, Zhang et al., 2010). PPD cross-reactivity 
causes TST poor specificity response to MTB infection due to shared antigens with 
M. bovis and other environmental NTM having false positive TST results more 
frequently in older age groups (> 40 years), and with bigger TST induration more 
than 10-mm (> 10-mm) or other non-significant induration (> 20-mm), while 
compared to false negative in anergic immuonocompromised people (Lalvani et al., 
2001b; Menzies et al., 2008). Accordingly, the study negative TST results did not 
usually contribute to the risks of re-activation of TB so, unless TST re-testing and 
having recent conversion to positive reaction then still cannot be considered as 
diagnosed LTBI.  
Despite cross-reactivity with other non-mycobacteria present in the BCG, Wang et 
al. (2002) in a meta-analysis of 26 studies from 1966-1999 concluded a positive 
reaction of 15-mm in diameter was more likely to be caused by M. tuberculosis 
infection than by previous BCG vaccination, (consistent with our proposed new 
scoring system for suspicion for carriers of LTBI and MTB). 
Diagnosed LTBI immigrants are miss-diagnosed using the TST alone. Low socio-
economic status of TB endemic countries is correlated with false-positive TST (LTBI 
diagnostic test) which results from routine BCG vaccination and exposure to 
environmental bacteria (Baker et al., 2008; Boccia et al., 2009; Elender et al., 1998; 
Lienhardt et al., 2005; Mangtani et al., 1995). Also socio-economic characteristics 
such as adulthood ages above 19 years, cultural and psychological factors, high 
family income and received BCG vaccination were significant risk factors for non-
compliance with tuberculin skin test follow-ups, the management and prevention of 
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non-compliance to the test (da Rocha et al., 2011). The results described here were 
not influenced by the immigrant’s surrounding environment in Kuwait. 
There was no statistically significant association between the Mantoux test result and 
presence of a BCG scar. Our results for all new immigrants coming from high TB 
incidence regions were also not significant. The effect of BCG vaccine on TST 
induration response will be further discussed in chapter 5, section 5.3). 
TST conversion to positive reactivity can be due to accurately diagnosed LTBI 
(Mancuso et al., 2008) or waning of a positive tuberculin reaction in specific delayed 
type hypersensitivity, indicating that mycobacterial antigen might be degraded and 
disappear from the body (Wiker et al., 2010). The two-step strategy is currently 
recommended for LTBI screening, but with the disadvantage of clinician counsel 
overloads and false-positive cases e.g. hypersensitivity reaction with BCG 
vaccination or missing false-negative cases e.g. immune-compromised individuals. 
Otherwise, result re-reading after one-week and/or re-testing after six weeks might 
facilitate correct decisions (Topic et al., 2009). Both conversion types did not meet 
the research criteria because the TST were not repeated but can be considered as a 
confirmatory test for either positive IGRAs in vaccinated new immigrants, with or 
without CXR testing.   
The usefulness of TST in diagnosing LTBI remains debated, especially since the 
introduction of more sensitive and specific IGRAs. INF-γ release assays provide a 
new tool for LTBI diagnosis and surveillance for new TB infections, and allow 
highly specific ex-vivo testing, with no boosting phenomenon. ‘RD-1’-based INF-γ 
release assay is more specific than the conventional TST using PPD for diagnosing 
latent TB in high BCG coverage population such as Asian countries (Zhang et al., 
2010). Blood INF-γ correlates with TST reactivity but IL-10 is inversely correlated 
with the size of TST induration suggesting separate factors involved in controlling T-
lymphocytes and the TST erythematous reaction (Burl et al., 2010). For a high 
suspicion of LTBI, at least both TSTs and either IGRAs should be performed, 
especially those with prior BCG vaccination (Smith et al., 2011). TST is not a 
reliable test in school children less than 15 years or in those BCG-vaccinated in 
infancy, and in those at low risk of TB infection. TST shows high specificity and 
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confirmatory to the new QNF-GIT screening test for LTBI diagnosis and is one of 
the recommendations of this study (Chun et al., 2008; Jacobs et al., 2011). 
PPD tuberculin has low specificity, especially in BCG positively vaccinated 
individuals, and necessitates discovery of new protein(s) specific to MTB like IGRAs 
antigens, ESAT-6 and CFP-10 and TB7.7 to improve sensitivity and specificity of 
immunologic response and to replace TST in diagnosing LTBI/TB (Ferrara et al., 
2006; Franken et al., 2007; Lalvani et al., 2001b; Pai et al., 2005; Zhang et al., 
2010). A new alternative to ordinary PPD reagent, DPPD (recombinant 6kDa, ESAT-
6 and CFP-10 antigens), is recognized only by the T cells of TB patienta and not by 
other healthy or BCG-stimulated cells. In the Philippines, a new patch-based TB test 
employed the MPH 64 (a new specific MTB antigen) and test continues for 3-4 days 
post-application with higher sensitivities (98%) and specificities (100%) (Tiwari et 
al., 2007).  Similar diagnostic trials for new MTB antigens are mandatory to improve 
TST specificity. 
5.2.7 Study strength and TST reliability 
1. Even with exclusion of three immigrants (one expatriate drop-out and two other 
cases returned after 5 days), still participant’s follow-up was 98.33% at the time 
addressed for the inclusion criteria. High rates of non-compliance can be 
observed in other studies among different population groups, still non-
compliance was not a limitation barrier in our research study efficacy.  
2. TST limitation: False-positive and false-negative results due to inter-observer 
variability were solved through double checking by the administrative nurse and 
the researcher. A false-negative result due to cutaneous anergy was not reported 
while the recent immigrants supposed to be healthy for employment in the 
country; similar finding was achieved by Richeldi et al. (2009). 
3. Negative history of previous diseases in addition to perfect intradermal 
administration of PPD reveals absence of ‘boosting effect ‘ or any TST adverse 
reactions except for small subcutaneous redness in a few immigrants (LLR χ
2
 (4) = 




1. Identification of latent Mycobacterium tuberculosis infection in new immigrants 
is that need to be solved: 
2. Diagnosis can be summarized in that LTBI cases are missed on the basis of a 
PPD test result hampered by reduced sensitivity of the tuberculin skin test which 
has critical problems as the second choice for diagnostic criteria of MTB 
infection.  
3. Treatment can be summarized in that inaccurate treatment of LTBI on the basis 
of tuberculin skin test results due to false-positives occurring after BCG 
vaccination and exposure to Mycobacterium bovis antigens or exposure to 
nontuberculous mycobacteria and/or the non-reactive false negatives. 
5.2.9 Recommendation 
1- Introduction of a new recording sheet for tuberculin skin test involving some 
major TB-associated risk factors (TST adverse reaction, BCG scar and body 
mass index) added to each immigrant identity number and date of TST 
performance plus follow-up notes. 
2- Even for the accepted TST use for new immigrant screening, old TST guidelines 
should be revised and replaced by higher specificity diagnostic tests such as 
IGRAs. 
3- The diagnostic use of the TST may be improved by modifying the ‘cut-off’ point 
values used to detect MTB infection and to diagnose LTBI according to the 
geographic region and epidemiological burden of tuberculosis. Targeted TST 
testing plays a role only as a confirmatory test in reducing unnecessary testing 
and treatment. 
The rule effect of BCG vaccination on the reaction of tuberculin skin test and chest 
X-ray will be discussed in the next section 5.3. 
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5.3 Bacille Calmette-Guérin (BCG) 
5.3.1 Introduction 
The Bacillus Calmette-Guérin (or Bacelle Calmette-Guérin) (BCG) vaccine has 
existed for 90 years (first used in 1921) and is the most widely used of all current 
national childhood immunization programmes. Protection is insufficient, and does 
not prevent primary infection and, more importantly, does not prevent re-activation 
of latent pulmonary infection, the principal source of bacillary spread in the 
community. The impact of BCG vaccination on transmission of Mycobacterium 
tuberculosis is not clear, it being unclear whether BCG confers lifelong immunity. 
TB incidence rose again after abandoning routine BCG in the mid-1980s even with 
the introduction of other preventive measures (Ladefoged et al., 2011). Latent TB 
infections are common among immigrant children from high TB incidence countries 
and require screening for TB development. For example BCG immunization is 
offered in the UK to previously unvaccinated, TST-negative new entrants below the 
age of 16 years who were born in, or lived for at least 3 months in, endemic countries 
(RCP-London, 2010). BCG has a role in aiding the clearance of a large bacillary load 
during chemotherapeutic treatment, with possibility of in-vivo cooperation between 
anti-TB antibiotics and the host immune response to reduce the mycobacterial cell 
burden (Lalvani et al., 2010).   
5.3.1.1 BCG vaccine history  
Following Robert Koch’s discovery of Mycobacterium tuberculosis in 1882, vaccine  
trials against TB were set out and in 1908 Leon Calmette, a French bacteriologist, 
and Camille Guérin, a French veterinarian at the Pasteur Institute, Lille, were able to 
devise a vaccine by attenuating a Mycobacterium bovis strain to lose its virulence. 
After thirteen years and 230 passages the new attenuated strain was protective in 
animal models due primarily to the loss of the genes in the ‘Region of Difference’-1 
(RD-1) region of the M. bovis genome. In 1921 the first dose of BCG was given as a 
disease-modifying agent before the era of antibiotics to an infant suffering from 
infectious tuberculosis and cared for by his grandmother. The BCG vaccine is 
 
316 
injected intra-dermally or sub-cutaneously as a 0.1 ml single injection into the upper 
arm (left deltoid muscle) and injection is preceded by tuberculin skin testing. 
5.3.1.2 BCG efficacy 
BCG itself still forms part of the strategies to improve TB vaccine solutions (Lalvani 
et al., 2010). The efficacy of BCG vaccine is globally variable (from zero to 80% 
protection) and maximally effective when administered to the immature immune 
system to enhance maturation of cell-mediated immunity during the neonatal and 
infancy periods (Grange et al., 2011). The induction of both antigen specific Th1 
(long term) and Th2 (short term) cytokine responses, with BCG scar formation have 
a strong association with high INF-γ responses to PPD indicating high exposure to 
environmental mycobacteria (Djuardi et al., 2010). The immune system is configured 
and maintained differently in different countries for both induction and maintenance 
of vaccine-induced immunity. Prior environmental exposures to NTM are 
responsible for blocking of BCG’s action rather than BCG masking (Crampin et al., 
2009). Causes of low BCG efficacy against PTB are attributed to: 1)- continuous 
exposure to environmental mycobacteria and/or co-infections, 2)- genetic variation of 
the target population or of vaccine strains (lead to MTB virulence), and 3)- 
nutritional differences among vaccinated subjects. BCG-produced antioxidants 
suppress host immunity and vaccine efficacy to prevent pulmonary TB (Frantz et al., 
2010; Sadagopal et al., 2009).  
5.3.1.3 BCG advantages/benefits 
Worldwide populations are obliged to continue using BCG due to low cost and high 
safety. TB control is largely dependent on BCG and early detection of active and 








Figure 5.6: Schematic representation of the protective effects of BCG at different steps in the 
natural history of tuberculosis. Grey arrows represent effects of BCG discovered in the last five 
years while the blue boxes represent effects historically known (Lalvani et al., 2010) (26/01/2012) 
5.3.1.4 BCG disadvantage/adverse effects 
TB prevention requires elimination of latent MTB infection, which the BCG vaccines 
are ineffective against. Lack of full protection against TB was not overcome by 
repeating BCG vaccination in adults, although protection against leprosy was 
improved (Crampin et al., 2009). Repeated BCG vaccination after MTB exposure 
has detrimental effects (‘Koch phenomenon’) promoting IL-17-dependent 
immunopathologies of the lung (Sadagopal et al., 2009; Thaiss and Kaufmann, 
2010). Exposure contacts to environmental mycobacteria prior to BCG vaccination 
can block the protection against subsequent M. tuberculosis and/or mask the 
protective effects of BCG vaccine efficacy (Frantz et al., 2010). Local 
hypersensitivity and cutaneous reactions and, less commonly, BCG-oma (abscess) or 
ugly large and raised ulceration scars (keloid) (Langenskiold et al., 2008) or BCG-
osis (fatal dessiminated BCG disease) (Grange, 1998) are significant adverse effects. 
5.3.2 Objective  
Assess the effect of BCG vaccine on the results of the tuberculin skin test according 






















BCG vaccination status was ascertained from the participants through reliable past 
history of vaccination and/or presence of a characteristic BCG scar. 
5.3.4 Results 
Analysis of the effects of Bacillus Calmette-Guérin vaccination status in relation to 




Table 5.9: Distribution of Bacillus Calmette-Guérin (BCG) vaccination status against tuberculosis according to latent tuberculosis infection 
categories of 180 new immigrants to Kuwait during February and May, 2010 






























Yes 78 87 28 77.78 0 0 4 100.00 41 89 3 75.00 154 85.56 
LLR χ2(8)= 
5.470 
0.706 No 10 11 7 19.44 0 0 0 0.00 5 11 1 25.00 23 12.78 






































No 39 43.33 18 50 0 0 3 75.00 22 47.83 4 100.00 86 47.78 
Having 
cow? 




No 74 82.22 31 86 0 0 4 100.00 39 84.78 4 100.00 152 84.44 
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Total immigrants answered ‘yes’ for history of previous BCG vaccination were 
85.56% (154/180) and only 1.67% (3/180) who answered ‘unknown’ and did not 
know about their BCG past history. These findings were not statistically significant 
when compared with LTBI categories (LLR χ2 (8) = 5.470, p = 0.706) (Figure 5.7, 
Table 5.9). 
 
Figure 5.7: Distribution of BCG vaccination history according to latent tuberculosis infection 




Presence of BCG vaccination scar was not statistically significant to be a risk factor 
for LTBI development or to cause positive TST reaction even in those classified as 
’high’ and ’extremely high’ LTBI cases were having forearm scar. A positive scar 
was detected in 86.11% (155/180) (LLR χ
2
 (4) = 6.104, p = 0.192) (Figure 5.8, Table 
5.9).  
 
Figure 5.8: Distribution of presence of BCG vaccination scar according to latent tuberculosis 
infection categories of 180 new immigrants to Kuwait during February and May, 2010  
The overall median age of BCG vaccination for the 180 participants was 5 years 
(IQR = 2 years). Both ’negligible’ and ‘extremely high’ LTBI groups were having 
similar median ages to the sample median age. The ‘high’ LTBI group had been 
vaccinated at older ages (median = 7.5 years, IQR = 6 years) but the ’low’ LTBI 
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group been vaccinated at median of 6 years (IQR = 3 years). The minimum 
(youngest) age of vaccination was one year versus the oldest maximum age of 13 
years was answered. However these findings did not show a statistically significant 
difference between normal vaccination ages for LTBI development (KW χ
2
 (4) = 
3.330, p = 0.504) (Figure 5.9, Table 5.9 and Table 5.10). 
Table 5.10: Distribution of BCG vaccination ages according to latent tuberculosis infection 
categories of 180 new immigrants to Kuwait during February and May, 2010 
(--) means cannot computed by SPSS Software, IQR = interquartile range, Q = quartile 
Different BCG vaccination status at different median ages of LTBI defined 
categories is shown in Figure 5.9.  
















Minimum 1 2 0 4 1 1 
Q1 4 4.25 0 4.25 4.5 2.5 
Median (IQR) 5 (2) 6 (3) --  (--) 7.5 (6) 5 (2) 4 (--) 
Q3 6 6.75 0 10 6 5 




Figure 5.9: Box-and-whisker plots of distribution of BCG vaccination age (years) according to 
the defined case categories of latent tuberculosis infection for 180 new immigrants to Kuwait 
during February and May, 2010 *Outlier values, x Maximum and minimum outlier values   
Immigrants having a history of exposure to different animal and poultries in their 
mother country were 52.22% (94/180), and had a significant statistical difference at 
the 10% level of significance according to the defined LTBI categories. Table 5.9 
shows the distribution of the majority for those considered as ’negligible’ LTBI cases 
in 56.67% and ’extremely high’ LTBI individuals in 52.17% (LLR χ2 (4) = 7.928, p = 
0.094) (Figure 5.10). On the other hand, a correlation between owning and exposure 
to cattle in mother countries and LTBI development was detected only in 15.56% 
(28/180) of total immigrant cases, but was not statistically significant (LLR χ2 (4) = 




Figure 5.10: Distribution of animal exposure in mother country according to latent tuberculosis 
infection categories of 180 new immigrants to Kuwait during February and May, 2010 
5.3.5 Discussion 
A history of BCG vaccine is not a contraindication for tuberculin testing. TST is 
extremely limited as a diagnostic tool to prove whether a positive result is caused by 
MTB infection or cross-reactivity resulting from BCG vaccination, especially in TB 
endemic countries such as India or China, with a 98% inoculation rate of BCG. Since 
BCG-TST positive reactivity wanes with time (if more than five years have elapsed 
since administration of BCG vaccine) - a positive TST reaction is most likely a result 
of exposure to M. tuberculosis infection (CDC, 2005c).  
5.3.5.1 BCG administration 
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The vaccine is ineffective against latent MTB. Administration routes and BCG dose 
and age of vaccination can affect its efficacy and safety and scar formation (Jeremiah 
et al., 2010). The dependence on scar formation as evidence of vaccine intake is 
affected by high prevalence (up to 50%) of vaccine recipients unable to form scar, 
which is not correlated with BCG-induced development of adaptive cellular immune 
responses (Lalvani et al., 2010). On the other hand Burl and colleagues (2010) 
concluded in a longitudinal study that a lack of BCG scar was unlikely to be due to 
incorrect administration of BCG vaccine 
5.3.5.2 Timing of BCG vaccination 
The age of BCG vaccination can be related to TST positivity of vaccination during 
infancy or after childbirth than older childhood period (Wang et al., 2002). In China, 
BCG vaccination is highly recommended and has been compulsory since the late 
1970s and is usually given to all newborns within the first 3 months of life and 
without booster vaccinations proved that no influences or interferences of BCG on 
TST reactive responses (He et al., 2010). Gomes and colleagues (2011) have recently 
concluded that waning of the BCG-induced protection was associated with raised 
risks of TB morbid rates in children aged between three and five years. A global 
meta-analysis suggested that minimal effects on TST for BCG vaccination received 
in infancy (especially more than 10 years after vaccination), and BCG received after 
infancy produces frequently more persistent and larger TST reactions (Farhat et al., 
2006). 
5.3.5.3 Testing for the BCG scar 
Successful vaccination can be assessed by the presence or absence of a BCG scar 
(Djuardi et al., 2010). Emphasis on skin testing in BCG-vaccinated individuals 
should be considered in the appropriate clinical setting (Wang et al., 2002). A BCG 
scar is associated with a three-fold increased risk of sputum culture conversion 
(Jeremiah et al., 2010). Similar to our research results Kik et al. (2009) showen no 
association between the presence of BCG scar with recent exposure to TB in 
immigrants having positive IGRAs and TST results. Similarly there was no 
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association between BCG scar and household contacts to diagnosed TB patients and 
progression to active TB (Hill et al., 2008).   
On the other hand, absence of an immunization scar was significantly associated with 
the severe disease form related to the amount of exposure and can be a determinant 
factor for TB infection. The occurrence of vaccinated TB infected children without 
scar production underpins the importance of reviewing vaccination health records 
(Soysal et al., 2005).  
This study proved that the presence of a BCG scar and related TST negative results 
of all immigrants were not significantly associated with a higher prevalence of LTBI. 
Similar findings were noted by Demkow et al., (2008) and by Kik et al., (2009). 
Other statistical significance also detected the absence of risk difference in TB 
patient contacts having positive BCG scar compared to other normal control contacts 
without scars (ATS and CDC, 1999; Lin et al., 2008).  
A statistically significant relation between the number of BCG scars and the diameter 
of TST, which was significantly higher in HCWs with two BCG scars than HCWs 
with one scar and HCWs without a BCG scar (Cagalayan et al., 2011). 
Similar to the majority of BCG-related publications, the size of BCG scar was not 
measured in our research because did not correlate with protection against TB, and 
also is not an indication for diagnosis (or presence) of LTBI. A similar result was 
also achieved by Crampin et al. (2009). 
5.3.5.4 Waning of BCG efficacy 
TST reactivity caused by BCG vaccine generally wanes with the passage of time, but 
periodic skin testing may prolong reactivity in vaccinated persons, the phenomenon 
of ‘boosting reactivity‘ (CDC, 2010b). On the contrary, TST reaction size and TST 
results were not affected by the time since the last dose of BCG vaccination, the 
number of BCG scars or BCG vaccination schedule in children, and significantly 
affected the decision for LTBI prophylaxis (Babayigit Hocaoglu et al., 2011). 
Exposure to previous BCG vaccination did not significantly reduce the risk of being 
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diagnosed as active or latent TB was also revealed by Caley et al. (2010), in common 
with our findings. 
5.3.5.5 Animal exposure 
Grafein et al. (2011) concluded that there was an absence of a significant association 
between the presence of LTBI and a BCG scar, but presence of a significant 
association with consumption of unpasteurized (cows) milk in the past 6 months, 
which can be related to Mycobacterium bovis. Bradshaw et al. (2011) suggested that 
advancing age increases the likelihood of exposure to unpasteurized dairy products 
and cross-reactions of environmental mycobacterial antigens using IGRA tests. A 
similar significance in our research results of those participants having past history of 
exposures to various animals and positive BCG scar without LTBI diagnosis.  
5.3.5.6 New vaccine challenges 
A new TB vaccine designed and evaluated to raise the protective efficacy and with 
less boosting phenomenon of the immune responses, then was primed by the 
vaccinated BCG, which means can prevent initial infection but not eradicate an 
established pathogen or to prevent latent infection (Grange et al., 2011). Current TB 
vaccine development is focused on a phenomenon called ‘heterologous prime-boost 
strategy’; ‘priming’ the infant with BCG or recombinant/genetically modified BCG 
(rBCG) followed by ‘boosting’, using some MTB antigens that are delivered in a 
different way. Boosting includes viral vectored vaccines and fusion protein vaccines 
which even can be given to children and adolescents or adults (Hawkridge et al., 
2011; Lalvani et al., 2010). RUTI (fragmented MTB cells) is a new efficacious 
vaccine that slows LTBI progression in experimental mice by inducing a strong 
immune response of mixed nature (Th1/Th2/Th3 cells) and promoting latent bacilli 
antigen recognition through inducing Th1 response then producing specific 
antibodies able to control MTB re-activation (Cardona, 2006).  




BCG acts as a surrogate marker in epidemiological screening trials estimating LTBI 
measured by either IGRAs, and can be used as the basis for the development of new 
vaccines (Soysal et al., 2005). On the other hand, IGRAs tests can detect latent 
tuberculosis infection by measuring interferon gamma releases in response to 
antigens present in M. tuberculosis, and not confounded by previous BCG 
vaccination and most non-tuberculous mycobacterial antigens. IGRAs by evidence-
based are more sensitive and specific than TST and CXR for LTBI diagnosis in BCG 
vaccinated subjects, saving costs and reducing health system overburden (Al-
Orainey, 2009). This is done through enumeration of INF-γ-secreting T cells (T-
SPOT .TB test) or by measurement of INF-γ concentration (QuantiFERON Gold In-
Tube test or ELISA test) (Eisenberg and Pollock, 2010).  
IGRAs test are less confounded by BCG vaccination than the association between 
BCG and TST positive results (CDC, 2011b; Pai et al., 2006). IGRAs use M. 
tuberculosis specific antigens and do not cross react with BCG and therefore do not 
cause false-positive reactions in BCG recipients (CDC, 2010b). BCG was not found 
to be as a risk factor associated with IGRA positivity in immigrants (Pareek et al., 
2011). There was a lack of consistency between TST and QFT-GIT results in 
subjects with previous BCG vaccination (Huang et al., 2010).  
As a new tool, the IFN-γ release assay has been used in counties with a low 
incidence of pediatric TB and low rate of BCG vaccination for detecting outbreaks in 
schools, monitoring therapy or diagnosis of tuberculosis and NTM disease (Sun et 
al., 2010). BCG vaccination of school children was significantly associated with 
negative IGRAs (Bradshow et al., 2011). The finding by Weir and colleagues (2006) 
in a study on older school children prior to vaccination revealed higher INF-γ 
production to PPD in Malawi than in the UK where exposure to environmental 
mycobacteria is lower. History of BCG vaccination was found to be predictive of 
positive TST and negative QNF-GIT in healthy individuals but not among HIV sero-
positive subjects due to HIV-associated immunosuppression (Santin et al., 2010).  
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5.3.6 Study limitation 
Absence of BCG scar in 25 participants forearm might present on other body sites 
such as thigh, which was ethically difficult for researcher to check out, and therefore 
immigrant was considered as unvaccinated.  
5.3.7 Conclusions 
Despite the promising research for new vaccine against tuberculosis, still BCG 
vaccine administration, with its deficiencies, should be continued as the only 
important tool (option) in controlling the harmful effects of tuberculosis, especially 
in endemic countries. Whether TST-positive reactions should be interpreted 
regardless of BCG vaccination history is still unclear which necessitate massive 
research trials comparing between the national resident and the various foreign-born 
residents and recent expatriates.   
5.3.8 Recommendations 
1- The relationship between immunogenicity (ability to induce delayed 
hypersensitivity reaction-type 4 against TST in the response to BCG vaccination 
need to be elucidated.  
2- Considering the confounding effect of risk factors, BCG efficacy and protection 
need further evaluation using IGRAs in both vaccinated and non-vaccinated 
population. 
3- Developments of new vaccines occur to raise efficacy of protection against 
LTBI/TB risk and replace BCG in the future. New vaccine candidates from 
preclinical to clinical testing might be accelerated by development of biomarkers 
able to predict the pre-clinical outcome of MTB such as adjuvant or viral-
vectored antigens in recombinant BCG (rBCG) (Kaufmann, 2011). 
Assessment and comparison of the two new tuberculosis (IGRAs) diagnostic tests 
will be detailed in chapter six before adherence to the newly defined evidence-based 
epidemiological-laboratory criteria used for early detection of latent tuberculosis 
cases, which will has a positive impact on future reduction of tuberculosis morbid 
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infection and laboratory costs, and overburdens of the health care services as 
described in chapters 7, 8, and chapter 9. 
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6 Chapter six 
Evaluation of the performance of two new diagnostic 
tests used for diagnosis of latent tuberculosis 




During the last two decades, molecular biological techniques to identify 
mycobacterial bacilli in pulmonary secretions have become more sensitive, with 
rapid MTB detection and accreditation for international use. Early detection of 
inactive bacillary carriers can prevent the spread of TB and reduce the high 
prevalence of latent tuberculosis infection, thus helping prevention of re-activation 
risks. In the absence of a true reference test for TB standard diagnosis, it is difficult 
to establish the actual diagnostic sensitivity and diagnostic specificity of TB 
diagnostic tests, consequently adding limitations to TB control. Chest X-ray and the 
tuberculin skin tests are of extremely low performance to detect LTBI in the 
immigrant screening programs, but IGRAs add accuracy for LTBI diagnosis and can 
be considered as a potential replacement test on the in vitro quantification of the 
immune cell response and increase prevention of MTB transmission. 
Compared with PPD (the choice for latent tuberculosis diagnosis), IGRAs biomarker 
tests detect the release of INF-γ response to specific tuberculous antigens. Two 
antigens, the early-secreted antigenic target 6-kDa protein (ESAT-6) and culture 
filtrate protein 10 (CFP-10), are products of a genomic region (RD1) that is present 
in all MTB and pathogenic M. bovis strains, but is absent from all BCG vaccine and 
NTM stains. Thus, the diagnosis of latent tuberculosis infection has increased in 
sensitivity, specificity and positive predictive value through the use of IGRAs, which 
are superior to replace both TST and CXR. The ability of IGRAs to distinguish LTBI 
from active TB in most circumstances allows new strategic guidelines for screening 
of LTBI and ‘suspect TB’ carriers in high-risk groups from TB endemic countries. 
IGRAs are predicted to become routine diagnostic tools in clinical practice in non-
endemic countries. 
The aim of this work is assessment of interferon gamma release assays performance 
in detection of dormant mycobacterium bacilli in high-risk groups, in the absence of 
a gold standard test. 
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6.1 QuantiFERON Gold In-Tube test (QFT-GIT) 
6.1.1 Introduction 
New diagnostic tests being developed and evaluated to optimize the use of current 
diagnostic tests to validate accuracy, predictive values, cost-effectiveness and 
impacts in prediction of future clinical managements. In vitro biomarker diagnostics 
are regularly validated against the standard tests. The QuantiFERON test and the 
specific QuantiFERON Gold In-Tube test (by means of the added specific proteins of 
MTB) are widely used for the identification of tuberculosis infection. The culture of 
clinical samples alone for intermittent excretion of MTB is an insensitive indicator of 
human infectiousness, which necessitates serologically-based assays without 
conversion or cross-reactivity to other mycobacterias. The in vitro biochemical test is 
based on quantification of interferon gamma levels from the stimulated peripheral 
blood lymphocytes, by which able to detect dormant bacilli at early stages of MTB 
infection before re-activation. Previous findings greatly suggest that both CXR and 
TST are not enough to diagnose latent tuberculosis cases in the immigrant screening 
programmes (Eisenberg and Pollock, 2010). In comparison with TST, both IGRAs 
more accurately discriminate and diagnose LTBI, based on the risk of TB exposure 
(Jong Lee et al., 2010).  
Making the best estimate of incident LTBI high risk groups such as new expatriates 
will provide data to guide and support policy recommendations. IGRAs are an 
accurate indicator of LTBI, providing more sensitive and specific results when 
diagnosing actively infected subjects to be treated. Until recently, the only tool for 
detection of LTBI was the tuberculin skin test, but recently the IGRAs, as well as 
QNF-GIT, have offered themselves as alternative or adjunct tests to the PPD test 
(Delgado Naranjo et al., 2011). QNF-GIT is a valuable public health tool with 
potential advantages over the standard TB diagnostics. Systemic reviews show 
evidence that IGRAs, especially QFT-GIT, have excellent specificity that is 
unaffected by BCG vaccination. Development of new national guidelines 
incorporating IGRAs in screening is occurring. Some high-income with TB low-
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incidence countries, such as the United States have, recommended IGRAs for 
repeated screening of health care workers (CDC, 2005; Zwerling et al., 2011). 
6.1.1.1 QNF-GIT merits 
These are rapid ex vivo blood-based tests, requiring a single screening visit, and, in 
contrast to the TST, can be repeated without sensitization or boosting. They require 
only one visit and do not require a baseline two-step protocol. In addition to ESAT-6 
and CFP-10 antigens which are used in the QNF test group, QuantiFERON-TB Gold 
In-Tube (QNF-GIT) test is the latest new version approved internationally and 
commercially licensed which includes addition of a third MTB specific antigen; 
TB7.7. All three antigens are not present in BCG or in most NTMs therefore 
increasing the specificity for diagnosing the presence of MTB and LTBI than PPD of 
Mantoux test (LoBue et al., 2010; Sun et al., 2010). 
QNF-GIT assays show higher sensitivity as well as being more specific than 
traditionally used PPD tests, and the results of ESAT-6, CFP-10 and TB7.7 IFN-γ-
based tests do not interact with NTM and are not affected by prior BCG vaccination 
(Drobniewski et al., 2007; Hardy et al., 2010; Lalvani et al., 2001b; Pai et al., 2005; 
Sauzullo et al., 2008). Interestingly, a positive Quantiferon tests in TB contacts is 
more predictive of subsequent active TB than a positive skin test (Diel et al., 2008), 
and does not produce false positive results to the extent that the skin test does. QNF-
GIT avoids useless, expensive treatments and unwanted effects of anti-tuberculosis 
medicines of miss-diagnosed individual from having LTBI/TB (Cagalayan et al., 
2011) 
Conflicted estimates of LTBI risks and uncertainty testing’s among expatriates and 
travelers such as military in Germany, Canada and USA had lead to variable 
screening policies and guidelines (Freeman et al., 2010). In developed countries, 
LTBI screening using QNF-GIT including the two-step preceded by positive TST is 
recommended (NICE, 2011; Pooran et al., 2010).  
Despite difficulties in isolation of MTB, still QNF-GIT test provided correct 
diagnosis and confirmation of LTBI/TB in BCG vaccinated school children having 
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positive TST and which is extremely challenging to be recommended as a gold 
standard test (Delgado Naranjo et al., 2011; Jacobs et al., 2011). Also, progression 
from LTBI to active tuberculosis forms was more reliably identified using QNF-GIT 
than TST in high-risk populations, especially in children (CDC, 2005; Chun et al., 
2008; Diel et al., 2011). 
6.1.1.2 QNF-GIT demerits 
IGRA’s performance varies in different settings. QNF-GIT results in high-TB burden 
regions are influenced by low immune responses such as HIV co-infection. Under-
estimation of LTBI prevalence using QNF-GIT might be attributed to differences in 
methods of BCG vaccination (Jong Lee et al., 2010). Even though QFT assays 
provide more accurate and quicker results, they are more expensive (due to high 
reagents cost) and produce indeterminate or nonreactive results in immuno-
compromised conditions such as malnutrition and tropical infections common in low 
income and TB endemic countries (Baboolal et al., 2010; Balcells et al., 2008; 
Thomas et al., 2010). QNF-GIT gave indeterminate results more frequently in 
children less than 4 years of age than in older children above 14 years of age, 
because of low levels of test mitogen responses (Bergamini et al., 2009). Other risk 
factors for false negative and indeterminate results of QNF test were old age, low 
BMI and wasting status, HIV co-infection (suppression of mitogenic response) and 
HLA-genotype (demonstration of new MHC class II allele) suppressing INF-γ 
response (Hang et al., 2011). Mahomed et al. (2011) concluded that the LTBI 
prevalence of large sample adolescents was nearly the same as detected by positivity 
of TST or QNF-GIT. 
6.1.2 Aim 





To evaluate the diagnostic performance of QuantiFERON-TB Gold In-Tube test in 
diagnosing latent tuberculosis infection in healthy humans with absence of a 
reference standard test. 
6.1.4 Methodology  
Quantiferon-TB Gold In-Tube tests were performed according to the manufacturer’s 
(Cellestis Limited, Carnegie, Victoria, Australia) specifications and CDC approval 
(CDC, 2011b). Control materials and M. tuberculosis antigens (ESAT-6, CFP-10, 
TB7.7) for QFT-GIT are contained in special tubes used to collect blood for the test, 
thus allowing more direct testing of fresh blood. One tube contains test MTB 
antigens that consist of a single mixture of 14 peptides representing the entire amino 
acid sequences of ESAT-6 and CFP-10 and part of the sequence of TB7.7. The two 
accompanying tubes serve as negative and positive controls: the negative-control 
tube contains heparin alone, and the positive-control tube contains heparin, dextrose, 
and phytohemaglutinin. 
Blood (1 ml) was collected into each of the three tubes, mixed with the reagents 
already in the tubes, and incubated for 16–24 hours. Plasma was separated, and the 
IFN-γ concentration in the plasma was determined using a sensitive single ELISA 
run machine. To interpret the calculated results of QNF-GIT was in accordance with 
the Cellestis manufacturere’s instructions and as approved by the FDA. The TB 
response was calculated as the difference in IFN-γ concentration in plasma which is 
released by the sensitized CD4+ T-cells stimulated with MTB antigen (i.e., the single 
cocktail of peptides representing ESAT-6, CFP-10, and TB7.7) minus the IFN-γ 
concentration in plasma from blood incubated without antigen (i.e. Nil). 
The results were defined ‘positive’ if the INF-γ value after stimulation with TB-
antigen minus the value in the Nil control was  more than 0.35 IU/ml and more than 
25% of Nil; ‘negative’ if value of TB-antigen minus Nil was less than 0.35 IU/ml or 
if that difference was more than 0.35 IU/ml and less than 25% of Nil, with Mitogen 
minus Nil more than 0.5 IU/ml; ‘indeterminate’ for TB antigen minus Nil less than 
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0.35 IU/ml or more than 0.35 IU/ml and less than 25% of Nil, with Mitogen minus 
Nil less than 0.5 IU/ml, or every time Nil was equal 0.8 IU/ml. Results are calculated 
by the Cellestis manufacturer’s Software programme. 
6.1.5 Results 
Interferon gamma levels were measured using QNF-GIT ELISA and results of the 
180 participants along with the LTBI case categories were represented accordingly 




Table 6.1: The distribution of QuantiFERON Gold In-Tube test results according to latent tuberculosis infection case categories of 180 new 
immigrants to Kuwait during February and May, 2010 




















n % n % n % n % n % n % n % 
QNF-GIT 
result 
Abnormal 0 0.00 4 11.11 0 0 0 0.00 46 100.00 1 25.00 51 28.33 LLR χ2(4)= 
184.972 
<0.001 








0.35-<1.00 0 0.00 3 8.33 0 0 0 0.00 17 36.96 0 0.00 20 11.11 
1.00- 0 0.00 0 0.00 0 0 0 0.00 7 15.22 0 0.00 7 3.89 
1.50- 0 0.00 0 0.00 0 0 0 0.00 1 2.17 0 0.00 1 0.56 
2.00- 0 0.00 0 0.00 0 0 0 0.00 3 6.52 0 0.00 3 1.67 
3.00- 0 0.00 1 2.78 0 0 0 0.00 3 6.52 0 0.00 4 2.22 
5.00- 0 0.00 0 0.00 0 0 0 0.00 2 4.35 0 0.00 2 1.11 
10.00- 0 0.00 0 0.00 0 0 0 0.00 2 4.35 0 0.00 2 1.11 
15.00- 0 0.00 0 0.00 0 0 0 0.00 3 6.52 0 0.00 3 1.67 

























There were no missing results for the 180 participants. The prevalence of LTBI 
having positive results was 28.33% (51/180). Negative QFT-GIT results were 
detected in 71.67% of participants (129/180) and no indeterminate results were 
reported (Table 6.1).  
The distribution of QNF-GIT results according to LTBI case categories. New 
immigrants having abnormal ‘positive’ results were detected in the entire ‘extremely 
high’ LTBI group as 100% (46/46) and the rest were in the ‘high’ LTBI group as 
11.11% (4/36). These differences were statistically significant (LLR χ
2
 (4) = 184.972, 
p < 0.001) (Figure 6.1, Table 6.1).  
 
Figure 6.1: Distribution of QuantiFERON Gold In-Tube test results according to latent 
tuberculosis infection categories of 180 new immigrants to Kuwait during February and May, 
2010 (Normal interferon gamma levels = < 0.35 IU/ml, Abnormal INF-γ = > 0.35 IU/ml)  
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The scores of our invented quantitative of interferon gamma levels were found 
statistically significant with the LTBI defined categories (LLR χ
2
 (4) = 195.007, p < 
0.001) (Figure 6.2, Table 6.1). Those LTBI defined cases having ‘abnormal’ scores 
of high INF-γ levels lay between 0.35 and less than one IU/ml in 11.11% (20/180) 
followed by INF-γ levels ranges of more than 20.00 IU/ml in 5% (9/180) and INF-γ 
levels ranges between 1 and 1.50 IU/ml in 3.89% (7/180). All ‘negligible’ LTBI 
categories had normal results below 0.35 IU/ml. In contrast, all ‘extremely high’ 
LTBI defined cases had high INF-γ levels above 0.35 IU/ml and high score results. 
 
 
Figure 6.2: Distribution of interferon gamma levels of QuantiFERON Gold In-Tube test results 
according to latent tuberculosis infection categories of 180 new immigrants to Kuwait during 
February and May, 2010  
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The median interferon gamma level of the total immigrants was 0.07 IU/ml (IQR = 
0.46 IU/ml, SIQR = 0.23). Similarly, the other LTBI categories also had normal 
median INF-γ levels less than 0.35 IU/ml. On the other hand abnormally high median 
levels of INF-γ were detected in the ‘extremely high’ LTBI group reaching 1.46 
IU/ml (IQR = 12.23 IU/ml), in addition to the highest calculated of both the 
minimum- (0.36 IU/ml) and the maximum- (30.52 IU/ml) INF-γ levels for the same 
group (KW χ
2
 (4) = 105.220, p < 0.001) (Table 6.1, Table 6.2). The quantitative 
interferon gamma levels (IU/ml) that had been measured by ELISA for all involved 
participants are represented accordingly in Table 6.2 and Figure 6.3.  
Table 6.2: Distribution of interferon gamma levels (IU/ml) measured by QuantiFERON Gold 
In-Tube test according to latent tuberculosis infection categories of 180 new immigrants to 
Kuwait during February and May, 2010  
(--) = means cannot computed by SPSS Software prgramme, (-) = negative result means immigrant 
antigens is less than the positive control (mitogen) antigens   
The distribution of different interferon gamma levels measured by the ELISA of 
QuantiFERON Gold In-Tube test according to the defined cases of latent 



















Minimum -0.26 -0.78 -- -0.08 0.36 -0.02 
Q1 -0.01 0.0150 -- -0.060 0.6450 -0.02 
Q2 (Median) 0.0150 0.1300 -- 0.0600 1.4600 0.0400 
Q3 0.0525 0.2600 -- 0.2325 12.8775 18.6925 




Figure 6.3: Box-and-whisker plots of distribution of interferon gamma levels (INF-γ) measured 
using QuantiFERON Gold In-tube test according to latent tuberculosis infection categories in 
180 new immigrants to Kuwait during February and May, 2010 (INF-γ = interferon gamma level)  
6.1.6 Discussion 
Notifications of incident cases of tuberculosis increased over the last one decade in 
non-endemic countries such as Kuwait (HVS, 1984-2009) and the UK (Coker et al., 
2006) due to morbid increments of TB in foreign-born residents. Effective control of 
TB requires identification of latent TB in populations (travelers’ and immigrants) 
arriving from high-risk countries. The weakness of the traditional screening strategy 
in recent immigrants from highly endemic countries is the low sensitivity/specificity 
of chest radiography. The higher QFT-GIT specificity prevents unnecessary overload 
on health care systems even though more expensive, still represents a cost-effective 
alternative tool to TST in targeted screening programmes. QFT-GIT able to identify 
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more LTBI cases than the NICE guideline even with low sensitivity of both TST and 
QNF-GIT tests in HIV-infected persons (Weinfurter et al., 2011). A QFT-first 
protocol was proven by the study of Hardy and colleagues (2010) on UK foreign-
born population to be cheaper and less costly than a CXR-first protocol, due to the 
reduced number of CXRs required (Hardy et al., 2010). Diel et al. (2007) reached the 
same conclusions. 
QuantiFERON-TB Gold In-Tube test appears to be a valuable public health tool with 
potential advantages over the PPD.  The high specificity and sensitivity of QNF-GIT 
suggest that it can replace the traditional (CXR and TST) screening tests, especially 
for immigrants within less than two years from entry to low incidence countries due 
to higher risks of LTBI re-activations. For immigrants from high risk countries, QFT 
blood testing followed by CXR is feasible and cheaper for TB screening than the 
traditional screening using the ordinary CXR followed by TST for radiographically 
suspicious positives (Hardy et al., 2010). Similar aims of targeted screening of 
immigrants of LTBI diagnosis were recently tested by Legesse et al. (2011) and 
Nenadic et al. (2011). A two-step strategy for the diagnosis of LTBI, using QNF-GIT 
to confirm positive TST cases was significantly cost-effective (NICE, 2011). Both 
IGRAs and QFT-GIT were cost-effective in reducing screening costs in TB contacts 
(Hardy et al., 2010).  
6.1.6.1 QNF-GIT results 
The increase in the prevalence of diagnosed cases of LTBI and ‘suspect TB’ 
measured by the QNF-GIT positive results 28.33% supported by a negative CXR and 
TST, and who had been missed by the ordinary screening programme applied within 
the Tuberculosis Control Unit in Kuwait. Hardy and colleagues were able to 
diagnose missed immigrant cases by the NICE protocol implemented in UK (Hardy 
et al., 2010; Nice, 2006).  
Our research results suggested that QFT-GIT is more reliable than the ordinary 
diagnostic tests for identifying population at risk of harbouring MTB before 
progression to active TB. Other evidence-based results of positive QNF-GIT were 
similar to other achieved published results (Coker et al., 2006; Hardy et al., 2010; 
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Kik et al., 2009). For example positive QFT-GIT is associated with the expatriate’s 
country of origin.   
Excluding active TB cases, the LTBI prevalence in our sample of recent immigrants 
ranged from zero% with CXR and TST to 28.33% with positive QFT-GIT. When 
considering any subject positive to at least one diagnostic test, the prevalence will 
increase. An Italian study on the new immigrants reached the same conclusion 
(Saracino et al., 2009).  
6.1.6.2 Interferon gamma levels of QNF-GIT 
Interpretation of QNF-GIT results and IFN-γ levels did not correlate with positive 
TST, and is not limited by indeterminate results our sample participants where all 
having no history of any health disorders such as anegry or malnutrition. These 
results concur with Thomas et al. (2010). Measurement of IFN-γ production is 
helpful to diagnose active tuberculosis in clinically diagnosed and confirmed TB 
cases. The estimated prevalence of LTBI was increased using the lower QFT-GIT 
‘cut-off’ point of IFN-γ levels, which are recommended by the manufacturer 
(Legesse et al., 2011). Immigrants with negative TST and positive QFT-GIT results 
usually showed INF-γ levels close to the ‘cut-off’ value of 0.35 IU/ml (Jong Lee et 
al., 2010). Therefore using an uncertainty zone around a new ‘cut-off’ point (e.g. 0.2 
to 0.7 IU/ml) can improve the discrimination between non-specific variations for 
LTBI diagnostic ‘cut-off’ point and true conversion to positive result or reversion 
negative results (Schablon et al., 2010a). Harada et al. (2006) used a grey zone of 
0.10 to 0.35 IU/ml as a standard for the conversion results. Follow-up for positive 
baseline QNF-GIT and to detect of converters (positive- or negative-) should be sited 
before the diagnosed LTBI individuals developing into active TB, which was also 
recommended by Schablon et al. (2010a).  
The research described here observed high median levels of the released IFN-γ levels 
of 1.46 IU/ml and were detected for all ‘extremely high’ LTBI immigrants, which 
can be supported by other research study results to be diagnostic level for LTBI 
without the need for other diagnostic testing’s (KWχ
2
(4) = 105.220, p < 0.001) (Table 
6.1). In addition, the observed IFN-γ levels of more than one ( > 1.00) IU/ml can be 
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accepted as the positive standard level value was statistically significant in those 
‘extremely high’ LTBI at risk of MTB re-activation (LLR χ
2
 (4) = 195.007, p < 0.001) 
(Table 6.1).  
The effect of changes in ‘cut-off’ points of TST induration and interferon gamma 
levels of QNF-GIT should be considered for the ‘extremely high’ LTBI immigrants 
coming from high incidence TB regions. Degrees of concordance are significantly 
correlated between the level of IFN-gamma production and diameter of TST skin 
induration (Saracino et al., 2009). Co-incident changes between both tests were 
achieved in a similar target study implemented by Saracino and colleagues (2009). 
Other studies relate higher concentrations of IFN-γ levels to epidemiological risk 
groups s such as children and the elderly, using positive QNF-GIT (Bergamini et al., 
2009), and country of origin (Kik et al., 2009), and other different TB risk groups; in 
TB patients was higher (INF-γ = 15.5 +/- 4.5 IU/ml) than nurses (high TB risk group) 
(INF-γ = 11.7 +/- 5.5 IU/ml) and medical students (low TB risk group) (INF-γ = 1.3 
+/- 0.9 IU/ml) (Eum et al., 2008). 
However other researchers related the high IFN-γ levels with the magnitude of TST 
induration (Demkow et al., 2008). Negative TST results in our research were 
difficult to correlate with IFN-γ levels. Limits of the negative and positive results of 
QNF-GIT are difficult to be defined because of the high number of immigrant’s 
spontaneous conversions and reversions, therefore, serial testing’s are recommended 
in other immigrant studies. Further research is required to detect the lowest 
‘uncertainty’ score ranges of IFN-γ levels in LTBI cases.  
Nenadic et al. (2011) have recently revealed that IFN-γ level concentrations in 
children were similar in LTBI and TB disease, and either before or at the end of anti-
TB treatment. Therefore concluded that IGRAs is not a useful screening tool to 
monitor the treatment of infected children diagnosed with LTBI or active TB. Also, 
Drobniewski and colleagues (2007) detected no correlation between the mean IFN-γ 
levels and age or number of years of medical practice. 
Even though IGRAs showed good correlation with occupational risk factors for TB 
exposure in low-incidence settings (Zwerling et al., 2011), still the number of 
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medical experience (practice per years) were not significantly associated with 
interferon gamma levels using QNF-GIT in endemic countries, such as Russia 
(Drobniewski et al., 2007). 
6.1.6.3 QNF-GIT accuracy  
IGRAs are known to be an accurate indicator of LTBI, providing higher specificity 
of diagnosis and reducing the number of treated subjects, and with lower 
indeterminate results, similar to other study findings (Diel et al., 2010; Ferrara et al., 
2006).  QFT-GIT increased the percentage of possibly diagnosed LTBI. In common 
with our research findings for identifying TB infection, there were no false negative 
or false positive results from a combination of both QNF-GIT and TST in relation to 
BCG (Jong Lee et al., 2010). In BCG-vaccinated immigrants, our research findings 
approved significantly that QFT-GIT can be considered as a useful confirmatory test 
for TST-positive individuals and as a replacement test for TST-negative individuals 
in cases of LTBI diagnosis versus the unreliable negative TST. Jacobs et al. (2011) 
came to the same conclusion. QNF-GIT diagnostic accuracy will be further discussed 
in chapter 7. 
6.1.6.4 BCG vaccine and QNF-GIT results 
Both IGRAs are the most promising tests for LTBI diagnosis because of the 
improvement of specificity and convenience, especially in BCG-vaccinated 
populations (Eriksen et al., 2010; Sun et al., 2010; Zhang et al., 2010). Estimation of 
the probability of having a positive QNF-GIT test can be as a function of other 
associated LTBI risk factors such as BCG vaccination. The recent study by Mendez-
Echevarria and colleagues (2011) revealed a significant association between absence 
of BCG scar and positive QNF-GIT. 
QNF-GIT results were significantly not affected by prior BCG vaccinations 
(Cagalayan et al., 2011; Hardy et al., 2010), and is known as excellent diagnostic 
tool for screening of nosocomial transmission, especially in BCG vaccinated people 
at high risk of exposure to MTB (Cagalayan et al., 2011; Choi et al., 2008; Jong Lee 
et al., 2010). The evaluation of occupational risk such as health care workers factors 
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done by Pai et al. (2005) revealed a stronger but non-significant association between 
positive IGRAs and the TST results, explained by differences in the prevalence of 
LTBI due to TB exposure. 
QNF-GIT and TST agreement was associated with a significant rate of prior BCG 
vaccination (Vinton et al., 2009). IFN-γ assays have a useful role in screening high-
risk groups of having LTBI and who are BCG vaccinated, such as TB health care 
workers. Similar associations, including higher risk staff, have been reported by 
others (Eum, et al., 2008; Harada et al., 2006; Mirtskhulava et al., 2008; Schablon et 
al., 2009).  
6.1.6.5 Is QNF-GIT preferred over tuberculin skin test? 
The potential benefits of QFT-GIT over the traditional TST were recognized in the 
study performed by Hardy and colleagues (2010). The comparative results revealed 
that immigrants with LTBI and positive results of QNF-GIT were not associated with 
negative TST results, even though the majority of participants (86.11%) had a past 
history of BCG vaccination. QNG-GIT and TST disagreement was more frequently 
observed in LTBI cases than in normal non-infected individuals or tuberculosis 
disease cases (Mendez-Echevarria et al., 2011). Similar to the research conclusion 
from this study on healthy adults, IGRAs results should be seriously considered in 
those young children having TST-negative/QTF-positive discordance because these 
false negative of LTBI diagnosed cases cannot be ruled out for future MTB re-
activations (Mendez-Echevarria et al., 2011; NICE, 2011). Higher TST indurations 
in LTBI diagnosed patients that have positive QNF-GIT were statistically significant 
and comparable to the results of those with smaller TST size (Cagalayan et al., 2011; 
Mendez-Echevarria et al., 2011). In this study all TST indurations below 10-mm 
were read as normal. 
QFT-GIT permitted the identification of more LTBI cases than TST. Normally, the 
greater specificity of QNF-GIT can be emphasized to the discordance against the 
positive TST results, which are usually justified by previous BCG vaccinations or 
non-mycobacterial infections (Pai et al., 2007; Saracino et al., 2009). QNF-GIT is 
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considered an alternative to TST for detection of LTBI in populations with 
compulsory BCG vaccination (Cagalayan et al., 2011).  
Both IGRAs respond to MTB exposure revealed positive association with increasing 
TST induration (Adetifa et al., 2007). Legesse and colleagues (2011) concluded that 
positive induration of TST more than 10-mm size was significantly associated with 
higher QNF-GIT positivity than the zero mm TST swelling. However our research 
findings were statically significant not associated with TST results and/or the size of 
indurations.  
Low rate of positive QNF-GIT results with a positive TST result support exposures 
to NTM. Reversion of the initially low-positive QNF-GIT to normal INF-γ levels 
indicates that IGRAs might be useful for the diagnosis of later re-infections (van 
Brummelen et al., 2010). The conclusion was that the mean TST indurations were of 
no difference in the QNF positive than the negative group. Similar findings were also 
revealed by Demkow and colleagues’ (2008) study of health care workers (a high 
risk group). Other studies also revealed lack of strong associations of either TST or 
QNF-GIT positivity to risk factors related to household infectivity and MTB 
exposure transmission (Shanaube et al., 2011).  
6.1.7 QNF-GIT strengths 
1. Based on a whole-blood ELISA, QNF-GIT overcomes TST weaknesses such as 
the need for return visits, reader variability, variable specificity, cross-reactivity 
with BCG vaccine and non-tuberculous mycobacterial infection (Cagalayan et 
al., 2011). Indeterminate QNF-IT results were observed in non 
immunosuppressed healthy adult immigrant’s of all included age groups, to be 
very low (zero%), indicating laboratory technician familiarity of samples 
manipulations and the diagnostic performance of QNF-GIT assays after blood 
samples were withdrawn. Similar results were also noted by Ferrara et al. (2006) 
and Hardy et al. (2010). 
2. Indeterminate results occur due to a lack of lymphocyte activation after 
stimulation with the mitogen when the time between blood sampling and blood 
incubation is less than 2 hours, the percentage of indeterminate results 
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consequently decreasing (Mendez-Echevarria et al., 2011). All of our samples 
were incubated in the first hour following venepuncture, which may explain the 
zero percentage of indeterminate results. In the future, the cost of testing should 
be reduced to avoid repetition of QNF-GIT testing. 
6.1.8 QNF-GIT weakness 
The QuantiFERON-TB Gold In-Tube and the TST cannot discriminate between 
active and latent TB infection in the current screening on immigrants, and in 
particular in those coming from TB-endemic areas which limit the free use of 
chemoprophylaxis. The uncertainty zone of QNF-GIT and interferon gamma levels 
leads to missing suspicious cases in high-risk groups. The positive QNF-GIT used to 
determine latent TB in foreign-born immigrants reflects prior TB exposure in the 
country of origin, but also can be related to recent TB infection. This late reactivity 
limits QNF-GIT usefulness unless supported with other diagnostic tests such as the 
highly specific T-SPOT .TB test. The same conclusion was also reached by Kik et al. 
(2009). 
6.1.9 Conclusions  
Limitation in implementation of the new diagnostic tests restricts TB prevention. The 
QuatiFERON Gold In-Tube test is a true innovation in clinical practice for TB 
control and elimination. QNF-GIT increases the identification of LTBI cases among 
recent immigrants to Kuwait. According to the evidence-based superior sensitivity 
and specificity, the use of QNF-GIT in the screening of latent TB infection is 
comparable to and predominates over the conventional screening with the chest X-
ray and tuberculin skin test, particularly in BCG vaccinated immigrants. Even though 
the use of single cut-off point criteria for QuantiFERON Gold In-Tube test can lead 
to over-diagnosis of TB infections, still interferon gamma levels of more than one (> 
1.00) IU/ml can be considered as the lower limit for LTBI definite diagnosis. Clinical 
evaluations then help prevent unnecessary diagnosis and therapy of miss-diagnosed 




Based on the interferon gamma levels of the QuantiFERON Gold In-Tube test 
results, we recommend: 
1- QNF-GIT can be considered as complementary rather than mutually exclusive 
test in immigrant screening and follow-up using the ‘two-step’ strategy 
approaches in conjunction with chest X-ray. 
2- Periodic QNF-GIT testing for the detection of latent TB as an alternative to CXR 
and TST in high-risk populations such as health care workers (e.g. laboratory 
technician) with routine BCG vaccination programmes. A new criterion to define 
the ‘cut-off’ point diagnostic of LTBI need to be further established, especially in 
high-risk groups. 
3- The classification of LTBI case categories should be strengthened and supported 
by testing QNG-GIT on larger cohort studies performed on high-risk immigrants 
newly entering the country from TB endemic areas to evaluate the ONF-GIT 
positivity and the diagnostic levels of the released interferon gamma suggestive 
of LTBI.  
6.2 T-SPOT .TB test  
6.2.1 Introduction 
Early diagnosis of Mycobacterium tuberculosis infection is an essential and difficult 
step in tuberculosis control and elimination. LTBI incidence can be over- or under-
estimated using the standard TB diagnostic tests such as chest X-ray or tuberculin 
skin test, which have a low sensitivity and specificity, especially in TB endemic 
countries with a predominantly BCG-vaccinated population (Sun et al., 2010; Zhang 
et al., 2010).   
The T-SPOT .TB test is a variant of the in-vitro enzyme-linked assay technique for 
enumerating effector T-lymphocytic cells that secrete IFN-γ upon overnight 
stimulation with peptide pools of two specific antigens from Mycobacterium 
tuberculosis; ESAT-6 and CFP-10, which is more specific and sensitive than the 
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standard LTBI test. The ELISPOT (enzyme-linked immunospot assay) has the 
highest sensitivity and is the most promising test to diagnose both LTBI and active 
TB due to improvement of its specificity and convenience, especially in M. bovis 
BCG-vaccinated populations. Sensitivity of T-SPOT .TB assay to detect active TB 
infection was not influenced by the TST results that were reliably low in healthy 
individuals (Dilektasli et al., 2010; Zhang et al., 2010), and is consistently higher 
than that of the QFT-GIT (Diel et al., 2010). 
T-SPOT .TB assay measures T-lymphocytic white cells, which play a major role in 
measuring the health of the immune system, in particular, against bacterial infections. 
‘CD positive’, or CD4+ (or T-‘helper’ cells) account for 30% and 70% of the total 
lymphocytes (between 500 and 1,000 cells per microlitre (µL). T-lymphocytes which 
had CD4+ molecules on its surface can lead the attack against intruders by sending 
signals, releasing cytokines and growth factors to activate and regulate the immunity 
response against Mycobacterium tuberculosis. Mean CD4+ counts of tuberculosis 
infection are significantly lower than in healthy subjects. 
The aim of TB control programmes is to reduce TB disease by rapid diagnosis. The 
T-SPOT .TB assay is more accurate for the diagnosis of TB and correlates better with 
the existence of risk factors for TB infection. The T-SPOT .TB assay is helpful for 
LTBI diagnosis in high-risk groups if carried out either with TST and/or to confirm 
the TST result (Ozekinci et al., 2007). 
Rapid determination of MTB infection will accelerate TB diagnosis and enable early 
treatment/control of TB. Detection of LTBI will prevent re-activation progression to 
active TB (Simsek et al., 2010). In addition to rapid diagnosis of active TB, T-SPOT 
.TB test allows rapid exclusion of people suspected of having active TB (Meier et al., 
2005). Similar conclusions were reached by Zhang et al. (2010), who demonstrated 
that T-SPOT .TB assay was more sensitive than conventional TST for detection of 
active TB infection in BCG-vaccinated populations. 
6.2.1.1 T-SPOT .TB assay merits 
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T-SPOT .TB assay describes both qualitative (type of immune protein) and 
quantitative (number of responding CD4+ cells) variables (Sun et al., 2010).  T-
SPOT .TB test, having a higher specificity than QNF-GIT or the standard old tests, 
can identify TB cases in relation to population risks, and is not confounded by BCG 
vaccination. For example, TSPOT .TB test is more specific than TST among BCG-
vaccinated people, compared to equal specificity in patients without BCG history 
(Sun et al., 2010). Close contacts having BCG negative and TST positive (BCG-
/TST+) results are less likely to have positive T-SPOT .TB test than BCG vaccinated 
healthy people (Brodie et al., 2008).   
The in-vitro IGRA is a useful tool to detect LTBI individuals without been affected 
or cross-reacted by BCG vaccination and to exclude reliably the active infected cases 
in low endemic settings, rather than intermediate and high TB-burden countries 
(Dilektasli et al., 2010).   
T-SPOT .TB test can serve as a potential predictor of therapeutic efficacy. INF-γ 
producing T-cell responses against Mycobacterium tuberculosis-specific antigens 
were significantly decreased during treatment with anti-TB regimens which can be a 
reliable reference for therapeutic success and improvement of active TB patients 
(Zhang et al., 2010).  
T-SPOT .TB test is significantly cost-effective and cost-saving, with superior 
specificity compared with both TST and QNF-GIT tests.  Even with repeated TST 
over two years, still no false positive results of the of T-SPOT .TB test due to absent 
induction of T-cell responses (Richeldi et al., 2006). A large cohort study revealed 
that the costs of a LTBI screening and treatment programme of 1,000 patients using 
TST alone was more expensive (U.S.$695,820) than using TST followed by T-SPOT 
.TB test (U.S.$342,563) or T-SPOT .TB test alone (U.S.$387,136) (Wrighton-Smith 
et al., 2006). Using T-SPOT .TB alone, or in combination with TST test, for 
screening of close contacts before isoniazid preventive treatment of LTBI was highly 
cost-effective in reducing the burden of TB and effective in non-endemic countries 
(Diel et al., 2007). 
6.2.1.2 T-SPOT .TB deficiencies 
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Although it has relatively high sensitivity and specificity, the higher costs and 
laboratory complexity of test should be considered. The use of IGRAs to diagnose 
active TB is still debatable and further large studies are needed.  Even though they 
have greater diagnostic accuracy than the standard diagnostics, still the IGRAs and 
T-SPOT .TB test are affected by cellular immunity that result in more indeterminate 
results even in immuno-competent individuals. These invalid results occur because 
of false negative results (i.e., T-SPOT .TB test fails to give a reportable result or there 
is insufficient response in positive-control wells) (Bergamini et al., 2009; Brodie et 
al., 2008; Diel et al., 2010; Passalent et al., 2007). Also subjective variation is 
reported in the interpretation of T-SPOT .TB test results between different observers 
compared to the newly automated reader (still not implemented in Kuwait), and 
which can lead to LTBI miss-/over- (wrong) diagnosis.(Dilektasli et al., 2010).   
6.2.2 Aim 
To assess the accuracy of T-SPOT .TB test (the new biomarker tuberculosis test). 
6.2.3 Objective 
To evaluate the diagnostic performance of T-SPOT .TB test in diagnosing latent 
tuberculosis infection in healthy humans with absence of a reference standard test. 
6.2.4 Methodology 
The ex-vivo ELISPOT assay was performed on fresh blood samples, which was 
previously detailed in chapter 3 (Materials and Methods; T-SPOT .TB test – section 
3.12.2.1.1).  The isolated peripheral blood mononuclear cells are incubated for 16–20 
hours in the presence of ESAT-6 and CFP-10 protein antigens (ABC, Imperial 
College, London, UK). Phytohaemaglutinin (PHA; Sigma-Aldrich, UK) was the 
positive control. Sensitized T-cells will secret IFN-γ in the blood of persons infected 
with Mycobacterium tuberculosis. Next, enzyme-labeled secondary antibodies are 
added, which bind to other epitopes of the examined cytokine. T-lymphocytic counts 
were separated and detected by the T-SPOT .TB manual and eyeglass reading along 
with the LTBI defined cases. Interpretation and assay criteria were applied 
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accordingly: T-SPOT .TB results are interpreted by subtracting the spot count in the 
Nil Control well from the spot count in each of the Panels, according to the following 
algorithm: 1- The test result is ‘positive’ if (Panel A minus Nil Control) and/or 
(Panel B minus Nil Control) is more than, or equals, six colony forming unit  (> 6 
spots), 2- The test result is ‘negative’ if both (Panel A minus Nil Control) and (Panel 
B minus Nil Control) is less than, or equal to, five spots (< 5 spots). This includes 
values less than zero. An abnormal or ‘positive’ result indicates that the sample 
contains effector T-lymphocytic cells reactive to MTB, whereas, a normal or 
‘negative’ result indicates that the sample probably does not contain effector T-cells 
reactive to MTB. Indeterminate results are represented by an inability to read the 
number of spots.  
6.2.5 Results 
T-SPOT .TB test results were measured for all 180 participants. Table 6.3 shows the 




Table 6.3: The distribution of T-SPOT .TB test results according to latent tuberculosis infection case categories of 180 new immigrants to Kuwait 
during February and May, 2010 
      Average category = no detected cases, (-) means cannot be computed by SPSS Software programme  
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n % n % n % n % n % n % n % 
T-SPOT. TB 
test response 
Reactive 0 0.00 23 63.89 0 0 4 100.00 46 100.00 1 25.00 74 41.11 
LLR χ2(8)= 
192.884 
<0.001 Non-reactive 88 97.78 13 36.11 0 0 0 0.00 0 0.00 3 75.00 104 57.78 
Indeterminate 2 2.22 0 0.00 0 0 0 0.00 0 0.00 0 0.00 2 1.11 
T-SPOT. TB 
test result 
Abnormal 0 0.00 23 63.89 0 0 4 100.00 46 100.00 1 25.00 74 41.11 
LLR χ2(8)= 
192.884 
<0.001 Normal 88 97.78 13 36.11 0 0 0 0.00 0 0.00 3 75.00 104 57.78 
Indeterminate 2 2.22 0 0.00 0 0 0 0.00 0 0.00 0 0.00 2 1.11 
T-lymphocyte 
count score 




50- 15 16.67 4 11.11 0 0 1 25.00 6 13.04 1 25.00 27 15.00 
100- 40 44.44 20 55.56 0 0 3 75.00 17 36.96 3 75.00 83 46.11 
200- 25 27.78 12 33.33 0 0 0 0.00 20 43.48 0 0.00 57 31.67 
300- 4 4.44 0 0.00 0 0 0 0.00 2 4.35 0 0.00 6 3.33 






















The predicted prevalence of LTBI and ‘positive’ results of T-SPOT .TB test in the 
group of 180 immigrants subjected to the test were detected in 41.11% (74/180), and 
was divided accordingly; both ‘high’ LTBI and ‘extremely high’ LTBI had abnormal 
results in 100% and ‘low’ LTBI in 63.89% (23/180). The ‘indeterminate’ results 
were for two cases and both were belonging to the ‘negligible’ LTBI cases 1.11% 
(2/180) cases. ‘Negative’ results were obtained in 57.78% (104/180) of immigrants, 
97.78% (88/90) of which in the ‘negligible’ LTBI group and 36.11% (23/36) in ‘low’ 
LTBI immigrants group (LLR χ
2
 (8) = 192.884, p < 0.001) (Figure 6.4, Table 6.3). 
 
Figure 6.4: Distribution of T-SPOT .TB test results according to latent tuberculosis infection 
categories of 180 new immigrants to Kuwait during February and May, 2010  
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Distributions of the score number of T-lymphocytes were detected invariably in the 
blood samples by T-SPOT .TB test according to the different LTBI defined 
categories of 180 new immigrants. The majority of participants had CD4+ T-
lymphocytes per microlitre (µL) of between 100 and 200 cells in 46.11%, between 
200 and 300 cells in 31.67% and between 50 and 100 cells in 15% of the total blood 
samples. However, these findings were not revealed a statistically significant 
difference of median scale number of T-lymphocytes (LLR χ
2
 (20) = 21.218, p = 
0.384) (Figure 6.5, Table 6.3).   
 
Figure 6.5: Distribution of number of T-SPOT .TB test lymphocytes per microlitre according to 
latent tuberculosis infection categories of 180 new immigrants to Kuwait during February and 
May, 2010  
 
358 
The overall median CD4+ T-lymphocytic cell count of the total immigrants was 180 
cells per microlitre (cells/µL) (IQR = 89 cells/µL); similar to the normal accepted 
human cell levels. The highest median T-lymphocytic cell counts was measured in 
the ‘extremely high’ LTBI, equaling 196 cells/µL (IQR = 80 cells/µL), whereas, the 
lowest median CD4+ cell level was calculated in the ‘high’ LTBI group as 146 
cells/µL (IQR = 105 cells/µL). The lowest calculated CD4+ was 20 cells/µL and the 
highest CD4+ was 419 cells/µL, and both belonged to the ‘negligible’ LTBI group. 
However, these differences were not statistically significant (KW χ
2
 (4) = 4.409, p = 
0.353) (Figure 6.6, Table 6.3). 
The numbers of enumerated T-lymphocytes separated by T-SPOT .TB assays for all 
the 180 involved participants are represented accordingly in Table 6.3, Table 6.4 and 
Figure 6.6. 
Table 6.4: Distribution of number of T-lymphocyte cells count per microlitre separated by the 
T-SPOT .TB test according to latent tuberculosis infection categories of 180 new immigrants 
to Kuwait during February- May, 2010  
(--) means cannot computed by SPSS Software 
The distribution of total T-lymphocyte counts measured by the T-SPOT .TB test 
according to the defined cases of latent tuberculosis infection for 180 new 
immigrants is shown in Figure 6.6. 
T-lymphocyte 
















Minimum 20 52 -- 55 48 83 
Q1 110.75 130.50 -- 72 131.50 87.25 
Q2 (Median) 177 180 -- 146 196 145 
Q3 209.25 204.25 -- 176.50 211.75 196 




Figure 6.6: Box-and-whisker plots of median T-lymphocytes (CD4+) per microlitre (µL) 
separated by T-SPOT.TB assay according to the defined cases of latent tuberculosis infection 
(LTBI) of 180 new immigrants to Kuwait during February and May, 2010 
6.2.6 Discussion 
Screening for latent tuberculosis infection in new immigrants is mandatory before 
entry to non-endemic countries and Kuwait, but its diagnosis still poses a challenge. 
Diagnostics of latent TBI have been based for the last century on the old tuberculin 
skin test. However, a positive reaction can result not only from infection with 
Mycobacterium tuberculosis but also from BCG vaccination or cross-reaction with 
non-tuberculous mycobacteria. Several studies have shown that IGRAs and the T-
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SPOT .TB test are superior diagnostic tools in the identification of individuals 
infected with TB (Anderson et al., 2000; Borkowska et al., 2011; de Andrade Lima 
et al., 2011; Dilektasli et al., 2010; Ewer et al., 2003; Ferrara et al., 2006, Pai et al., 
2005). 
6.2.6.1 T-SPOT .TB results 
The two IGRA tests perform similarly with superior diagnosis of LTBI and suspect 
TB new immigrants. The ELISPOT test was more sensitive than the QFT-GIT and 
the two old diagnostic tests for diagnosing latent TB immigrant carriers (41.11% 
versus 28.33% for QNF-GIT, 10.06% for chest X-ray and zero% for tuberculin skin 
test). Significant discordance between the two IGRAs and between each and the TST 
remain largely unexplained (Adetifa et al., 2007). 
6.2.6.2 T-lymphocyte cell counts  
The cellular immunity of T-lymphocytes plays a role in the immune system and is an 
important factor in the outcome of tuberculosis infection. These cells have no 
phagocytic activity and cannot kill infected host cells or pathogens. Rather, they 
activate and direct other immune cells such as activation and growth of cytotoxic T 
cells, and in maximizing bactericidal activity of phagocytes such as macrophages.  
The present study shows that 77.78% of total immigrants had median T-lymphocytes 
levels between 100 and 300 cells/µL, which is lower than normal cell counts 
(between 500-1,000 cells/µL) (Davoudi et al., 2008). This proved that suppression of 
cellular immunity occurs even in the asymptomatic immigrants who were diagnosed 
with latent TB and had abnormal low CD4+ cell counts similar to any tuberculosis 
infection such as pulmonary and military TB. Comparative studies depend on 
standard CD4+ cell counts more than 100 cells/µL as the lowest diagnostic level for 
cellular quantitative comparison in a whole blood assay against positive TST (Lawn 
et al., 2007). Both HIV infection (such as TB/HIV patients) and the lower 
immunological CD4+ cells are associated with a high risk of a normal CXR, even 
though symptoms of cough and dyspnea and sputum smear positivity are associated 
with a higher TB risk (Pepper et al., 2008). INF-γ-producing T-cell responses against 
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Mycobacterium tuberculosis-specific antigens decrease during the treatment with 
anti-TB regimens (Chee et al., 2008; Zhang et al., 2010).  
CD4+ lymphocyte cell counts are known to be associated with the clinical and 
radiographic presentation of LTBI and PTB (Asimos et al., 1996; Davoudi et al., 
2008; Greenberg et al., 1994), and lead to TB suspicion in immigrants (Martin et al., 
2011), which can be related to various CXR findings. The extent of CXR cavitation 
(which was an absent finding in this research) can be directly correlated with CD4+ 
cell counts, and the radiographic changes may reflect immune-suppression at the 
time of MTB infection (Sacks et al., 1999). Suspects with more than 200 CD4+ 
lymphocytes/µL demonstrate atypical CXR with more apical infiltrates and 
cavitations, whereas, those with less than 200 CD4+ lymphocytes/µL often have 
lower lobe infiltration, opacities, interstitial nodules and hilar or mediastinal 
lymphadenopathy. Similar findings were observed by both Keiper et al. (1995) and 
Geng et al. (2005). Quantitative T-cell response was higher and revealed high 
median spot forming cells of monomorphonuclear T-cells in active TB cases 
compared to their LTBI contacts (Chee et al., 2009). 
Martin and colleagues (2011), in contrast to our findings, recently revealed a 
statistically significant association between tuberculosis and high CD4+ 
lymphocytes. Also Zhao and colleagues (2011) revealed a significant increase in the 
mean value of peripheral blood mononuclear cells using T-SPOT .TB test and the 
induration size of positive TST.  
6.2.6.3 BCG vaccine and T-SPOT .TB results 
Ewer et al. (2003) studied latent TB among school pupils in a British school and 
achieved 89% concordance between both T-SPOT .TB and TST and concluded that 
BCG vaccination did not influence the results of T-SPOT .TB test, compared with 
higher TST indurations in BCG-vaccinated children. Dilektasli et al. (2010) 
concluded that diagnostic accuracy of T-SPOT .TB assay was markedly higher for 
LTBI diagnosis in BCG-vaccinated individuals than TST performance. According to 
Borkowska et al. (2011), discordance of positive TST was due to BCG vaccination 
and discordance of positive T-SPOT .TB occurred due to lack of skin reaction to 
tuberculin in those participant’s with poor health status. T-SPOT .TB positivity 
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among BCG-scar students was significantly lower than the TST positive rate, but not 
for 899 ‘no-scar’ Chinese students, denoting no BCG vaccine effect of the high 
specific T-SPOT .TB results (Zhao et al., 2011).   
6.2.6.4 Is T-SPOT .TB assay to be preferred over TST? 
The T-SPOT .TB test was superior to the tuberculin skin test in diagnosing latent TBI 
and offers a more sensitive and accurate approach than TST in the identification of 
tuberculosis infection (de Andrade Lima et al., 2011). Variability of T-SPOT .TB 
positive results were not consistent with TST indurations in the healthy immigrants, 
which indicates that 10-mm diameter size cannot be used as a diagnostic ‘cut-off’ 
induration for LTBI diagnosis in BCG-vaccinated TB endemic populations and 
which need to be increased. A good correlation between positive T-SPOT .TB test 
results and TST diameter of induration of more than 15-mm was recently achieved 
by Borkowska and colleagues (2011). TST sensitivity increases and specificity 
decreases if induration size is accepted as more than 15-mm (> 15-mm), in 
comparison to a higher specificity of T-SPOT .TB assay was achieved by Dilektasli 
et al. (2010). In contrast to our study, 10-mm size was accepted by Zhang et al. 
(2010) as the ‘cut-off’ size for immigrants.    
Our research findings concluded that T-SPOT .TB assay can be used in active TB 
patients during anti-TB chemotherapy which can serve as potential predictor of 
treatment accuracy and also representing LTBI prevalence better than undetected 
cases by the TST. The same conclusion was reached by Zhang et al. (2010). Other 
studies, with the similar conclusion that T-SPOT .TB assay improved the sensitivity 
for detection of active TB over both TST and QFT-GIT in non-endemic countries, 
are by Zhang et al. (2010) and Zwerling et al. (2011).. 
Wrighton-Smith and colleagues (2006) have suggested that a TST followed by a T-
SPOT .TB test protocol is cost-effective for contact screening for latent TB infection. 
However, the negative results of well-performed TST’s described here did not 
support such follow-up criteria of LTBI and TB contacts. 
Borkowska et al. (2011) obtained general concordance of 79% in a sample of healthy 
volunteers at risk of harbouring MTB in three subgroups; health care employees, 
suspected tuberculosis cases and suspected individuals to have other than 
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tuberculosis. According to Brodie et al. (2008), the general concordance between T-
SPOT .TB test and TST results among BCG-vaccinated immigrants was 64%, 
compared with 82% in unvaccinated individuals.  
In Gambia, a recent study on 2,348 household contacts showed excellent TST and T-
SPOT .TB test performance for the diagnosis of LTBI from recent exposure, and 
concluded that positivity by either test can be an indication for preventive 
chemoprophylaxis without favouring TST replacement by the ELISPOT assay (Hill 
et al., 2008).  
For the T-SPOT .TB test, none of the independent variables and included risk factor 
predictors for LTBI such as age, nationality and place of birth, vaccination history or 
close contact with a patient with active TB disease was significantly associated with 
positive IGRAs results, compared with TST-BCG vaccination positivity (Sun et al., 
2010). 
6.2.7 T-SPOT .TB strengths 
1. The observed indeterminate (two samples) results were interpreted to have low 
number of T-lymphocytic cells, and which might occur because of insufficient 
INF-γ production in PHA mitogen well and also can be associated with 
malnourished (under-nutrition) immigrants coming from low income and food 
resource countries. But the assay nevertheless shows superior specificity in 
detection of INF γ-producing sensitized CD4+ cells (Dilektasli et al. 2010; 
Kobashi et al., 2009). The same finding were noted even at younger ages 
(Bergamini et al., 2009), compared with indeterminate results of QNF-GIT or 
false negative TST. 
2. Sample transportation within 15 minutes and technical sample preparation in the 
central laboratory did not influence the occurrence of indeterminate results.  
3. Performance of IGRAs blood withdrawal was conducted before tuberculin 
administration of TST that reduce unreliable results of IGRAs due to the release 
of INF-γ from the sensitised T-cells for up to 6 months following TST 
(Borkowska et al., 2011).  
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6.2.8 T-SPOT .TB limitations 
1. IGRA diagnostic tools are limited in underestimating the true number of LTBI 
cases. The high cost of T-SPOT .TB test and the test implementation by the 
central laboratory of tuberculosis in the Tuberculosis Control Unit for only four 
days per week (except Thursday) making it difficult to be a compulsory 
screening diagnostic for high risk groups. The results of Hill and colleagues 
(2008) do not support the appropriateness of a two-stage TB approach suggested 
by the NICE guidelines (NICE, 2006) and only seven of the 21 latent TB 
progressors to active TB might benefit from the preventive treatment. Cost-
effectiveness of ELISPOT test approach as diagnostic or confirmatory test 
requires further study. 
2. Even though indeterminate results are known to be less frequent in T-SPOT .TB 
test than QFT-GIT (result of choice of ‘cut-off’ point read by Cellestis Software) 
but still our research observed two indeterminate results of T-SPOT .TB test and 
not for QNF-GIT (Kobashi et al., 2009).  
6.2.9 Conclusions 
The study revealed that the T-SPOT .TB assay is a good diagnostic tool in identifying 
latent tuberculosis carriers. The use of T-SPOT .TB assay in high-risk groups and 
new immigrants who are miss-diagnosed or missed by the negative ordinary CXR 
and TST is helpful and can enhance LTBI diagnosis even in BCG-vaccinated 
community. At public health policy level in Kuwait, the T-SPOT .TB test results 
support the addition and/or replacement of the CXR or Mantoux test with a T-cell 
based test for the diagnosis of LTBI in any suspected new immigrant.  
6.2.10 Recommendations 
1- T-SPOT .TB assay should be used as an alternative diagnostic approach or as a 
complementary tool for suspected CXR or negative TST cases, and also to 
exclude positive TST caused by BCG vaccination.  
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2- Large cohort study is warranted to study the correlation between T-SPOT .TB test 
results and lower TST indurations (such as 5-mm) in high resource countries.  
3- To evaluate the clinical utility of T-SPOT .TB assay in accurate diagnosis of 
LTBI in high risk groups such as health care workers and laboratory employees.  
4- Assessment of levels of sencitized T-lymphocytes using T-SPOT .TB assay 
should be repeated on diagnosed TB patients before, during and after anti-TB 
therapy to find diagnostic correlation with active tuberculosis convertors.  
 
A combination of the evidence-based radiographic and laboratory diagnostic tests 
(chapters 5 and 6) and evidence-based epidemiological risk factors (chapter 4) which 
would facilitate prediction and early diagnosis of latent tuberculosis infection in 




7 Chapter seven 
Evidence-based laboratory diagnostic criteria for 
detection of latent tuberculosis infection and ‘suspect 
tuberculosis’ cases – Classification 
 
‘‘Absence of a gold standard test to correctly identify the sensitivity and specificity of 
each of the four diagnostic tests poses a challenge for evaluation and comparative 




Despite management advances worldwide, tuberculosis still remains a serious 
uncontrolled disease with threatening consequences, such as nosocomial outbreaks of 
TB/HIV co-infections and the rise of drug-resistant strains (Sacks et al., 1999; He et 
al., 2010). Accurate and timely detection of LTBI hiding bacilli is crucial but 
difficult due to inability to recognize the epidemiology of TB species and the 
implemented (whether effective) strategies to limit its spread. Therefore an important 
factor in successful elimination of TB is accurate and timely detection of LTBI to 
enhance early effective prophylaxis and help to reduce progression from dormancy to 
overt disease and consequently prevent further MTB transmissions. Delayed 
diagnosis may worsen TB into a more severe illness and increase the risk of 
morbidity and mortality. Therefore worldwide concerns are always targeted toward 
screening the high risk groups and foreign-born immigrants by encouraging detection 
of infectious transmission and allowing health care systems to operate effectively. 
Active case findings are influenced by the degree of diagnostic indication (clinical 
suspicion) and the quality of laboratory facilities. The performance and accuracy of 
diagnostic tests for LTBI/TB varies with the stage and consequent disease severity. 
For example, IRGAs are currently recommended for those with positive TST and 
normal CXR to confirm the diagnosis of LTBI (CDC, 2011b; Hardy et al., 2010). 
A conflict in risk estimation of TB disease and limitations of LTBI diagnostic tests 
plays a role in MTB infectiousness and uncontrolled epidemiological spread 
(Freeman et al., 2010). The diagnosis of tuberculosis in patients with a negative 
radiographic or bacteriological examination is still problematic in clinical settings. 
The newly developed IGRAs, including both T-SPOT .TB and QFT-GIT, show 
advances in TB diagnosis, which require research to discriminate the accuracy of all 
diagnostic tests (Ferrara et al., 2006; Jong Lee et al., 2010; Kobashi et al., 2009; 
Zwerling et al., 2011). Tuberculosis threats rise in those having a positive IGRAs 
(QuantiFERON and/or T-SPOT .TB tests) and negative TST with free radiographs 
leaving many high-risk immigrants (mainly from endemic countries) unidentified, if 
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not tested with IGRAs. To overcome the TST shortcomings, use of IGRAs is 
currently recommended as two-step strategy (CDC, 2011b; Jong Lee et al., 2010).  
Choice of LTBI screening test 
Indications for tuberculosis infection diagnostics should depend on the followings 1- 
the purpose of the test (whether monitoring, follow-up or research), 2- the target 
population for screening, 3- sample turnover (number of samples tested per day), 4- 
availability of technically skilled personnel and equipments, 5- the time within assay 
performed (e.g. IGRAs within 6 hours), and 6- the costs, including instruments, 
reagents, shipping, laboratory infrastructure and labour cost.  
Pai et al. (2006) compared the performance and operational characteristics of the 
















Table 7.1: Comparison of the operational characteristics of the old tuberculin skin test and the 
two new interferon- gamma release assays used for latent tuberculosis infection diagnosis (Pai 

















Initial Process Intradermal injection 












Single mixture of 
synthetic peptides 
representing ESAT-6, 






prior BCG or with 
NTM 
Yes 






Yes (better correlation with  exposure than 
TST) 
Test In vivo skin test In vitro blood test 
Reliable 
(reproducibility) 
Moderate and variable High (no inter-subject variability) 
Boosting 
phenomenon 
Yes (if repeated) No 
Result conversions 
and reversions 
Yes Not always 
Adverse reactions 





Low (Euro 23, $ 9.79, 
£8) 
Moderate-high (Euro 129, $37.5, £20-40) 
Patient visit to 
complete testing 










< 1 day (16-24 hour) 





INF-γ  concentration 
units 
Number of  INF-γ  
producing cells 
(spots number) 














Regardless of the tuberculosis diagnostics used, targeted testing is critical in reducing 
unnecessary testing and treatment (Mancuso et al., 2011). CDC guidelines 
recommend targeted testing of only persons with known risk factors for TB, 
specifically stating that ‘‘targeted tuberculin testing programs should be conducted 
only among high risk groups and discouraged in those at low risk’’ (CDC, 2000; 
CDC, 2011a). But a known limitation is the limited data on the use of both IGRAs 
tests to predict who will progress to TB disease in the future (CDC, 2011c). In 
addition, using ordinary chest radiography is the most critical step of missing cases 
with high index of clinical suspicion for LTBI re-activations in TB non-endemic 
countries and pulmonary tuberculosis in TB-endemic areas, particularly in 
foreigners/immigrants with past history of contracted TB disease or contact with 
pulmonary TB infection (Wu et al., 2009). False-positive TST results due to prior 
BCG vaccination lead to unnecessary treatment of presumed wrongly diagnosed 
latent tuberculosis infection where IGRAs recently approved as more sensitive and 
specific in this suspicious individuals. NICE guidelines currently further 
recommended IGRAs for those with positive TST and normal CXR to confirm LTBI 
diagnosis, while the old criteria recommended only CXR for screening immigrants 
coming from countries with TB incidence more than 40 per 100,000 populations 
(NICE, 2006). A two-step strategy is still recommended for LTBI diagnosis using the 
Mantoux skin test as a screening tool and QNF-GIT as a confirmatory test (NICE, 
2006), or using either IGRAs (CDC, 2011b), but requires further research.  
The previous findings in chapter five suggested that LTBI prevalence in the new 
immigrants screening measured using both CXR and TST are of extremely low to 
yield LTBI prevalence in addition to no bacteriological confirmation, compared with 
a higher LTBI prevalence’s detected by the new biomarker IGRAs assays in chapter 
six, which were also similar to other publications and research programme findings 
(ATS, 2000; Brodie et al., 2008; CDC, 2011b; Demkow et al., 2008; Diel et al., 
2010; Diel et al., 2011a; Eisenberg and Pollock, 2010; Ferrara et al., 2006; Hardy et 
al., 2010; Mahan et al., 2011; Mazurek et al., 2007; Mazurek et al., 2010; Menzies et 
al., 2007; Nienhaus et al., 2011; Rangaka et al., 2011; Soysal and Bakir, 2011; Sun 




The main aim is to assess the evidence-based laboratory diagnostic testing for 
detection of latent tuberculosis infection among new immigrants to non-endemic 
Kuwait. 
7.1.2 Objectives 
To estimate the accuracies of both the old and new diagnostic tests for detection of 
latent tuberculosis with absence of a gold standard diagnostic test able to rule out 
Mycobacterium tuberculosis exposures. 
7.1.2.1 Sub-objective 1: 
The first sub-objective is to introduce a new classification tree and scoring system of 
evidence-based radiographic-laboratory tuberculosis diagnostics combinations for 
detection of latent tuberculosis infection and ‘suspect TB’ carriers.  
7.1.2.2 Results of sub-objective 1  
According to the evidence-based laboratory-related criteria for LTBI diagnosis which 
were previously described in chapter three; section 3.16 (Table 3.2) the study 
subjective one facilitates the use of the estimated accuracies of the four tuberculosis 
diagnostics help to determine the frequency and percentage distribution of LTBI 
defined categories. Similarly, using the optimal accuracy after implementation of the 
two old and two new diagnostic tests either singly or in combination permitted 
estimation of suspicious tuberculosis cases or facilitate TB control.  
Following the use of risk assessment definitions for defining LTBI case categories 
according to Thrusfield M. (2007), the study results permitted the introduction of 
new screening criteria and tuberculosis testing guidelines for diagnosis of latent 




Table 7.2: New evidence-based radiographic-laboratory classification criteria for the diagnosis 
of latent tuberculosis infection case categories and suspect tuberculosis cases implemented on 
the 180 new immigrants to Kuwait during February and May, 2010  
CXR = chest X-ray, TST = tuberculin skin test, QNF-GIT = QuantiFERON Gold In-Tube test, T-SPOT .TB = T-




CXR TST QNF-GIT T-SPOT .TB LTBI case diagnosis 
Frequency 
(%) 






























































Continue of Table 7.2: *Risk assessment definitions according to Thrusfield M. (2007): 
Negligible (of ‘likelihood’) = That need not to be considered, Insignificant (c.f. ‘significant’), 
Insignificant (of ‘likelihood’) = Unimportant, trifling (c.f. ‘significant’), Low (of ‘likelihood’) = 
Less than average; coming below the normal level, Average (of ‘likelihood’) = The usual amount 
or extent or rate, High (of ‘likelihood’) = Extending above the normal or average level, 
Extremely (of ‘likelihood’) = Outermost; furthest from the centre; situated at either end; the 
highest or most extreme degree of anything.  
The percentage distribution of the defined LTBI case categories implemented on the 
180 new immigrants that was described in Table 7.2 is represented accordingly in 
Figure 7.1. 
 
Figure 7.1: Percentage distribution of the defined latent tuberculosis infection case categories 
representing the sample 180 new immigrants to Kuwait during February and May, 2010 
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The study results permitted introduction of new screening guidelines for latent 
tuberculosis in high risk groups and general population (Table 7.2). These new 
testing’s guidelines can be accepted as ‘the paradox of gold standard’ for 
development of an interventional strategies involving the use of various diagnostics 
for latent tuberculosis diagnosis and will have useful applications to field research 
projects toward preventing tuberculosis worldwide. 
Diagnostic test accuracy cannot be accurately determined because of absence of the 
gold standard for latent and active tuberculosis for comparison. Therefore it is 
impossible to definitely rule out MTB exposure which can be a significant limitation 
in IGRAs specificity (Dilektasli et al., 2010). 
7.1.2.3 Sub-objective 2:  
The second sub-objective is to assess the performance characteristics, through 
comparative evaluation, of the accuracy of the two old and the two new laboratory 
diagnostic tests in the clinical diagnosis of latent tuberculosis infection.  
7.1.2.3.1 Methodology of sub-objective 2 
Data on the diagnostic test outcomes in question were extracted by the same 
reviewers from the full text of studies that satisfied the research inclusion criteria as 
explained in chapter 3 (Materials and Methods; section 3.18): 
1. Sensitivity (SN), defined as the ability of a test to identify latent tuberculosis 
infection among new immigrants as abnormal or ‘positive’ result by any result of 
the four combination tests. 
2. Specificity (SP), defined as the ability of the test to identify subjects without 
suspicion or evidence of LTBI as normal or ‘negative’ test results of all four 
diagnostic tests. 
3. Positive predictive value (PPV), defined as the probability that the positive result 
is a true positive, whereas, the negative predictive value (NPV) of the test is the 
probability that the negative result is a true negative. 
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4. Diagnostic accuracy (DA) of the testing’s combinations, calculated according to 
the following equation; SN+SP/SN+SP+PPV+NPV (Knapp and Miller, 1992; 
Simundic, 2008; Thrusfield, 2007).   
‘Indeterminate’ result of IGRAs is defined as the number of a test failed to give a 
reportable finding result. Our research study accepted any defined indeterminate 
result as normal or ‘negative’ result.  
Implementation of various tuberculosis diagnostics, either singly or in combination, 
to ‘maximize’ the accuracy of latent tuberculosis infection diagnosis and high risk 
group carriers of MTB was undertaken. Diagnostic-test parameters outcomes (SN, 
SP, PPV, NPV, and DA) and their 95% confidence intervals, for the four tuberculosis 
diagnostic test statistics, were calculated using the SPSS 17.0 Software.   
7.1.2.3.2 Results of sub-objective 2 
Table 7.3 shows the diagnostic-test parameters outcomes and related 95% confidence 
intervals and kappa values (detailed in chapter 3: Materials and Methods) for various 
combinations of the four tuberculosis diagnostic tests. The parameter outputs 
involved only test results for the included immigrant cases (defined as the total 
sample number for each combined diagnostic test) for each two combinations of the 
three implemented tuberculosis diagnostics, with exclusion of the TST (due to 




Table 7.3: Diagnostic accuracy of various combinations of the four screening diagnostic tests used for diagnosis of latent tuberculosis infection suspected 
cases implemented on the 180 new immigrants to Kuwait during February and May, 2010  (LTBI = latent tuberculosis infection, CXR = chest X-ray, TST = 
tuberculin skin test, QNF-GIT = QuantiFERON Gold In-Tube test, T-SPOT .TB = T-SPOT .TB test, SN = sensitivity, SP = specificity, PPV = positive predictive 
value, NPV = negative predicitive value, DA = diagnostic accuracy, TCU = medical staff of the Tuberculosis Control Unit, N/A = cannot be computed by SPSS 
Software programme)   
 
TB diagnostic test combinations 
 













CXR (two radiologists)  &  CXR (TCU/three pulmonologists) 
 
179 N/A 94.32 0.00 100.00 94.32 N/A 
 
TST & CXR (TCU/three pulmonologists) 
 
176 N/A 100.00 N/A 100.00 100.00 N/A 
 
QNF-GIT  &  CXR (TCU/three pulmonologists) 
 
179 N/A 71.59 0.00 100.00 71.59 N/A 
 
T-SPOT .TB &  CXR (TCU/three pulmonologists) 
 
179 N/A 58.52 0.00 100.00 58.52 N/A 
 
TST &  CXR (two radiologists) 
 
176 N/A 94.32 0.00 100.00 94.32 N/A 
 






























QNF-GIT & TST 
 
177 N/A 71.75 0.00 100.00 71.75 N/A 
 
T-SPOT .TB & TST 
 
177 N/A 58.76 0.00 100.00 58.76 N/A 
 
















Values that could not be calculated by SPSS 17.0 were presented as N/A (not 
available values) due to absent of positive diagnostic test results, which lead to zero 
positive predictive values. 
The highest calculated sensitivity was calculated between the two IGRAs 92.16% 
(95% CI: 81.5-96.9), whereas, the lowest sensitivity was calculated between both the 
QNF-GIT and chest radiography read by the two radiologists 30% (95% CI: 10.8-
60.3). The highest specificity was measured in comparison between the two IGRAs 
79.07% (95% CI: 71.3-85.2), in comparison to the lowest specificity was calculated 
between the T-SPOT .TB test in compared with chest X-ray read by radiologists 
59.75% (95% CI: 52.2-66.9). 
Both the highest PPV 63.51% (95% CI: 52.1-73.6) and the highest NPV 96.23% 
(95% CI: 90.7-98.5) were calculated in comparison between both IGRAs assays. On 
the other hand, the lowest PPV was 5.88% (95% CI: 2-15.9) and the lowest NPV was 
94.53% (95% CI: 89.1-97.3) and were both belonging to the comparison between 
both the QNF-GIT and chest radiography read by the two radiologists. The highest 
diagnostic accuracy was calculated for comparison between both IGRAs as 82.78%, 
whereas, the lowest diagnostic accuracy was calculated in comparison between both 
T-SPOT .TB test versus chest X-ray read by the two radiologists as 59.78%.  
Considering the two indeterminate results of T-SPOT .TB test as ‘normal’, then both 
IGRAs assays revealed concordant ‘abnormal’ results in 26.11% (47/180) and 
concordant ‘normal’ results in 56.66% (102/180). Discordance of IGRAs were 
detected as the following; T-SPOT .TB+/QNF-GIT- in 15% (27/180), whereas, QNF-
GIT+/T-SPOT .TB- in 2.22% (4/180) (Figure 7.2). Similarity of IGRAs results was 
observed with ‘good’ kappa agreement of 0.627 (0.507-0.746) for LTBI detection 
(Figure 7.2, Table 7.3).  
Agreement between both IGRAs (T-SPOT .TB+/QNF-GIT+) was the highest 83.2% 
(k = 0.66) compared with lower T-SPOT .TB+/TST+ agreement of 64.5% (k = 0.34) 




Figure 7.2: Percentage distribution of the defined latent tuberculosis infection case categories 
representing the sample 180 new immigrants to Kuwait during February and May, 2010  
7.1.3 Discussion 
Early diagnosis of Mycobacterium tuberculosis infection is an essential, but difficult, 
step in tuberculosis control and elimination. Screening and treating individuals 
harbouring LTBI will minimize the risk of subsequent development to active TB, 
especially in immigrants from TB endemic regions. LTBI incidence can be over- or 
under-estimated using the standard TB diagnostic tests such as chest X-ray or the 
tuberculin skin test, which have a low sensitivity and specificity, especially in TB 
endemic countries with predominantly BCG-vaccinated populations (Sun et al., 
2010). Current evidence supports use of IGRAs. In comparison with the TST, the 
newer commercial IGRAs were superior and more specific for detecting confirmed 
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active TB disease, especially when performed in developed countries where 
economic resources are of little concern (Diel et al., 2010). 
To evaluate the implications of screening on arrival, this research explored the 
changes the prevalence of latent tuberculosis in new immigrants coming from high-
incidence TB areas. Identifying the role of new TB screening strategy in early and 
accurate detection of LTBI and indirectly reducing the consequent TB outcomes. 
IGRA results related to measures of the level of exposure better than the PPD test did 
(Arend et al., 2007). For example, molecular epidemiology suggests that the majority 
of resistant TB cases are due to ongoing transmission of drug-resistant MTB strains, 
which is likely to be the result of diagnostic delay, thereby emphasizing the need for 
rapid accurate diagnostics and comprehensive contact tracing of high risk groups. 
Current diagnosis of LTBI in the low-income and high-burden regions relies on chest 
X-ray and TST following suspected abnormal CXR findings of any healthy 
asymptomatic expatriate. The high non-compliance rates reduce the efficacy of TB 
disease control measures. Socio-economic characteristics such as age and 
behavioural attitudes of the studied groups towards monitoring are common cultural 
or psychological factors influencing participants’ opinions. For example, higher 
family income predisposes to non-compliance with test administration among 
medical students, versus compliance among physiotherapy students (da Rocha et al., 
2011). 
7.1.3.1 Absence of a gold standard test  
While positive smear microscopy and bacteriology culture can still be accepted as the 
gold standard in laboratory diagnostics, remarkable technical progress has been  
made recently with  advance in MTB detection through the implementation of ex 
vivo interferon-gamma release assays for the detection of latent TBI. The IGRAs 
were developed to overcome the difficulties and limitations of the standard 
tuberculin skin test in accurately diagnosing latent tuberculosis. Still fewer 
publication of literature reviews are available on using IGRAs to screen immigrants 
within TB control programmes (Carvalho et al., 2005; Winje et al., 2008). 
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It is impossible to establish the actual sensitivity and specificity of any of the four TB 
diagnostics because of the lack of a gold standard for the diagnosis of LTBI 
(Borkowska et al., 2011), and surrogate measures, such as gradient of recent 
exposure, have been used to evaluate IGRAs (Brodie et al., 2008, Ewer et al., 2003; 
Lalvani et al., 2001b),  
To improve LTBI/TB diagnostic specificity, new IGRAs have been developed, but 
updated IGRA guidelines are always needed worldwide. The accumulating evidence 
suggests that the commercial IGRAs have higher sensitivity to detect infection after 
known M .tuberculosis exposure in regions with low tuberculosis incidence and 
specificity than the TST in detecting LTBI, particularly in BCG-vaccinated patient’s 
who comprise the majority of the developing world. For example, IGRAs are 
suggested to be superior in detecting recent rather than old infection (Mazurek et al., 
2010). 
Diagnostics accuracy estimates can be used to determine guidelines for the optimal 
implementation of the two old and two new diagnostic tests; either singly or in 
combination, and to maximize diagnostics accuracy. These guidelines may have 
useful applications to field research projects and the development of intervention 
strategies involving the use of laboratory tests to control and prevent TB worldwide.  
The  results show considerable diversity in the recommendations on IGRAs, with 
four approaches commonly proposed: 1- a two-step approach of TST, followed by 
IGRA either when the TST is negative (to increase sensitivity, mainly in immune-
compromised individuals), or when the TST is positive (to increase specificity, 
mainly in BCG-vaccinated individuals); 2- either TST or IGRA (but not both), 3- 
IGRA and TST together (to increase sensitivity even with decreased TST 
specificity), and 4- IGRA only to replace the TST. All these IGRAs testing 
guidelines are supported with evidence-based results and periodical updates should 
be monitored (CDC, 2011b).  
 
Interferon-gamma release assays can be used at the community level for 
epidemiological studies and LTBI detection to control MTB transmission due to 
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immigration, and is not suggested for serial testing of active tuberculosis diagnosis 
(Legesse et al., 2011; Nenadic et al., 2011). IGRAs have been reported to be better 
predictors of the risk of developing tuberculosis disease than the TST, and correlate 
better with the intensity and duration of TB exposure than the TST (Mendez-
Echevarria et al., 2011; NICE, 2011). Old studies performed in the developed 
countries have shown superior sensitivity and specificity of the currently available 
two IGRA kits for the diagnosis of latent TBI, as compared with TST (Ewer et al., 
2003). New guidelines of some developed countries are starting to recommend a 
two-step strategy for the diagnosis of LTBI, using IGRA to confirm positive TST 
cases, and has significant cost-benefit reductions in TB chemoprophylaxis 
administration (CDC, 2011b; NICE, 2011).  
 
Considering the confounding effect of risk factors, there is a need for further 
evaluation using IGRAs in both vaccinated and non-vaccinated new immigrant 
populations, which can estimate (measure) the protective effect of BCG vaccination 
against latent TB infection. Evidence of protection (assessed by positive IGRAs) and 
reducing risk of severe TB disease forms (66% reduction), and cost effectiveness of 
BCG immunization was highlighted for revision in the next-step of universal BCG 
vaccination and careful monitoring and follow-up for TB incidence associated with 
high travel and MTB exposures of international groups (Eriksen et al., 2010).   
Similar to our comparable results, both IGRAs were superior in sensitivity and 
specificity, and were acceptable substitutes for chest radiography and the tuberculin 
skin tests, without complications such as exaggerated delayed type hypersensitivity 
reactions (Tavast et al., 2009). However, the accuracy of IGRAs for diagnosing 
latent tuberculosis remains unknown because of the absence of a reference/gold 
standard diagnostic test. Additional evidence-based data are needed before deciding 
that positive IGRAs result should receive tuberculosis preventive chemoprophylaxis 
with caution. Ultimately, the gold standard for evaluating the significance of 
diagnostic tests is the consequent progression to active TB disease therefore long-
term longitudinal follow-up will be required to clarify the predictive values of all 
diagnostics (Mahan et al., 2011). 
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7.1.3.2 Accuracy of tuberculosis diagnostic tests  
Diagnostic accuracy is a measure of proportions of the correct test results and is 
measured by assessment of specificity (proportion of true negatives that are actually 
negative test results) and sensitivity (proportion of true positives that are actually 
positive test results). Assessments of accuracy of Mycobacterium tuberculosis 
diagnostic tests are difficult because there is no ‘gold standard’ to confirm a 
diagnosis of LTBI, but, ‘approximations’ of accuracy can be made by testing 
populations with known characteristics (Mazurek et al., 2010). 
Estimation of diagnostic accuracies permits defining LTBI prevalence more 
precisely. Due to the lack of a gold standard in LTBI diagnostics, it is impossible to 
establish the sensitivity or specificity of any of the four TB diagnostic tests. This 
correlation was not specifically defined in any of the previous studies of TB 
diagnostics. No single diagnostic test is able to exclude MTB exposure which can be 
related to significant reduction in IGRA’s specificity and accuracies (Dilektasli et al., 
2010). Therefore, our study analyzed the diagnostic accuracies between the 
combination results of two diagnostics which possibly can be considered as a 
substitute criteria used for diagnosis of LTBI and estimation of TB risks (Borkowska 
et al., 2011).  
All diagnostic tools (old and new tests) are being developed and evaluated after 
careful evaluation of accuracy, society impacts and cost-effectiveness. Estimation of 
diagnostic test accuracy for maximum TB diagnosis would help to determine 
guidelines for the optimal implementation of these tests, either singly or in 
combination (Diel et al., 2011a). The greater attainable specificity and sensitivity in 
diagnosing and detecting LTBI cases of both IGRAs and the requirement of a ‘one-
visit-result’ is a compelling advantage over the old less specific diagnostic test and’ 
two-visit-result’ TST test (Table 7.1). IGRA tests did not show false positive results 
in BCG-vaccinated individuals similar to the observed boosting phenomenon leading 
to false positive TST (Borkowska et al., 2011). Erikson et al. (2010) and Zhang et al. 
(2010) concluded that a significantly lower proportion of IGRA positivity was seen 
in BCG vaccinated people than in non-vaccinated individuals.  
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Sun et al. (2011) undertook a meta-analysis from 2000 to 2011; the sensitivities of 
both IGRAs and the TST in active tuberculosis were similar. The pooled specificity 
was 100% for ELISA and 90% for ELISPOT, but was lower for the TST (56%), and 
even lower (49%) in children with positive BCG vaccination. 
LTBI and are a more specific way of diagnostic and reducing the number of treated 
patients IGRAs represent advances in tuberculosis immunology and evolutionary 
microbial biology and are designed to replace TST for LTBI diagnosis because of 
their logistical advantages and enhanced specificity over TST. For example, the 
boosting effect of IGRAs results by the TST was absent in the findings of Bradshaw 
et al. (2011). Both diagnostic tests still lack the expected sensitivity and 
reproducibility. IGRAs are more accurate indicators, and are a valuable public health 
tool with diagnostic advantages over the PPD test, which require improvements in 
governmental feasibility resources.  
 
The present study attempted to establish the rate of LTBI infection in new 
immigrants using the novel T-cell based in vitro IGRAs recently developed to detect 
LTBI and overcome the limitations of the CXR and TST, which provides for targeted 
intervention through a new screening policy. A similar attempt was performed by the 
American Thoracic Society (ATS, 2000). A combination of both QNF-GIT and TST 
add higher sensitivity, even in LTBI endemic areas such as Indonesia, but with 
lowered specificity for active TB disease (Rutherford et al., 2010). Our findings 
revealed QNF-GIT specificity was consistently high same as T-SPOT .TB test 
specificity, and with lower indeterminate estimates in the new expatriates. Similar 
results on adult participants were also detected by other screening findings (Diel et 
al., 2010; Ferrara et al., 2006). The T-SPOT .TB test can be comparatively better 
over the TST in routine clinical use in identifying the BCG-vaccinated high risk 
groups and foreign-born populations from endemic regions (Brodie et al., 2008). 
 
Even the achieved high correlation and agreement between both IGRAs assays than 
between the TST and either IGRAs assay, still little discrepancy is present between 
both IGRAs which needs future study evaluations at different IGRAs ‘cut-off’ levels 
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and re-test the predictive values of diagnostics result before development of active 
TB disease (Arend et al., 2007). 
 
T-SPOT .TB test had significantly higher specificity, with less indeterminate results, 
even in immunosuppressed hospital patients with LTBI or suspected active TB 
disease than QNF-G and TST (Ferrara et al., 2006). On the other hand, our research 
T-SPOT .TB test results were more specific, but had two indeterminate results, 
compared with no indeterminate results in QNF-GIT.  
Regardless of any test used, targeted testing is critical in reducing unnecessary 
testing and treatment for accurately diagnosed conditions. As with the TST, testing 
with IGRAs can give false-positive results if used in low-prevalence populations. 
Current guidelines and evidence available on the use of IGRAs do not address the 
importance of serial testing or provide the guidance to properly interpret IGRA 
results, which need to be updated with specific recommendations (Zwerling et al., 
2011).  
Future directions in IGRA development are always reviewed for new targeted 
indications. As a new promising tool, both interferon gamma release assays were 
used in countries with a low incidence of pediatric TB and a low rate of BCG 
vaccination to detect outbreaks in schools (Ewer et al., 2003), to monitor anti-TB 
therapy (Sun et al., 2010; Zhang et al., 2010) or to diagnose of tuberculosis and 
NTM disease.  
Nowadays, the use of IGRAs is increasingly recommended, but still their role in the 
diagnosis of active tuberculosis remains unclear. For example, diagnostic 
sensitivities of both IGRAs are higher than that of the TST but are still not high 
enough to be used to rule out TB. Sound evidence for the use of IGRAs requires 
independent and carefully designed prospective studies that the thesis aim and 
methodology were focused. Even with restrictions of low PPV, IGRAs diagnostic 
results to diagnose active TB in the last years are promising (Lalvani et al., 2001a; 
Lalvani et al., 2001b; Meier et al., 2005; Simsek et al., 2010). 
Correlations with or confirmatory to other TB diagnostic tests in predicting the 
clinical outcomes and stage markers of disease severity, IGRAs were also used for 
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monitoring treatment response in the context of TB clinical trials. For example, 
diagnostic scores can be utilized in a separate and comparable patient population 
(Ralph et al., 2010). IGRAs showed good correlation with occupational risk factors 
for TB exposure in low-incidence settings (Zwerling et al., 2011). Still persistent 
positive IGRA responses following old TB infection among immigrants limit their 
usefulness, and by which cannot be considered as a discriminative test to reflect 
‘recent’ TB infection in contact investigation (Kik et al., 2009). Also serial IGRAs 
results should be interpreted cautiously because of their high variability associated 
with both conversion and reversion phenomena.  
Extensive studies evaluating the cost, feasibility, and effectiveness of new screening 
policies, such as using IGRAs, is a national policy pre-requisite. Internationally, new 
intervention guidelines will impact on clinical practice differently. IGRA positivity is 
not influenced by BCG-vaccination, and is associated with exposure to contagious 
tuberculosis cases and remote TB exposures (Diel et al., 2011a). IGRAs high 
specificity will stop unnecessary preventive prophylaxis in BCG-vaccinated 
individuals with a false-positive TSTs, whereas improved sensitivity for LTBI 
detection in individuals with weakened cellular immunity at highest risk and 
vulnerable groups (for example malnutrition or HIV-positive individuals) will enable 
reliable targeted testing and treatment before progressing to active tuberculosis. The 
role of IGRAs in the diagnosis of active TB is still not clear, but either these tests can 
be useful as adjunct tests in diagnostic work-ups of suspected TB cases. Irrespective 
of the economic resources, Diel et al. (2010) concluded that IGRAs are superior to 
the TST for detecting confirmed active TB disease, and also for LTBI diagnosis by 
Dilektasli and colleagues which was more specific if applied in non-endemic and 
developed countries (Dilektasli et al., 2010).   
Fifteen studies assessed the prediction ability of the studied population before 
developing active TB concluded that neither IGRAs nor TST were not highly 
accurate or specific. Until accurate predictive biomarkers are identified, existing 
IGRAs for latent tuberculosis infection should be preferred over the TST and chosen, 
in addition, on the basis of higher specificity in different populations, cost and 
feasibility, and individuals’  preferences (Rangaka et al., 2011). 
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The clinical performance of the T-SPOT .TB assay, for TB (active and latent 
infection) diagnosis, in adults and children, in immune-compromised and immuno-
competent individuals, in BCG-vaccinated subjects, and in pulmonary and 
extrapulmonary TB diseases, has better sensitivity and specificity than the TST 
(Soysal and Bakir., 2011). 
Prevalence of LTBI was 77% in Georgian HCWs, detected by using combination of 
QNF test and TST, and was significantly higher than single use test (QNF +ve detect 
LTBI prevalence 66 % and 60 % for TST +ve result). Length of employment > 5 
years was associated with TST +ve result (OR 5) against QNF +ve test (OR 2.26) 
with moderate agreement of 73% with positive TST > 10-mm (k = 0.43) 
(Mirtskhulava et al., 2008). A study done on 119 crack cocaine-smoking drug users 
in Houston, USA showed LTBI prevalence of 28% using TST and 34% using both 
IGRAs. Among TST negative participants, 18% were detected by QNF-G test and 
21% by T-SPOT .TB test (Grimes et al., 2007). 
On the other hand Mandalakas and colleagues (2011), assessing the value of IGRAs 
and TST, revealed similar accuracy for the detection of TB infection or the diagnosis 
of disease in children which is target evaluation for further research. 
New guidelines in some developed countries are starting to recommend a two-step 
strategy for the diagnosis of LTBI, using IGRA to confirm positive TST cases, and 
has significant cost-benefit reductions in TB chemoprophylaxis administration 
(CDC, 2011b; NICE, 2011). IGRAs can be used also for epidemiological studies for 
LTBI detection at the community level to control immigration MTB transmission 
and can be used for serial testing of active tuberculosis (Legesse et al., 2011; 
Nenadic et al., 2011). 
7.1.3.3 Tuberculosis diagnostics concordance/discordance 
Multiple studies have confirmed concordance between IGRA and TST tests, but the 
reported concordance is variable between the four diagnostic tests for diagnosis of 
LTBI in new immigrants and high risk groups. For example, in people with 
discordant test results (i.e., one positive and the other negative), decisions about 
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medical or public health management will require individual judgment to assess the 
quality and magnitude of each test result, such as the size of  TST indurations or the 
IGRAs TB response (Mazurek et al., 2010). The finding of TST +/QTF − discordant 
results in presumed LTBI suspected cases was recently revealed as a well-described 
phenomenon (Mendez-Echevarria et al., 2011).  
Among 759 BCG-unvaccinated individuals with no history of exposure to 
occupational TB, there were concordant negatives of both IGRAs in 80.1% 
compared with concordant positives in 9.5% versus discordant results in 10.4%. 
(Arend et al., 2007).  
 
The poor correlation between the TST and QFT-GIT assays in the present study is 
consistent with previous studies in Japan (Harada et al., 2006), South Korea (Choi et 
al., 2008) and Australia (Vinton et al., 2009). Immigrants screened for TB revealed 
more TST+/QTF− discordance in the BCG-vaccinated population than in the 
unvaccinated group (Mendez-Echevarria et al., 2011). Another example of similar 
discordance between a TST at ‘cut-off’ point more than 5-mm of skin indurations 
and QFT-GIT at a ‘cut-off’ point more than 0.35 IU/ml level of IFN-γ is described by 
Legesse and colleagues (2011). The low level of concordance between the TST and 
IGRAs tests was mainly because the two assays evaluate different mechanisms of 
immunological response against MTB elicited by different antigens (Ferrara et al., 
2006; Harada et al., 2006; Mazurek et al., 2007; Menzies et al., 2007; Pai et al., 
2005; Saracino et al., 2009; Winje et al., 2008).  
 
Discordance of TST and IGRAs results have been noted in other study results 
(Ferrara et al., 2006; Harada et al., 2006; Mazurek et al., 2007; Pai et al., 2005; 
Winje et al., 2008), but the disagreement factors are still unclear whether adding 
IGRAs alone or as an alternative to TST is currently questionable. For example TST 
negative/QFT-GIT positive discordance was significantly associated with foreign 
birth and age more than 50 years (Weinfurter et al., 2011), and similar to our TST-
/QNF-GIT+ discordance findings of while conversely, TST-/QFT-GIT+ discordance 




Discordance between TST induration and INF-γ levels indicates that different 
factors, such as interleukin-10 (IL-10), might contribute to regulating the size of the 
TST reaction (Burl et al., 2010).  In mice, IL-10 is found to be an important chronic 
inflammatory regulator and has been shown to decrease DTH-IV and expression of 
cutaneous lymphocyte-associated antigen (CLA) on T cells (Sigmundsdottir et al., 
2004). Other studies observed that the majority of discordant results were as TST 
positive/IGRA negative, with concerns that IGRAs may not be as sensitive as the 
TST for diagnosis of LTBI in very young and immune-compromised subjects such as 
children, and also whether the primary infection was very old with recent diagnosis 
or complications (Bakir et al., 2008; Farhat et al., 2006). 
A study by Cagalayan and colleagues (2011) revealed intermediate concordance 
between both the TST and QNF-GIT, and QNF-GIT diagnostic accuracy was only 
65.38%. Rutherford and co-workers (2010) observed no differences between patients 
with discordant results of the TST and QFT-GIT in Indonesia (TB endemic country), 
and similar test discordances was associated with foreign-born and old persons 
(Weinfurter et al., 2011), and recent immigrants (Saracino et al., 2009).  
Other studies (Arend et al., 2007; Igari et al., 2007; Luetkemeyer et al., 2007; Pai 
and Menzies, 2007) found poor agreement between TST induration of more than 15-
mm and QFT-GIT.  
Concordance was unachieved if TST ‘cut-off’ was raised to more than 15-mm which 
might miss LTBI due to MTB infection than due to NTM or BCG (Menzies et al., 
2007; Mazurek et al., 2007; Saracino et al., 2009; Wang et al., 2002). In contrast, 
Brodie and colleagues (2008) found general concordance between T-SPOT .TB test 
and TST results among BCG vaccinated immigrants was 64% compared to 82% in 
unvaccinated individuals. Poor concordance, due to BCG vaccination and/or NTM 
infection, has been described in other studies (Carvalho et al., 2005; Ferrara et al. 
2006; Mazurek et al., 2007; Menzies et al., 2007; Saracino et al., 2009).  
7.1.3.4 Tuberculosis diagnostics agreements  
Agreement between tests for Mycobacterium tuberculosis infection varies widely in 
different studies (Chee et al., 2008; Choi et al., 2008; Leung et al., 2008). Agreement 
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is known to be affected by various factors such as the prevalence of LTBI infection, 
estimates of recent and remote exposure history, socio-demographic characteristics 
(e.g., age, race, prior BCG vaccination and coexisting diseases), and technical errors 
such as test interpretation. Similar to our findings, baseline epidemiological and 
demographic characteristics such those aging more than 28 years, male and birth in 
TB endemic regions and recorded diagnostics positive results of both IGRAs are 
associated with increased likelihood of LTBI diagnosis more than positive TST 
(Mahan et al., 2011).  
Positive IGRA results with negative TST and CXR results strongly pointed to a 
higher probability of LTBI/TB infection in BCG vaccinated subjects, in comparison 
to positive TST and negative IGRAs result. In our study, optimum agreement can be 
reached by lowering the ‘cut-off’ value for both IGRAs and TST with CXR 
suspicious findings for latent TB. Arend and colleagues (2007) differed, in  
concluding that maximum agreement (more than 89.5% achieved or k = 0.59) can be 
reached through increasing sensitivity by lowering the ‘cut-off’ value of the QNF-
GIT but improving specificity by raising the ‘cut-off’ value for the T-SPOT .TB test. 
As expected, lowering the ‘cut-off’ value of the QNF-GIT to more than 0.1 IU/ml 
instead of > 0.35 IU/ml increases the total number of positive tests (Mahan et al., 
2011). 
Agreement of both the QNF-GIT and TST tests was ‘excellent’ in tuberculosis 
disease cases and non-vaccinated children, but on the other hand, disagreement 
between the tests was frequently observed among latent tuberculosis infection cases 
than in non-infected normal children or TB disease cases (Mendez-Echevarria et al., 
2011), in comparison to lower observed or ‘moderate’ agreement between both tests 
(TST and QNF-GIT) detected by Weinfurter  and colleagues’ (2011) study of 1,653 
foreign-born and homeless individuals.  
Even though both T-SPOT .TB and TST tests show ‘good’ agreement in the control 
normal group compared with psoriasis patients in a highly tuberculosis endemic 
setting, T-SPOT .TB test was still superior to TST in diagnosing latent tuberculosis 
infection (de Andrade Lima et al., 2011). 
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Pai and colleagues’ (2005) findings on healthy adults from a rural community in 
South Africa (TB endemic country) demonstrated ‘poor’ agreement between the TST 
and IGRAs, with a high proportion of individuals (between 30% and 56%) with TST 
indurations more than 15-mm who tested negative on the IGRAs The poorer 
agreement between TST indurations more than 15-mm and QNF-GIT positive results 
was also observed elsewhere (Luetkemeyer et al., 2007; Pai and Menzies, 2007; 
Saracino et al., 2009). Zhao and colleagues (2011) relate low agreement between the 
T-SPOT .TB test and the TST due to BCG vaccination.  
The agreement between the TST and IGRAs in non-BCG-vaccinated individuals was 
higher than that in BCG-vaccinated children. IGRAs specificity was far greater than 
the TST, particularly in BCG-vaccinated children (Sun et al., 2011). Consistent with 
our research’s ‘good’ agreement findings, the two commercial IGRAs (QNF and T-
SPOT .TB tests) also revealed good agreement and were cost-effective in screening 
contacts of tuberculosis patients (Diel et al., 2007; Dominguez et al., 2008). Using 
different TST and QNF-GIT ‘cut-off’s, the highest concordance was obtained for 
QNF-GIT at units more than 2.64 IU/ml (more than manufacturer’s ‘cut-off’ up 0.35 
IU/mL) and TST at more than 10-mm (Saracino et al., 2009). 
7.1.4 Study strength 
1. This is the first study to compare the diagnostic performance effectiveness of 
targeted testing by using ‘simultaneously’: 1- the two old TB diagnostic tests 
(chest X-ray and tuberculin skin test), and 2- the two new biomarker IGRA tests 
on a high risk group (new immigrants) for latent tuberculosis infection diagnosis.   
2. Both IGRA assays were highly reliable and reproducible, and the findings 
substantially lying within-subject variability during the study period which can 
be considered when interpreting serial testing’s in comparable populations and 
similar settings.  
7.1.5 Study limitations  
A major limitation in the study is lack of a standard diagnosis of LTBI. 
Reproducibility is low and small sample size limits generalization of the new 
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diagnostic strategy which needs further studies on large number of participants to 
determine the diagnostic performance precisely. Repeatability might be difficult for 
other researchers to perform similar methodology of implementing the four TB 
diagnostic tests simultaneously. The two old diagnostics weaken the performance 
and diagnostic accuracy of the new IGRAs assays.  
7.1.6 Conclusions 
Because of higher sensitivity and specificity of both IGRAs, it should be no longer 
justified to perform lung X-ray or TST alone to define (diagnose) LTBI and ‘TB 
suspect’ cases. Advantages of both IGRAs overlapped over the performance of chest 
X-ray and tuberculin skin test in detecting latent tuberculosis and allowing the 
exclusion of Mycobacterium tuberculosis infection. Both IGRAs are useful for 
screening high-risk groups and recent immigrants, even without other diagnostic 
results. The study findings suggested the targeted screening of recent and foreign-
born immigrants using quantiFERON Gold In-Tube test, in addition to the ordinary 
chest X-ray, would enhance the diagnosis of latent tuberculosis and Mycobacterium 
tuberculosis carriers, especially in situations where the old diagnostics are unreliable 
such as in young children and immunocompromised individuals. 
IGRAs are reported to be better predictors of the risk of developing tuberculosis 
disease than the TST, and correlate better with the intensity and duration of TB 
exposure than the TST (Mendez-Echevarria et al., 2011; NICE, 2011). The study 
results permitted introduction of new screening guidelines for latent tuberculosis high 
risk groups and the general population (Table 7.3). In view of the high risk of 
Mycobacterium tuberculosis carriers, a combination of either IGRAs or chest X-ray 
interpreted by a radiologist will be appropriate for diagnosis of latent tuberculosis 
cases and exclusion of active tuberculosis. After IGRA evaluation, an alternative 
strategy can be followed before starting preventive prophylaxis to suspected LTBI 
immigrants. Compulsory QNF-GIT followed by complementary CXR can be cost-
effective and available diagnostic tools for immigrant screening (Hardy et al., 2010). 
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Even with difficulty to differentiate between active and latent tuberculosis using the 
‘cut-off’ validity values recommended by the manufacturers, still both IGRAs can 
add scientific knowledge about the global epidemiology of LTBI/TB.  
7.1.7 Recommendations 
Even with the substantial progress in documenting the utility of IGRAs compared 
with chest radiography and the tuberculin skin test, further additional research is 
needed, and future studies should focus on determining the values and limitations of 
the IGRA assays and their related importance to medical care, such as tuberculosis 
control and elimination. From the previous significant findings, future research 
recommendations can be targeted accordingly; 
1- Are IGRAs (the new diagnostics) better at predicting subsequent active tuber-
culosis than CXR and TST (the old diagnostics)?. 
2- Are high-risk persons with discordant results of negative TST or CXR diagnostic 
results and positive of either IGRAs test  are truly at higher risks to develop 
active tuberculosis compared with immigrants with concordant negative results 
of both the old and new diagnostics ?. 
3- Can sensitivity and specificity of IGRAs be improved by modification in testing 
methods, application of different interpretation criteria, or inclusion of additional 
new specific antigens?. 
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8 Chapter eight 





Diagnosis and treatment of latent tuberculosis infection is a cornerstone of 
tuberculosis control all over the world. Since the last century, the tuberculin skin test 
has been the only means of diagnosing the disease, but missed dormant inactive 
tuberculosis carriers, in contrast to new promising diagnostic tools - namely, 
interferon-gamma release assays - for diagnosis and tuberculosis surveillance. This 
study focuses on the use of both ‘evidence-based’ epidemiological characteristics and 




8.1  Introduction 
Awareness of the global burden and threat of communicable diseases and the 
opportunities for disease control has permitted the development of various 
international partnerships and alliances to coordinate efforts to control diseases 
globally, an example being the global campaign to eradicate smallpox in the 1960s 
and 1970s. Similarly, the high burden of TB disease, with almost four deaths each 
minute worldwide, has stimulated of the World Health Organization Stop TB 
Strategy (WHO-STOP TB) and the Global Plan to Stop TB plan, the goal being 
eradication of tuberculosis by 2050. Additionally, the United Nations Millennium 
Development Goals (UNMDGs) aim to halve TB incidence, prevalence and deaths 
by 2015, compared with their levels in 1990, and has already saved 14 million lives 
(WHO, 2010c). Even with having a similar aims and targets with the Stop TB 
Partnership programme to globally accelerate social and political action against 
tuberculosis, still MDGs of eliminating TB will not be achieved by 2050 (less than 
one case per 1 million population). Goals unachieved due to: 1- incident cases are in 
major occurring within population-dense TB endemic regions of fast growing 
populations; Africa and Asia, 2- TB persistence in communities with poor health 
infrastructure, which lead to 3- increase in drug-resistant cases and TB/HIV co-
infection cases. Therefore these unidentified gaps in both national- and international-
directed TB control efforts in which political governments should address the 
preventive challenges on regular pattern (Jassal and Bishai, 2010). Most countries in 
sub-Saharan Africa (an HIV pandemic region) reported that more than 30% of active 
TB are TB/HIV co-infected (WHO, 2009a; WHO, 2011a). 
The global cost of the partnership’s activities until 2015 is estimated at U.S.$56 
billion, of which U.S.$47 billion for implementation of available diagnostic 
interventions and U.S.$9 billion for research and development. However, an overall 
estimated funding gap for the Global Plan was U.S.$30 billion due to several 
countries reduced spending on overseas developmental programs. These developing 
countries are instead trying to compensate for the annual 100 million persons 
entering poverty and increased household overcrowding and poor nutrition, which 
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are known risk factors to enhance the incidence and transmission of TB. Shortage in 
governmental contributions and budgeted plans lead to scientific obstacles toward 
failure to end the burden of human-TB suffers and prevalence’s (Figure 8.1).  
 
 
Figure 8.1: Three key time points in achieving tuberculosis elimination by 2050, if all criteria 
established by the Stop TB Partnership are effectively obtained (Jassal and Bishai, 2010) 
Tuberculosis elimination criteria for any society can be met only if new infections 
are effectively prevented. Delay in tuberculosis diagnosis is an important factor in 
the spread of TB and a poor outcome for patients due to inadequate health-seeking 
behavior at patient level or inadequate diagnosis at the level of the health care 
system. Research studies have investigated the causes of delay among diagnosed 
cases, but, only few have investigated causes of delays among undiagnosed 
individuals detected in the community. Therefore, case-finding in the community and 
investigating the risk factors among suspected cases of latent tuberculosis are crucial 
to the development of optimum interventions that will improve early case detection 
through determining the prevalence of tuberculosis suspects. Preventive measures for 
future cases of TB in non-endemic areas is to identify and provide chemoprophylaxis 
to individuals with latent tuberculosis infection, in addition to tracing suspected TB 
cases with minimal diagnostic delay. Understanding the overlapping socio-economic 
nature of TB epidemics and their structural determinants is key to the design and 
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implementation of effective prevention programmes. Epidemic control of chronic 
communicable diseases should be preceded by long-term planning that is able to 
change specific dynamics of disease transmission such as promoting research and 
development of improved diagnostics, drugs and vaccines that are provided in 
community implementation programmes (Jassal and Bishai, 2010). 
Research- and health-related data sources among new immigrants can identify more 
precise population- and individual-level risk factors associated with both differential 
risks for LTBI and risk of progression to active TB, which can be generalized and 
applied on a regional basis (Freeman et al., 2010). Individual risk behaviours 
influence the probability of contact with other infected or infectious individuals and 
can delay TB diagnosis with further MTB transmission from LTBI cases that are 
generally defined as positive TST and/or positive IGRAs with no evidence of active 
TB disease form. Therefore a new evidence-based LTBI classification can be used to 
predict TB suspicious cases that require isolation before re-activation active TB 
disease or producing cross infections. History about risk factors using questionnaire-
guided evidence-based results can help health care workers to recognize TB 
suspicious cases and to confirm diagnosed cases (Solari et al., 2008). 
8.2 Aim 
To define latent tuberculosis infection index case by which able to raise the quality of 
health care services. 
8.3 Objectives 
1. To apply prediction criteria based on evidence-based epidemiological and 
laboratory diagnostic criteria on high-risk group which permit rapid 
identification of latent tuberculosis immigrants. 
2. To introduce a new evidence-based laboratory criterion using diagnostic 




Tuberculosis remains a major global health threat. The latest reportable cases by 
WHO in 2009 observed more diagnosed and loss of lives than in the previous years. 
For example 9.4 million incident cases of active TB been diagnosed in 2008 was 
increased to 10 million in 2010 around the world. The majority of incidences were 
due to MTB re-activation from reservoir of LTBI (WHO, 2010c). 
Mycobacterium tuberculosis causing tuberculosis remains a formidable health 
problem and disease control is largely based on early detection and treatment of 
infected persons with active or latent TB disease (WHO, 2011a).  
The target of studies worldwide is to reach a timely and accurate diagnosis of latent 
tuberculosis infection which enables reduction of the risk of progression to severe 
tuberculosis. Individual risk behaviours influence the probability of contact with 
other infected or infectious individuals and can produce delays in TB diagnosis with 
consequent uncontrolled MTB transmission. Several trials of clinical prediction rules 
have been developed to recognize TB suspicious cases by using a scoring system 
composed of TB risk (questionnaire-related) variables and diagnostic tests 
(laboratory-related) similar to Solari and colleagues (2008) trial. 
Tuberculosis was firmly put on the global health agenda because of: first TB 
identified by the Global Burden of Disease Study in 1990 (GBD 1990) as one of the 
top 10 causes of mortality and morbidity worldwide, second the case fatality rate for 
untreated TB disease reached 50% and costing loss of millions of young adult 
healthy, and third anti-TB management with DOTS follow-ups was supervened by 
the Stop TB strategy in 2006 revealed social and economical barriers were the most 
effective targets for saving costs of all health interventions. Among the follow-up 
successes of the WHO strategies worldwide, 36 million patients were treated 
between 1995 and 2008 and 8 million deaths were averted (WHO, 2009a), but still 
both DOTS and the Stop TB Strategy are only prioritized/restricted to sputum smear 
positive for TB infectious cases in low-resource countries such as Africa.   
 
399 
Tuberculosis has become an international public health priority due to the migratory 
flow of high-risk groups from high incidence countries, leadings to micro-epidemics 
in closed environments (e.g. hospitals, jails), and the recent AIDS pandemic 
(TB/HIV syndemic) (Dye et al., 1999).  
The CDC recommendation for LTBI screening of foreign-born individuals is still not 
commonly practiced. Challenges include low health seeking behaviours for screening 
for latent infection and active disease, as well as suboptimal treatment compliance. 
The reasons for these barriers vary by country of emigration and duration of 
acculturation. For example, the majority (half) of the active TB disease in the USA 
immigrants is due to re-activation of LTBI dormant bacilli (Geng et al., 2005). 
Variable pulmonary impairments (from mild to severe dysfunctions) after 
tuberculosis such as obstructive and/or restrictive lung abnormalities. These 
deformity patterns resulting in common from caseating granuloma and cavity 
formation followed by anatomic changes, which are occurring more in PTB 
compared to LTBI. Worldwide, human function-associated disabilities require 
aggressive case prevention strategies and post-treatment follow-up evaluations 
(Pasipanodya et al., 2007). 
TB is a preventable and treatable condition, but if left untreated can be life-
threatening. Worldwide, inconsistent policies are due to the uncertainty regarding 
risk for LTBI among long-term travelers from low- to high-risk countries, with 
difficulties in estimating the risk for LTBI, as measured by TST conversion. From a 
clinical perspective, identification/diagnosis and treatment of LTBI is important in 
reducing the risk of progression and associated complications. Making the best 
estimation of LTBI incidence can provide scientific data to support policy 
recommendations, and estimation of LTBI prevalence (e.g. using IGRAs) can help to 
evaluate the performance of health policies and interventions. LTBI is an important 
occupational problem among health care service and staff (Demkow et al., 2008).  
The two billion people estimated to harbor latent MTB carry 2-23% lifetime risk of 
developing re-activation TB and constitute a major impediment to TB control efforts. 
For all who became infected, the course and duration of progression to active disease 
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are highly variable. Lack of uniformity in disease manifestations among infected 
individuals reflects complex interaction between genetic and environmental factors 
and both influence susceptibility to infection and disease pathogenesis. For example 
nested IGRA-TST maximizes the sensitivity for LTBI diagnosis and has the potential 
to identify MTB mode and can be applied to the high-risk populations (Dodd et al., 
2010). 
The challenges of TB control remain unachieved, and scientific and financial 
investments are both required for further substantial progress, aiming to create a 
strategy that allows prevention and/or sterile eradication of Mycobacterium 
tuberculosis infection. The study by Berry and colleagues (2010) reported 
identification of a 393 gene set which enables a gene expression signature to 
differentiate between latent and active TB transcriptomes compared with healthy 
individuals. Duarte and colleagues (2011) revealed the presence of HLA-DRB*14 
allele frequency higher in a small sample of TB patients compared with a control 
group of healthy staff on daily exposure to TB. This could be a susceptibility allele 
toward evolution of TB disease.  
8.4.1 Definition of latent tuberculosis infection case 
Latency is a dynamic event where the active immune response keeps controlling the 
persistence of mycobacteria, and re-activation of 5 to 10% of LTBI will lead to 
active TB. Because tuberculosis itself is a stigmatizing disease, latent tuberculosis 
definition through reporting of the predictive risk factors such as history of contact 
with a tuberculosis patient case and related results of the diagnostic tests might be 
able to rule out a diagnosis of developing active tuberculosis in high-risk group 
immigrants. 
Latent tuberculosis infection can be defined as the presence of any tuberculous lesion 
which fails to produce any symptoms of its presence, and is also considered as a 
clinical syndrome with absence of clinical symptoms and signs. The immune 
responses surround foreign pathogens into inactive (quiescent) state, which control 
bacillary spread and inhibit disease transmission and lowering public health risks. 
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Within two to four weeks, MTB bacilli can proliferate intracellularly within alveolar 
macrophages of the lungs and disrupt macrophage acidification to prevent 
phagosome–lysosome fusion. Inadequate host immunity permits tubercule bacilli to 
escape causing transient bacteraemia and dissemination throughout the body. 
Recruitment of both T-cells and macrophages can control the infection and 
immunological memory persist for decades (for up to 25 years) in the form of a 
positive delayed hypersensitivity reaction-type IV to the PPD of Mycobacterium 
tuberculosis and calcified scar lesion in chest radiographs (Parrish et al., 1998).  
8.4.1.1 Latency timing  
Tuberculosis latency is characteristic of TB disease, and is a life-long variable period 
(sometimes decades) following MTB bacillary infection. Other results suggest no 
relationship between re-activation latency period and raised TB incidence diagnosed 
in the young population due to hyperendemicity (den Boon et al., 2005). It is difficult 
to attribute observed disease rates to risk factors or current environmental exposures 
particularly in immigrants from high-incidence regions. Active TB disease in low-
endemic countries arises from a growing proportion of latently-infected individuals 
facing risks of re-activation. Rates of increments of the latent infection continued to 
be high in endemic regions with high infection pressure such as in India and South 
Africa, because of maintained exogenous re-infection phenomenon during latency 
period (Wiker et al., 2010). Cases of latent TB infection convert to active TB within 
the first two years of infection. Diagnostic delay of TB among pastoral communities 
in Africa revealed the longest patients’ delay from developing countries with a mean 
of 130 days (range: 10-1800 days), and 50% had pulmonary TB with positive 
sputum, and each patient can dispense up to 3,500 bacilli per cough, infecting 10 to 
15 people each year, raising the public suffer (Gele et al., 2009).   
8.4.1.2 Human latent tuberculosis   
Individuals with latent tuberculosis infection should be identified as sources of 
persistence and multiplication of viable Mycobacterium tuberculosis bacilli localized 
within macrophages, and also defined as asymptomatic subject without clinical 
manifestation of disease. Such individuals are also benefit from subsequent 
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chemoprophylaxis as important preventive measure before development of active 
disease and consequently reducing TB incidence. Tuberculosis acid-fast bacilli, the 
characteristic bacterial forms, usually failed to be revealed in microscopic 
examination of infected tissues of latent dormant TB suspects. Initial absence or low 
predominance of MTB bacillary emerging antigens for sensitizing immunity added to 
the gradual degeneration and necrosis of antigen-specific T-cells in the infected 
lungs, and would physically prevent cellular penetration and promote MTB bacillary 
resistance (Henao-Tamayo et al., 2009). Paradox observation is opposite to the 
expects that the latent bacilli might be altered to non-acid fast status or may remain 
acid fast but in a number low enough to defy microscopic detection. Location of the 
latent bacilli within the old pulmonary granulomatous lesions (e.g. lungs) and 
dissemination permits bacilli seeding to their early bactermic phase, post-exposure.  
Latent bacilli are expected to be in a metabolically active state of stationary (slow 
growth within granuloma) evidenced by response of LTBI cases to 
chemoprophylaxis treatment and reduced risk of developing reactivated TB. 
Mycobacterium bacilli are spore-like and metabolically inactive, with evidence of 
sporulation regulatory genes, such as sigma factor gene (sigF gene), which permit 
MTB ‘invisibility’ to the host immune system for long periods (Parish et al., 1998). 
8.4.2 Identification of latent tuberculosis index case 
Tuberculosis is the only disease clarified as clinical probability, radiological 
possibility and bacteriological certainty. Matching of laboratory diagnostic tests with 
epidemiological risk factors can predict and help pick up latent tuberculosis cases, 
preventing bacterial flare-up risks and facilitating elimination/control of tuberculosis. 
The mechanisms by which Mycobacterium tuberculosis establishes a latent 
metabolic state is still unknown, but theoretically accepted that reduced oxygen 
tension might trigger the bacillus to enter a state of latency. 
8.4.2.1 Immunological definition of latently infected cases 
The immune system is the single and most important factor for the control of LTBI 
and halting MTB spread. Improving discrimination between LTBI and the active 
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symptomatic form of TB disease is a priority, mainly in areas where treating all 
infected cases is not possible. But it is still not understood how the immune system 
controls LTBI except for the major role of CD4+  T-cells and antagonizing effects of 
tumour necrosis factor- alpha (TNF-α) (produced by CD4+ cells), which result in re-
activation of LTBI (Mankia et al., 2011). Number of tuberculin-specific CD4+  T-
cells in peripheral blood carrying either of activation markers such as IFN-γ (with 
dominance; is a marker for LTBI) and/or IL-2 in LTBI cases, were higher in LTBI 
than active pulmonary TB patients due to migration of active CD4+ T-cells to 
infected tissues (Streitz et al., 2010). Mantoux test and IGRAs can identify a memory 
of a previous adaptive immune response against Mycobacterium tuberculosis bacilli. 
Worldwide, the diagnosis of LTBI is made with positivity of TST and recently on the 
T-cell-based IGRAs before initiation of chemo-preventive therapy (LoBue et al., 
2010).   
8.4.2.1.1 The immune response and evasion strategies of 
Mycobacterium tuberculosis  
After the infection of two to four weeks, specific CD4+ and CD8+ responses are 
evident, and cells produce INF-γ and TNK-α to enhance the effectors’ mechanisms 
of innate immunity. The adaptive immune response against MTB encompasses 
CD4+ and CD8+ effecter cells’ expansion and generation of long-lived memory T-
cells. CD4+ cells are considered the main source for INF-γ, a critical cytokine for an 
anti-mycobacterial protective immune response. Diminished INF-γ production 
correlates with disease severity and development of extra-pulmonary TB or low 
immunity, whereas increased production levels are indicative of actively replicating 
mycobacteria in those recently exposed to active TB cases and are biomarkers of 
high risk susceptibility from previous MTB infection (Rueda et al., 2010).  
Adaptive immune responses through the immune cells and the fibrotic wall 
surrounding the granulomas will prevent bacterial and outbreak spreading for long 
periods. After being inhaled, MTB are phagocytosed by antigen-presenting cells 
(APCs) in the lung, such as alveolar macrophages (AM), lung parenchyma 
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macrophages (LPM) and dendritic cells (DC), which elicit local inflammatory 
responses, for recruitment of mononuclear cells (MNC) to target the infection.  
Within the granuloma MTB will be enclosed and prevent phagosome acidification to 
survive and escape within the cytosol of the granuloma (defined as aggregated of 
macrophages, neutophils, and monocytes). Caseation of granulomas denotes massive 
cell death and difficulties in enclosing MTB bacilli even though apoptotic cell death 
would impede MTB spread. Another strategy of MTB evasion is blocking apoptosis 
through inhibiting prostaglandin E2 (PGE2) production, which is crucial for T-cells 
in containment of MTB. CD4+ T-cells, predominantly T-helper 1 (TH 1) exerting 
protection by producing IFN-γ after activation by antigen presenting cells from MHC 
class II molecules. Other strategic evasion of MTB is through inhibiting MHC-II 
expression and antigen presentation via Toll-like receptor 2 (TLR2). IFN-γ as a key 
cytokine activates macrophages (protective immunity) to kill intracellular 
Mycobacterium tuberculosis through the induction of nitric oxide (NO). Also, CD8+ 
T-cells contribute to host defences by cytokine production and also by perforin- and 
granzyme-mediated cytotoxic activity, but require APCs exogenous presentation 
with MHC class II molecules, which is also inhibited by the MTB bacilli. Post-
infection, memory response cells are able to elicit a secondary response after re-
encountering the pathogens (Feng Y. et al., 2011; Thaiss and Kaufmann, 2010).   
Acting as a co-factor for induction of antimycobacterial activity, vitamin D is a 
potent immuno-modulator of the innate immune responses and its deficiency is 
associated with LTBI. Serum levels less than 20 ng/mL impair the macrophage-
initiated innate immune response against Mycobacterium tuberculosis (Talat et al., 
2010). 
8.4.2.1.2 Predictors of latent tuberculosis infection   
Millions of people are living with latent tuberculosis infection, representing a 
reservoir of potentially active tuberculosis disease, and are associated with re-
activation consequences such as intense suffering, permanent disability, and high 
economic costs for populations, especially as the MTB bacillus spreads. 
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This section summarizes the current knowledge of epidemiological and laboratory 
diagnosis aspects of LTBI discussed in chapters 4, 5 and 6. We have developed a 
study proposal for LTBI definition and a classification tree using common predictor 
factors from the history of epidemiological characteristics (questionnaire-related) and 
radiographic-laboratory (four diagnostic tests-related) investigational data from a 
representative sample of high-risk groups (the 180 new immigrants) which has been 
validated during February and May 2010. 
The study proposal for LTBI definition might facilitate early prediction of LTBI and 
help staff of the health care system through clinical prediction rules (CPRs) in 
identification of suspected pulmonary and extra pulmonary tuberculosis. CPRs are 
tools to help clinicians to reach a diagnosis or predict/guide decisions towards the 
probability of a health event (active TB) before it occur especially in high-risk group 
populations (Solari et al., 2008). Also combining the results of TB laboratory 
diagnostics increases the sensitivity of detection of LBTI, which has confirmed and 
supported our study recommendations. For example, our results approved that 
negative diagnostic results of the TST should not be enough alone to exclude 
LTBI/TB, but can be interpreted in conjunction with other clinical and diagnostic 
findings. Baboolal and colleagues (2010) also described similar significant findings 
(Baboolal et al., 2010).  
The relationship between the four tuberculosis diagnostic tests results and the major 
socio-demographic variables and common risk factors of tuberculosis can be 
assessed. The predictor risk variables and laboratory results facilitating definition of 
latent tuberculosis infected cases are listed in Tables 8.1, 8.2, and 8.3, respectively. 
8.4.2.2 Epidemiological definition of latent tuberculosis index cases  
The epidemiological risk factors (which can be accepted as predictors) for suspected 
TB cases and Mycobacterium tuberculosis carriers can be direct or indirect, and are 




Table 8.1: Classification of evidence-based epidemiological risk factors and related diagnostic 
levels of both IGRAs for development of latent tuberculosis infection and tuberculosis 
suspicious carriers of 180 new immigrants to Kuwait during February and May, 2010 






LLR χ2(24) = 38.244 0.033 92.22 
Gender (Male) LLR χ2(4) = 14.008 
 
0.007 76.1 
Nationality (Endemic countries) LLR χ2(52) = 72.522 
 
0.032 82.9 





Total number of sleeping rooms (1-4) 
 
KW χ2(4) = 8.977 0.062 95 
Risk factors for Mycobacterium tuberculosis 
infection 
 
Microbus/bus/train LLR χ2(4) = 14.884 0.005 75.6 
Tuberculosis knowledge 
 
   
General knowledge LLR χ2(4) = 16.103 0.003 82.2 
Cough LLR χ2(8) = 24.553 0.002 81.1 
Hemoptysis LLR χ2(8) = 22.590 0.004 68.3 
Fever LLR χ2(8) = 22.032 0.005 71.1 
Night sweating LLR χ2(8) = 15.726 0.046 38.9 
Generalized weakness LLR χ2(8) = 24.435 0.002 68.3 
Weight loss/wasted LLR χ2(8) = 24.824 0.002 68.3 
Vomiting/diarrhea LLR χ2(8) = 17.087 0.029 43.9 
Sources of tuberculosis knowledge 
 
 
Study area (e.g. school/friend) LLR χ2(4) = 11.512 0.021 41.1 
Public shared talks LLR χ2(4) = 11.236 0.024 81.1 
TV/Newspaper/magazine advertisement LLR χ2(4) = 15.275 0.004 76.7 
Medical campaign/Poster LLR χ2(4) = 16.627 0.002 58.9 
History of environmental contacts (inside- and 
outside- households) 
 
Duration of contact to outside non-households (> 6 
hours) 
LLR χ2(12) = 20.285 0.062 88.9 
Have been infected or contacted with TB case LLR χ2(8) = 13.799 0.087 6.1 
TB stigma (in-door close contacts) LLR χ2(4) = 11.047 0.026 7.8 
Risk factors for progression of infection to active 
tuberculosis: History of smoking 
 
Positive history of smoking 
(current and ex-smokers) 
LLR χ2(4) = 9.135 0.058 51.1 
Laboratory diagnostic result 
 
 
Interferon gamma level (IU/ml) = 0.07 (0.46) KW χ2(4) = 105.220 < 0.001 
T-lymphocytes number (cells/µl) (IQR) = 180 (89) KW χ2(4) = 4.409 0.353 
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Analysis of epidemiological risk factors such as socio-demographic characteristics 
associated with tuberculosis infection/exposure can be utilized for defining latent 
tuberculosis cases to achieve variable uniformity for comparison with other LTBI 
studies. Increased TB awareness is needed, in particular in low TB incidence 
communities and in immigrants originating from high-endemic areas. Health care 
professionals should be aware that immigrants from LTBI/TB endemic countries 
remain at risk of re-activation after they immigrate. Also TB controllers need to 
focus on particular immigrants, location sites, cultural behaviours, and risk groups 
such as family/children contacts (Cowie and Sharpe, 1998). 
Knowledge of different socio-demographic factors relating to tuberculosis permits 
the development of appropriate integrated social and health policy responses, and 
quantitatively can determine the disease-specific cost benefit. Pai and colleagues 
(2005) reported a four-fold higher prevalence of LTBI in Indian medical students 
aged more than 23 years than in those aged between 18 and 20 years, whereas, older 
age ranges between 15 and 34 years were significantly detected by Langlois-Klassen 
and colleagues (2011) as targets for preventive management, compared to the 
average age of 30 years in our non-endemic country.    
Epidemiological risk factors can be supported with positive diagnostics result(s), and 
vice versa, by which can increase diagnosis of suspected latent tuberculosis. Chest 
radiographic findings must be interpreted in the context of the individual’s exposure 
and medical history which immigrant’s should sign for information responsibility. 
This facilitates assessment of the challenges of re-activation prediction (Eisenberg 
and Pollok, 2010). 
Communities are still focusing only on the clinical management of patients with 
active disease, but preventive programmes can identify and treat prophylactically 
individuals with LTBI and are recommended for the future. Cost-effectiveness of 
immigrant screening then follow addressing the characteristics of the population’s 
health in addition to assessing the impacts of enhanced screening policies. Cost-
effectiveness of immigrant screening guidelines is further explained in chapter 9.   
8.4.2.3 Laboratory definition of latent tuberculosis index cases  
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A ‘definite’ case of tuberculosis is normally defined as any condition with positive-
culture-confirmed disease due to Mycobacterium tuberculosis complex. Any new 
immigrant can be defined by an evidence-based definition in those healthy, without 
any clinical manifestations of active TB disease, and who were diagnosed by positive 
radiological changes of MTB in chest radiographs, or by having positive results of 
either or both IGRAs (QNF-GIT more than 0.35 IU/ml or T-SPOT .TB tests, 
interpreted having more than or equal six spots (> 6 spots)) and without radiological 
abnormalities. Laboratory reports also define latent tuberculosis infection 
alternatively as any case ‘other than definite’ (Rieder et al., 1994).  
The introduction of diagnostic interventional and targeted measures can improve 
LTBI detection and raise the quality of health care. The results of four different 
tuberculosis tests (the two old; CXR and TST, and the two new immunological 
IGRAs) were included for comparison of new evidence-based combinations. 
Evidence-based laboratory criteria of diagnostic tests for diagnosing latent 
tuberculosis and Mycobacterium tuberculosis carriers can be integrated, as outlined 
in Table 8.2 (described in detail in chapter 5) and Table 8.3 (as detailed in chapter 6).  
Table 8.2: Diagnostic result frequencies of evidence-based laboratory diagnostic tests in 
predicting the development of latent tuberculosis infection and Mycobacterium tuberculosis 
suspicious carriers in 180 new immigrants to Kuwait during February and May, 2010 
CXR = chest radiography, QNF-GIT = QuantiFERON Gold In-Tube test, T-SPOT.TB = T-SPOT 
.TB test 
Including those excluded cases and added as having negative test results (each 
according to its relevant diagnostic test), then combinations of the laboratory 
diagnostic test results to achieve more evidence-based of the highest diagnostic 
accuracy for detection of LTBI are shown in Table 8.3. 




CXR (score II, III, or IV) LLRχ2(16) = 46.593 < 0.001 18 (10.06 ) 
QNF-GIT (positive result > 0.35 IU/ml) LLRχ2(4) = 184.972 < 0.001 51 (28.33) 
T-SPOT.TB (positive result > 6 spots) LLRχ2(8) = 192.884 < 0.001 74 (41.11) 
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Table 8.3: Evidence-based results of combinations from three tuberculosis diagnostic tests and 
diagnostic performances in 180 new immigrants to Kuwait during February and May, 2010 
Radiologist = means chest radiography interpreted by at least one radiologist 
The highest accuracy of LTBI diagnostics was a combination of IGRAs (82.78%), 
then CXR (with radiologist) plus QNF-GIT and CXR (with radiologist) plus T-SPOT 
.TB test respectively (69.27%, 59.78%). The cost-effectiveness of dual-testing 
screening guidelines for LTBI detection in immigrant’s is further discussed in 
chapter 9.   
8.4.3 New laboratory classification against a ‘proposed’ gold 
standard test’  
Another aim was testing a new current recommended criterion for the diagnosis of 
LTBI in asymptomatic and apparently normal recent immigrants. Accepting the 
results of only one type of TB diagnostic test can limit the value of evaluation of 
high-risk immigrants and under-estimate LTBI prevalence, in which our study 
recommended LTBI assessment by at least two TB diagnostic methods. Another new 
guideline (a two-test strategy) for the evidence-based diagnostic accuracy of TB 
diagnostic test combinations previously shown in Table 8.3 was re-tested as a 
combination of two diagnostic tests against a ‘proposed’ gold standard test for latent 
tuberculosis infection, shown in Table 8.4. 




Frequency (%) Frequency (%) Percentage % 
Chest X-ray (radiologist) plus QNF-GIT 175 (97.2) 5 (2.8) 69.27 
Chest X-ray (radiologist) plus T-SPOT .TB 171 (95) 9 (5) 59.78 
Both IGRAs (QNF-GIT plus T-SPOT .TB) 133 (73.9) 47 (26.1) 82.78 
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Table 8.4: Estimation of diagnostic test accuracy for combinations of tuberculosis diagnostic test results versus a ‘proposed’ gold standard test 
implemented in 180 new immigrants to Kuwait during February and May, 2010 (GST = proposed as theoretical-laboratory ‘gold standard test’) 
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CXR = chest radiography, QNF-GIT = QuantiFERON Gold In-Tube test, T-SPOT.TB = T-SPOT .TB test, SN = sensitivity, SP = specificity, PPV = positive 




Table 8.4 shows that the results of a combination of chest radiography (interpreted by 
a radiologist) and QNF-GIT test against T-SPOT .TB test as a ‘proposed’ gold 
standard test revealed the highest diagnostic accuracy of 97.22% with statistical 
significance (LLR χ
2
 (1) = 9.094, p = 0.003). Another combination of CXR plus T-
SPOT .TB test against QNF-GIT as theoretical gold standard revealed diagnostic 
accuracy of 95% but with no significant statistical relationship (LLR χ
2
 (1) = 3.086, p 
= 0.079). A combination of both IGRAs versus chest radiography as ‘a proposed’ TB 
gold standard also revealed the lowest diagnostic accuracy of 73.89, without 
statistical significance (LLR χ
2
 (1) = 0.029, p = 0.866).   
8.4.4 Research evidence-based supports 
Our findings support those of Moon and  others (2011); the first combination of CXR 
and QNF-GIT diagnostics can be recommended for all new immigrants carrying 
Mycobacterium tuberculosis, and can be started as ordinary testing in  high-income 
and low endemic countries instead of applying only CXR, by which latent 
tuberculosis and foreign-born suspicious cases can be detected (Moon et al., 2011).   
Latent TB infection can be miss-diagnosed because of over-reliance on positive TST, 
due to antigen interactions from prior BCG vaccination and environmental non-
mycobacterial infection, versus lower screening costs using QNF-GIT for TB 
contacts as shown by Hardy et al. (2010). On the contrary our research findings 
revealed under-estimation of LTBI if relied only on TST results. Analysis of 
prospective cohort studies using TST indurations of more than 10-mm and/or 
radiographic evidence of old and healed TB calcifications has demonstrated that the 
lifetime risk of TB re-activation reached more than 20% of the population (in 
particular, adults older than 35 years or children less than five years) (Horsburgh, 
2004).  
The new IGRAs diagnostic techniques have a higher specificity and sensitivity than 
the Mantoux test (standard LTBI diagnostic) for LTBI diagnosis in recent 
immigrants and high suspicious TB cases, and whether BCG vaccinated or not (Al-
Orainey, 2009; Brodie et al., 2008; Diel et al., 2010; Grimes et al., 2007; Menzies et 
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al., 2007; Orlando et al., 2010; Pai et al., 2005; Pai et al., 2006; Tavast et al., 2009). 
Regular IGRAs screening instead of only chest radiography in the high-income 
countries is recommended same as our study recommended indicators. Using IGRAs 
achieved majority of all health care workers to be latently infected with tuberculosis 
in the high TB incidence such as India, attributable to increased occupational 
exposure to Mycobacterium tuberculosis plus repeated exposures in the community 
(Joshi et al., 2007). Lower IGRAs positive results than TST are related to a lower 
QNF-GIT sensitivity but higher specificity (Orlando et al., 2010).  
8.5 Conclusions 
Detection of latent tuberculosis cases in certain foreigners and nationalities can 
facilitate future tuberculosis control and prevention. Susceptibility to MTB infection, 
the pathogenesis and the asymptomatic/symptomatic manifestations of LTBI/TB will 
depend on the immunological status of the exposed hosts, which can be indirectly 
determined by combinations of both evidence-based epidemiological co-morbid risk 
factors and/or laboratory diagnostic test results. The challenges of LTBI control and 
TB elimination then can be rapidly met.  
8.6 Study recommendations 
1- New similar study trials should be tested on large sample of recent expatriates of 
implementing both evidence-based epidemiological and laboratory diagnostic 
criteria using both QNF-GIT plus chest X-ray for defining a latent tuberculosis 
index case. Then, 
2- Compare the research findings to other samples of high-risk groups; first from 
recent immigrants (from TB endemic countries) and second from foreign-born 
residents of similar immigrant nationalities living in Kuwait.  
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9 Chapter nine  





Latent tuberculosis cases are undetermined/under-estimated in the high-incidence 
settings, in which 9.4 million active TB disease cases recently correspond to an 
estimated incidence of 140 per 100, 000 population occurring throughout the world 
in 2009. On the other hand, out of these total active TB cases only 5.7 million (new 
cases and relapsed cases) were actually notified to the various countries’ national 
tuberculosis programmes (NTP) and the rest were based only on estimated 
assessments of effectiveness of surveillance systems with an estimated 1.4 million 
(15%)  incident TB/HIV co-infections in 2008 (WHO, 2010c; WHO, 2010g).  
During infection with Mycobacterium tuberculosis, it is still unknown whether the 
organism inside the body is in a persistent slow replicating state or is settled in a 
dormant non-replicating state, with the latter ultimately possibly causing a latent 
infection with the potential to reactivate to active disease forms. International TB 
epidemiology and endemic veracity of world countries limit TB diagnosis and 
management even the outlines recommended by the WHO. The majority of new TB 
cases arise from re-activation of dormant foci of infection. Thus, management of 
LTBI is a major recommended national strategy for TB disease prevention 
(Horsburgh et al., 2004). 
The aim, worldwide, is to manage/control and prevent tuberculosis, but, there is only 
limited evidence to support the current TB screening guidelines, which are still 
unable to identify individuals with latent tuberculosis in particular from TB endemic 
regions. TB control can be supported through chemoprophylaxis and prevention of 
individual cross-infections such as those occurring in newly hired health care 
workers, or prevention of secondary transmission using preventive medication when 
immigrants enter from highly endemic countries (He et al., 2010; Schwartzman and 
Menzies, 2000).  
Successful control of LTBI/TB in low-incidence countries will depends on early 
detection of patient with the acute clinical form of the disease, in addition to effective 
screening and treatment programmes for the identification and preventive 
prophylaxis of latent tuberculosis cases at high risk of MTB re-activation/progression 
(Orlando et al., 2010). 
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Evidence-based approaches and tuberculosis control policy should enable clearer 
determination of the risk factors influencing tuberculosis incidence that are tailored 
to local needs. Effective estimation of health impacts of both the broad social and 
economic policy interventions then can focus on the disease- or population-specific 
public health programmes. 
9.2 Aim 
To describe the cost-effectiveness of preventing latent tuberculosis infection in a 
screened high-risk group of new immigrants.  
9.3 Discussion 
The challenges for ease access to the primary health care system and follow-up 
control of treatment adhesion added to contacts tracing, all can be facilitated by 
‘effective’ screening and treatment programmes for recent immigrants (Orlando et 
al., 2010).  
Improvement of the effectiveness of tuberculosis control programmes in Kuwait can 
be achieved by identifying cost-effective priorities for screening for latent 
tuberculosis in new immigrants entering the country each day. New ‘two-step’ LTBI 
screening guidelines can facilitate progress towards TB elimination by prioritizing 
screening for new immigrants arriving from TB high-incidence and endemic 
countries, in particular for specified epidemiological variables.  
9.3.1 Screening of high-risk groups (new immigrants)  
Screening is a systematic search for LTBI/TB, often performed by radiological 
investigation, and/or followed by the Mantoux skin test for positive radiographic 
findings, and newly recommended to use the biomarker (immunological) IGRAs 
tests. Increased knowledge of LTBI progression rates in those individuals having 
positive IGRAs (one-step or two-step strategy) would help to improve the 
hypothetical cost-effectiveness outcomes were statistically achieved in the systemic 
review analysis performed by Nienhaus and colleagues (Nienhaus et al., 2011).  
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A major concern of public health is the screening of high-risk populations such as 
foreign-born and recent immigrants or contacts to actively infected TB patients. In a 
recent survey of 26 European countries, 13 reported and strictly implemented 
national TB screening programmes for immigrants and/or refugees, while only a few 
of them  recommended treatment for LTBI detected by the  screening (Coker, 2004). 
The observed results of Losi and colleagues (2011) were similar to our study 
findings, and highlighted the potential advantages and concerns of using a blood test 
for diagnosing LTBI in a 'two-step' strategy in foreign-born children. Uncontrolled 
intensification of immigrant screening and TB surveillance were unable to reflect the 
challenges of LTBI prevention. Then the issue had been solved by careful planning, 
pilot testing, enhanced information sharing, health care services availability/training, 
and continuous programme evaluations (Richard et al., 2005). 
The study findings are relevant to public-health interventions, the ultimate aim of 
LTBI screening being the prevention of progression to active TB using 
chemoprevention. Whether the introduction of IGRAs in the TB screening of new 
immigrants is cost-effective need always to be studied according to each the country 
health system. Recent immigrants from the TB endemics (less than two years since 
immigration) can re-activate and develop active TB disease which should be 
targeted. In countries with an incidence of active TB less than 10/100,000 habitants 
(such as Kuwait) the screening strategies for the identification of those high risk 
subjects are cost effective for TB control and reduce epidemic risk (Orlando et al., 
2010).  
9.3.2 Is screening immigrants for latent tuberculosis a cost-
effective preventive procedure? 
Routine screening of new immigrants and foreign-born high-risk groups, although 
costly, would help to detect latent tuberculosis cases early, to improve public health. 
Screening and identification of latent tuberculosis cases was found cost-effective 
before development of new active TB cases, thus preventing future cases of active 
tuberculosis in UK (Pareek et al., 2011). 
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Identify ‘suspect TB’ carriers was tested through building a classification tree using 
epidemiological-radiographic-laboratory test results was described in chapter 8, 
section 8.4.2.  
The prevalence and predictive factors associated with tuberculosis in adolescents 
were found to be latently infected with MTB in TB high-burden settings, in endemic 
predictable regions with socio-demographic and economic poverty-related factors 
and by which able to predict the risk of TB infection. Such deprived adolescents 
should be the target group for educational interventions by TB control programmes 
(Mahomed et al., 2011). 
 
The guidelines of LTBI screening can raise the community health toward TB 
elimination by prioritizing screening for close contacts of TB infected patients and 
the foreign-born residents and/or new immigrants regardless of their time living or 
even if coming to non-endemic countries was observed to be more cost-effective than 
only TST screening (Linas et al., 2011), which was consistent with our study’s 
recommendations. The lower sensitivity/specificity of TST can be associated with 
drop-out follow-ups of participants which can reduce the effectiveness of the CXR-
TST dual strategy of LTBI detection in suspected tuberculosis cases (Orlando et al., 
2010). Systematic review studies of cost and cost-effectiveness for different TB-
screening strategies revealed with evidence-based that either IGRA single-screening 
strategy was cost-effective than the IGRA two-step strategy or other used guidelines 
(Nienhaus et al., 2011).  
 
Systematic screening is known to have a positive impact on community health. 
Raising the level of public awareness of LBTI/TB, early detection and effective 
treatment, early contact recognition, adoption of protective measures, and effective 
screening of LTBI cases, are all necessary for controlling the risk of TB in a country 
(Horsburgh, 2004). 
 
Regular reliable surveillance is essential part for any TB control programme and 
under-registration is rare in Kuwait due to high-notification system. In Kuwait, post-
entry registration of immigrants denotes a strong and effective immigration 
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registration system and within short time, which coincide with strict TB case 
notification and 100% detection rates. This denotes strict legislative laws and 
implemented interventions to increase the registration completeness and legal 
notification of both active TB cases and latent TB cases requiring chemoprophylaxis 
(WHO, 2010i).  
 
The screening policy of new immigrants recommended by WHO, implemented all 
over the world and compulsory in Kuwait, is primarily using chest X-ray and 
secondly by TST or other diagnostic test for suspected CXR positive findings (Al 
Jahdali et al., 2010; CDC, 2011a; Hardy et al., 2010). Educational programmes 
should re-enforce the consequences of treatment delay among tuberculosis cases 
which contributes to the greatest number of infectious days. Also clarifications are 
needed of the loss of follow-ups and the related threatened negative expectations of 
MTB transmission within the family and society (Gust et al., 2011). Positive 
diagnostic results can be approved as a reference standard for LTBI diagnosis and 
reflects exposures to MTB among high-risk groups and foreign-born residents from 
endemic countries (O'Donnell et al., 2010). 
 
With the absence of a gold standard TB test, evidence-based future guidelines for 
diagnosis of LTBI case must be re-organized, periodically updated, and without 
financial conflicts or health care overloads. 
 
The six Gulf state countries are one of the largest markets for immigrant Arab and 
Asian job seekers. After the discovery of oil, the absence of a workforce necessitated 
employment of an expatriate labour force, which brought negative socio-economic, 
cultural and health consequences, such as changes in infectious disease 
epidemiology. Planned migration screening programmes for TB can be improved 
using evidenced-based identification criteria of suspect MTB carriers, through 
cooperative research between countries. Direct costs in the developed/in-migrant 
countries include expenditures on hospitalization and transportation, consultation 
fees, diagnostic tests and medicines/treatments fees. Indirect costs on the health care 
system can be accessed through the days lost from work due to symptomatic 
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complaints or health-seeking behaviours such as recurrent visits for uncontrolled 
relapse of active TB disease (Pantoja et al., 2009).  
Post-arrival immigrant screening decreases the infectiousness period and identifies 
cases of latent TB infection. For example our research findings if implemented can 
facilitate improvements in the morbid rates of Kuwait residents through the 
immigrant’s future screening for latent TBI without missing cases.  
Pareek and colleagues (2011) advanced the evidence-base by using the more accurate 
and empirical IGRA screening, which can be objectively applied and achieved cost-
effective screening of immigrants at different regions. Screening of all immigrants 
aged less than 35 years from any country would cost more than £1.5 million and 
could prevent 44.5 cases of tuberculosis, whereas application of NICE guidelines 
would cost about £850,000 and only prevent 13.2 cases of active disease in UK.   
Even with overall discordances between TST and IGRAs, various studies proved that 
the performance of interferon gamma release assays for LTBI diagnosis was higher 
and more efficient than the gold standard TST (Ferrara et al., 2006; Harada et al., 
2006; Mazurek et al., 2007; Pai et al., 2005; Pai et al., 2006; Richeldi, 2006; 
Sauzullo et al., 2008; Winje et al., 2008).  
Screening for LTBI with positive TST followed by an IGRA was a cost-effective 
approach for the high-income and low-risk countries. The UK-NICE guidelines 
protocol estimated about £47.67 per screened immigrant and about £160.81 per LTBI 
case identified (NICE, 2006). Pooran and colleagues (2010) showed that, per 1,000 
screened contacts, the TST/IGRA dual screening strategies using TST/T-SPOT .TB 
was costed at £162,387 versus TST/QFT-GIT costs of £157,048, which costed less 
than the single strategy counterparts (T-SPOT .TB and QFT-GIT; £203,983 and 
£202,921 respectively). Single IGRAs strategies should be requested accurately by 
the health care staff and only to those truly suspected/infected TB cases and 
harboring MTB, with subsequent correct treatment/follow-up of LTBI cases in the 
high-risk groups. A dual strategy is more cost effective than a single strategy, but this 
conclusion is sensitive to the used screening test assumptions and LTBI prevalence. 
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The implementation of LTBI screening programmes is strictly indicated only in 
settings where LTBI prophylaxis and follow-up can be offered and monitored. The 
use of IGRAs to screen immigrants in TB control programmes have been 
recommended by Carvalho and others (2005) and Winje and others (2008). The 
average cost of identifying one latent tuberculosis case following UK-NICE 
guidelines was £160.81, whereas, using the first-line QFT followed by CXR 
protocol, it was only £93.16 (Hardy et al., 2010). Recent analysis of the available 13 
studies on cost-effectiveness provides strong evidence in support of the use of IGRAs 
in screening the high-risk groups such as new immigrants and their close contacts 
from high-incidence countries (Nienhaus et al., 2011).   
9.3.3 Preventive therapy (chemoprophylaxis) of latent 
tuberculosis infection  
Tuberculosis is still a global public health problem and a major leading cause of 
infectious disease morbidity and mortality all over the world, particularly in low-
income and middle-income countries, especially where tuberculosis is hyper-
endemic because of  increased exposure and transmission. 
The American Thoracic Society and Center for Disease Control and Prevention 
recommended using the terminology ‘Treatment of Latent Tuberculosis Infection’ 
instead of ‘Preventive Therapy’ or ‘Chemoprophylaxis’, which mean prevention of 
development of active TB disease in individuals that are currently well and 
asymptomatic, but infected and carrying Mycobacterium tuberculosis (ATS and 
CDC, 2000). For example, immigrants born in high-incidence countries that had 
arrived within less than two years averaged 25 years of age on arrival are major 
targets for preventive therapy (Langlois-Klassen et al., 2011). Preventive efforts are 
noticed to begin LTBI prophylaxis and ensure treatment follow-ups. Even after initial 
screening, treated cases can drop-out and miss the medication schedule follow-ups. 
Therefore, LTBI will not be prevented because of non-adherence to LTBI treatments. 
Our findings were generally similar to WHO guidelines and recommended strict 
follow-up to ensure LTBI/TB control.  
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Before LTBI prophylaxis, active TB disease should be excluded, and then the full 
prophylactic regimen should be followed carefully. Screening and preventive 
prophylaxis of LTBI are key tools for reduction in the risk of developing active TB 
among immigrants from endemic and non-endemic countries by more than 50%, and 
is targeted for TB control programmes which depend on screening biomarkers (CDC, 
2000; Rieder et al., 1994). For example, a positive TST can be confirmed by positive 
IGRAs in BCG-vaccinated individuals, and then LTBI chemoprophylaxis can be 
initiated after exclusion of active TB (Al Jahdali et al., 2010).  
Treatment of latent tuberculosis infection is an essential component of tuberculosis 
control and elimination. The goal of preventive treatment is to minimize the 
transmission of Mycobacterium tuberculosis by carrying out a public health action to 
prescribe and follow-up completion of treatments.  Therefore, treatment of latent TB 
reduces the risk of TB infection progressing to TB disease (CDC, 2011d). LTBI is 
associated with a lower burden (or number) of MTB organisms, therefore requiring 
fewer drugs compared with the four-drug therapy of active TB without creating drug-
resistance (Al Jahdali et al., 2010).  
Isoniazid preventive therapy (IPT) is cheap and highly efficacious (up to 90%) in 
stopping progression to active TB among TST-positive people, but, despite having an 
effective drug, LTBI progression to active TB still largely unchecked. Efficacy and 
compliance results were considerably higher and acceptable alternative using a new 
regimen of short-course regimen with isoniazid for six months and/or rifampicin for 
three or four months than a nine-month of isoniazid treatment, which may also was 
more effective against infection with isoniazid-resistant or rifampin-susceptible 
mycobacteria with uncommon drug-related adverse effects in children and is a 
recommendation for adult investigation (Al Jahdali et al., 2010; Spyridis et al., 
2007). Table 9.1 shows the latest CDC recommendations and the future preventive 





Table 9.1: Treatment regimens for latent tuberculosis infection in adults (CDC, 2011d)  
Drugs Duration Interval Minimum dose (mg) Maximum dose (mg) 
Isoniazid 9 months 
Daily 270 300 
Twice weekly* 76 900 
Isoniazid 6 months 
Daily 180 300 
Twice weekly* 52 900 
Isoniazid      and 
Rifapentine 
3 months Once weekly* 12 INH (900)/Rif (900) 
Rifampin 4 months Daily 120 450-600 
*means use Directly Observed Therapy, short course (DOTS) 
Note: CDC recommends that the combination of rifampin (RIF) and pyrazinamide (PZA) should generally not be 
offered for LTBI treatment due to reports of severe liver injury and death. 
Chemoprophylaxis of LTBI using a short-course regimen is indicated to ensure that 
infection does not progress to active TB. Studying the socio-cultural believes and 
behavioural attitudes can demonstrate the treatment acceptance/adherence in the 
foreign-born individuals and in-migrants (Minodier et al., 2010). Out of 1,414 close 
contacts having similar exposures revealed, 903 refused chemoprevention and 19 
developed active TB within four years and all of the latter previously had positive 
QFT-GIT results and the progression rate was higher in children than for adults (Diel 
et al., 2011b).  
LTBI therapy consists of nine-month course of daily isoniazid (INH) or combination 
of isoniazid-rifampicin (INH-R) for three months, and monthly clinic visits for 
monitoring medication side effects. The majority of contacts showing evidence of 
harbouring dormant LTBI were reduced by seventy percent of the risk of progressive 
developments to active disease by completing a six-to-nine month’s course of INH 
(Salazar-Vergara et al., 2003; Spyridis et al., 2007). A recent cost-effective analysis, 
which considered INH-related hepatoxicity and post-exposure TB contacts, 
concluded that a dual strategy of TST followed by an IGRA was more cost-effective 
(Pooran et al., 2010). Diel and colleagues (2007) described a previously similar cost-
effective study of the outcomes of INH treatment for close contacts in non-endemic 
countries such as Switzerland. 
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The use of rifapentine (900 mg) plus isoniazid (900 mg) (combination-therapy 
group) for 3 months was as effective as the standard regimen 9 months of isoniazid 
(100 mg) (isoniazid-only group) alone in preventing tuberculosis at high risk groups, 
and had a higher treatment completion rate for the shorter therapeutic duration 
(82.1% versus 69% respectively) (Sterling et al., 2011). Patients with LTBI treated 
with rifampin for 4 months show higher completion rate than those given INH for  
nine (91.3%) or even four  months (77.2%), respectively (Young et al., 2009). 
The shorter regimen and application of directly observed preventive therapy (DOPT) 
increases therapeutic completion rates (Sterling et al., 2011). Rifamycin is a new 
medication that has strong sterilizing activity against both dormant and semi-dormant 
TB bacilli and more potent than INH regimen alone. Rifapentine (long acting 
rifamycin/isoniazid combination) is better tolerated with less hepatotoxicity 
compared with rifampicin or pyrazinamide (Yew et al., 2007). In addition to higher 
therapeutic compliance with short-course regimens, rifampicin can be considered as 
replacement therapy for children with LTBI in countries with more than 11% of 
isoniazid resistance (Finnell et al., 2009). 
9.3.4 Obstacles to latent tuberculosis infection prevention 
The chronic slow growth of the mycobacterium tubercle bacillus is the greatest 
obstacle to rapid diagnosis of LTBI/TB disease, but unfortunately, there are still no 
accurate guidelines to indicate how LTBI can be prevented. Early detection and 
treatment of active TB cases by DOTS cannot reduce MTB transmission among 
immigrants because most active TB occurs due to re-activation of infections acquired 
in their country of origin (El-Hamad et al., 2001). Reduction of exposure risks 
should be a high priority, especially for occupational and environmental TB risk 
factors. Loss of infected skilled labourers and health care workers such as nurses and 
doctors who are essential in the fight against TB disease (Bradshaw et al., 2011; He 
et al., 2010; Jong Lee et al., 2010; Rafiza et al., 2011). In the Poland IGRAs are not 
licensed added to the absence of utilization guidance complicated subsequently with 
higher risks of nosocomial exposures and MTB transmission between HCW’s and to 
the general population (Demkow et al., 2008). 
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The introduction of a free TB treatment policy in the high income countries with no 
financial complaints still barriers to tuberculosis care are detected among migrants 
occurs due to weak health care system. Limited access to medical services was 
reduced by solving the financial stress/constraints, however, these limitations cannot 
be accepted by those immigrants being laid off from work (cause of in-migration) or 
facing the community avoidance after diagnosed to have LTBI/TB (Wei et al., 2009). 
Inadequacies in the screening process and increased TB prevalence in the general 
population can occur due to increased TB frequencies (Mankia et al., 2011). When 
IGRAs are used to determine latent TB infection in foreign-born individuals, positive 
findings relate to recent TB infection and also reflect prior TB exposure in the 
country of origin (Kik et al., 2009). 
Diagnostic test cost-effectiveness can be enhanced by increased adherence to 
chemoprophylaxis recommendations (Schwartzman and Menzies, 2000). Risk factors 
of treatment non-compliance due to the long preventive treatment duration of INH 
for nine months or INH-R combination for three months, and adverse effects in 
addition to the needs for regular monitoring during treatment, results in suboptimal 
treatment completion rates, which are closely related to demographic factors e.g. age, 
gender, smoking habit, different education level and recent immigrants less than five 
years of residence and/or with social maladaptations e.g. unemployment (Anibarro et 
al., 2010; El-Hamad et al., 2001; LoBue and Moser, 2003; Young et al., 2009). High 
medication completion levels are directly but marginally related to short treatment 
regimens (Spyridis et al., 2007). Non-adherence to preventive measures during 
screening is under-estimating LTBI prevalence post-treatment. Multi-generational 
households and unstable living cultures are socio-demographic factors associated 
with poor adherence to LTBI prophylaxis (Minodier et al., 2010). Language barriers 
between immigrants and medical providers are a major obstacle to effective 
surveillance of health care (CDC, 2007). The appearance of drug-resistant 
tuberculosis is another urgent pre-request for LTBI detection through screening of 
high risk groups. In 2008, 440,000 multidrug resistant cases emerged globally, with 
an estimated 50% in India and China (WHO, 2010h). In Kuwait, nine cases out of 
reported 428 TB confirmed cases were recently confirmed and started treatment, and 
all were tested for MDR-TB (WHO, 2010i). LTBI conversion (after lifetime 
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dormancy) and risks of progression to active TB disease ranges from 10% to 20% 
also impedes TB control (Horsburgh, 2004).  
9.3.5 Cost-effectiveness of evidence-based new 
recommendations for using IGRAs 
Tuberculosis has enormous public health and economic implications in high-burden 
countries, therefore providing targeted interventions is recommended, particularly for 
those high-risk groups (WHO, 2008a). Wiker et al. (2010) concluded that in several 
populations, latent tuberculosis appears to be more rapidly cleared than previously 
thought. The early detection and treatment of LTBI constitutes an essential 
component of the tuberculosis control strategy in resource-rich and low-prevalence 
countries and helps to interrupt MTB transmission. The risk of nosocomial 
transmission and incidence of TB in the majority of high-income countries has 
dramatically declined after implementation of a recommended set of infection-
control practices to reduce TB burden (Drobniewski et al., 2007; Seidler et al., 
2005).  
Radiographic CXR screening of immigrants from TB endemic countries can save 
money, but remains less diagnostic than the new biomarker IGRAs or PCR. 
Compared with no screening, radiographic screening (cost U.S.$3,943 per prevented 
active TB case) prevented 4.3% of expected active TB cases in the highest risk 
group, and 8% in the lowest risk people (U.S.$236,496 per case prevented). Also 
tuberculin skin testing further reduces the expected incidence to 8% and 4% 
respectively, but still is less cost-effective than adding either IGRAs (Schwartzman 
and Menzies, 2000).  
Routine careful scheduling and case counseling followed by monitoring of LTBI 
diagnosed cases and utilizing with completion of the low-cost chemo-preventive 
medication especially for contacts of diagnosed active TB patient are recommended 
(Anibarro et al., 2010; Young et al., 2009). A school-based TB-screening programme 
was effective when targeted towards children of recent immigrants detected early 
with LTBI (Minodier et al., 2010). IGRAs screening for LTBI treatment was found 
highly cost-effective in reducing the burden of active TB disease (Diel et al., 2007). 
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Gray and colleagues (2011) recently detected that out of 94 HIV patients with QNF-
GIT-positive results, 45 patients were not re-tested and all were offered LTBI INH-
preventive treatment , and none developed active tuberculosis during follow-up. 
LTBI prevalence through nosocomial transmission of MTB is an important 
occupational problem among health care workers, and risk reductions should be a 
priority (He et al., 2010; Seidler et al., 2005), and need strict infection control (Sacks 
et al., 1999), which necessities accurate LTBI diagnosis through serial screening 
using IGRAs instead of the annual chest X-ray similar to our research 
recommendations.  
Several studies on cost-effectiveness provide strong evidence supporting the use of 
IGRAs in screening risk groups such as HCWs and immigrants from high-incidence 
countries and close contacts of patients developing active TB (Nienhaus et al., 2011).  
Moon and colleagues’ (2011) results showed a high prevalence of positive TST and 
QFT-Gold in 173 samples of laboratory personnel which recommended the use of 
IGRAs to screen for LTBI and as helpful confirmatory follow-up tests for MTB 
infection. Similarly, Hardy and colleagues (2010) revealed that QNF-GIT followed 
by chest X-ray can be a complementary and available cost-effective diagnostic tool 
for immigrant screening because of the reduced number of CXR’s following the 
positive QNF-GIT results. Screening for latent TB using blood biomarker tests 
(IGRAs) is obligatory before starting anti-tumour necrosis factor treatment for 
rheumatologic disorders, and instead of  tuberculin skin test especially in the BCG 
vaccinated populations (Anderson et al., 2000; de Andrade Lima et al., 2011). The 
use of IGRAs for identifying subjects requiring anti-tuberculosis chemoprophylaxis 
also might be considered a better cost-effective long-term curative strategy (Diel et 
al., 2007).  
The choice of diagnostic test should be based on cost-effectiveness. Diel et al. (2008) 
evaluation of 601 close TB contacts detected higher QNF-GIT accuracy and 
specificity than TST for the presence (or diagnosis) of LTBI who will progress to 
active TB. Similarly, QFT-GIT was found more reliable than the TST in identifying 
those individuals who soon might progress to active TB, especially in children (Diel 
et al., 2011b). The higher QFT-GIT specificity over TST prevents unnecessary 
overloads on the health care system and, even though IGRAs are more expensive, 
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can represent a cost-effective alternative to TST in high-risk and targeted screening 
programmes (Orlando et al., 2010).  
 
Kowada and colleagues (2008) evaluated different screening strategies against a 
hypothetical cohort of 1,000 immunocompetent 20-year-old individuals had contact 
with sputum-smear-positive PTB patients. The study findings of a base-case analysis, 
the QFT-alone strategy was dominant (U.S.$S471.54; 28.1099 quality-adjusted life-
years [QALYs]) and the most cost-effective for TB screening in close contacts within 
a medium-incidence country with a completely BCG-vaccinated society like Japan, 
compared with the combined TST/QNF strategy (U.S.$500.55; 28.1087 QALYs) and 
the TST-alone strategy (U.S.$573.98; 28.1079 QALYs).  
  
Pooran and colleagues’ (2010) analysis revealed that the cost-effectiveness of five 
different screening criteria for contact tracing over two years post contact in UK was 
the two-step strategy using both TST and T-SPOT .TB test (₤37,206 per case of 
active TB prevented), followed by the near similar costs as the TST and QFT 
strategy (₤37,699 per case of active TB prevented) as the most cost-effective 
strategies, in comparison to the use of TST alone was the least cost-effective 
(£47,840 per active TB case prevented). 
In contrast, Mancuso and colleagues’ (2011) findings detected that ‘targeted’ 
strategies’ costs were over U.S.$250,000 per case prevented, whereas, ‘universal’ 
testing strategies’ costs were over U.S.$700,000 per case prevented in rising-
incidence countries. Even though targeted testing offered the best solution, it is still 
expensive compared with no testing, and ‘sequential’ testing using both TST and 
IGRAs. However ‘targeted’ and ‘universal’ testing strategies using the TST alone 
was the slightly more cost effective strategy than targeted testing using either 
QuantiFERON-TB Gold In-Tube or T-SPOT .TB test for LTBI diagnosis. 
9.4 Conclusions 
Screening for latent tuberculosis infection can be justified among populations at a 
higher risk of carrying Mycobacterium tuberculosis infection and developing 
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tuberculosis disease. Awareness of the health care staff about early detection and 
chemoprophylaxis and aggressive follow-ups proved reduction of TB prevalence 
risks. Targeting of the most vulnerable high-risk groups and new immigrants with 
diagnostic interventions is essential for the progress of preventive control measures. 
Either IGRAs can be implemented cost effectively with or without positive 
radiographic interpretation. A global dual-strategy approach for LTBI diagnosis was 
possibly more cost-effective strategy than a single strategy for the healthcare contacts 
in UK (NICE, 2011; Pooran et al., 2010), which can be tested in Kuwait to estimate 
LTBI prevalence before diagnostic guideline generalization.  
9.5 Study recommendations  
Screening and resources for planning, training and supervision are required to 
safeguard health quality. All these can directly and indirectly assess the country 
national health system; 
1- There is a requirement for funds for the development of new technologies, with 
better use and scale-up of the existing tuberculosis diagnostic tools, and adequate 
treatment capacity to care for the increasing numbers of diagnosed latent 
tuberculosis cases. This should greatly reduce the costs and work time in the 
future for the high-risk group comprising recent immigrants entering from 
tuberculosis-endemic countries. 
2- There is a need for analysis of cost-effectiveness of latent tuberculosis infection 
screening using the new dual-step diagnostic criteria. 
3- Future studies are suggested to evaluate chemo-prophylactic efficacy using short-
term one-drug regimens, in addition to effective diagnostic tools delivered 
through the authorized or specialized health care centres and medical care 
services to all suspect immigrants from tuberculosis endemic and Asian 
(particularly East Asian) countries at point of entry/registration. 
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It is important for any researcher to think about the bigger picture/context/issues that 
frame and inform TB infection and policy in non-endemic countries. Innovating and 
testing for evidence-based thesis structure (included in the nine chapters headings 
and described the contents/arguments of each) can be useful for other innovative 
frameworks through different data analysis and result interpretations toward raising 
the community health. 
10.1 Introduction 
The aims and objectives of this thesis have concentrated on ‘accurate’ and ‘early’ 
diagnosis of latent tuberculosis infection, which serves three major purposes; first, 
enabling an evidence-based diagnosis of latent TB cases and allowing future timely 
interventions; secondly, allowing epidemiological characterization of high-risk 
groups and ‘suspect TB’ cases where better TB control can be facilitated; and thirdly, 
indirectly assessing the health care system and related medical services of the 
country’s residents.  
Public health authorities should ensure they are;  
 offering appropriate health care and treatment services,  
 carrying out contact tracing of LTBI diagnosed cases, in addition to  
 early recognition of local outbreaks and monitoring of tuberculosis epidemiology 
represented by the recommendations of the WHO.  
As tuberculosis is the only disease clarified as clinical possibility, as radiological 
probability and as bacteriological certainty, therefore, Mycobacterium tuberculosis 
carriers and ‘suspect TB’ cases have to be early diagnosed and managed before 
bacillary re-activations 
10.2 Discussion 
The problem of latent tuberculosis infection is: 
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Nearly two billion of the world’s population are infected at least once with 
Mycobacterium tuberculosis, and are considered to have latent tuberculosis infection. 
The high-risk groups at risk of re-activation do not secrete the harbored and dormant 
bacilli, which are hard to diagnose by conventional laboratory tests such as sputum 
smear and bacterial culture. With the absence of a gold standard test for LTBI 
diagnosis, the results of various diagnostics for asymptomatic individual are still 
without clinical significance. To date, there are no evidence-based data to assess the 
performance for IGRAs in comparison with the TST, and the latter test remains the 
recommended test for LTBI diagnosis all over the world. Practical, cost-effective 
strategies to identify immigrants with latent tuberculosis infection and to deliver 
treatment for accurately diagnosed latent TB infection are still unavailable, but are 
needed in the future. 
Chapter 1 presented the general view of international pandemic latent tuberculosis 
infection and active tuberculosis disease and its related consequences, with the need 
for global epidemic control. Immigration of latent tuberculosis infected cases from 
tuberculosis-endemic regions is considered the main risk factor for bacillary 
transmission to low incidence countries. The problem with tuberculosis in the low 
prevalence countries in particular is the continuous unresolved leakage of latent 
tuberculosis immigrant cases, where increased tuberculosis morbidity and resurgence 
of Mycobacterium tuberculosis drug-resistance strains are internationally observed 
problems. Early identification and successful treatment of latent tuberculosis cases 
remains the most effective step against MTB transmission and towards its prevention 
(Orlanso et al., 2010).  
Chapter 2 explained the consequences of dominance of foreign-born residents due 
to continuous in-migration, even with controlled case notification of all infected 
tuberculosis cases in non-endemic countries such as Kuwait, and consequent 
increments of all tuberculosis morbid rates since the last three decades (HVS, 1984-
2009). Therefore continuous supervision of the control measures of all infectious 
diseases and tuberculosis is necessitated. The higher fatality rates in Kuwaitis, 
compared with the majority of diagnosed active tuberculosis cases in the foreign born 
residents requires further genotypic polymorphism analysis studies, especially within 
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the first one and two years post-entry due to high risks of MTB exposure-
transmissions. Without screening and treatment for latent tuberculosis, case 
notification rates of active tuberculosis disease among high-risk groups and recent 
immigrants remain high (El-Hamad et al., 2001).  
Chapter 3 described the material and methods for screening a sample of 180 new 
immigrants during obligatory registration at entry points using an epidemiological 
questionnaire and three tuberculosis diagnostic tests, in addition to the ordinary chest 
X-ray. Our findings show a significant difference between recent immigrant 
individuals for various variables and diagnostic test results, similar to Losi and 
colleagues’ (2011) recent findings in foreign-born children’s of settled immigrants to 
Italy. 
Chapter 4 demonstrated the commonest causes and evidence-based related risk 
factors for latent tuberculosis infection and active tuberculosis disease, which was 
one of the main objectives of this research work. The results of the questionnaire 
showed that social determinants of health should be addressed in the design of 
tuberculosis information campaigns. Barriers to diagnostics and management for TB 
control in Kuwait can be tackled by prioritizing tuberculosis public health 
interventions, as also recently noted by Mauch et al., (2011). Worldwide, LTBI 
diagnosis is still made using the tuberculin skin test, but this has disadvantages, such 
as shared interaction with the Bacille Calmette-Guérin vaccine antigens (applied in 
99% of countries) and false positive TST outcomes. Chest X-ray and the tuberculin 
skin test should not be continued as the ordinary diagnostic tests for abnormal chest 
findings and latent tuberculosis infection, but can help as confirmatory tests.  
Universal chest radiography and tuberculin skin test in a large pre- or post-
employment TB screening program was of low yield in the detection of active TB or 
the increased LTBI re-activation risks, and provided no assistance to decide which 
individuals to prioritize for LTBI chemoprophylaxis.  
The second objective was to demonstrate the potential utility and performance of 
both the two traditional tests used for diagnosis of latent tuberculosis infection; 
namely, chest X-ray and tuberculin skin test. This was addressed in chapter 5. A 
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new radiological criterion for LTBI diagnosis (chapter 5; section 5.1.5, Table 5.1) 
was developed from combination of previous evidence-based findings. The presence 
of radiologist opinions during interpretation is strictly recommended to raise the 
weakness of radiographic diagnosis from other non-specialized authorities. Both 
radiologists also were able to detect the abnormal CXR findings (10.8%) which were 
similar to the average worldwide LTBI prevalence (5-10%). Additionally, following 
the diagnostic criterion and scoring system of tuberculin skin test response of latent 
tuberculosis infection reaction (chapter 5; section 5.2.5, Table 5.5), which is followed 
by the Ministry of Health in Kuwait as recommended by ATS and CDC, 2000; CDC, 
2005c; CDC, 2010b, had still revealed a low diagnostic performance, with a need to 
present a new TST recording system for the non-endemic countries.  
Recently, interferon-gamma release assays were demonstrated to be excellent tests 
for detection of latent tuberculosis, and replacement alternative tests characterized 
with superior sensitivity and specificity to the CXR and TST and/or CXR alone in 
recent adult immigrants. Moreover, there was no interference from BCG vaccine, 
with consequent better prediction of latent tuberculosis cases (Al-Orainey, 2009; 
Brodie et al., 2008; CDC, 2011b; Diel et al., 2010; Gray et al., 2011; Grimes et al., 
2007; Mazurek et al., 2007; Menzies et al., 2007; Moon et al., 2011, Orlando et al., 
2010; Pai et al., 2005; Pai et al., 2006; Tavast et al., 2009).  
Chapter 6 described the comparative performance of the two-biomarker IGRAs 
diagnostics (QuantiFERON Gold In-Tube test and T-SPOT .TB test) for detection of 
LTBI in high-risk groups. Kik and colleagues (2009) observed that positive IGRAs 
results might be associated with previous remote infection without evidence of clear 
re-activation. Interferon gamma detective tests, both IGRAs, are reported to be better 
predictors and to correlate more the MTB exposure-re-activation risks toward 
developing tuberculosis disease than the standard Mantoux test (Mendez-Echevarria 
et al., 2011; NICE, 2011). 
Chapter 7 noted that absence of a gold standard test to correctly identify the 
sensitivity and specificity of each of the four tuberculosis diagnostic tests (Kunst, 
2006), thus challenging evaluation of test performance and comparative assessment 
 
434 
of different tests. A proposed new classification for detection of latent tuberculosis 
infection and ‘suspect tuberculosis’ cases using evidence-based laboratory diagnostic 
criteria was statistically tested and elucidated (chapter 7; section 7.3.3, Table 7.2). 
Chapter 8 re-capitulated the significant results of previous chapters 4-7 for the 
identification of latent tuberculosis infection index cases diagnosed from the 
evidence-based immunological (section 8.4.2.1), epidemiological (section 8.4.2.2.1, 
Table 8.1) and laboratory diagnostics (section 8.4.2.2.2, Table 8.2). A new two-step 
diagnostic criterion was tested versus a theoretical ‘proposed’ gold standard test and 
estimated for test combination accuracy (chapter 8; section 8.4.2.3, Table 8.5).  
Any clinical, radiological or bacteriological evidence of tuberculosis disease contra-
indicates chemo-preventive therapy, which should be prescribed only for definitely 
diagnosed LTBI cases after exclusion of active TB disease (Al Jahdali et al., 2010). 
The literature does not yet provide sufficient data on the definite accuracy of TST, 
CXR or IGRAs in detecting latent tuberculosis cases - even in high-risk groups. An 
urgent preventive measure through a new and more accurate diagnostic strategy 
requires further studies to determine the optimal use of new developed diagnostic 
algorithms.  
Chapter 9 described the cost-effectiveness of high risk group screening able to 
structure an evidence-based new recommendation for using a two-step diagnostic 
criteria procedure, using either IGRAs as compulsory test for high-risk groups and 
complementary CXR read by radiologists (Hardy et al., 2010; Losi et al., 2011; 
Nienhaus et al., 2011). This would raises the infection control measures and reduce 
the consequent rises in tuberculosis morbid rates previously explained in chapter 2. 
Chapters 7 and 9 demonstrated that immigrants should be screened at access points 
using the two-step combination criterion of both chest radiography (read by at least 
one radiologist) plus QuantiFERON Gold In-Tube test, before being identified as 
candidates for LTBI prophylaxis (Orlando et al., 2010). 
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10.3 Final conclusions 
Neither interferon gamma release assays nor chest radiography and the tuberculin 
skin test have high accuracy for the prediction of latent tuberculosis infection or 
active tuberculosis cases, although the use of interferon gamma release assays in 
certain high-risk groups such as immigrants from TB endemic regions can reduce the 
number of people considered for chemo-preventive therapy. Regardless of the 
diagnostic test(s) used, targeted testing for high-risk groups within low prevalence 
populations is critical in reducing unnecessary testing(s), which is similar to the 
recent conclusion of Mancuso et al. (2010). The recommended two-step strategy is 
cost effective than a single strategy for immigrant screening, depending on the 
country economic funds for IGRAs implementation and LTBI prevalence in relation 
to rising incidence of active TB and/or drug-resistance cases (Pooran et al., 2010). 
Until more specific and predictive biomarkers are identified, the existing interferon 
gamma release assays - QuantiFERON Gold In-Tube test in particular - can be 
chosen for detection of latent tuberculosis infection on the basis of calculated relative 
specificity in different populations, logistics, test cost, and also patients’ preferences, 
rather than on predictive suspicions alone. A similar conclusion was reached by 
Rangaka et al. (2011).  
10.4 Final recommendations 
1- Latent tuberculosis infection can be detected on the basis of history taking of 
epidemiologically-related risk factors, physical examination and chest X-ray plus 
either IGRAs. 
2- Screening should be a component of a wider intervention approach, even with 
overloads of false positive results on the health care system, thus exceeding the 
barrier of higher costs of a single test (Orlando et al., 2010). Data improvements 
to assess the frequency and duration of cost-effective screening and access of 
healthcare services would ensure a continuum of preventive care for high-risk 
groups.  
3- We introduce the new classification (or ‘Edinburgh classification’) for detection 
of latent tuberculosis cases (Table 10.1). The research results can be supported 
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through implementation of our screening methodology on large sample size of 
high-risk groups, and by which can evaluate the cost-effectiveness of the 
recommended dual-step diagnostic testing of QNF-GIT and chest radiography. 
Also subsequent periodic monitoring for suspect tuberculosis cases is 
recommended to compare the rates of sensitivity and specificity between 
different methods (Losi et al., 2011; Nienhaus et al., 2011).  This is crucial, 
before generalization of the new diagnostic guidelines. 
4- Health system problems caused the biggest barrier to migrant patients' access to 
TB care. Enhancement of financial resources and decentralization of medical 
services, especially in low income counties, is crucial and is recommended for 
the implementation of the TB control strategies (Xu et al., 2010). It is also 
essential to provide social welfare, including living subsidies, for poor migrant 
TB patients because the free treatment policy alone has little effect in reducing 
migrant patients' financial stress (Wei et al., 2009). Therefore tuberculosis 
screening programmes considering two-step diagnostics for LTBI should ensure 
medically evaluation and therapeutic completion for positive results individuals 
(Oxlade, 2007).  
5- Application of a whole-genome sequencing (WGS) for all Mycobacterium 
tuberculosis isolates and testing for gene polymorphism which might be 
associated with susceptibility to tuberculosis. Analysis should be performed for 
different high-risk group nationalities particularly for East Asian regions 
associated with multi-drug resistance strains of Mycobacterium tuberculosis 
bacilli newly discovered in Kuwait (Feng J.Y. et al., 2011; Ladefoged et al., 
2011; WHO, 2010i). DNA sequencing can identify drug susceptibility and 
genetic characterization of Mycobacterium tuberculosis, which was a recent 
finding, observed in Thuong et al., 2011, and is recommended as the secondary 
laboratory diagnostic tool for the future, worldwide. 
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Table 10.1: New classification representing categorization criteria for diagnosis of latent 
tuberculosis infection cases using a combination of four-tuberculosis diagnostic tests and score 
for latent tuberculosis infection case diagnosis  
 
CXR = chest X-ray, TST = tuberculin skin test, IGRAs = interferon gamma release assays, QFT-









Old (Standard) New 








+ - - - 2 Low 
- + - - 3 Low 
- - + - 4 Low 
- - - + 5 Low 




+ - + - 7 High 
- + + - 8 High 
+ - - + 9 High 
- + - + 10 High 
- - + + 11 Extremely High 
+ - + + 12 Extremely High 
- + + + 13 Extremely High 
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Appendix 1: Table A represents tuberculosis hospital discharges for every 1,000 population 
according to gender and nationality in Kuwait during a 26-year-period (1984-2009) (HVS, 
1984-2009 
 
MK = Kuwaiti males, FK = Kuwaiti females, TK = total Kuwaiti’s, MNK =non-Kuwaiti males, FNK = non-Kuwaiti females, TNK = total non-
Kuwaiti’s, MT = total males, FT = total females, GT = grand total (Source: ‘HEALTH, KUWAIT’ annual publications; 1984-2009   (N/A = 
data not available due to Iraqi invasion on 1990-1991, N/S = data not available due to implementation of incomplete new statistical system for 
data collectionl)  
Year MK FK TK MNK FNK TNK MT FT GT 
1984 0.30 0.22 0.26 0.70 0.47 0.62 0.58 0.35 0.49 
1985 0.23 0.24 0.23 0.75 0.50 0.65 0.57 0.38 0.48 
1986 0.21 0.20 0.20 0.61 0.39 0.52 0.47 0.30 0.40 
1987 0.23 0.18 0.20 0.49 0.37 0.45 0.40 0.28 0.35 
1988 0.26 0.27 0.27 0.41 0.22 0.34 0.38 0.23 0.32 
1989 0.21 0.23 0.22 0.35 0.26 0.31 0.32 0.25 0.29 
1990 N/A N/A N/A N/A N/A N/A N/A N/A N/A 
1991 N/A N/A N/A N/A N/A N/A N/A N/A N/A 
1992 0.19 0.14 0.17 0.33 0.22 0.29 0.27 0.18 0.23 
1993 0.20 0.18 0.19 0.37 0.36 0.37 0.31 0.26 0.29 
1994 0.15 0.08 0.12 0.36 0.34 0.36 0.29 0.20 0.26 
1995 N/S N/S N/S N/S N/S N/S N/S N/S N/S 
1996 0.21 0.20 0.20 0.35 0.32 0.34 0.31 0.26 0.29 
1997 0.26 0.16 0.21 0.34 0.34 0.34 0.32 0.26 0.29 
1998 0.19 0.18 0.18 0.31 0.30 0.30 0.27 0.24 0.26 
1999 0.21 0.11 0.16 0.28 0.30 0.29 0.26 0.21 0.24 
2000 0.09 0.08 0.09 0.06 0.11 0.08 0.07 0.10 0.08 
2001 0.08 0.08 0.08 0.06 0.09 0.07 0.07 0.08 0.07 
2002 0.08 0.07 0.08 0.06 0.12 0.08 0.06 0.10 0.08 
2003 0.08 0.07 0.07 0.06 0.09 0.07 0.06 0.08 0.07 
2004 0.07 0.06 0.06 0.07 0.11 0.08 0.07 0.08 0.07 
2005 0.21 0.14 0.18 0.21 0.29 0.24 0.21 0.22 0.22 
2006 0.18 0.11 0.14 0.22 0.30 0.25 0.21 0.21 0.21 
2007 0.14 0.11 0.12 0.19 0.26 0.21 0.17 0.20 0.18 
2008 0.13 0.08 0.10 0.18 0.26 0.21 0.17 0.19 0.17 
2009 0.12 0.09 0.11 0.24 0.35 0.28 0.21 0.24 0.22 
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Appendix 2: Table B represents tuberculosis hospital discharges for every 1,000 hospital 
discharges according to gender and nationality in Kuwait during a 26-year-period (1984-2009) 
(HVS, 1984-2009) 
 
MK = Kuwaiti males, FK = Kuwaiti females, TK = total Kuwaiti’s, MNK =non-Kuwaiti males, FNK = non-Kuwaiti females, TNK = total non-
Kuwaiti’s, MT = total males, FT = total females, GT = grand total (Source: ‘HEALTH, KUWAIT’ annual publications; 1984-2009   (N/A = 
data not available due to Iraqi invasion on 1990-1991, N/S = data not available due to implementation of incomplete new statistical system for 
data collectionl)  
Year MK FK TK MNK FNK TNK MT FT GT 
1984 4.32 1.96 2.86 10.27 2.56 5.77 8.42 2.36 4.81 
1985 3.13 2.05 2.47 8.90 2.72 5.35 7.05 2.48 4.36 
1986 2.85 1.64 2.11 7.69 2.28 4.55 6.07 2.04 3.68 
1987 2.98 1.53 2.10 6.30 2.19 3.93 5.17 1.94 3.27 
1988 2.47 1.56 1.92 6.41 1.66 3.71 5.07 1.62 3.06 
1989 2.12 1.39 1.68 5.61 2.09 3.61 4.46 1.83 2.92 
1990 N/A N/A N/A N/A N/A N/A N/A N/A N/A 
1991 N/A N/A N/A N/A N/A N/A N/A N/A N/A 
1992 2.29 1.03 1.52 6.50 2.57 4.48 4.35 1.63 2.80 
1993 2.11 1.24 1.58 6.63 2.88 4.70 4.40 1.91 3.00 
1994 1.59 0.57 0.97 6.86 2.67 4.69 4.31 1.47 2.71 
1995 N/S N/S N/S N/S N/S N/S N/S N/S N/S 
1996 N/S N/S 1.58 N/S N/S 4.12 N/S N/S 2.81 
1997 3.89 1.46 2.36 11.32 3.94 6.98 7.59 2.59 4.54 
1998 2.21 1.38 1.71 7.57 2.92 5.03 4.98 2.08 3.30 
1999 2.24 0.84 1.41 6.51 2.94 4.61 4.39 1.77 2.92 
2000 0.95 0.61 0.74 1.51 1.08 1.28 1.22 0.81 0.99 
2001 0.77 0.55 0.64 1.54 0.91 1.20 1.14 0.70 0.89 
2002 0.84 0.53 0.66 1.43 1.33 1.38 1.13 0.88 0.99 
2003 0.99 0.59 0.75 1.81 1.14 1.44 1.40 0.83 1.07 
2004 0.85 0.49 0.64 1.88 1.26 1.56 1.39 0.84 1.08 
2005 2.58 1.27 1.82 6.21 3.41 4.74 4.51 2.29 3.28 
2006 2.23 1.05 1.55 6.77 3.48 5.04 4.68 2.24 3.34 
2007 1.77 1.07 1.37 6.20 3.51 4.77 4.18 2.29 3.14 
2008 1.68 0.78 1.16 6.41 4.02 5.15 4.27 2.42 3.26 
2009 1.50 1.03 1.24 7.59 4.61 6.00 4.81 2.91 3.78 
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Appendix 3: Table C represents tuberculosis cause-specific mortality rates for every 100,000 
mid-year populations according to gender and nationality in Kuwait during a 26-year-period 
(1984-2009) (HVS, 1984-2009) 
 
MK = Kuwaiti males, FK = Kuwaiti females, TK = total Kuwaiti’s, MNK =non-Kuwaiti males, FNK = non-Kuwaiti females, TNK = total non-
Kuwaiti’s, MT = total males, FT = total females, GT = grand total (Source: ‘HEALTH, KUWAIT’ annual publications; 1984-2009   (N/A = 
data not available due to Iraqi invasion on 1990-1991, N/S = data not available due to implementation of incomplete new statistical system for 
data collectionl)  
Year MK FK TK MNK FNK TNK MT FT GT 
1984 6.48 4.19 5.32 1.21 0.78 1.06 2.82 2.36 2.63 
1985 3.52 5.51 4.52 1.74 1.02 1.46 2.36 3.11 2.69 
1986 1.69 0.28 0.98 0.30 0.72 0.46 0.79 0.52 0.67 
1987 1.36 1.62 1.49 1.01 0.46 0.79 1.13 0.99 1.07 
1988 2.97 1.55 2.28 0.35 0.88 0.56 0.97 1.09 1.02 
1989 2.86 0.75 1.83 0.11 0.34 0.20 0.76 0.47 0.64 
1990 N/A N/A N/A N/A N/A N/A N/A N/A N/A 
1991 0.33 0.00 0.17 N/A N/A N/A N/A N/A N/A 
1992 0.64 0.34 0.50 0.41 0.32 0.38 0.50 0.33 0.43 
1993 0.94 1.23 1.09 1.39 0.00 0.95 1.23 0.68 1.01 
1994 1.18 0.60 0.89 0.31 1.02 0.53 0.60 0.80 0.68 
1995 2.03 0.57 1.30 0.93 1.41 1.08 1.28 0.99 1.17 
1996 1.65 0.00 0.84 0.42 0.62 0.48 0.83 0.30 0.63 
1997 1.90 1.06 1.47 0.73 0.49 0.65 1.09 0.76 0.96 
1998 0.78 0.25 0.52 0.12 0.74 0.32 0.33 0.50 0.39 
1999 0.50 0.74 0.62 0.68 2.38 1.23 0.63 1.57 1.00 
2000 1.95 0.24 1.08 0.43 0.23 0.37 0.90 0.23 0.64 
2001 0.95 0.46 0.70 0.43 1.54 0.79 0.59 1.01 0.76 
2002 1.38 0.22 0.79 0.81 1.63 1.08 0.98 0.96 0.97 
2003 0.89 0.65 0.77 0.38 0.98 0.57 0.53 0.82 0.64 
2004 1.29 0.63 0.95 0.43 1.11 0.65 0.68 0.88 0.76 
2005 0.84 1.01 0.92 0.38 1.38 0.69 0.50 1.21 0.77 
2006 0.61 0.39 0.50 0.42 1.30 0.69 0.47 0.88 0.62 
2007 0.79 0.57 0.67 0.44 1.82 0.87 0.53 1.29 0.81 
2008 0.57 0.55 0.56 0.35 0.96 0.54 0.40 0.80 0.55 
2009 1.28 1.05 1.16 0.75 1.03 0.85 0.89 1.04 0.95 
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Appendix 4: Table D represents tuberculosis case fatality rate (TB deaths for every 100 TB 
hospital discharges) according to gender and nationality in Kuwait during a 26-year-period 
(1984-2009) (HVS, 1984-2009) 
 
MK = Kuwaiti males, FK = Kuwaiti females, TK = total Kuwaiti’s, MNK =non-Kuwaiti males, FNK = non-Kuwaiti females, TNK = total non-
Kuwaiti’s, MT = total males, FT = total females, GT = grand total (Source: ‘HEALTH, KUWAIT’ annual publications; 1984-2009   (N/A = 
data not available due to Iraqi invasion on 1990-1991, N/S = data not available due to implementation of incomplete new statistical system for 
data collectionl)  
Year MK FK TK MNK FNK TNK MT FT GT 
1984 21.43 19.44 20.59 1.74 1.66 1.72 4.87 6.72 5.41 
1985 15.19 23.17 19.25 2.33 2.05 2.25 4.17 8.30 5.55 
1986 8.00 1.43 4.83 0.50 1.83 0.88 1.68 1.71 1.69 
1987 6.02 8.96 7.33 2.04 1.23 1.78 2.82 3.49 3.05 
1988 11.27 5.63 8.45 0.84 4.10 1.66 2.56 4.66 3.21 
1989 13.56 3.28 8.33 0.32 1.30 0.64 2.40 1.86 2.20 
1990 N/A N/A N/A N/A N/A N/A N/A N/A N/A 
1991 N/A N/A N/A N/A N/A N/A N/A N/A N/A 
1992 3.39 2.38 2.97 1.25 1.49 1.32 1.83 1.83 1.83 
1993 4.62 6.78 5.65 3.79 0.00 2.60 3.99 2.56 3.47 
1994 7.69 7.14 7.50 0.84 3.03 1.48 2.07 3.94 2.64 
1995 N/A N/A N/A N/A N/A N/A N/A N/A N/A 
1996 7.79 0.00 4.08 1.19 1.92 1.40 2.73 1.15 2.18 
1997 7.22 6.45 6.92 2.14 1.44 1.91 3.45 2.99 3.29 
1998 4.23 1.45 2.86 0.39 2.50 1.06 1.21 2.12 1.54 
1999 2.35 6.52 3.82 2.40 7.81 4.23 2.39 7.47 4.13 
2000 21.62 2.86 12.50 7.14 2.13 4.85 12.90 2.44 8.00 
2001 12.50 6.06 9.23 6.67 17.50 11.00 8.70 12.33 10.30 
2002 17.14 3.13 10.45 14.04 13.33 13.68 15.22 9.78 12.50 
2003 11.76 9.68 10.77 6.45 10.64 8.26 8.33 10.26 9.20 
2004 18.18 11.11 15.00 6.25 10.34 7.97 9.73 10.59 10.10 
2005 3.92 7.14 5.23 1.79 4.71 2.89 2.36 5.42 3.54 
2006 3.37 3.51 3.42 1.88 4.40 2.79 2.21 4.18 2.94 
2007 5.71 5.26 5.51 2.40 6.95 4.18 3.04 6.56 4.46 
2008 4.48 7.32 5.56 1.94 3.65 2.65 2.39 4.23 3.14 
2009 10.94 11.11 11.02 3.12 2.99 3.06 4.23 4.35 4.28 
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Appendix 5: Questionnaire of immigrant participants 
Data Collection Sheet (Questionnaire) 
 
PhD project title: ‘The challenges of Tuberculosis Prevention through Early 




  Participant name   Date …...…./…/…/…
… 
A)- Socio-economic/Demographic Characteristics: 
Q2 Age (years) : [……….]  
Q3 Gender : Male [1] Female [2] 
Q4 Nationality : [……………...........................] 
Q5 
Place of birth 
: 




Single [1] Married [2] Widowed [3] 
Divorced/Separated 
[4] 
Q8 Ethnic origin : Asian [1] Black [2] White [3] 
Caucasian [4]  
Other [5] 
Q9 Education : 
Illiterate [1] Primary [2] Intermediate [3] Secondary [4] 
Diploma [5] University & above [6] 
Q10 Occupation (in mother country):   [ ……………………………………] 
Q11 Duration of employment experience (years) : [.…………] 
Q12  












Total number of sleeping rooms in the living 
place : 
[……….….] 
B)- Entry to the State of Kuwait: 
Q16  Date of entry to Kuwait : [……./……./…….] 
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Q17 Proposed occupation in Kuwait : [………………….] 
Q18 Did you live previously as a resident in Kuwait? Yes [1] No [2] 
Q19  If Yes, since when from last visit to Kuwait 
(year): 
[…………..…..]  
Q20 Diagnostic test(s) performed before entry to Kuwait? 
A Chest X-ray Yes [1] No [2] 
B Sputum microscopy   
C Tuberculin skin test   
D Forced cough test   
C)- Tuberculosis Disease History  
Q21 Any history of travel or working outside mother 
country of origin : 
Yes [1] if Yes, go to Q22 
No [2] if No, go to Q 24 
Q22 Which country been worked in and total duration (years)? 
Country (worked in) Duration (year) 
A   
B   
C   
D   
E   
Q23 Which country been visited/traveled to and total duration (weeks)? 
Country (travelled to) Duration (week) 
A   
B   
C   
D   
D)- Tuberculosis disease knowledge: 
Q24 Do you have access to medical/health care 
service :  
Yes [1] No [2] Unknown [3] 
Q25 What is the average duration to reach the nearest medical/health 
care service(minutes): 
[………..…] 
Q26 What is your general knowledge about tuberculosis? Correct [1] Incorrect [2] 
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Q27 What is your knowledge about common symptoms/signs of TB disease: 
Respiratory complaint Yes [1] No [2] Unknown [3] 
 A Continuous productive cough (+/- 
thick colored sputum) 
   
B Hemoptysis (bloody cough)    
Constitutional complaint Yes [1] No [2] Unknown [3] 
 C Fever (+/- shivering)    
D Night sweating (drenching fever)    
E Generalized weakness    
F Weight loss (wasted)    
G Vomiting/Diarrhoea    
H Body pains (joint/bone)    
I Other    
Example(s) of other TB complaint(s): 
[………………………………………………………..……..]            
Q28 From which of the following sources was knowledge obtained?  
Knowledge source Yes [1] No [2] 
A Family member/Relative   
B Study area (school, subject)   
C Work (peer, close contact)   
D Public shared talks   
E TV/newspaper advertisement   
F Medical campaign/health-related poster   
G Other   
Examples(s) of other knowledge source(s):         [………………………………………………….] 
Q29 Do you have history of BCG vaccination 
against TB disease: 
Yes [1] No [2] Unknown [3] 
Q30 If Yes, at which age of vaccination:            […………………………………...] 
Q31  Have you been infected or contacted with 
TB diagnosed patient? 
if No or Unknown, go to Q40 
Yes [1] No [2] Unknown [3] 
 
Q32 If Yes, TB disease was diagnosed by:  Physician [1] Other (e.g. lay person) [2] 
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Q33 What was the duration of complaints before 
TB diagnosis (years) 
[………………………………..…] 
Q34 Has anti-TB therapy been prescribed? 
Yes [1] No [2] Unknown [3] 
if No, or Unknown, go to Q40 
Q35 Compliance to prescribed anti-TB therapy? 
Anti-TB therapy course and outcome Yes [1] No [2] Unknown/Not remember [3] 
A Complete    
B Cured    
C Default    
D Failure    
E Relapse    
F Resistance (MDR/XDR)    
G DOTS follow-up    
Q36 What is the type of anti-TB therapy prescribed? 
Prescribed anti-TB therapy Yes [1] No [2] Unknown/Not remember [3] 
A Rifampicin    
B Perizanamide    
C INH    
D Ethambutol    
E Other (e.g. streptomycin)    
Q37 Have anti-TB therapeutic adverse 
effect(s) been noticed? 
if No or Unknown, go to Q40 
Yes [1] No [2] Unknown [3] 
Q38 What type of anti-TB therapy adverse effects? 
Adverse effect(s) Yes [1] No [2] 
A Fever   
B Vomiting/Diarrhea   
C Orange-red urine                  
D Yellowish skin discoloration  
E Other  




If Yes, then against which type of  
anti-TB therapy? 
[…………………………………………] 
E)- Tuberculosis-Associated Risk Factors: TB exposure 
Q40 What is the average number of daily contacts to? : 
Inside household (HH) area : […………………………...] 
Outside non-household (NHH) area : [……………..………….…] 
Q41 What is the average duration (hour) of contact to? : 
Household (HH) area : <1 [1] 2-5 [2] 6-10 [3] >10 [4] 
Non-household (NHH) area 
: 
<1 [1] 2-5 [2] 6-10 [3] >10 [4] 
Q42 Any previous history of 
contact with TB 
diagnosed/infected patient:   
if Yes, go to Q43 
 if No or Unknown, go to 
Q46 
Yes[1] No [2] Unknown [3] 
Q43 What is the type of relationship to TB diagnosed patient? : 
Relationship Yes [1] No [2] 
A Close contact/indoor 









C Other   
Examples of relationship(s) : [……….…………..] 
Q44 What is the average number of daily contacts to TB patient in? : 
Inside household (HH) area : […….…………..…] 
Outside non-household (NHH) area : [………...…………] 
Q45 What is the average duration (hours) of contact TB patient in? 
Household (HH) area : <1 [1] 2-5 [2] 6-10 [3] >10 [4] 
Nonhousehold (NHH) area : <1 [1] 2-5 [2] 6-10 [3] >10 [4] 
Q46 What is the common route of outdoor transport(s)? : 
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Transport route Yes [1] No [2] 
A Walking   
B Bicycle/Tricycle/Motorcycle   
C Microbus/Bus/Train   
D Car   
E Other   
Examples(s) of other route(s) (e.g. airplane, 
ship) : 
  [……………………………………….…….] 
G)- TB exposure place/living area in Kuwait: 
Q51  What is the total number of individual(s) living in the same room:  
[……………………….....]  
Q52 What is the general condition of sleeping area/place? : 
Presence of sleeping closed-room with good ventilation  [1] 
Presence of sleeping closed-room without good ventilation  [2] 
Presence of outdoor exposure area  [3] 
G)- TB exposure place/living area in Kuwait: 
Q51  What is the total number of individual(s) living in the same room:  
[……………………….....] 
Q52 What is the general condition of sleeping area/place? : 
Presence of sleeping closed-room with good ventilation  [1] 
Presence of sleeping closed-room without good ventilation  [2] 
Presence of outdoor exposure area  [3] 
H)- History of Smoking & Smoking Behaviors: 
Q53 Are you a : Current smoker [1] Ex-smoker [2] 
Never smoke [3] 
if Never smoke, go to Q60 
Q54 What is the starting age of 
smoking (years) ? : 
[………………………………………………..…...] 
Q55 If ex-smoker: What was the age of 
stop smoking (years)?: 
[…………………………………………………….] 




3-5 [3]  
6-10 [ 4]   
>10 [5] 
Q57 What type of smoking habit preferred? : 
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Smoking type Yes [1]                    No [2] 
A Cigarette (manufactured)  
B Pedis (manual)  
C Tambaco  
D Birri  
E Hukka (hubble bubble)  
F Shisha/Qedo  
G Cigar  
H Pipe  
I Other  
Example(s) of other smoking habit(s) : […………………………………………………….] 
Q58 What is the frequency 
consumption of cigarette (number 
of cigarettes/day) : 
<5 [1] 5-10 [2] 10-20 [3] >20 [4] 
Q59 What is the frequency 
consumption of other preferred 
smoke(s)/day: 
<5 [1] 5-10 [2] 10-20 [3] >20 [4] 
I)- History of infectious/non-infectious(chronic) disorder(s): 
Q60 History of catching the following disorder(s) and total duration of complaint(s) since 
diagnosis (years)?:  
 Disorder Yes [1] No [2} Unknown [3] Duration (year) 
A Skin allergy     
B Malnutrition     
C Malaria     
D Asthma     
E Hepatitis     
F HIV/AIDS     
G Silicosis     
H Alcoholism     




    
K Blood disorder     
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L Other     
Example of other disorder(s) :  […………………………………………………….………...] 
Q61 Any previous history of surgical 
procedure?: 
Yes [1] No [2] 
Q62  If Yes, what type of surgical 
procedure? : 
[…………………………………………………] 
Q63 Any history of taking 
medical/pharmaceutical drugs: 
Yes [1] No [2] 
Q64 If Yes, what type of 
medical/pharmaceutical drugs?: 
Corticosteroids [1] 
Anti-allergic steroids [2] 
Immunosuppressive(s) [3] 
Herbal medicine [4] 
Other (5) [………………………………………]  
Researcher:  Dr. Adel Mohanna AL-Harbie 
                     PhD (Resrarch-Infectious Diseases) 




Appendix 6: Chest X-ray result sheet of immigrant participant  
Chest X-Ray Recording Sheet 
PhD project title: ‘The Challenges of Tuberculosis Prevention through Early Detection 
of Latent Tuberculosis Infection in New Immigrants to the State of Kuwait’ 
A) - Parenchyma abnormality 
A.1 Abnormal changes  
Finding RL Size (mm) Number LL Size (mm) Number 
Cavity       
Fibrosis       
Infiltration       
Opacity/ consolidation       
 
A.2 Nodule abnormality:                Nodule number: RL (   )        LL (   )                    
                                                          Size (mm):           <5 (   )        >5 (   )  
Shape:  Round (  )    Irregular (  )    Homogeneous (  )    Heterogeneous (  ) 
A.3 Cavity Pathology 
Finding RL LL 
Cavity (granuloma)   
Calcified   
Non-calcified   
Number   
 
A.4 Other CXR changes 
Finding RL LL 
Bronchectasis   
Honeycomb fibrosis   
Collapse   
Lobar volume loss   
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B) - Pleural abnormality 
Finding RL LL 
Thickening/ scar   
Apical caps   
Effusion   
Obscured costo-phrenic angle   
 
C) - Central structure abnormality 
Finding RL LL 
Tracheal deviation   
Hilar elevation   
Mediastinal shift   
Pericardial effusion (calcified)   
Bone abnormality (vertebral column)   
 
D) - Lymphadenopathy abnormality 
Finding Hilum Mediastinum Calcified Non-calcified Number 
RL      
LL      
 
Scoring system (chest X-ray score reading) 
CXR result Score Final score assessment 
Normal (no pathology) I  
Pathology not consistent with TB II  
Pathology consistent (significant) for TB III  
Pathology highly consistent (highly significant) for TB IV  




Appendix 7: Tuberculin skin test sheet of immigrant participant  
Tuberculin Skin Test Recording Sheet 
PhD project title: ‘The Challenges of Tuberculosis Prevention through Early 
Detection of Latent Tuberculosis Infection in New Immigrants to the State of 
Kuwait’ 
Date of TST performance: […./…./….]  Date of TST result reading: […./…./….] 
 
TST cutaneous induration size (mm) = […………………]  







Grade Score level 
< 5  1 Negative 
5-<10  2 Borderline 
10-15  3 Positive 
>15  4 highly Positive 
 
TST adverse reaction(s): Negative […..]   -    Positive […..]:  
[Hematoma ( )  Arm swelling ( )   Fever ( )   Bleeding ( )   Abscess/discharge ( )   
Allergic itching ( )  Vesicular rash ( )      Bullae ( )   Skin ulcer ( )   Other (  )]   
 
Body weight (Kg): [.…]   Body height (M): [….]   Body mass index: [….] 
 
BCG vaccination scar:  Positive [……]       Negative [……]   
Nurse:                                                                                              Signature: 
Researcher: Dr. Adel Mohanna AL-Harbie                                    Signature:               
PhD-Research-Infectious Diseases; University of Edinburgh-UK 
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Appendix 8: QuantiFERON Gold In-Tube test result sheet of immigrant participant  
 
QuantiFERON Gold In-Tube test Result Sheet 
 
PhD project title: ‘The Challenges of Tuberculosis Prevention through Early 
Detection of Latent Tuberculosis Infection in New Immigrants to the State of 
Kuwait’  
 
Subject ID. number:  
Date of performance:   
 
Interferon gamma level (INF-γ) (IU/ml):  […………….] 
 
 







Laboratory technician:                                                         Signature: 
 
 
Researcher: Dr. Adel AL-Harbie                                         Signature: 
                    PhD (Research-Infectious Diseases)  
                    University of Edinburgh-UK  
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Appendix 9: T-SPOT .TB test result sheet of immigrant participant  
T-SPOT .TB Test Result Sheet 
 
PhD project title: ‘The Challenges of Tuberculosis Prevention through Early 
Detection of Latent Tuberculosis Infection in New Immigrants to the State of 
Kuwait’ 
 
Subject ID. name/serial number:  
Date of T-SPOT .TB  test performance:   
 
Panel A (ESAT-6) Response: Spot number [……..] 
Panel B (CFP-10) Response: Spot number [……...] 
Positive Control Panel, ‘Mitogen’:  Spot Number [………] 
Negative Control Panel, ‘Nil’: Spot Number [………] 
 
Test Response: Reactive [……]     Nonreactive […...]   Indeterminate [……] 
 
T-SPOT .TB test Result: Positive […..]     Negative […..]     Indeterminate […..]   
  




Laboratory technician:                                                                  Signature:                                    
Researcher:   Dr. Adel Mohanna AL-Harbie                               Signature: 
                      PhD (Research-Infectious Diseases)  




Appendix 10: Immigrant informed consent (English) 
Adoption agreement to participate in the research study  
Informed Consent 
 
PhD project title: ‘The Challenges of Tuberculosis Prevention through Early 
Detection of Latent Tuberculosis Infection in New Immigrants to the State of 
Kuwait' 
This study aims to examine accuracy of new diagnostic tests in detecting latent 
tuberculosis infection which is part of PHD research study in medicine 
(Infectious Diseases) for assessment in diagnosing inactive form of tuberculosis 
and you are free to participate in the study. If you agree, please give accurate 
answers to questions of the annexed questionnaire under supervision of the 
researcher Dr. Adel Mohanna AL-Harbie (department of Public Health).  
 
The research also aims to measure the body weight, body height and taking blood 
sample only 11 ml for tests, performing tuberculin skin test and returning within 
2-3 days checking for skin test result provided not having any previous skin 
allergy in addition to shoulder skin examination for previous BCG vaccination 
scar. 
 
Researcher undertakes to preserve the privacy of information and deal with it 
with utmost secrecy, declined to name or personal use only participant and within 
the framework of research and in accordance with the ethics of medical research.  
 
You are free to agree or not agree to participate in this study with also complete 
freedom to refuse to answer any question from the questionnaire in the event of 
approval.The health services will still be fully provided for you even in case of 
disagreements to participate in the study.  
For extra information you are most welcome to call Dr. Adel Mohanna AL-
Harbie mobile: (00965) 66011406  
Are you OK to participate in the study?    Agree:                                 Signature:    
We thank your cooperation with us.                   
Researcher:  Dr. Adel Mohanna AL-Harbie 
                    PhD (Research–Infectious Diseases)  
                    University of Edinburg-UK 
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Appendix 11: Immigrant informed consent (Arabic)  
 اقرار الموافقة على المشاركة فى دراسة البحث
(Informed consent) 
 
عنوان  الدراسة "االكتشاف المبكر لعدوى مرض الدرن الكامن ومنع انتشاره باستخدام الطرق 
"التشخيصية  وتقييمها على الوافدين الجدد فى دولة الكويت  
مهنا الحربى من إدارة الصحة العامة  وهى جزء من رسالة الدكتوراة في الطب للباحث الدكتور عادل 
وتهدف الدراسة الى الوقاية من مرض الدرن عن طريق تقييم الفحوصات الجديدة واستخدامها لتشخيص 
   مرض الدرن الكامن
ولك كامل الحرية في أن تقررا لمشاركة ضمن هذه الدراسة والمساهمة بحرية تامة وبإجابات دقيقة على  
ق مع الباحث كما سيتم عمل الفحوصات والمتضمنة على قياس الطول والوزن واخذ أسئلة االستبيان المرف
ملم اجمالى لكال الفحصين المطلوب دراستهما وسيتم  عمل فحص الجلد الدرنى 11عينة دم بحجم     
tuberculin) (skin test فى منطقة العضد وضرورة الرجوع للتاكد من نتيجة   3-1فحص الجلد فى مدة  
اثر سابق لتطعيم  الدرن فى منطقة الكتف أو الفخذ للتعرف على مدى وجود ندبات  ا فحص وجودايام وايض
. بسبب اخذ تطعيم سابق ضد مرض الدرن  
وفى حالة موافقتك فان نتائج فحوصات البحث لن تعرضك ألى مخاطر ولن تعيق من دخولك للبالد ومن 
.ظ على االجابة على بعض االسئلةحقك االنسحاب فى اى مرحلة من المراحل ومن حقك التحف  
.وفى حالة عدم الموافقة فان ذلك لن يؤثر على الرعاية المقدمة لك  
ويتعهد الباحث بالمحافظة على خصوصية المعلومات والتعامل معها بسرية تامة مع عدم اإلفصاح عن اسم 
. طبيةاو شخصية المشارك واستخدامها فقط ضمن إطار البحث وفقا ألخالقيات البحوث ال  
وأيضا الحرية التامة لرفض  ولكم  كامل الحرية في الموافقة او عدم الموافقة على المشاركة فى هذه الدراسة
   .اإلجابة على أي سؤال من أسئلة االستبيان
بالباحث  واذا رغبت فى الحصول على اى معلومات فال تتردد فى االتصال  
: نقال  66011406 (00965)     
على المشاركة فى الدراسة؟  فهل انت موافق    
:              موافق   :                              التوقيع           
,,,,,نشكر لك تعاونك معنا    
 الباحث :  د/ عادل مهنا الحربي                
(  االمراض المعدية -رسالة دكتوراة)            





Appendix 12: Researcher adoption pledge (English)  
Researcher adoption pledge 
 
The title of research study for a doctorate in the Epidemiology of Infectious 
Diseases – Department of Public Health (Ministry of Health) is;  
 
PhD project title: ‘The Challenges of Tuberculosis Prevention through Early 
Detection of Latent Tuberculosis Infection in new immigrants to the State of 
Kuwait’ 
 
 and to assess tuberculosis epidemiology. 
 
 
I promise to maintain complete confidentiality of information and not circulated 
outside the framework of scientific research in accordance with the ethics of 





Researcher:   Dr. Adel Mohanna AL-Harbie                               Signature:  
                      PhD (Research-Infectious diseases) 




Appendix 13: Researcher adoption pledge (Arabic) 
 اقرار تعهد
قسم الصحة -يهدف عنوان بحث دراسة الدكتوراة فى االمراض الوبائية والمعدية     
 ' العامة  الى  فائدة منع انتشار عدوى مرض الدرن عن طريق االكتشاف المبكر   
 لمرض الدرن الكامن باستخدام الطرق التشخيصية  وتقييمها على الوافدين الجدد
فى دولة الكويت   
 
PhD project title: ‘The Challenges of Tuberculosis Prevention through Early 
Detection of Latent Tuberculosis Infection in New Immigrants to the State of 
Kuwait’ 
 
  ودراسة حالة مرض الدرن فى دولة الكويت كما اتعهد بالمحافظة التامة على
ار البحث العلمى  وذلك لضمان حقوقسرية المعلومات وعدم تداولها خارج اط  
 االفراد المشاركين فى الدراسة وفقا الخالقيات البحوث الطبية
 
 اسم الباحث:  د/ عادل مهنا الحربى
 موضوع البحث: رسالة دكتوراة - االمراض المعدية
  التوقيع:
 
 
